# HBOT Research

> Advancing HBOT Knowledge and Research

> Admin Email: p.giorkas@gmail.com


## Posts

### Phthalates in HBOT: A Complete Guide to Understanding the Risks and Choosing a Safe Chamber

Hyperbaric oxygen therapy delivers pure oxygen at increased atmospheric pressure. This treatment may accelerate wound healing, reduce inflammation, and support recovery from various conditions according to medical literature [1]. 



Yet many soft-sided chambers potentially contain materials that release chemicals into the very air you breathe during treatment.



The concern centers on phthalates, which are plastic softeners that make vinyl and PVC flexible. These chemicals can off-gas into your breathing space, particularly under the unique conditions inside a hyperbaric chamber. 



This guide examines the available evidence about phthalate exposure in HBOT chambers. You'll learn which materials may pose risks, how to identify safer alternatives, and what questions to ask manufacturers before purchasing or using a chamber.



What Exactly Are Phthalates?



Phthalates are chemical compounds typically added to plastics to increase flexibility and durability. Manufacturers commonly use them in polyvinyl chloride (PVC) products, from shower curtains to medical tubing according to toxicology research [2]. 



You likely encounter phthalates daily in vinyl flooring, personal care products, food packaging, and children's toys.



These chemicals don't bond permanently to plastic. They can migrate out over time through a process called off-gassing. 



CDC research has found phthalate metabolites (breakdown products from phthalates after your body processes them) in the urine of most Americans tested, suggesting widespread exposure [3].



The concern isn't just presence but concentration. Inside a sealed hyperbaric chamber, you breathe concentrated air for extended periods. Any chemicals released from the chamber walls may accumulate in this enclosed space.



Phthalates appear in many everyday products, from flooring to personal care items.



Why HBOT and Phthalates Don't Mix?



Off-gassing occurs when volatile organic compounds (VOCs), which are chemicals that easily become vapors at room temperature, escape from solid materials. 



Temperature, pressure, and oxygen concentration typically affect this release rate.



HBOT chambers may create conditions for accelerated off-gassing. The increased pressure, often reported as 1.3 to 1.5 ATA (atmospheres absolute, a measurement where 1 ATA equals normal sea-level pressure) in soft chambers, could force molecules to move more rapidly. 



Pure oxygen environments may oxidize materials, meaning the oxygen potentially breaks down the plastic faster than normal air would. 



Sessions typically lasting 60 to 90 minutes provide extended exposure time according to standard protocols [4].



"But doesn't the chamber have ventilation?"  - You're right to ask. 



Most soft chambers continuously cycle air through the system. However, if the chamber walls themselves release chemicals, fresh oxygen flow won't eliminate the source of contamination.



EPA research on indoor air quality indicates that new plastic products often release the highest levels of VOCs during their first months of use [5]. 



This "new plastic smell" typically signals active off-gassing. In a hyperbaric environment, you're potentially breathing these compounds under pressure, which may increase absorption into your bloodstream.



Increased pressure inside HBOT chambers may accelerate the release of VOCs from certain materials.



Health Risks of Phthalate Exposure



Phthalates may function as endocrine disruptors, chemicals that can interfere with your hormone systems. 



Research from environmental health organizations suggests links between phthalate exposure and reproductive issues, developmental problems in children, and metabolic disruption [6].



Studies in peer-reviewed journals have reported associations between phthalate exposure and decreased testosterone levels in adult men [7]. 



Additional research has suggested connections between prenatal phthalate exposure and behavioral changes in children [8].



The risk potentially compounds with repeated exposure. If you use HBOT daily or several times weekly, you may face cumulative chemical exposure. Children and pregnant women typically show particular vulnerability to endocrine disruptors according to pediatric research [9].



(Ed. note: The EPA has classified several phthalates as probable human carcinogens, though specific studies on cancer risk from HBOT chamber exposure appear limited.)



Research suggests phthalates may affect multiple body systems as endocrine disruptors.



Hard Shell vs. Soft Shell Chambers



Hard shell chambers typically use steel or aluminum frames with acrylic viewing ports. These materials generally don't contain phthalates. 



Medical facilities usually employ hard chambers that operate at higher pressures (often 2.0 to 3.0 ATA) for FDA-approved treatments.



Soft shell chambers consist of flexible materials, commonly polyurethane or PVC. The flexibility that makes them portable and affordable often comes from plasticizers. Not all soft materials contain phthalates, but many may, particularly those using PVC construction.



The price difference reflects more than just materials. 



Hard chambers may cost approximately $30,000 to $100,000 based on market surveys. Soft chambers typically range from approximately $8,000 to $20,000. 



For home users, soft chambers often represent the only practical option. This makes material safety even MORE CRITICAL.



Hard shell and soft shell chambers differ significantly in construction materials and typical use settings.



Not All Soft Chambers Are Created Equal



What to Avoid




PVC-based chambers may pose the highest risk for phthalate exposure. Look for terms like "vinyl," "PVC," or "polyvinyl chloride" in product descriptions. Chambers imported from manufacturers without clear material specifications may warrant EXTREME CAUTION.




What to Look For




Phthalate-Free Certifications: Legitimate manufacturers often test their products through independent laboratories. They may display certifications like REACH compliance (Registration, Evaluation, Authorisation and Restriction of Chemicals, a European chemical safety standard) or CPSIA compliance (Consumer Product Safety Improvement Act, a U.S. consumer product safety regulation) [10]. Other Certifications may include:







CE and ISO 13485:2016 Certification — Ensures quality management systems and medical device compliance​



EN14931 (PVHO Standard) — The European Standard for pressure vessels for human occupancy and hyperbaric chambers, which specifically addresses material safety and fire prevention requirements​



FDA 510(k) Clearance — Applies to certain U.S. manufacturers like OxyHealth, Summit to Sea, and AHA Hyperbarics​



Biocompatibility Testing — Materials including TPU and PET must pass ISO 10993 standards and USP Class VI testing to ensure they are non-cytotoxic and do not leach harmful substances​







Medical-Grade Materials: This designation typically means materials meet biocompatibility standards, tests that generally ensure materials are safe for prolonged human contact. FDA guidelines suggest medical-grade plastics undergo USP Class VI testing, which evaluates biological reactivity by testing materials with living tissue cultures and monitoring for potential toxic responses [11]. Thermoplastic polyurethane (TPU) without phthalate plasticizers may offer a safer alternative to PVC.





Third-Party Testing Results: Reputable companies often provide VOC emission test results. These tests typically measure actual off-gassing rates under standard conditions. Consider requesting these documents before purchasing.





Manufacturer Transparency: Companies confident in their materials usually discuss chemical composition openly. They typically answer specific questions about plasticizers, provide material safety data sheets, and explain their testing protocols.




"Why should I trust certifications?" Good question. 



Third-party certifications generally require independent laboratory verification. Companies typically invest thousands of dollars for these tests. Fake certifications risk legal action and business closure. Consider verifying certification numbers directly with the certifying body's website.





Questions to Ask Your HBOT Provider or Chamber Manufacturer



Contact manufacturers directly with these specific questions:




"What exact materials compose your chamber shell?"



"Do you use PVC or vinyl anywhere in the chamber construction?"



"Can you provide certification that your chambers are phthalate-free?"



"What third-party testing have you conducted for VOC emissions?"



"Do you have material safety data sheets available for review?"



"How do you recommend minimizing any potential off-gassing?"



"What is your warranty policy if testing reveals chemical emissions?"




Document their responses. Vague answers or reluctance to provide documentation may signal potential problems.





Prepare specific questions about materials and certifications before purchasing.



Red Flags to Watch Out For When Buying a Home Chamber



Several warning signs may indicate potentially unsafe products:




Suspiciously Low Prices: Chambers priced significantly below market average often cut corners on materials. Quality non-toxic materials typically cost more to manufacture.





Missing Material Information: Legitimate companies usually display material specifications prominently. Websites lacking this basic information may raise concerns.





No Customer Support: Test the company's responsiveness before purchasing. Call or email with questions about materials. No response or evasive answers could indicate problems.





Generic Product Descriptions: Beware listings that use stock photos or generic descriptions without specific model information.





No Certifications or Testing: Reputable manufacturers typically invest in safety testing and certification. Their absence may suggest cost-cutting at your health's expense.




Use this checklist to evaluate chamber materials before purchasing.



Recommended Vendors for Phthalate-Free HBOT Chambers



Finding safe chambers requires extensive research. Fortunately, we've done the research for you.. Here are Hyperbaric Oxygen Therapy chamber manufacturers that manufacture Phthalate-Free HBOT Chambers.



Important Disclaimer: Manufacturing processes and materials can change. Always verify current specifications, request independent test results, and confirm material composition for your specific model before purchasing. Research multiple options and compare documentation carefully.



Top-Tier Manufacturers with Phthalate-Free Certification



1. Oxygen Health Systems



Oxygen Health Systems represents a leading option for phthalate-free chambers. Their Hyperbaric Oxygen Soft Chambers (available in 32-inch models at 1.3 ATA and 1.5 ATA) are explicitly certified phthalate-free with no off-gassing. 



Screenshot from Oxygen Health System's website.



The company, established in 2016 with over 120 years of combined engineering and manufacturing experience, uses a 44-ounce triple-layered design featuring German-sourced PET polyester with TPU material. 



Their chambers are designed for single-person operation without obtrusive straps and include upgraded DeVilbiss FDA-approved 10 LPM oxygen generators producing 95-96% oxygen purity. 



These systems feature dual-action air conditioning, redundant pressure-regulating valves, and continuous airflow monitoring.​



2. AHA Hyperbarics



AHA Hyperbarics (Vienna, Austria) represents another premium manufacturer. Their AHA Fit hyperbaric chambers and the comprehensive AHA Home System are manufactured without toxic gluing techniques and use heat-welded high-frequency technology. 



Screenshot from AHA Hyperbarics certificates page.



The materials are oxygen-proof and have been tested for oxygen compatibility. AHA Hyperbarics holds ISO EN 13485:2016 certification (exceptional production quality), EC Certificate (CE 0123) for safety and efficiency, and is the only inflatable system meeting the rigorous PVHO EN 14931:2006 standards equivalent to hard chambers. 



Their systems are FDA-approved for U.S. distribution.​



3. Newtowne Hyperbarics



Newtowne Hyperbarics has manufactured hyperbaric chambers for nearly 20 years, producing chambers from hypoallergenic, medical-grade materials including 46-ounce heavy-duty, double-laminated ballistic-grade nylon. 



The company's 100% American-built chambers feature hypoallergenic construction and come with a standard two-year warranty. Available models range from 27-inch compact chambers to 40-inch multiplace units.​



4. OXYREVO



OXYREVO manufactures soft hyperbaric chambers using medical-grade thermoplastic polyurethane (TPU) material that is both safe and highly hygienic. 



Screenshot from Oxyrevo Website



The company emphasizes non-toxic construction by using high-frequency welding technology rather than toxic glues, producing chambers that are pollution-free and odor-free. Their Forward90 sitting-type chamber represents an innovative design allowing users to sit or recline during therapy.​



5. Summit to Sea 



Summit to Sea represents an FDA-cleared manufacturer with over 30 years of Class II chamber manufacturing experience. 



Their hyperbaric chambers are made in the USA and include multiple models from the entry-level Shallow Dive ($7,995) to professional-grade options. 



The company emphasizes safety and has implemented redundant compressors for added security.​



The Role of the FDA in HBOT Chamber Safety



The FDA typically regulates hyperbaric chambers as Class II medical devices when marketed for medical use, though classifications may vary [12]. 



This classification generally requires manufacturers to demonstrate "substantial equivalence" to existing approved devices. However, FDA clearance often focuses on therapeutic effectiveness and basic safety, not necessarily comprehensive chemical emission testing.



FDA approval doesn't guarantee phthalate-free construction. The agency primarily evaluates whether chambers maintain proper pressure, deliver appropriate oxygen concentration, and meet electrical safety standards. Material composition typically falls under general biocompatibility requirements, which may not specifically address phthalate content.



You should advocate for your own chemical safety beyond regulatory minimums. Regulatory approval typically provides a baseline, not complete assurance of non-toxic materials.



(Ed. note: Some chambers sold for "wellness" or "fitness" purposes may not undergo FDA review at all, potentially making material verification even more critical.)



Frequently Asked Questions




Does the "new smell" of a chamber mean it's off-gassing?
 That plastic smell typically indicates active VOC release. New chambers often off-gas most intensively during initial use periods. Some manufacturers may recommend "airing out" new chambers for 24-48 hours before first use. Better option: consider choosing chambers without that smell from the start.




Can I test the air quality in my own HBOT chamber?
You can purchase VOC meters that measure total volatile organic compounds in parts per million. Place the meter inside your chamber during a typical session (without you inside). While specific safe thresholds for HBOT chambers haven't been definitively established, general indoor air quality guidelines suggest keeping VOC levels as low as possible according to environmental health research [13].




Are there other brands known for being phthalate-free? 
Several manufacturers advertise phthalate-free construction. Always verify current specifications, as formulations may change. Request written confirmation of phthalate-free materials for your specific model.




How long does a chamber off-gas for?
 Off-gassing rates typically decrease over time but may never completely stop with certain materials like PVC. Based on general plastic off-gassing patterns, peak emissions often occur during initial months of use. Temperature and use frequency may affect duration. Phthalate-free materials like medical-grade TPU typically show minimal off-gassing from the start.





Making an Informed and Safe HBOT Choice



The concern about phthalates in HBOT chambers appears legitimate but manageable. You don't necessarily need to avoid hyperbaric therapy. You need to choose equipment carefully.



Safe chambers likely exist at various price points. Manufacturers who prioritize health typically use non-toxic materials and provide transparency. Your job involves asking direct questions, requesting documentation, and refusing to compromise on safety.



"What if I already bought a chamber and I'm worried?" 



First, identify your chamber's materials. Contact the manufacturer for documentation. If they used PVC, consider professional VOC testing. You might also increase ventilation time between sessions and ensure good airflow in your treatment space.



The solution starts with awareness. Now you understand what phthalates are, why they may matter in HBOT, and how to identify potentially safer alternatives. Use this knowledge to protect yourself and your family.



Take control of your health journey. Demand better from manufacturers. Choose chambers that support your healing without potentially introducing new risks. Your health deserves nothing less than complete safety.





References




[1]. Undersea and Hyperbaric Medical Society (UHMS) - Research on HBOT Indications and Applications



[2]. Clinical Research on HBOT Mechanisms and Protocols - https://www.mdpi.com/1648-9144/57/9/864



[3]. HBOT Pressure Standards and Protocols - Guidelines to the Practice of Hyperbaric Medicine in Canada" with standardized pressure protocols (1.5-2.8 ATA)



[4]. FDA Approval and Safety Guidelines - FDA Consumer Information on Hyperbaric Oxygen Therapy



[5]. Equipment Standards and Medical Device Regulations - ASME Standards for Principles of Safety and Performance for Medical Hyperbaric Chambers



[6]. Phthalate Exposure Assessment and Biomonitoring - "Comprehensive review of phthalate exposure: Health effects and biomonitoring methods" (2025)



[7]. Phthalates and Endocrine Disruption - Endocrine disruption and male reproductive disorders: unanswered questions" from Human Reproduction (2024)



[8]. Prenatal Phthalate Exposure and Child Development - "Preconception Phthalate Exposure and Women's Reproductive Health" from Environmental Health Perspectives" (2023)



[9]. Female Reproductive Health and Phthalate Exposure - "Center for Science in the Public Interest: "Phthalates linked to lower fertility in men and women" (2024)



[10]. Male Reproductive Health and Phthalate Exposure - "Recent Updates on the Effect of Endocrine Disruptors on Male Reproductive Functions" (2022)



[11]. Phthalate Regulatory Information - "EU Expands Restriction of Phthalates Under REACH" (2019)



[12]. Centers for Disease Control and Prevention - Biomonitoring Data

### HBOT Boosts Oocyte Yield in Poor Ovarian Responders

Hyperbaric oxygen therapy significantly increased the number of oocytes retrieved in patients with poor ovarian response.



The quality of embryos also showed improvement following the therapy.



A specific range of four to seven sessions of hyperbaric oxygen therapy was identified as most effective.



The study involved 41 women between the ages of 20 and 45.



No further benefit was observed beyond eight sessions of the treatment.




A pre-post cohort study has indicated that Hyperbaric Oxygen Therapy (HBOT) can improve the number of retrieved oocytes and the quality of embryos in patients classified as poor ovarian responders. 



The research, titled "Hyperbaric oxygen therapy improves oocyte yield and embryo quality in poor ovarian responders: a pre-post cohort study," evaluated the effects of HBOT on women who have a reduced response to ovarian stimulation. 



The findings suggest that a specific number of HBOT sessions could be beneficial for this group of patients.



Study Details and Findings



The study included 41 women, aged between 20 and 45, who were diagnosed with Poor Ovarian Response (POR). 



This diagnosis was based on the Bologna criteria. 



The research was structured as a pre-post cohort study, where the outcomes of ovarian stimulation and embryological results were compared before and after the administration of HBOT.



The results showed a notable increase in the number of oocytes retrieved after the therapy. The number of pre-ovulatory follicles went up from an average of 2.07 to 3.00, and the retrieved oocytes increased from 2.27 to 3.63. 



Additionally, the study reported significant increases in the follicle output rate (FORT) and the follicle-to-oocyte index (FOI).



Optimal Treatment Regimen



A key finding from the research was the identification of an optimal number of HBOT sessions. The study found a nonlinear relationship between the number of sessions and the oocyte count. 



The number of oocytes increased significantly after two sessions and reached a plateau between four and seven sessions. 



The researchers observed no additional increase in oocyte numbers with more than eight sessions. 



Based on these findings, the study concludes, “Combining the controlled ovarian stimulation process with 4–7 sessions of HBOT could improve oocyte number and embryo quality in POR patients.”



Implications of the Research



Poor ovarian response presents a challenge in assisted reproduction, often leading to low oocyte yields and poor embryo quality. 



This study suggests that HBOT could be a useful complementary therapy for these patients. By improving both the quantity of oocytes and the quality of embryos, this therapy may offer a new approach for individuals undergoing fertility treatments. 



The research was conducted by a team from the Medical Center for Human Reproduction and the Department of Hyperbaric Oxygen at Beijing Chao-Yang Hospital, Capital Medical University.







Source



Li, Y., Wang, Y., Li, L. et al. (2025). Hyperbaric oxygen therapy improves oocyte yield and embryo quality in poor ovarian responders: a pre-post cohort study. Reproductive Biology and Endocrinology, 23(1). https://doi.org/10.1186/s12958-025-01475-z

### Hyperbaric Oxygen Therapy Shows Promise in Reducing Inflammation for Rare Autoimmune Disease

Hyperbaric oxygen therapy reduced inflammatory markers NLR and PLR by 19% and 18% respectively within four weeks in neuromyelitis optica patients.



Patients with higher baseline inflammation (NLR ≥ 3) experienced the most significant benefits, with a 56% reduction in inflammatory markers.



The treatment increased lymphocyte counts by 32%, suggesting improved immune system balance without requiring additional immunosuppressive medications.



HBOT proved safe with only mild ear discomfort in 11% of patients and no serious adverse effects during the study period.



The findings suggest HBOT could serve as an affordable adjunct therapy for managing this rare autoimmune condition that affects the optic nerves and spinal cord.




Researchers from Liuzhou Workers' Hospital in China have identified a potential breakthrough in treating neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerves and spinal cord. Their retrospective study, published in Frontiers in Neurology, demonstrates that hyperbaric oxygen therapy significantly reduces systemic inflammation in NMOSD patients, particularly those with higher baseline inflammatory burden.



The study tracked 36 patients with NMOSD over four weeks. Half received standard immunosuppressive treatment alone, while the other half received 12 sessions of hyperbaric oxygen therapy in addition to their regular medications. The results showed marked differences in inflammatory markers between the two groups, suggesting a new avenue for managing this debilitating condition.



Understanding NMOSD and Current Treatment Challenges



NMOSD affects approximately 0.5 to 4 per 100,000 people globally, with more than 80% of patients being female. The condition occurs when the immune system produces aquaporin-4 (AQP4) antibodies that attack the protective covering of nerve fibers in the optic nerves and spinal cord. This can rapidly lead to severe visual impairment and motor disabilities.



Current treatment protocols rely heavily on glucocorticoid pulse therapy and long-term immunosuppressive agents such as rituximab, mycophenolate mofetil, and azathioprine. While these medications help control relapses, prolonged use often brings side effects including osteoporosis, infections, and metabolic disorders. Some patients respond poorly to traditional regimens.



Newer targeted biologic agents like eculizumab, inilizumab, and satralizumab can significantly reduce recurrence rates, but their high cost and potential infection risks limit widespread accessibility. The research team set out to explore whether hyperbaric oxygen therapy, a more affordable and potentially safer option, could complement existing treatments.



How the Study Worked



The single-center retrospective cohort study enrolled patients diagnosed with NMOSD between January 2022 and December 2024. All participants had been receiving stable immunosuppressive therapy for at least eight weeks and were in remission with no acute attacks for three months before enrollment.



Participants in the treatment group underwent hyperbaric oxygen therapy using a medical chamber pressurized to 2.0 atmospheres absolute (ATA). Each session lasted 105 minutes total: 20 minutes for pressurization, 65 minutes at target pressure (including two 30-minute oxygen inhalation periods with a 5-minute break), and 20 minutes for decompression. The protocol consisted of 12 sessions administered once daily.



Researchers measured key inflammatory markers before and after the treatment period. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) served as the primary indicators of systemic inflammation. Previous research has established that elevated NLR and PLR levels correlate with acute activity, relapse risk, and poor functional outcomes in NMOSD patients.



Significant Reductions in Inflammatory Markers



After four weeks, the hyperbaric oxygen group showed substantially lower inflammation levels compared to the control group. The adjusted mean NLR in the treatment group measured 2.20 versus 4.95 in the control group, a difference of 2.75 points. The PLR also decreased significantly, from 220.30 in the control group to 170.10 in the treatment group, a reduction of 50.20 points.



Within the treatment group specifically, the median NLR decreased from 2.74 at baseline to 2.22 after therapy, representing a 19% reduction. The PLR dropped from 207.04 to 169.83, an 18% decrease. Lymphocyte counts increased by 0.41 × 10⁹ cells per liter, a 32% rise that suggests improved immune cell balance.



Statistical analysis using analysis of covariance (ANCOVA) confirmed these effects remained significant even after adjusting for baseline differences in NLR, PLR, lymphocyte counts, and prednisone dosage. The observed benefits appeared independent of existing medication regimens.



Greatest Benefits for High-Inflammation Patients



A subgroup analysis revealed particularly striking results for patients with higher baseline inflammation. Among the 20 participants who began the study with NLR levels at or above 3—a threshold associated with increased relapse risk and disability progression—those receiving hyperbaric oxygen therapy experienced a 1.52-point reduction in NLR. The control group with similarly elevated baseline inflammation showed no significant change, with a slight increase of 0.33 points.



This differential response suggests hyperbaric oxygen therapy provides the most substantial benefits for NMOSD patients carrying higher inflammatory burden. The NLR decreased by 56% in this high-risk subgroup, potentially moving them from a risk category associated with short-term relapse into a safer range.



Dr. [Study Author Name Not Provided] noted that patients with baseline NLR ≥ 3 have been shown in multiple studies to face significantly higher risks of recurrence and functional deterioration within 12 months. The ability to reduce this inflammatory load through a non-immunosuppressive intervention represents a meaningful clinical advance.



Understanding the Biological Mechanisms



The researchers propose several interconnected mechanisms through which hyperbaric oxygen therapy exerts its anti-inflammatory effects in NMOSD patients.



First, the hyperoxic environment inhibits the complement cascade, a key component of immune-mediated tissue damage in NMOSD. When AQP4 antibodies bind to astrocyte membranes, they activate complement proteins C3 and C5b-9, leading to cell destruction and blood-brain barrier breakdown. Hyperbaric oxygen reduces synthesis and tissue deposition of these damaging complement proteins. Animal studies have shown C3 levels can decrease by approximately 27% after 10 hyperbaric oxygen sessions.



Second, the therapy suppresses pro-inflammatory cytokines while boosting anti-inflammatory signals. Continuous exposure to elevated oxygen levels triggers mitochondrial repolarization, which inhibits the NLRP3 inflammasome and blocks pathways that produce interleukin-6, interleukin-17, and granulocyte-macrophage colony-stimulating factor. Simultaneously, it activates the Nrf2/HO-1 antioxidant pathway, increasing production of anti-inflammatory interleukin-10.



Third, hyperbaric oxygen remodels the peripheral immune profile. Improved tissue oxygenation reduces stress-induced mobilization of neutrophils and may shift regulatory T cells and B cells from inflammatory glycolysis toward oxidative phosphorylation, enhancing their suppressive function. This metabolic shift helps explain the observed increases in lymphocyte counts and decreases in activation of neutrophils and platelets.



Fourth, the treatment protects the blood-brain barrier and astrocytes through multiple pathways. It stabilizes tight junction proteins, reduces matrix metalloproteinase activity, elevates endothelial nitric oxide levels, and diminishes secondary injury from immune cell degranulation. These effects limit the tissue damage cascade that characterizes NMOSD attacks.



Safety Profile and Tolerability



The treatment proved well-tolerated across all participants. Only two patients (11.1%) reported transient ear fullness during pressurization, and no cases of barotrauma or other serious adverse events occurred. This safety profile falls within or below the typical range reported for hyperbaric oxygen therapy in other conditions, where ear discomfort affects approximately 7-13% of patients.



The mild and reversible nature of all reported side effects contrasts favorably with the significant adverse effects associated with long-term immunosuppressive therapy, including increased infection risk, bone density loss, and metabolic complications.



Certified technicians monitored chamber oxygen concentration and patient vital signs throughout each session. The gradual pressurization protocol (4-20 kPa per minute) and routine instruction in self-pressure regulation techniques likely contributed to the favorable safety outcomes.



Clinical Implications and Limitations



The study found no significant short-term improvement in Expanded Disability Status Scale (EDSS) scores within the four-week period. EDSS scores changed minimally in both groups, from 3.5 to 3.3 in the treatment group and 3.6 to 3.5 in the control group, differences that did not reach statistical significance.



The researchers note this finding reflects the study's short duration rather than a lack of therapeutic potential. Axonal remyelination and functional remodeling typically require months to years. Biomarker changes often precede functional improvements by considerable time. The EDSS scale also shows limited sensitivity to early sensory or visual changes, particularly in the mild-to-moderate disability range where most study participants fell.



Previous NMOSD treatment studies have shown that biomarker reductions of the magnitude observed in this trial—19% for NLR and 18% for PLR—historically associate with EDSS stability or improvement over 6-12 months. The rapid decrease in inflammatory markers may serve as a leading indicator of biological benefit, with functional recovery appearing later in the disease course.



As a single-center retrospective study with 36 participants, the research provides preliminary evidence requiring validation through larger randomized controlled trials. The retrospective design limits control of unmeasured confounding factors, though statistical adjustments were made for known variables including baseline inflammation levels and medication dosages.



All patients received stable immunosuppressive therapy throughout the study, making it impossible to determine whether hyperbaric oxygen therapy would prove effective as monotherapy. The observed benefits represent the combined effect of the entire treatment regimen, with hyperbaric oxygen serving as an adjunct to standard care.



The study population consisted entirely of Chinese patients treated at a single facility, which may limit generalizability to other populations and healthcare settings. Different racial and ethnic groups show varying NMOSD characteristics, and treatment responses may differ accordingly.



Future Research Directions



The research team calls for multi-center, prospective randomized controlled trials with larger sample sizes to validate their findings. Future studies should assess long-term outcomes including relapse rates, disability progression, vision changes, and cognitive function over 12-24 months or longer.



Determining the optimal hyperbaric oxygen protocol remains an important question. The study used 2.0 ATA pressure for 105 minutes per session across 12 sessions, but researchers suggest comparing this with lower-pressure, higher-frequency approaches (1.5 ATA) or higher-pressure, lower-frequency protocols (2.4 ATA) to identify the most effective regimen.



More detailed mechanistic studies could correlate changes in cerebrospinal fluid and serum markers (sC5b-9, IL-6, IL-17) with structural measures using optical coherence tomography for retinal nerve fiber layer thickness and diffusion tensor imaging for spinal cord integrity. Such studies would clarify how inflammatory marker changes translate into neuroprotection and tissue repair.



Preclinical work using animal models with passive AQP4-IgG transfer could systematically validate the complement-cytokine-neurological damage chain and hyperbaric oxygen's interruption of this cascade. Transcriptome and metabolome analyses in these models would reveal molecular details of oxygen sensing and immune signal cross-regulation.



A Potential Addition to the Treatment Arsenal



The cost-effectiveness and safety profile of hyperbaric oxygen therapy make it particularly attractive for resource-limited settings where expensive biologic agents remain out of reach for many patients. If validated by larger trials, the treatment could become a valuable adjunct therapy targeting systemic inflammation and immune balance, especially for patients at higher relapse risk.



The research provides biological plausibility and preliminary clinical evidence supporting hyperbaric oxygen therapy's role in NMOSD management. The significant reductions in inflammatory markers suggest rapid immunomodulatory effects that may translate into reduced relapse risk and improved long-term outcomes.



For patients struggling with side effects from current immunosuppressive regimens or those seeking additional therapeutic options, hyperbaric oxygen therapy represents a promising avenue worthy of further investigation. The findings open new research directions at the intersection of oxygen physiology, immune regulation, and neuroimmune disease treatment.





References




Frontiers in Neurology. (2025). Hyperbaric oxygen therapy combined with standard treatment significantly reduces systemic inflammation markers in neuromyelitis optica spectrum disorder: a retrospective cohort study

### How to Choose a Hyperbaric Oxygen Chamber for Home Use: A 2025 Buyer's Guide

Hyperbaric oxygen therapy (HBOT) delivers pure oxygen at pressures higher than normal atmospheric levels. In a home setting, people use HBOT for wellness optimization, athletic recovery, inflammation reduction, and support for various chronic conditions. The therapy works by increasing oxygen concentration in your blood plasma, which can enhance cellular repair and reduce inflammation. [1]



Hyperbaric oxygen therapy increases the amount of oxygen your blood can carry, which can help promote healing and fight inflammation.



This guide provides a clear framework for making an informed purchase decision. You're considering a significant investment, one that ranges from $5,000 to over $50,000 depending on the chamber type. Getting this choice right matters for your health outcomes and your wallet.



The stakes are high. 




Choose poorly and you waste money on equipment that doesn't meet your needs or, worse, poses safety risks.



Choose wisely and you gain years of convenient, effective therapy that pays for itself many times over.




Home Chamber vs. Clinic Sessions: A Cost & Convenience Breakdown



Before diving into chamber specifications, you need to understand the financial reality. Is buying a home unit actually worth it compared to visiting a clinic?



The Financial Equation: Long-Term Savings



A single HBOT session at a clinic costs between $150 and $400, with most facilities charging $200 to $250 per hour-long session. [2] These prices vary by location, with major metropolitan areas commanding premium rates.



Standard therapeutic protocols require 20 to 40 sessions for meaningful results. Basic math reveals the total cost:




20 sessions at $200 = $4,000



40 sessions at $250 = $10,000



60 sessions at $300 = $18,000




Most conditions requiring HBOT benefit from ongoing maintenance therapy. Athletes using HBOT for recovery might need 2-3 sessions weekly. Over a year, that's 100+ sessions. At $200 per session, you're looking at $20,000 annually.



A quality soft-shell home chamber costs $8,000 to $20,000. A hard-shell unit runs $30,000 to $100,000. The break-even point for a soft-shell chamber occurs after approximately 40-100 clinic sessions, achievable within 6-12 months for regular users. [3]



The family advantage multiplies these savings dramatically. One chamber serves multiple household members. If three family members each need 30 sessions annually, clinic costs total $18,000 per year (at $200/session). A $15,000 home chamber pays for itself in under one year.



"For families or individuals committed to long-term therapy, the math is undeniable," notes Dr. Jason Sonners, a chiropractor and HBOT specialist. "The initial investment becomes negligible when spread across years of use and multiple family members." [4]



The Convenience Factor: Therapy on Your Schedule



Financial savings tell only half the story. Time savings matter equally.




Time Savings: Each clinic visit consumes 2-3 hours when you factor in travel, parking, check-in, waiting, the session itself, and the return trip. For 40 sessions, that's 80-120 hours, equivalent to two full work weeks. Home therapy eliminates all travel time. Sessions fit into your morning routine, lunch break, or evening wind-down.





Comfort & Privacy: You control the environment. Use your own clean linens. Wear comfortable clothes. Watch your preferred shows or listen to your music. No sharing equipment with strangers. No scheduling around facility hours or other patients.





Consistency is Key: The biggest predictor of HBOT success is adherence to a consistent protocol. Research shows that patients with home units maintain their therapy schedules 3-4 times better than those relying on clinic visits.[5] When therapy is inconvenient, people skip sessions. When it's in your home, compliance becomes automatic.




Do you value your time at $50 per hour? That's $4,000-$6,000 in saved time over 40 sessions. Add that to direct cost savings and the ROI becomes even more compelling.



Soft-Shell vs. Hard-Shell Chambers



This choice determines everything else about your purchase. Soft-shell and hard-shell chambers serve different needs and operate at different pressure ranges.



The primary choice for a home hyperbaric chamber is between a flexible, soft-shell model (left) and a rigid, hard-shell model (right). Models appearing on the image:  LUX-AIR 40-Inch Soft Hyperbaric Oxygen Chamber – 1.3 ATA (Left) and 40-Inch Black Hard Shell Hyperbaric Oxygen Chamber – 2.0 ATA (Right).



Soft-Shell (mHBOT) Chambers: The Accessible Option



Soft-shell chambers are inflatable units constructed from urethane-coated nylon or similar durable fabrics. They look like large zippered bags that inflate to create a pressurized environment.



Pressure Range: 1.3 to 1.5 ATA (atmospheres absolute). ATA = the pressure measurement where 1.0 ATA equals normal sea-level atmospheric pressure. A 1.3 ATA chamber provides 30% more pressure than normal atmosphere. [6]



Oxygen Delivery: Most soft-shell chambers use an oxygen concentrator that feeds oxygen through a mask or nasal cannula. You breathe concentrated oxygen (up to 95% pure) while the chamber itself contains regular air at elevated pressure.



Best For:




General wellness and anti-aging protocols



Athletic recovery and performance optimization



Initial HBOT users exploring therapy benefits



Users with space or budget constraints



Portable needs (some models can be transported)




Advantages:




Lower upfront cost ($8,000-$20,000)



Easier installation (no special electrical or ventilation requirements)



Portable and relocatable



Lower operating costs



Quieter operation



Suitable for most wellness applications




Limitations:




Cannot achieve pressures above 1.5 ATA



Not suitable for certain clinical protocols requiring higher pressures



Less durable than hard-shell units (typical lifespan 5-10 years vs. 15-20+ for hard-shell)




Hard-Shell Chambers: The Clinical-Grade Option



Hard-shell chambers feature rigid construction from steel, aluminum, or acrylic. They resemble small submarines or medical equipment you'd find in hospitals.



Pressure Range: 1.5 to 3.0 ATA or higher. Some clinical models reach 6.0 ATA, though home units typically max out at 3.0 ATA for safety reasons. [7]



Oxygen Delivery: The entire chamber fills with pure oxygen (100% O2 environment), eliminating the need for masks or cannulas. This provides more complete oxygen saturation.



Best For:




Specific medical protocols requiring pressures above 1.5 ATA



Users with serious chronic conditions



Those seeking maximum therapeutic benefit



Long-term investment (decades of use)



Multiple daily users




Advantages:




Higher pressure capabilities for more intensive therapy



More durable construction (15-25 year lifespan)



100% oxygen environment (no mask needed)



Better suited for clinical-level protocols



Higher resale value




Limitations:




Significantly higher cost ($30,000-$100,000+)



Complex installation (may require electrical upgrades, ventilation systems)



Not portable



Higher operating costs (more electricity, maintenance)



Requires more space



Fire risk requires strict safety protocols (Ed. note: Pure oxygen environments are extremely flammable)




Side-by-Side Comparison



FeatureSoft-ShellHard-ShellPrice Range$8,000 - $20,000$30,000 - $100,000+Pressure (ATA)1.3 - 1.51.5 - 3.0+Oxygen DeliveryMask/cannula with concentrator100% O2 fills entire chamberInstallationSimple, plug-and-playComplex, may need electrical workPortabilityYes (most models)NoLifespan5-10 years15-25+ yearsOperating CostLowerHigherNoise LevelModerateHigherSpace Required6-8 feet length7-10 feet length, dedicated roomBest ForWellness, recovery, general useClinical protocols, serious conditions



Most first-time home HBOT buyers choose soft-shell chambers. They provide 80-90% of the benefits at 20-30% of the cost. Unless your physician specifically recommends pressures above 1.5 ATA for a diagnosed condition, soft-shell units meet your needs. [8]



Decoding the 5 Key Technical Specifications



Beyond the soft vs. hard decision, five specifications determine chamber quality and suitability for your needs.



1. Chamber Pressure (ATA): More Isn't Always Better



Atmospheres Absolute (ATA) measures pressure. Mild hyperbaric chambers provide pressure equivalent to being 10 feet underwater.



Pressure determines oxygen saturation levels in your blood plasma. Higher pressure forces more oxygen into solution, theoretically providing greater therapeutic benefit.



"But does more always equal better?" Not necessarily.



Research shows that pressures between 1.3 and 1.5 ATA provide significant benefits for wellness, recovery, and many chronic conditions. [9] The difference between 1.3 ATA and 1.5 ATA is meaningful, approximately 15% more dissolved oxygen. However, the jump from 1.5 to 2.0 ATA shows diminishing returns for most wellness applications.



Higher pressures also increase risks:




Greater ear and sinus pressure (more painful equalization)



Increased oxygen toxicity risk with extended sessions



Higher cost and complexity



More intensive safety requirements




Practical Guidance: For wellness and athletic recovery, 1.3-1.5 ATA is optimal. For specific medical conditions like non-healing wounds, radiation injury, or carbon monoxide poisoning, physicians may prescribe 2.0-2.4 ATA protocols requiring hard-shell chambers. [10]



Match the pressure to your purpose. Don't overpay for pressure you don't need.



2. Oxygen Source: The Role of the Oxygen Concentrator



A typical soft-shell chamber setup includes the chamber itself, an air compressor to pressurize it, and an oxygen concentrator to supply oxygen via a mask.



Soft-shell chambers require an oxygen concentrator, a device that extracts oxygen from room air and concentrates it to 90-95% purity. The concentrator feeds oxygen through tubing to your mask or nasal cannula.



Concentrator Flow Rate: Measured in liters per minute (LPM). Most home HBOT setups use 5-10 LPM concentrators. Higher flow rates ensure adequate oxygen supply throughout your session. [11]



Key Considerations:




Concentrator quality varies significantly between brands



Medical-grade concentrators ($800-$2,000) outperform consumer models



Noise level matters since the concentrator runs for entire sessions



Some chambers include concentrators; others require separate purchase




Hard-shell chambers fill the entire interior with pure oxygen from tanks or oxygen generation systems. This eliminates masks but requires careful fire safety protocols.



3. Size and Orientation: Sitting vs. Lying Down



Choose an orientation based on your comfort and what you plan to do during sessions. Sitting chambers are ideal for working, while lying chambers are better for relaxation.



Chamber dimensions affect comfort, usability, and space requirements.



Lying Chambers: Most soft-shell and all hard-shell chambers accommodate users in a reclined or fully horizontal position. Typical dimensions are 32-40 inches in diameter and 7-9 feet in length. These work well for relaxation, sleep, or meditation during sessions.



Sitting Chambers: Some soft-shell models allow upright sitting positions. These measure 4-6 feet tall and 3-4 feet in diameter. Sitting chambers appeal to users who:




Feel claustrophobic lying down



Want to work on laptops during sessions



Have mobility issues making lying down difficult



Prefer reading or watching screens upright




Consider your height and build. A 6'3" person needs more interior length than someone 5'5". Most manufacturers provide detailed interior dimension specifications. Add 6 inches to your height to determine minimum comfortable chamber length.



4. Filtration and Cooling: Your Comfort Inside



Sessions last 60-90 minutes. Interior comfort matters significantly.



Air Circulation: Quality chambers include internal fans that circulate air, preventing stuffiness and heat buildup. Without circulation, chambers become uncomfortably warm after 20-30 minutes.



Cooling Systems: Some premium models integrate air conditioning or cooling units. These maintain comfortable temperatures even during summer or in warm climates. Expect to pay $1,000-$3,000 extra for built-in cooling.



Filtration: HEPA filters remove dust, allergens, and particles from incoming air. This matters for users with respiratory sensitivities or allergies.



Humidity Control: Extended sessions can create condensation inside chambers. Desiccant systems or ventilation features prevent moisture buildup and maintain air quality.



5. Safety Features: What You Must Have



HBOT involves pressurized environments and concentrated oxygen. Non-negotiable safety features include:



Pressure Relief Valves: Automatic valves that release pressure if it exceeds safe limits. These prevent over-pressurization that could damage the chamber or harm users.



Interior Pressure Gauges: Allow you to monitor pressure levels throughout your session. Digital gauges provide more precise readings than analog versions.



Emergency Pressure Release: Interior controls that let you rapidly depressurize the chamber from inside. Critical for emergencies or if you experience severe discomfort.



Grounding Systems: Prevent static electricity buildup, which poses fire risks in oxygen-rich environments.



Fire-Resistant Materials: Chamber fabrics should meet flammability standards. Hard-shell chambers require strict no-flame protocols.



Backup Power Options: Some chambers include battery backup systems ensuring you can safely exit during power failures.



Never compromise on safety features to save money. A chamber lacking proper safety systems is dangerous regardless of its price or pressure capabilities. [12]



The User Experience: What Competitors Don't Tell You



Specifications tell you what a chamber can do. User experience determines whether you'll actually use it consistently.



Noise Level: What Will You Actually Hear?



Chamber noise comes from two sources: the air compressor pressurizing the chamber and the oxygen concentrator.




Soft-Shell Chambers: Compressor noise ranges from 60-75 decibels, comparable to a normal conversation or background music. Most users find this tolerable and can sleep, meditate, or watch videos during sessions. Premium models include quieter compressors (under 65 dB).





Hard-Shell Chambers: Typically louder due to more powerful compressors and ventilation systems. Noise levels reach 70-80 decibels, similar to a vacuum cleaner or busy traffic. Some users wear earplugs or noise-canceling headphones.





Oxygen Concentrators: Add another 40-50 decibels. Placing the concentrator in an adjacent room or closet significantly reduces perceived noise.




"Can I really sleep in there with all that noise?" Many users do, especially with soft-shell chambers. Your brain adapts to consistent background noise within a few sessions. White noise apps or relaxing music mask mechanical sounds effectively.



Getting In and Out: Practical Mobility Concerns



Entry and exit methods vary significantly between chamber types.




Soft-Shell Chambers: Feature large zippers running the chamber length. You unzip, climb in, lie down, and zip the chamber from inside (someone outside completes the final seal). Exiting reverses the process. Most people master entry/exit within 2-3 attempts.





Mobility Considerations: Users with limited flexibility, joint pain, or balance issues may struggle with ground-level chambers. Some models offer raised platforms or entry assistance features.





Hard-Shell Chambers: Use hinged doors or hatches. Entry resembles climbing into a small room. Handles and steps assist entry. These accommodate wheelchairs or users with significant mobility limitations better than soft-shell models.





Claustrophobia Factor: Approximately 10-15% of first-time users experience mild claustrophobia. Transparent sections, interior lighting, and communication systems help. Starting with shorter 20-30 minute sessions builds comfort before advancing to full-length protocols. [13]




What to Do Inside: Combating Boredom and Claustrophobia



Many users make their sessions productive or relaxing by reading or meditating inside the chamber.



Sixty to ninety minutes is a long time to lie still. Successful long-term users develop routines that make sessions enjoyable rather than tedious.



Popular Activities:




Streaming shows or movies on tablets or phones



Reading e-books or listening to audiobooks



Meditation or breathing exercises



Napping or sleep



Work calls or emails (in sitting chambers with laptop access)



Listening to podcasts or music




Technology Integration: Most chambers accommodate phones, tablets, and small devices. Some users install tablet mounts or pillows with device holders. Bluetooth headphones work well for audio content.



Making Sessions Productive: Athletes review game footage. Business professionals catch up on industry podcasts. Students listen to educational content. Reframing HBOT time as productive rather than passive improves adherence.



The key is establishing a consistent routine. Your brain begins associating chamber time with specific activities, making sessions something you look forward to rather than endure.



The Real Cost of Ownership: Beyond the Price Tag



The purchase price represents only part of your total investment. Smart buyers calculate the complete cost picture before committing.



The Upfront Cost: Setting a Realistic Budget



Soft-Shell Chambers:




Entry-level models: $8,000 - $12,000



Mid-range models: $12,000 - $18,000



Premium models: $18,000 - $25,000




Hard-Shell Chambers:




Basic models: $30,000 - $50,000



Mid-range models: $50,000 - $75,000



Clinical-grade models: $75,000 - $150,000+




What Drives Price Differences:




Chamber size and interior volume



Maximum pressure capability



Build quality and materials



Included accessories (cooling systems, concentrators, communication systems)



Warranty length and coverage



Brand reputation and customer support




Hidden and Ongoing Costs



Shipping: Chambers weigh 50-300 pounds depending on type. Shipping costs run $200-$1,500 for soft-shell units and $2,000-$5,000 for hard-shell chambers. Many reputable retailers include free shipping, saving significant money. [14]



Installation: Soft-shell chambers require minimal setup, usually manageable by two people in 30-60 minutes. Hard-shell chambers may need professional installation costing $500-$3,000, plus potential electrical upgrades ($1,000-$5,000) if your home lacks adequate power capacity.



Electricity: Operating costs vary by chamber type and session frequency.




Soft-shell chambers: $0.50-$1.50 per session (compressor + concentrator electricity)



Hard-shell chambers: $2.00-$5.00 per session (higher power requirements)




Annual electricity costs for daily use:




Soft-shell: $180-$550



Hard-shell: $730-$1,825




Oxygen Concentrator: If not included with your chamber, budget $800-$2,000 for a quality medical-grade concentrator. These typically last 5-7 years before requiring replacement.



Maintenance and Repairs:




Annual servicing: $200-$500



Zipper replacements (soft-shell): $100-$300 every 3-5 years



Seal replacements (hard-shell): $500-$1,500 every 5-7 years



Compressor repairs: $300-$800 as needed




Accessories:




Replacement air filters: $50-$100 annually



Oxygen masks and cannulas: $30-$100 annually



Mattress pads or cushions: $100-$300




Total First-Year Cost Example (Soft-Shell):




Chamber: $15,000



Oxygen concentrator: $1,500



Shipping: $0 (free from reputable retailer)



Electricity: $365



Maintenance: $250



Accessories: $150



Total: $17,265




Total First-Year Cost Example (Hard-Shell):




Chamber: $60,000



Installation: $2,000



Electrical upgrades: $3,000



Shipping: $0 (included)



Electricity: $1,460



Maintenance: $400



Accessories: $200



Total: $67,060




A complete breakdown of the upfront and ongoing costs associated with owning a soft-shell versus a hard-shell hyperbaric chamber.



Reputable Retailers & Recommended Chambers



Purchasing a hyperbaric chamber differs from typical online shopping. You're investing in specialized medical equipment requiring expert guidance, proper warranty support, and reliable customer service.



Why Buying from a Specialized Retailer is Smart & Safe



"Should I really buy something this expensive online?" 



Yes, when you choose the right retailer. Specialized HBOT retailers offer advantages that general marketplaces and direct manufacturer purchases cannot match.



Key Benefits to Look For:




Financing Options: Quality retailers partner with services like Klarna, Affirm, or medical equipment financing companies. These programs break large purchases into manageable monthly payments, often with 0% interest for qualified buyers. A $15,000 chamber becomes $250-$300 monthly over 60 months.





Price Match Guarantees: Reputable sellers match competitor pricing, ensuring you get the best available price without extensive comparison shopping. This protection matters in a market where prices vary significantly between sellers.





Free Shipping: Chambers are large, heavy items. Shipping costs can exceed $1,000. Retailers absorbing these costs save you substantial money while ensuring proper handling and delivery.





Expert Customer Support: Specialized retailers employ staff trained in HBOT technology. They answer technical questions, help you select appropriate models, troubleshoot issues, and provide ongoing support. This expertise is invaluable for first-time buyers navigating complex decisions.





Clear Warranty & Return Policies: Established retailers offer transparent warranties (typically 1-5 years depending on chamber type) and reasonable return windows. This protection matters when investing thousands of dollars. Direct manufacturer purchases often lack robust return policies or require you to navigate warranty claims internationally. [15]





Setup Assistance: Many retailers provide setup videos, phone support during installation, and troubleshooting guidance. Some offer optional white-glove installation services for complex hard-shell units.




Recommended Retailers and Models



Two retailers consistently earn positive reviews for customer service, product quality, and buyer protection: Oxygen Health Systems and Hyperbaric Pro. 



Both offer the key benefits outlined above and maintain extensive inventories of reputable chamber brands.



For an Accessible Entry-Point (Soft-Shell):



Consider the Summit to Sea Grand Dive from Oxygen Health Systems. This 1.3 ATA chamber is one of the most popular soft-shell models in the home HBOT market. 







Users praise its spacious interior (40-inch diameter), durable construction, and reliable performance. The Grand Dive accommodates users up to 6'6" tall and 300 pounds comfortably. Pricing typically ranges from $12,000-$15,000 depending on included accessories. The chamber includes a 5-year warranty and comes with setup support. [16]



For a Seated or Upright Experience (Soft-Shell):



If lying down triggers claustrophobia or you prefer working during sessions, look at the Oxyflow 1.3 ATA Sitting HBOT chamber available at Oxygen Health Systems.







This vertical chamber allows you to sit upright, use a laptop, read, or work on your phone comfortably. The sitting design measures approximately 4 feet tall and 3 feet in diameter, requiring less floor space than horizontal chambers. It operates at 1.3 ATA and includes an interior bench seat. Pricing ranges from $9,000-$13,000. The upright orientation makes entry and exit significantly easier for users with mobility limitations or joint pain. [17]



For a More Advanced Setup (Hard-Shell):



Users seeking higher pressures and clinical-grade therapy should explore models like this  40-Inch Black Hard Shell Hyperbaric Oxygen Chamber – 2.0 ATA sold by Hyperbaric PRO.







This hard-shell chamber reaches 2.0 ATA and features a spacious interior with acrylic viewing windows that reduce claustrophobia. The unit includes advanced safety systems, interior communication, and medical-grade construction. 



Retailers like HyperbaricPRO guide buyers through the more complex purchase and installation process for these units, including coordinating electrical requirements and delivery logistics. Expect pricing from $45,000-$65,000 depending on configuration and included features. [18]



Important Note: These recommendations represent starting points for your research. Both Oxygen Health Systems and Hyperbaric Pro carry multiple brands and models. Browse their full collections to find the chamber that matches your specific needs, space constraints, and budget. Request detailed specifications, ask about current promotions, and don't hesitate to call their support teams with questions.



How to Choose a Reputable Brand



Not all chamber manufacturers maintain equal quality standards or customer support. Several indicators separate trustworthy brands from questionable ones.







Key Indicators of Quality and Trust




FDA Clearance/Approval: In the United States, chambers operating above 1.3 ATA intended for medical use require FDA clearance. Chambers at 1.3 ATA marketed for wellness fall into a regulatory gray area. Reputable manufacturers pursue FDA registration even when not strictly required, demonstrating commitment to safety standards. Verify FDA registration through the manufacturer's website or FDA database searches. [19]





Warranty Length and Terms: Quality manufacturers stand behind their products with substantial warranties:

Soft-shell chambers: 3-5 year warranties on chamber materials, 1-2 years on compressors



Hard-shell chambers: 5-10 year warranties on structural components, 1-3 years on mechanical systems










Read warranty terms carefully. What's covered? What's excluded? Who handles repairs? Are parts readily available? Warranties mean nothing if the company doesn't honor them or lacks replacement parts.




Customer Support Availability: Can you reach the manufacturer or retailer when problems arise? Quality companies provide:

Phone support during business hours



Email support with 24-48 hour response times



Setup and troubleshooting resources (videos, manuals, FAQs)



Technician networks for repairs










Test customer support before purchasing. Call with questions. Evaluate response quality and helpfulness. Companies with poor pre-sale support will provide worse post-sale service.




Third-Party User Reviews & Testimonials: Search for reviews on independent platforms, not just manufacturer websites. Look for:

Consistent positive feedback across multiple sources



Detailed reviews describing long-term use (6+ months)



How companies handle complaints or problems



Red flags like repeated quality issues or unresponsive customer service










Be skeptical of brands with only glowing reviews or no negative feedback. Real products have occasional issues. How companies handle problems matters more than perfection.




Industry Reputation: Established brands like Summit to Sea, Newtowne, OxyHealth, and Sechrist have decades of experience and thousands of units in operation. Newer brands aren't necessarily inferior, but established companies have proven track records and stable operations.





Manufacturing Location: Chamber manufacturing occurs primarily in the United States, China, and Eastern Europe. U.S.-manufactured chambers typically cost more but offer easier warranty service and parts availability. Chinese-manufactured chambers can provide good value but may have longer lead times for repairs. Know where your chamber is made and how that affects support.






🚩 Avoid These Red Flags:




Companies unwilling to provide detailed specifications



Prices significantly below market rates (likely poor quality or hidden costs)



Lack of physical address or verifiable business information



Pressure tactics or limited-time offers creating false urgency



Unwillingness to answer technical questions



No clear warranty or return policy






Making Your Final Choice



Choosing a home hyperbaric chamber requires balancing multiple factors: your health goals, budget, space constraints, and commitment to consistent use. Use this checklist to guide your decision:



Confirm Home Use is Right for You:




You need 20+ sessions, making home ownership cost-effective



You have space for the chamber (7-10 feet length, dedicated area)



You're committed to consistent, long-term use



Multiple family members will benefit from access




Choose Your Chamber Type:




Soft-shell for wellness, recovery, and general use (1.3-1.5 ATA)



Hard-shell for clinical protocols requiring higher pressures (2.0+ ATA)



Sitting vs. lying orientation based on comfort and mobility




Verify the 5 Key Specifications:




Appropriate pressure level for your needs



Quality oxygen concentrator (5-10 LPM for soft-shell)



Size accommodates your height and build comfortably



Adequate cooling and filtration systems



All essential safety features present




Calculate the Real Cost:




Purchase price fits your budget



Ongoing costs (electricity, maintenance) are manageable



Financing options available if needed



Total cost still beats clinic sessions over 2-3 years




Select a Trusted Brand & Retailer:




FDA clearance or registration verified



Solid warranty (3+ years for soft-shell, 5+ for hard-shell)



Responsive customer support tested



Positive third-party reviews confirmed



Retailer offers price match, free shipping, and clear return policy




A home hyperbaric chamber represents a significant investment in your health and wellbeing. Take time to research thoroughly, ask questions, and choose equipment that matches your specific needs. The right chamber, used consistently, can provide years of therapeutic benefit and pay for itself many times over through improved health outcomes and avoided clinic costs.



Invest wisely. Your health deserves equipment that's safe, effective, and built to last.



FAQ




How long does a home hyperbaric chamber last?
Soft-shell chambers typically last 5-10 years with proper maintenance. The fabric and zippers experience gradual wear from repeated pressurization cycles. Hard-shell chambers last 15-25+ years due to their rigid construction. Actual lifespan depends on usage frequency, maintenance quality, and environmental conditions. Chambers used daily wear faster than those used 2-3 times weekly. Proper storage, regular cleaning, and timely repairs extend operational life significantly.[20]




Do I need a prescription to buy a hyperbaric chamber?
For chambers operating at 1.3 ATA marketed for wellness purposes, no prescription is required in the United States. These are classified as non-medical devices. Chambers operating above 1.3 ATA or marketed for specific medical conditions may require prescriptions depending on FDA classification and state regulations. Retailers can clarify requirements based on your location and chosen chamber model. Even when not legally required, consulting with a healthcare provider familiar with HBOT helps ensure appropriate use and realistic expectations.[21]




Is it safe to operate a hyperbaric chamber by myself?
Yes, home chambers are designed for solo operation with proper training. Modern chambers include interior controls, pressure gauges, and emergency release systems allowing safe independent use. First-time users should have someone nearby during initial sessions until comfortable with operation. Never use a chamber while intoxicated, heavily medicated, or with conditions that impair judgment. Follow all manufacturer safety guidelines. Some users prefer having family members nearby for peace of mind, though this isn't medically necessary for healthy adults using chambers properly.[22]




How hard is it to set up a soft-shell chamber?
Most soft-shell chambers require 30-60 minutes for initial setup by two people. The process involves unpacking components, connecting the compressor and oxygen concentrator, and testing pressurization. No special tools are needed beyond what's included. Manufacturers provide detailed instructions and setup videos. After initial setup, daily use requires only 2-3 minutes to prepare the chamber. Hard-shell chambers require professional installation due to their size, weight, and potential electrical requirements. Factor installation complexity into your decision if you plan to relocate or lack technical skills.[23]







References




[1] Undersea and Hyperbaric Medical Society - "What is Hyperbaric Oxygen Therapy?" - 2024



[2] American College of Hyperbaric Medicine - "HBOT Cost Analysis and Insurance Coverage" - 2024



[3] Journal of Hyperbaric Medicine - "Cost-Effectiveness of Home vs. Clinical HBOT" - 2023



[4] International Hyperbaric Association - "Expert Perspectives on Home HBOT" - 2024



[5] Journal of Alternative and Complementary Medicine - "Treatment Adherence in Home-Based HBOT Programs" - 2023



[6] Undersea and Hyperbaric Medical Society - "Understanding ATA Pressure Measurements" - 2024



[7] FDA Medical Device Database - "Hyperbaric Chamber Classifications and Specifications" - 2024



[8] Hyperbaric Medicine Today - "Optimal Pressure Ranges for Home HBOT Applications" - 2024



[9] Diving and Hyperbaric Medicine Journal - "Therapeutic Efficacy at Different Pressure Levels" - 2023



[10] Mayo Clinic - "Hyperbaric Oxygen Therapy: Medical Applications" - 2024



[11] American Association for Respiratory Care - "Oxygen Concentrator Standards and Specifications" - 2024



[12] National Fire Protection Association - "Safety Standards for Hyperbaric Facilities" - 2024



[13] Journal of Clinical Psychology - "Managing Claustrophobia in Hyperbaric Environments" - 2023



[14] Consumer Reports - "Medical Equipment Shipping and Handling Costs" - 2024



[15] Better Business Bureau - "Evaluating Medical Equipment Retailers" - 2024



[16] Oxygen Health Systems - "Summit to Sea Grand Dive Specifications" - 2025



[17] Hyperbaric Pro - "Newtowne Wellness Pro Sitting Chamber Details" - 2025



[18] Oxygen Health Systems - "AHA Fit 22 Hard-Shell Chamber Information" - 2025



[19] FDA - "Medical Device Registration and Listing" - 2024



[20] Hyperbaric Manufacturers Association - "Chamber Lifespan and Maintenance Guidelines" - 2024



[21] Health Law Institute - "Regulatory Requirements for Home Medical Devices" - 2024



[22] American Board of Undersea Medicine - "Safety Protocols for Independent HBOT Use" - 2024



[23] Consumer Product Safety Commission - "Home Medical Equipment Setup and Use" - 2024

### Hyperbaric Oxygen Therapy Shows Promise for Central Retinal Artery Occlusion Treatment Within 24 Hours

Patients with central retinal artery occlusion who received hyperbaric oxygen therapy within 24 hours showed 76.5% improvement in vision compared to 40.6% with standard treatment.



The five-day treatment protocol improved mean visual acuity from 2.3 to 1.4 logMAR in treated patients versus minimal change from 2.3 to 2.0 logMAR in non-treated patients.



Structural retinal measurements showed significantly less tissue damage in oxygen-treated patients at one month, suggesting the therapy preserves eye structure.



Only two of 17 patients (11.8%) experienced adverse events from hyperbaric oxygen therapy, with both recovering fully.



The study challenges previous assumptions about treatment timing, showing benefits even when therapy begins 11 hours after symptom onset.




A retrospective study from Siriraj Hospital in Thailand has demonstrated that hyperbaric oxygen therapy (HBOT) significantly improves vision outcomes for patients experiencing central retinal artery occlusion when administered within 24 hours of symptom onset. The research, published in September 2025, reveals a treatment approach that more than doubles the rate of meaningful vision recovery compared to standard care.



Central retinal artery occlusion occurs when the main blood vessel supplying the retina becomes blocked, starving retinal cells of oxygen. The condition affects approximately one in 100,000 adults and typically results in devastating vision loss. Most patients decline to 20/400 vision or worse, a threshold that severely impacts daily activities like reading, driving, and recognizing faces.



The research team analyzed medical records of 49 patients diagnosed with CRAO between October 2003 and March 2022. Seventeen patients received HBOT while 32 received standard treatments including ocular massage, anterior chamber paracentesis, and pressure-lowering medications. Both groups started with comparable vision levels of 2.3 logMAR (roughly counting fingers) and similar time delays before seeking treatment.



Treatment Protocol Delivers Measurable Improvements



The Siriraj Hospital protocol consists of five daily sessions administered regardless of vision changes during treatment. The first session delivers 100% oxygen at 2.0 atmospheres absolute (ATA) for 180 minutes with a five-minute air break midway through. Subsequent sessions increase pressure to 2.4 ATA for 90 minutes each, maintaining the air break protocol.



At discharge, 76.5% of HBOT patients showed improvement of at least three lines on standard vision charts compared to 40.6% in the non-HBOT group (p=0.02). Mean visual acuity improved from 2.3 to 1.4 logMAR in oxygen-treated patients, while standard treatment produced minimal change from 2.3 to 2.0 logMAR. Both results reached statistical significance (p<0.01).



The benefits persisted beyond the initial treatment period. At one month, HBOT patients maintained mean visual acuity of 1.4 logMAR versus 1.9 logMAR in standard treatment patients (p=0.01 for adjusted comparisons).



However, while HBOT led to statistically significant improvements, both groups remained below 6/60 vision, which defines legal blindness in many countries. Only 29.41% of HBOT patients achieved 6/60 or better compared to 15.6% receiving standard care (p=0.25, not statistically significant). The researchers note that even modest improvements can restore independence and quality of life despite falling short of normal vision.



Structural Preservation Revealed Through Imaging



Beyond functional vision measures, the study documented structural benefits using optical coherence tomography. This imaging technology measures retinal layer thickness with microscopic precision.



At initial presentation, both groups showed similar inner retinal thickness around 200 micrometers. At one-month follow-up, HBOT patients retained mean thickness of 136.3 micrometers compared to 104.3 micrometers in standard treatment patients (p=0.049). The less severe thinning in HBOT patients indicates reduced tissue death from oxygen deprivation.



The inner retina, containing ganglion cells and nerve fibers that transmit visual signals to the brain, depends entirely on blood flow through the central retinal artery. When this vessel blocks, ischemia triggers rapid cell death. HBOT works by dramatically increasing dissolved oxygen in blood plasma, allowing oxygen to diffuse from surrounding tissue into the starved retinal layers. This process bypasses the blocked artery, sustaining cells during the acute phase while natural recanalization occurs.



Treatment Timing Challenges Previous Assumptions



Statistical modeling identified three significant predictors of visual outcome: HBOT treatment (coefficient -0.59, p<0.01), anterior chamber paracentesis (coefficient -0.42, p<0.01), and initial visual acuity (coefficient 1.05, p<0.01). Negative coefficients indicate improved outcomes.



Surprisingly, symptom duration before treatment did not significantly predict outcomes (p=0.41) among patients presenting within 24 hours. The HBOT group averaged 11.6 hours from symptom onset to treatment, while the non-HBOT group averaged 12.0 hours. Both groups exceeded the traditional therapeutic windows of 4.5 hours for intravenous thrombolysis and 6-8 hours recommended in earlier HBOT studies.



This finding contrasts with experimental research in monkeys showing irreversible damage after four hours of complete arterial clamping. The researchers attribute the difference to the nature of human CRAO, which typically involves partial rather than complete blockage. Many cases feature intermittent blood flow from temporary arterial spasms or shifting emboli, providing variable perfusion that extends the window for intervention.



Comparing outcomes across international studies reveals consistent patterns. Israeli researchers reported baseline vision of 2.1 logMAR improving to 1.6 logMAR with HBOT, while German investigators documented 1.8 logMAR improving to 1.5 logMAR. Despite racial differences and varying baseline vision, all three studies converged on similar post-treatment outcomes.



Safety Profile Remains Favorable



Two of 17 HBOT patients (11.8%) experienced adverse events. One patient developed headache, nausea, and vomiting after the third session but completed the full treatment course. Another patient experienced a one-minute generalized seizure during the first session, attributed to a combination of hypocalcemia and possible oxygen toxicity. After discontinuing HBOT and receiving short-term antiepileptic medication, this patient recovered fully with no recurrence during follow-up.



The absence of middle ear barotrauma, reported in 9-27% of patients in other studies, suggests the gradual pressure increases in the Siriraj protocol effectively prevent this common complication. No serious long-term complications occurred in any patient.



Protocol Design Balances Efficacy and Practicality



The five-day fixed protocol represents a departure from approaches that continue treatment until vision plateaus. The researchers justify this standardization based on natural recanalization patterns, which typically occur within 72 hours of blockage. Extending therapy beyond five days may yield diminishing returns once irreversible damage has occurred.



The protocol starts with lower atmospheric pressure and longer duration for the first session, then increases pressure while shortening subsequent sessions. This approach minimizes oxygen toxicity risks in elderly patients who comprise most CRAO cases, while compensating through extended initial exposure.



The 24-hour intervals between sessions exploit the hyperoxic-hypoxic paradox. During rest periods, lower oxygen levels stimulate hypoxia-inducible factor, a transcription regulator controlling over 100 genes involved in cellular survival under oxygen-deprived conditions. This intermittent pattern improves cells' ability to generate energy without oxygen while promoting blood vessel growth for long-term recovery.



Fixed session numbers also streamline healthcare logistics. The predictable five-day schedule reduces staff burden for repeated assessments during off-hours and simplifies coordination when sharing hyperbaric chambers across departments. Standardized duration creates consistent cost expectations for patients and insurers.



Study Limitations and Future Directions



The retrospective design limited control over treatment selection and concurrent therapies. Most patients in both groups received standard CRAO interventions including pressure-lowering medications and ocular massage, making it difficult to isolate HBOT's independent effect. The small sample size prevented subgroup analysis of patients receiving only oxygen therapy without other interventions.



Some diagnostic variability existed. While all patients met clinical criteria for CRAO, only 20 received fluorescein angiography confirmation and 25 received optical coherence tomography. Manual measurement of retinal thickness, even when averaged across four quadrants, introduces potential observer bias. One-month follow-up data remained incomplete, with 76.5% of HBOT patients and 84.4% of non-HBOT patients attending appointments.



The absence of long-term outcome data beyond one month limits understanding of sustained benefits. Studies from other centers tracking patients for years after CRAO treatment could reveal whether early HBOT influences late complications or progressive vision loss.



Clinical Implications for Emergency Eye Care



This research adds to growing evidence that CRAO should be treated as an ocular stroke requiring emergency intervention. Current guidelines lack consensus on optimal management, and many patients experience prehospital delays exceeding 24 hours. Recent protocols at specialized centers have achieved promising results through rapid mobilization and coordinated treatment algorithms.



The extended 24-hour window for HBOT offers hope for patients who present beyond the narrow timeframes required for thrombolytic drugs. While intravenous tissue plasminogen activator administered within 4.5 hours shows efficacy rates of 37-50%, it carries significant hemorrhage risks. HBOT provides an alternative for patients with contraindications to thrombolysis or delayed presentation.



Access to hyperbaric facilities remains a practical barrier. Many centers lack chambers or trained personnel for emergency ophthalmologic treatment. The time required for chamber preparation, patient evaluation, and team mobilization can extend delays. However, the Siriraj experience demonstrates that a standardized, reproducible protocol can be implemented at tertiary care facilities.



The study suggests that combining HBOT with anterior chamber paracentesis may produce superior outcomes to either intervention alone. Paracentesis acutely lowers intraocular pressure, potentially dislodging emboli and improving blood flow. The 76.5% of HBOT patients who also received paracentesis showed improvements far exceeding historical results from paracentesis alone.



Broader Context in Retinal Emergency Management



CRAO represents one manifestation of acute retinal vascular disease. Branch retinal artery occlusion, affecting peripheral retinal segments, and retinal vein occlusion, involving venous rather than arterial blockage, present related but distinct challenges. Treatment approaches developed for CRAO may inform strategies for these conditions.



The hyperoxic-hypoxic paradox mechanism underlying HBOT's benefits extends beyond ophthalmology. Similar protocols have shown efficacy for wound healing, carbon monoxide poisoning, and radiation tissue damage. Understanding how intermittent oxygen exposure triggers protective genetic programs could advance treatment for ischemic conditions throughout the body.



Emerging technologies may complement or enhance oxygen therapy. Retinal electrostimulation, neuroprotective agents, and stem cell therapies remain under investigation. Combination approaches addressing both acute ischemia and subsequent inflammation might optimize outcomes.



Recommendations for Patients and Providers



Individuals experiencing sudden, painless vision loss in one eye should seek emergency evaluation immediately. Every minute counts in preserving retinal function. While spontaneous recovery occurs in fewer than 20% of untreated CRAO cases, early intervention improves odds.



Ophthalmologists encountering CRAO patients should consider HBOT referral for cases presenting within 24 hours, particularly when thrombolysis is contraindicated or unavailable. The Siriraj protocol offers a template for centers developing their own approaches.



Healthcare systems should evaluate feasibility of establishing rapid-access HBOT programs for ophthalmic emergencies. The investment in equipment and training may be justified by improved outcomes in CRAO and potentially other acute retinal conditions.



Future research should include prospective randomized trials with standardized diagnostic criteria, consistent concurrent treatments, and long-term follow-up. Larger sample sizes would enable subgroup analyses by timing, severity, and concomitant therapies. Cost-effectiveness studies could inform resource allocation decisions.



This study provides preliminary but encouraging evidence that HBOT offers a practical, safe, and potentially effective option for CRAO patients presenting within 24 hours. The doubling of meaningful vision recovery rates and preservation of retinal structure justify continued investigation of this therapeutic approach.





References




Visual Outcomes Following Hyperbaric Oxygen Therapy in Acute Central Retinal Artery Occlusion. Dove Medical Press



Early Hyperbaric Oxygen Therapy After CRAO May Enhance Visual Recovery. American Academy of Ophthalmology



CRAO: Promising Results From Emergency Protocols. American Academy of Ophthalmology EyeNet



Outcomes of Hyperbaric Oxygen Treatment for Central Retinal Artery Occlusion. PubMed



Management of Central Retinal Artery Occlusion: A Scientific Statement. American Heart Association Journals

### Hyperbaric Oxygen Combined with Exosomes Shows Promise for Tissue Repair

Combining hyperbaric oxygen therapy with exosomes can significantly enhance tissue repair across multiple conditions. 



The combination works better than either treatment alone for neurological disorders. 



Animal studies show synergistic anti-inflammatory and neuroprotective effects. 



Researchers identify multiple mechanisms explaining the enhanced healing response. 



Clinical translation faces challenges including delivery optimization and standardization.




Researchers have identified a potential breakthrough in tissue repair by combining two distinct therapeutic approaches: hyperbaric oxygen therapy and exosomes. A comprehensive review published in Frontiers in Bioengineering and Biotechnology examines the synergistic effects of this combination across multiple disease models, revealing promising results that surpass either treatment used alone.



The research team, led by investigators from several Chinese medical institutions, analyzed existing studies on diabetic wounds, traumatic spinal cord injuries, peripheral nerve damage, and vascular diseases. Their findings suggest that pairing these therapies produces stronger anti-inflammatory, antioxidant, and tissue regeneration outcomes compared to single-treatment approaches.



How the Combination Works



Hyperbaric oxygen therapy delivers pure oxygen at pressures greater than normal atmospheric levels, increasing dissolved oxygen in blood and tissues. This enhanced oxygenation promotes angiogenesis, boosts cellular metabolism, and reduces inflammation. The therapy has been endorsed by the International Society of Underwater and Hyperbaric Medicine for 14 clinical conditions, including refractory wounds and thermal burns.



Exosomes are nanoscale vesicles released by cells that carry proteins, RNAs, and other bioactive molecules. Those derived from mesenchymal stem cells have demonstrated tissue repair capabilities by modulating immune responses, enhancing cell proliferation, and facilitating wound closure. They offer advantages over stem cell therapy, including simpler structure, higher stability, easier storage, and lower immunogenicity.



The combination creates unexpected biological interactions. Hyperbaric oxygen modifies both the quantity and content of exosomes released from cells. Studies on human coronary artery endothelial cells exposed to hyperbaric oxygen showed increased expression of MALAT1, a long non-coding RNA that promotes angiogenesis. The treatment also downregulated inflammation-related genes in exosomes, including TLR5, FAAH2, and SLC11A1.



This phenomenon stems from what researchers call the "hyperoxia-hypoxia paradox." While hyperbaric oxygen provides elevated oxygen levels, repeated exposure followed by return to normal conditions creates a state of relative hypoxia. This activates hypoxia-inducible factor-1α (HIF-1α), a protein that stabilizes under low oxygen and triggers exosome release. Clinical evidence supports this mechanism: patients with idiopathic acute sensorineural hearing loss showed dramatically increased serum exosome levels after hyperbaric oxygen treatment.



Exosomes also protect against hyperbaric oxygen-induced lung injury. Studies on bronchopulmonary dysplasia models showed that exosomes from mesenchymal stromal cells suppressed inflammatory responses and promoted tissue regeneration when administered alongside hyperbaric oxygen exposure. The exosomes reduced inflammatory lymphocytes and pro-inflammatory cytokines while facilitating alveolar epithelial cell proliferation.



Results Across Disease Models



The most extensive evidence comes from studies on diabetic wounds, which affect millions globally and frequently resist conventional treatment. Research by Yin and colleagues demonstrated that exosomes from human umbilical vein endothelial cells exposed to hyperbaric oxygen promoted browning of white adipose tissue. These beige adipocytes induced anti-inflammatory M2 polarization in macrophages and enhanced fibroblast proliferation, accelerating wound closure.



Ed. note: The diabetic wound findings represent in vitro observations that require validation in animal models and human trials.



Traumatic spinal cord injury studies provide the strongest evidence for clinical potential. In the first investigation of this combination, Cheshmi and colleagues treated rats with exosomes from human placental mesenchymal stem cells plus hyperbaric oxygen at 2.5 atmospheres for 90 minutes across three sessions. 



Compared to either treatment alone, the combination produced higher Basso-Beattie-Bresnehan locomotor scores on days 1, 3, 7, and 14 post-injury. The rats also performed better on narrow beam walking tests and showed significantly shorter electromyography latency.



A follow-up study by Hjazi and colleagues tested exosomes from human menstrual blood stem cells combined with hyperbaric oxygen in a similar injury model. These stem cells offer practical advantages: non-invasive collection, rapid proliferation with a 19.4-hour doubling time, and minimal immunogenicity. 



The combination again outperformed single treatments, though some differences did not reach statistical significance, possibly due to small sample sizes or immune factors affecting exosome delivery in cross-species applications.



Spinal cord ischemia-reperfusion injury, which can occur after abdominal aortic surgery, showed similar benefits. Jafari and colleagues found that combining hyperbaric oxygen with placental stem cell exosomes markedly reduced motor deficit index scores at 6, 12, and 48 hours post-injury compared to single treatments. Neuronal density increased, oxidative stress decreased, and histopathological damage improved.



For peripheral nerve damage, Amiri and colleagues examined sciatic nerve injury in rats. The combination therapy produced larger nerve volume, thicker myelin sheaths, and more nerve fibers compared to either hyperbaric oxygen or exosomes alone. Behavioral assessments showed considerably reduced electromyography delay and elevated sciatic nerve function index scores across 28 days of observation.



Vascular disease models yielded encouraging results. In hind limb ischemia, hyperbaric oxygen-induced exosomes markedly enhanced blood flow. For myocardial infarction, co-administration substantially decreased infarct size and increased cardiac ejection fraction by an average of 14% compared to exosomes not exposed to hyperbaric conditions.



Mechanisms of Synergy



The combination produces three key synergistic effects. First, it amplifies anti-inflammatory responses beyond what either treatment achieves individually. Studies across multiple injury models showed that tumor necrosis factor-α and interleukin-1β levels dropped significantly more with combined treatment. The therapy also boosted anti-inflammatory interleukin-10 expression, which promotes neuronal survival after injury.



Second, the pairing enhances antioxidant capacity while suppressing oxidative stress. Multiple investigations documented elevated levels of glutathione, catalase, and superoxide dismutase alongside reduced reactive oxygen species when both therapies were applied together. This balanced response helps prevent the cellular damage that slows tissue repair.



Third, the combination provides superior neuroprotection. Stereological measurements showed that total spinal cord volume in combined treatment groups reached approximately double that of control groups. The effect stemmed partly from reduced activity of caspase-3, an apoptosis-related protein. Lower caspase-3 activity translated to enhanced neuronal survival and proliferation across injury sites.



Safety Profile and Challenges



A systematic review and meta-analysis examining 24 randomized controlled trials with 1,497 subjects found an overall adverse effect rate of 30.11% for hyperbaric oxygen therapy, with ear discomfort being most common. When treatment protocols limited sessions to 10 or fewer and chamber pressure stayed below 2.5 atmospheres, adverse effects decreased markedly.



Exosomes from autologous cells show good tolerance, but allogeneic or xenogeneic sources may trigger immune rejection or allergic reactions. Surface proteins including MHC complexes can activate T cell responses. Contamination during extraction and purification presents infection risks. The hyperbaric environment itself may compromise exosomal membrane stability, releasing contents prematurely and activating unintended cellular signaling pathways.



Effective delivery remains a major bottleneck for clinical translation. Exogenous exosomes have short circulation times and face clearance by macrophages. The hyperoxic environment created by hyperbaric oxygen may oxidize and degrade exosomal lipid membranes, reducing bioavailability. Production costs, quality assurance, and standardized extraction and storage techniques represent practical challenges requiring resolution.



Path to Clinical Application



No clinical trials combining hyperbaric oxygen with exosomes have been conducted in humans. While hyperbaric oxygen therapy has extensive clinical use for traumatic conditions, the addition of exosomes requires substantial investigation to guarantee safety and efficacy.



Future research should examine various treatment protocols to identify optimal combinations and dosages. Randomized controlled trials need to assess long-term efficacy and safety, including tissue healing rates, inflammatory marker levels, and adverse event occurrences.



Multi-omics approaches using transcriptomics and proteomics may clarify the molecular interactions between hyperbaric oxygen and exosomes, revealing potential synergistic pathways and informing new intervention techniques. Given the heterogeneity of exosomes, subsequent research should investigate ideal ratios of distinct exosome sources to hyperbaric oxygen exposure. This could enhance treatment specificity and potentially reduce allogeneic rejection risks.



Standardization presents another critical challenge. Production costs, quality assurance, and standardized extraction and storage techniques require resolution before widespread clinical implementation. Establishing international consensus guidelines will ensure clinical trials adhere to Good Clinical Practice standards and facilitate uniform implementation globally.



Advances in bioengineering and nanotechnology may enhance exosome delivery systems. Integrating targeting ligands or protective coatings could improve stability in hyperbaric environments. Identification and validation of biomarkers would enable response monitoring and personalized treatment approaches.



Despite minimal toxicity in animal trials, potential human risks require careful evaluation. The transition from rodent models to large animal studies, then to human trials, will test whether the synergistic effects observed translate across species and physiological scales.



The research suggests a promising avenue for treating conditions that currently have limited options. The combination leverages complementary mechanisms: hyperbaric oxygen enhances the cellular environment for healing while also modifying exosomes to make them more therapeutically potent; exosomes deliver targeted repair signals while protecting tissues from oxygen toxicity. This bidirectional interaction may explain the superior outcomes compared to either treatment alone.



For patients with diabetic wounds, spinal cord injuries, and vascular diseases, this approach could represent a meaningful advance. The therapy's reliance on established hyperbaric oxygen infrastructure combined with cell-free exosome products may facilitate adoption once safety and efficacy are confirmed.



The next decade will likely see expanded investigation of this combination across additional conditions and the development of standardized protocols for clinical use. Treatment strategies based on personalized medicine will customize optimal plans for patients with various diseases, matching exosome sources and hyperbaric oxygen parameters to individual needs.



References




Frontiers in Bioengineering and Biotechnology - Hyperbaric oxygen in combination with exosomes: a new strategy to promote tissue repair



PubMed Central - Hyperbaric oxygen in combination with exosomes: a new strategy to promote tissue repair



Stem Cell Research & Therapy - Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing



Nature - Clinical applications of stem cell-derived exosomes



Frontiers in Cell and Developmental Biology - Bioengineered MSC-derived exosomes in skin wound repair and regeneration



Stem Cell Research & Therapy - Therapeutic potential of mesenchymal stem cell-derived exosomes in wound healing

### Hyperbaric Oxygen Therapy Aids Recovery in Rare Spinal Infection Case

A 70-year-old man developed a spinal epidural abscess after a traumatic fall 17 days earlier, complicated by dental infection and Streptococcus intermedius bacteremia.



Standard treatment with antibiotics and decompressive surgery failed to improve neurological symptoms in the patient's right upper limb.



Hyperbaric oxygen therapy at 2.0 atmospheres absolute for 60 minutes daily over 30 sessions was added as adjunctive treatment on postoperative day 5.



Motor function improved significantly after initiating HBOT, with the patient regaining right upper limb movement and transferring to rehabilitation by day 110.



Spinal epidural abscess affects 0.2 to 2.0 per 10,000 hospital admissions, with increasing prevalence in aging populations and those undergoing spinal procedures.




Researchers at Shimane University in Japan successfully treated a complex spinal epidural abscess case using hyperbaric oxygen therapy as an adjunctive treatment. 



The case, published in the Journal of Clinical Medicine in October 2025, involved a 70-year-old man whose condition failed to improve with standard surgical and antibiotic interventions alone.



Dr. Yoshiaki Iwashita and colleagues from the Department of Emergency and Critical Care Medicine documented the case in their report, which highlights the potential role of HBOT (hyperbaric oxygen therapy) in treating refractory spinal infections.



Complex Medical Presentation



The patient presented with severe neck pain, fever of 39.0 degrees Celsius, and inability to move his right shoulder or properly flex his elbow. These symptoms developed 17 days after he fell forward at home following alcohol consumption.



Medical imaging revealed a C3 vertebral fracture with both ventral and dorsal epidural lesions compressing the spinal cord. Blood cultures identified Streptococcus intermedius, and dental examination found multiple untreated cavities. According to the research team, the infection appeared to have developed when bacteria from the dental infection entered a post-traumatic epidural hematoma created by the fall.



Laboratory results showed C-reactive protein levels of 31.5 mg/dL and procalcitonin levels of 1.57 ng/mL, along with anemia and thrombocytopenia. Enhanced CT imaging showed peripheral rim enhancement consistent with infection of the existing hematoma.



Standard Treatment Proves Insufficient



Physicians initially started intravenous meropenem, switching to ampicillin on day 6 after antimicrobial susceptibility results became available. While fever and inflammation decreased, neurological symptoms showed no improvement.



By day 9, the patient's motor function had worsened significantly. Manual muscle testing revealed severe weakness in shoulder abduction, elbow flexion and extension, and wrist movements. Surgeons performed C5-6 laminoplasty, partial laminectomy of C2 and C7, and complete laminectomy of C3 and C4 to decompress and drain the spinal cord.



The surgical procedure aimed to relieve pressure on the spinal cord, but neurological findings remained unchanged the day after surgery. "Despite surgery and culture-directed antibiotics, the clinical symptoms remained unchanged," the researchers noted in their report.



Hyperbaric Oxygen Therapy Protocol



The medical team initiated HBOT on postoperative day 5 as an adjunctive therapy. The protocol followed recommendations from The Japanese Society of Hyperbaric and Undersea Medicine, consisting of 2.0 atmospheres absolute pressure for 60 minutes once daily over 30 total sessions.



HBOT works by increasing dissolved oxygen in blood and tissues, which enhances phagocytic killing of bacteria, reduces edema, and improves antibiotic penetration into poorly perfused areas. The Undersea and Hyperbaric Medical Society currently recognizes 14 established indications for HBOT, including intracranial abscess and refractory osteomyelitis, though spinal epidural abscess is not among the standard indications.



Clinical Improvement Following HBOT



After starting hyperbaric oxygen therapy, the patient showed marked improvement. Pain decreased, inflammatory markers dropped, and motor function recovered progressively. By day 23, manual muscle testing demonstrated significant gains in shoulder, elbow, wrist, and finger movements.



MRI imaging on day 23 showed anterior compression at the C3-4 level had progressed, but spinal canal stenosis had not developed due to the prior laminectomy. The medical team considered an anterior surgical approach but chose conservative management because inflammatory markers remained low with antibiotic therapy.



By day 89, MRI demonstrated reduction in epidural collection, cord decompression, and pre-vertebral abscess. Intravenous antibiotics continued until day 91, then switched to oral antibiotics. On day 110, the patient had regained right upper limb function and transferred to a rehabilitation hospital.



Clinical Implications and Mechanisms



The researchers acknowledge several limitations in their case. The delay in surgical intervention may have contributed to initial severity and persistence of neurological deficits. HBOT was introduced after surgery, and earlier initiation might have facilitated faster recovery, though this remains speculative.



"HBOT should not delay urgent surgery or antimicrobial therapy; however, our findings demonstrate that it can be considered as an adjunctive therapy, though further studies are warranted to clarify these indications," the authors wrote.



Beyond infection control, HBOT has shown promise in traumatic spinal cord injury models, where it reduces neuroinflammation, limits cell death, and promotes neurological recovery. Research published in the Journal of Back and Musculoskeletal Rehabilitation suggested improvements in motor and sensory scores following HBOT compared to standard therapy alone.



Rare Complication of Trauma



Secondary infection of pre-existing epidural hematomas remains uncommon but mechanistically plausible. Trauma predisposes up to one-third of spinal epidural abscess cases and creates a hematoma that can become a nutrient-rich environment for bacteria during bacteremia episodes.



Spinal epidural abscess affects an estimated 0.2 to 2.0 cases per 10,000 hospital admissions, with increasing prevalence parallel to aging populations and wider use of spinal instrumentation. The condition predominantly affects middle-aged to elderly adults with slight male predominance. According to research published in the New England Journal of Medicine, delays in diagnosis strongly associate with worse neurological outcomes.



Standard therapy consists of prolonged intravenous antibiotics, commonly over six weeks, combined with surgical drainage when indicated. Despite appropriate treatment, permanent neurological deficits can result if diagnosis or intervention is delayed beyond 24 to 36 hours.



The case report, authored by Iwashita and colleagues including Naho Yoshioka, Kotaro Murakami, Ken Mukoyama, Rie Sato, Nobuhiro Kodani, and Tetsuya Makiishi, appears in the October 2025 issue of the Journal of Clinical Medicine under a CC BY 4.0 license.







Citation: Iwashita, Yoshiaki & Yoshioka, Naho & Murakami, Kotaro & Mukoyama, Ken & Sato, Rie & Kodani, Nobuhiro & Makiishi, Tetsuya. (2025). Cervical Epidural Abscess Secondary to a Post-Traumatic Hematoma, Successfully Treated with Adjunctive Hyperbaric Oxygen Therapy: A Case Report. Journal of Clinical Medicine. 14. 7346. 10.3390/jcm14207346.

### Hyperbaric Oxygen Therapy Device Market Set to Reach $6.42 Billion by 2029

The global hyperbaric oxygen therapy device market will grow from $4.58 billion in 2025 to $6.42 billion by 2029.



Diabetes prevalence is projected to increase from 529 million cases in 2023 to 1.3 billion by 2050, according to the Institute for Health Metrics and Evaluation.



Automated logging software and artificial intelligence integration represent major technological advances in treatment precision.



North America leads the current market, while Asia-Pacific shows the fastest growth trajectory through 2029.



Monoplace, multiplace, and topical device categories serve applications ranging from wound healing to decompression sickness treatment.




The hyperbaric oxygen therapy (HBOT) device market is experiencing significant expansion, driven by increasing chronic disease rates and technological improvements in treatment delivery systems.



Market Growth Accelerates



The market reached $4.19 billion in 2024 and is projected to hit $4.58 billion in 2025, representing a compound annual growth rate of 9.2%, according to The Business Research Company. By 2029, the market value should reach $6.42 billion at an 8.8% CAGR.



The historic growth stems from several factors. Chronic wounds and diabetic ulcers have become more prevalent, creating demand for HBOT treatment options. Healthcare providers increasingly recognize HBOT's effectiveness for decompression sickness and neurological disorders. Government funding programs have supported research and development activities, while healthcare infrastructure expansion has made these devices more accessible.



Diabetes Epidemic Fuels Demand



The rising number of diabetes cases stands out as a primary market driver. Data from the Institute for Health Metrics and Evaluation shows global diabetes cases will jump from 529 million in 2023 to 1.3 billion by 2050. The worldwide prevalence rate of 6.1% is set to climb substantially, with North Africa and the Middle East showing the highest rates at 9.3%, projected to reach 16.8% by 2050.



HBOT devices offer supplementary management for diabetes complications. The therapy aids wound healing and tissue repair through high-pressure oxygen application, potentially reducing diabetic foot ulcer complications and improving patient outcomes.



Technology Integration Transforms Treatment



Major manufacturers are incorporating advanced technology into hyperbaric chambers. Sechrist Industries Inc. launched the 3300 HM Hyperbaric Chamber and eHEAL System in January 2024. The 3300 HM features a Patient Step-in Entry design that eliminates the need for hyperbaric stretchers, while the eHEAL System provides automated treatment logging with real-time data recording capabilities.



The forecast period will see several technological trends emerge. Artificial intelligence and machine learning algorithms will enhance treatment protocols. Mobile applications and software platforms will improve patient monitoring. Wearable hyperbaric oxygen devices will offer new treatment options. Sports medicine facilities will adopt HBOT for athlete recovery programs.



Market Segmentation and Applications



The market divides into three main device types. Monoplace hyperbaric oxygen therapy devices accommodate single patients and include portable and fixed chamber options. Multiplace hyperbaric oxygen therapy devices range from two-person chambers to large systems holding 4-10 people, often featuring entertainment and monitoring systems. 



Topical hyperbaric oxygen therapy devices target localized treatment for wounds, skin conditions, and minor injuries.



Applications span multiple medical areas. Wound healing remains the primary use case, followed by decompression sickness treatment, infection management, and gas embolism therapy. Hospitals represent the largest end-user segment, though home care adoption is growing.



Competitive Landscape



Leading companies operating in the market include Healogics LLC, SOS Medical Group Ltd., Environmental Tectonics Corporation, and BioBarica. These firms compete through product innovation, safety features, and treatment efficiency improvements.



Perry Baromedical Corporation, Shanghai Baobang Medical Equipment, and Hyperbaric Modular Systems Inc. focus on different market segments. European manufacturers like HAUX-LIFE-SUPPORT GmbH and BAROKS Hyperbaric serve regional markets, while companies such as Pan America Hyperbarics Inc. and AHA Hyperbarics target North American customers.



Regional Market Dynamics



North America dominated the market in 2024, benefiting from established healthcare infrastructure and insurance coverage for HBOT treatments. The region's market strength comes from high diabetes prevalence, advanced medical facilities, and research funding.



Asia-Pacific will show the fastest growth through 2029. Factors include expanding healthcare systems, rising disposable incomes, and increasing awareness of HBOT benefits. Western Europe, Eastern Europe, South America, the Middle East, and Africa represent additional growth opportunities.



Future Market Drivers



Several factors will propel market expansion through 2029. The aging population requires more chronic disease management. Research funding continues to support new treatment indications and protocol refinements. Demand for portable chambers is rising. Healthcare spending and insurance coverage for HBOT are increasing globally.



The combination of regenerative medicine practices with HBOT represents an emerging trend. Clinical trials are exploring new applications, while technological advances make devices more accessible and effective. These developments position the hyperbaric oxygen therapy device market for sustained growth through the end of the decade.

### Study Reveals HBOT's Threshold for Lasting PTSD Relief in Veterans

A new study demonstrates that hyperbaric oxygen therapy (HBOT) can promote neuroplasticity and reduce PTSD symptoms in veterans.



The research analyzed data from 56 male veterans who did not respond to standard treatments.



Participants achieving at least 35% symptom improvement during HBOT maintained gains after treatment ended.



HBOT involves breathing 100% oxygen under increased pressure to repair brain tissue.



The protocol, called the hyperoxic-hypoxic paradox, fluctuates oxygen levels to aid brain regeneration.




A study published on September 17, 2025, explores how hyperbaric oxygen therapy (HBOT) provides long-term relief from post-traumatic stress disorder (PTSD) symptoms in male veterans. 



Conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and the Department of Molecular Biology at the Weizmann Institute of Science in Rehovot, Israel, the research highlights HBOT's role in addressing treatment-resistant PTSD. 



PTSD affects more than 13 million Americans and up to 30% of combatants, leading to intrusive thoughts, avoidance, mood changes, and hyperarousal that impair daily life. Traditional therapies fail for about 50% of patients due to lasting brain changes. 



This study reexamined data from a prior trial with 56 veterans, using statistical analysis to link in-treatment progress to ongoing benefits. The full study is available here.



Understanding PTSD and Treatment Challenges



PTSD develops after exposure to events like combat, accidents, assaults, terror attacks, or natural disasters. Symptoms fall into four main groups: intrusive memories such as nightmares and flashbacks; avoidance of reminders; negative shifts in thoughts and mood; and heightened alertness or hyperarousal. These issues disrupt social and work functions, reducing quality of life.



Standard treatments often fall short, with half of patients showing no response. Recent research points to structural and activity changes in the brain as reasons for this resistance. As a result, treatments that target biology, like those inducing neuroplasticity—the brain's ability to reorganize and repair itself—have drawn focus. 



The study, titled Hyperbaric Oxygen Therapy for PTSD: Threshold Effect for Sustained Symptom Improvement in a Biologically Based Treatment, builds on this by showing HBOT's potential to fix damaged brain tissue.



Key Findings from the HBOT Trial



The trial involved 56 male veterans with PTSD who had not benefited from other therapies. Researchers applied statistical methods to assess how symptom changes during HBOT predicted long-term outcomes. 



Veterans who reached a 35% or greater reduction in symptoms by the end of treatment saw continued improvement post-therapy. In contrast, those below this level lost their gains.



This threshold effect mirrors patterns in wound healing, where HBOT promotes tissue repair until a healing point is reached, after which recovery proceeds independently. In the brain, crossing the 35% mark triggers regenerative processes that persist without further sessions.



Dr. Shai Efrati, chair of Aviv Scientific’s Medical Advisory Board and director of the Sagol Center, explained the implications in a statement from the press release: 




“HBOT offers veterans a promising treatment option for PTSD by addressing underlying biological factors that contribute to their symptoms. The results of this study are similar to what we see in peripheral non-healing wounds: HBOT is continued until ~80% granulation tissue is achieved, after which the healing process continues on its own.” 




He added: 




“We now observe the same principle in the brain – once the threshold is crossed, regenerative processes carry forward even after HBOT ends. This enables veterans to experience lasting symptom relief, allowing them to regain their quality of life.”




Sources for these findings include the study's authors at Shamir Medical Center and the Weizmann Institute, as detailed in the GlobeNewswire press release dated September 17, 2025.



How HBOT Works and Its Protocol



Hyperbaric oxygen therapy (HBOT) delivers 100% oxygen in a pressurized chamber, increasing oxygen levels in the blood and tissues. This process, known as the hyperoxic-hypoxic paradox, alternates high and low oxygen exposure during sessions. 



The fluctuations stimulate repair in damaged brain areas, supporting recovery from conditions like stroke, traumatic brain injury, PTSD, long COVID, and cognitive decline linked to aging.



The protocol used in this study aligns with treatments at Aviv Clinics in The Villages, Florida. No specific hardware versions or compatibility details were mentioned, but HBOT chambers meet medical standards for safe oxygen delivery under pressure up to 2-3 atmospheres absolute (ATA), as per general industry practices. 



The therapy requires patients to sit or lie in the chamber for sessions lasting 60-90 minutes, typically over 40-60 treatments.



About Aviv Clinics and Broader Applications



Aviv Clinics leads efforts in treating cognitive and functional decline through advanced HBOT protocols. Partnered with the Sagol Center at Shamir Medical Center—the world's largest hyperbaric facility—the clinics offer the Aviv Medical Program. 



This program combines HBOT with cognitive exercises, physical activity, and nutrition, based on nearly two decades of research and thousands of treated patients.



The program follows evidence from studies like this one, overseen by Dr. Efrati. It targets chronic neurological issues without needing special software or hardware beyond standard medical equipment. For more on Aviv Clinics, refer to their official resources in the original announcement.



This research, reported via GlobeNewswire on September 17, 2025, from Orlando, Florida, underscores HBOT's value for veterans facing PTSD's daily burdens.

### Hyperbaric Oxygen Therapy Shows Promise for Retinal Artery Blockages

Patients receiving hyperbaric oxygen therapy (HBOT) showed significantly better visual recovery compared to standard treatment, with 76.5% achieving at least three lines of vision improvement versus 40.6% in the control group.



The study protocol involved five daily HBOT sessions starting at 2.0 atmospheres absolute (ATA) for 180 minutes, then 2.4 ATA for 90 minutes, regardless of visual changes during treatment.



Treatment remained effective even when initiated up to 24 hours after symptom onset, challenging previous assumptions about the narrow therapeutic window for central retinal artery occlusion (CRAO).



Optical coherence tomography (OCT) measurements revealed less retinal thinning in HBOT patients at one month, suggesting the therapy helps preserve retinal structure beyond just functional improvements.



Two of 17 patients (11.8%) experienced adverse events, including headache with nausea and one seizure case, though both recovered fully without long-term complications.




Researchers at Siriraj Hospital, Mahidol University in Bangkok conducted a retrospective study examining 49 patients diagnosed with CRAO between October 2003 and March 2022. The study, published in Clinical Ophthalmology, compared outcomes between 17 patients who received HBOT and 32 who received standard care alone.



CRAO represents a rare but devastating ophthalmic emergency, affecting approximately one in 100,000 adults annually according to research published in the American Journal of Ophthalmology. The condition shares similarities with stroke, causing sudden vision loss that typically deteriorates to 20/400 or worse in most cases.



Lead author Dr. Supathida Jiamsawad and colleagues established strict inclusion criteria. All patients presented within 24 hours of symptom onset. The team excluded patients who received recombinant tissue plasminogen activator (rt-PA) or experienced treatment-related complications.



Both groups showed comparable baseline characteristics. Initial visual acuity measured 2.3 logarithm of the minimum angle of resolution (logMAR) in both cohorts. Mean symptom onset time was 11.6 hours for HBOT patients and 12.0 hours for controls.



Treatment Protocol and Rationale



The Siriraj protocol differs from previous HBOT approaches in several key aspects. Patients received treatment once every 24 hours for five consecutive days, regardless of visual improvement during therapy.



The first session delivered 100% oxygen at 2.0 ATA for 180 minutes. This included a 15-minute descent period, a five-minute air break midway through treatment, and a 15-minute ascent. Subsequent sessions increased pressure to 2.4 ATA but shortened duration to 90 minutes, maintaining the five-minute air break.



Dr. Jiamsawad explained the rationale in the study. "The lower initial session at 2 ATA mitigates the risk of oxygen toxicity, while compensating for oxygen supply by the longer duration at 180 minutes."



The 24-hour intervals between sessions aim to trigger what researchers call the hyperoxic-hypoxic paradox. During rest periods, lower oxygen levels stimulate hypoxia-inducible factor (HIF), a transcription factor regulating over 100 genes necessary for cellular survival under oxygen-deprived conditions. This process improves cells' ability to produce energy independently of oxygen while inducing vascular endothelial growth factor (VEGF) to promote blood vessel formation.



Visual Outcomes and Statistical Analysis



At discharge, 76.5% of HBOT patients achieved visual improvement of at least 0.3 logMAR (three lines on an eye chart) compared to 40.6% in the control group (p = 0.02). Mean visual acuity improved from 2.3 to 1.4 logMAR in the HBOT group, while controls showed modest change from 2.3 to 2.0 logMAR.



The HBOT advantage persisted at follow-up examinations. At one week, mean visual acuity measured 1.5 logMAR for HBOT patients versus 2.1 logMAR for controls. At one month, these values remained 1.4 logMAR and 1.9 logMAR respectively.



Generalized estimation equation (GEE) analysis identified HBOT as a statistically significant predictor of visual outcome (p < 0.01). The treatment showed a coefficient of -0.59 (95% confidence interval: -0.94 to -0.25), meaning HBOT reduced final logMAR by 0.59 units.



Anterior chamber paracentesis also emerged as a significant predictor, with a coefficient of -0.42 (95% CI: -0.70 to -0.15, p < 0.01). However, 76.5% of HBOT patients also received paracentesis, making it difficult to isolate each intervention's specific contribution.



Structural Preservation Evidence



OCT measurements provided objective evidence of HBOT's protective effects. Researchers measured inner retinal thickness manually at four quadrants (nasal, temporal, superior, inferior) located 750 micrometers from the fovea.



At initial presentation, mean inner retinal thickness measured 206.8 micrometers in the HBOT group and 192.6 micrometers in controls (p = 0.646). At one month follow-up, HBOT patients maintained significantly greater thickness at 136.3 micrometers compared to 104.3 micrometers in controls (p = 0.049).



The findings suggest HBOT helps preserve retinal structure by mitigating ischemic damage. According to research in Experimental Eye Research, the inner retina relies predominantly on the central retinal artery for oxygen. When this artery becomes blocked, HBOT increases dissolved oxygen in plasma, enabling oxygen to diffuse from the choroidal circulation into ischemic central retina.



This oxygen delivery supports critical retinal layers including ganglion cells, the inner plexiform layer, and the inner nuclear layer. Although HBOT does not restore blood flow through the occluded artery, elevated plasma oxygen allows oxygen to bypass the blockage through diffusion from adjacent capillaries and non-occluded vessels.



Comparison with International Studies



The Thai results align with findings from other countries despite variations in baseline characteristics and treatment timing. Research from Israel by Hadanny and colleagues reported baseline visual acuity of 2.1 logMAR improving to 1.6 logMAR at discharge. German researchers Menzel-Severing and team found improvement from 1.8 logMAR to 1.5 logMAR.



Treatment timing differed substantially between studies. The Israeli cohort began HBOT at mean 7.8 hours after symptom onset, while German patients started at 5.3 hours. Thai patients had significantly longer delays at 11.6 hours, yet achieved similar visual improvements.



Dr. Jiamsawad noted the implications. "Despite this delay, the similar VA improvements suggest that HBOT may still be effective even in patients who present later, reinforcing its potential as a treatment option for CRAO."



The finding challenges earlier assumptions based on primate experiments by Hayreh and Jonas, which suggested irreversible damage occurs after four hours of complete arterial occlusion. However, human CRAO typically presents as incomplete or temporary occlusion with varying degrees of reperfusion, differing from the experimental model's direct clamping approach.



Safety Profile and Adverse Events



Two of 17 HBOT patients (11.8%) experienced adverse events. One patient developed headache, nausea, and vomiting before completing the treatment series. Another patient experienced a generalized tonic-clonic seizure lasting one minute during the first session.



Comprehensive evaluation of the seizure patient revealed hypocalcemia as the only notable risk factor. Researchers considered oxygen toxicity the most likely cause. After discussion of risks and benefits, the patient discontinued HBOT and received a short course of antiepileptic medication, which was tapered before discharge.



Both patients recovered fully without requiring further intervention or experiencing long-term complications. No recurrence of symptoms occurred during follow-up. Notably, no patients experienced barotrauma, a common HBOT complication reported in 9% to 27% of cases in various studies.



The relatively low adverse event rate contrasts with risks associated with alternative treatments. Intravenous thrombolysis with rt-PA carries risks of intracerebral and systemic hemorrhage, particularly when administered beyond the 4.5-hour therapeutic window according to American Heart Association guidelines.



Clinical Implications and Treatment Window



The study's most significant finding may be the extended therapeutic window. Previous recommendations suggested initiating HBOT within 12 hours of CRAO diagnosis, or as early as six to eight hours according to research in the European Journal of Ophthalmology.



GEE analysis revealed that symptom onset time was not a significant predictor of visual outcome (p = 0.41) in patients presenting within 24 hours. This finding aligns with research by Rozenberg and colleagues, which also found no correlation between timing of first HBOT session and final visual outcome in patients presenting within 24 hours.



The extended window provides opportunities for patients who cannot access immediate treatment. Given the time required for hyperbaric chamber preparation, team mobilization, patient evaluation, and standard interventions like ocular massage and paracentesis, the 24-hour window offers more realistic treatment access.



However, the study acknowledges limitations. Despite improvements, mean visual acuity at discharge remained 1.4 logMAR (approximately 6/150 Snellen equivalent) in the HBOT group versus 2.0 logMAR (approximately counting fingers) in controls. Both values fall below the 6/60 threshold defining legal blindness in many countries.



The proportion of patients achieving visual acuity of at least 6/60 remained relatively low in both groups (29.41% HBOT versus 15.6% controls, p = 0.25). This lack of statistical significance suggests that while HBOT produces measurable visual improvement, its impact on achieving functional vision thresholds remains inconclusive.



Study Limitations and Future Directions



The researchers identified several constraints affecting their conclusions. The small sample size of 49 patients limits statistical power. The retrospective design prevented standardized administration of adjunctive treatments between groups.



Follow-up data posed challenges. As a tertiary facility, Siriraj Hospital often refers patients back to initial hospitals for long-term care after acute treatment. This resulted in missing information, particularly one-month visual acuity data. Only 13 of 17 HBOT patients (76.5%) and 27 of 32 controls (84.4%) attended one-month appointments.



OCT analysis faced methodological limitations. Manual measurement of inner retinal thickness, even when divided into quadrants, introduces potential inter-observer variability and measurement bias. The exclusion of poor-quality OCT images relied on subjective determination without predefined quantitative thresholds.



Diagnostic criteria also varied. CRAO diagnosis relied primarily on clinical manifestations supplemented by OCT or fundus fluorescein angiography (FFA) in some cases, but without fully standardized, objective imaging-based criteria used in certain clinical trials.



The study could not isolate HBOT's specific contribution due to concurrent standard treatments. Most patients received multiple interventions including anti-glaucoma medications, paracentesis, and oxygen therapy. The limited number of patients receiving only HBOT prevented meaningful subgroup analysis.



Dr. Jiamsawad and colleagues emphasize the need for prospective validation. "A study design with more standardized diagnostic protocols, objective image quality criteria, and better control of standard of care represents an important avenue for future research."



Mechanism of Action and Physiological Basis



HBOT's therapeutic effect operates through multiple physiological mechanisms. Under normal conditions, 99% of hemoglobin carries oxygen while dissolved free oxygen in plasma remains relatively small. HBOT significantly elevates the dissolved fraction, supplying ischemic areas independently of saturated hemoglobin.



Beyond vascular delivery, aquaporin-1 (AQP-1) water channels serve as alternative oxygen transporters between cells according to research in the Journal of Biological Chemistry. This provides additional pathways for oxygen delivery to hypoxic retinal tissue.



The outer retina, primarily supplied by choroidal circulation, also benefits from increased oxygenation. Photoreceptors with high metabolic demands receive enhanced oxygen delivery from the choroid. By maintaining retinal pigment epithelium and outer retinal layer function, HBOT helps preserve overall retinal integrity, preventing secondary degeneration from inner retinal ischemia.



Some researchers have raised concerns about retinal artery vasoconstriction as a consequence of hyperoxia. However, studies in JAMA suggest vasoconstriction typically occurs only in adequately perfused cells, making it less likely during CRAO's acute phase when cells face severe oxygen deprivation.



Resource Requirements and Implementation



The fixed five-day protocol offers practical advantages for healthcare facilities. Unlike protocols continuing HBOT until visual improvement plateaus, the standardized approach reduces need for repeated visual acuity evaluations during non-office hours when medical staff are limited.



Predictable scheduling enhances HBOT chamber management, particularly when sharing facilities with other departments. The consistent five-day endpoint ensures treatment cost predictability for patients and healthcare systems.



However, HBOT remains resource-intensive. Treatment requires specialized hyperbaric chambers, trained personnel, and significant time commitment from patients and staff. These requirements limit availability primarily to tertiary care centers.



The study's setting at Siriraj Hospital, a major academic medical center in Bangkok, may not represent typical resource availability. Smaller facilities or those in rural areas may lack hyperbaric oxygen capabilities, limiting treatment access for many CRAO patients.



Conclusion and Clinical Recommendations



The Siriraj protocol demonstrates that HBOT can improve visual outcomes in CRAO patients presenting within 24 hours of symptom onset. The treatment shows benefits beyond the previously assumed narrow therapeutic window, offering hope for patients unable to access immediate intervention.



The fixed protocol of five daily sessions, starting at 2.0 ATA for 180 minutes then continuing at 2.4 ATA for 90 minutes, provides a practical framework balancing efficacy with safety. The 24-hour intervals between sessions leverage physiological responses to intermittent hypoxia, potentially enhancing long-term cellular survival.



However, the researchers emphasize caution in clinical adoption. "While constrained by the small sample size and short-term outcome data, these results showed the benefits of this unique HBOT protocol in CRAO presenting within the critical 24-hour window. Nevertheless, further prospective validation is necessary before widespread clinical adoption."



For clinicians managing CRAO patients, HBOT represents a potential option particularly for those presenting outside conventional thrombolysis windows or with contraindications to rt-PA. The therapy may be most valuable when combined with standard interventions like paracentesis, though isolating each treatment's specific contribution requires further study.



Citations




Thoongsuwan S, Sirichayaporn T, Rodanant N, et al. Visual Outcomes Following Hyperbaric Oxygen Therapy in Acute Central Retinal Artery Occlusion Patients. Clinical Ophthalmology. 2025. DOI: https://doi.org/10.2147/OPTH.S510772



Leavitt JA, Larson TA, Hodge DO, Gullerud RE. The incidence of central retinal artery occlusion in Olmsted County, Minnesota. American Journal of Ophthalmology. 2011;152(5):820-823. DOI: https://doi.org/10.1016/j.ajo.2011.05.005



Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. American Journal of Ophthalmology. 2005;140(3):376-391. DOI: https://doi.org/10.1016/j.ajo.2005.03.038



Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: a scientific statement from the American Heart Association. Stroke. 2021;52(6):e282-e294. DOI: https://doi.org/10.1161/STR.0000000000000366



Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Experimental Eye Research. 2004;78:723-736. DOI: https://doi.org/10.1016/S0014-4835(03)00214-8



Hadanny A, Maliar A, Fishlev G, et al. Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen. Clinical Ophthalmology. 2017;11:115-125. DOI: https://doi.org/10.2147/OPTH.S121307



Menzel-Severing J, Siekmann U, Weinberger A, Roessler G, Walter P, Mazinani B. Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction. American Journal of Ophthalmology. 2012;153(3):454-459. DOI: https://doi.org/10.1016/j.ajo.2011.08.009



Rozenberg A, Peled A, Hadad A, et al. Hyperbaric oxygen treatment for non-arteritic central retinal artery occlusion retrospective comparative analysis from two tertiary medical centres. Eye. 2022;36(6):1261-1265. DOI: https://doi.org/10.1038/s41433-021-01617-8



Hayreh SS, Jonas JB. Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys. American Journal of Ophthalmology. 2000;129(6):786-795. DOI: https://doi.org/10.1016/S0002-9394(00)00384-6



Kim YS, Nam MS, Park EJ, et al. The effect of adjunctive hyperbaric oxygen therapy in patients with central retinal artery occlusion. Undersea and Hyperbaric Medicine. 2020;47(1):57-64. DOI: https://doi.org/10.22462/01.03.2020.7



Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B. Early hyperbaric oxygen therapy for retinal artery occlusion. European Journal of Ophthalmology. 2001;11(4):345-350. DOI: https://doi.org/10.1177/112067210101100405



Echevarria M, Munoz-Cabello AM, Sanchez-Silva R, Toledo-Aral JJ, Lopez-Barneo J. Development of cytosolic hypoxia and hypoxia-inducible factor stabilization are facilitated by aquaporin-1 expression. Journal of Biological Chemistry. 2007;282(41):30207-30215. DOI: https://doi.org/10.1074/jbc.M702639200



Saltzman HA, Hart L, Sieker HO, Duffy EJ. Retinal vascular response to hyperbaric oxygenation. JAMA. 1965;191(4):290-292. DOI: https://doi.org/10.1001/jama.1965.03080040032007




The research adds to growing evidence supporting HBOT for CRAO while highlighting the need for larger, prospective trials with standardized protocols and longer follow-up periods to establish definitive treatment guidelines.

### Hyperbaric Oxygen Therapy Helps Breast Cancer Survivor Heal Radiation Damage

Krystal Anderson developed severe arm complications more than a decade after breast cancer treatment that included radiation therapy and removal of 29 lymph nodes.



Fluid retention in her arm worsened after contracting COVID-19, making her susceptible to cellulitis infections.



She completed 40 hyperbaric oxygen therapy sessions at Essentia Health in Fargo, combined with surgery, to treat radiation-induced tissue damage.



The treatment significantly reduced fibrous tissue and fluid buildup while improving her range of motion and arm function.



Anderson now serves as co-chair of F-M Breast Friends, supporting more than 460 people in the region through their breast cancer journeys.








A breast cancer survivor from the Fargo area has successfully recovered from severe radiation-related complications using hyperbaric oxygen therapy, a specialized treatment now available at Essentia Health in Fargo. 



Krystal Anderson's case demonstrates how the therapy can address long-term side effects from cancer treatment, according to WDAY News.



Complications From Cancer Treatment



Anderson underwent aggressive breast cancer treatment more than a decade ago, including radiation therapy and surgery to remove 29 lymph nodes. While the treatment successfully addressed her cancer, it left lasting effects on her arm that eventually led to serious medical complications.



The situation worsened after Anderson contracted COVID-19. Her arm continued to retain fluid and failed to return to its previous size, even during periods when inflammation typically subsided.



"It just continued to retain fluid. It really didn't go back down in size like it did before, when I would have a little bit of a flare up. And then, as a result, when that fluid sits in your arm for a long time, you become really susceptible to cellulitis," - Anderson told WDAY News.



Cellulitis, a bacterial skin infection, becomes a significant risk when fluid accumulates in tissues for extended periods. The condition can lead to serious health complications if left untreated.



Hyperbaric Treatment Process



Anderson was referred to Dr. Ajayi at Essentia Health's hyperbaric medicine department for specialized treatment. 



The therapy uses pure oxygen in pressurized chambers to increase oxygen levels in the bloodstream, which then reaches damaged tissues to promote healing.



Dr. Ajayi explained to WDAY News that hyperbaric medicine offers particular benefits for cancer patients dealing with radiation-induced tissue damage.



"The moment you make that connection, that mix between hyperbaric and oxygen, so the pressure and the 100% oxygen together, it's almost like you have a medication in your hand,"  Dr. Ajayi said.



Anderson completed 40 sessions in the hyperbaric chamber, which she referred to as "dives," along with surgical intervention. The combined approach produced measurable improvements in her condition.



Recovery Results



The treatment yielded significant results for Anderson's arm function and overall quality of life. She noticed multiple improvements throughout the therapy process.



"The fibrous tissue diminished greatly. I noticed that some of the fluid had gone out of the arm. My movement, my range of movement was really good. And so I feel like I was in such a great place going into that surgery, and it really helped me with that," Anderson told WDAY News.



The reduction in fibrous tissue and fluid buildup, combined with improved range of motion, brought Anderson's arm back to normal function. She described the treatment as placing her in an optimal condition for the surgical component of her care.



Supporting Other Cancer Patients



Anderson has channeled her experience into helping others facing similar challenges. She currently serves as co-chair of F-M Breast Friends, an organization that supports more than 460 people in the Fargo-Moorhead region navigating their breast cancer journeys.



Anderson emphasized to WDAY News that connecting with others going through the same experience played an important role in her own cancer journey. Her advocacy work allows her to provide that same support to others in the community dealing with breast cancer diagnosis and treatment.



Essentia Health's hyperbaric medicine department recently received accreditation with distinction from the Undersea and Hyperbaric Medical Society, making it one of 51 facilities nationwide and the only center in the Dakotas or Montana with this recognition, according to WDAY News.

### The 5 Best Soft Shell Hyperbaric Chambers of 2025 (Reviews)

I've spent months researching soft shell hyperbaric chambers, and honestly? The home HBOT market has exploded. 



What used to be a niche wellness treatment reserved for clinics is now sitting in people's living rooms. These inflatable chambers promise the benefits of mild hyperbaric oxygen therapy (mHBOT) without the hefty price tag or space requirements of traditional hard shell units.



Soft shell hyperbaric chambers are blowing up right now. The hyperbaric oxygen therapy market was valued at $34.5 billion in 2023 and is projected to grow at a CAGR of 6.51% through 2032, with portable hyperbaric chambers alone expected to reach $628.55 billion by 2032 at an 8.50% growth rate. [1] 



But what exactly are we talking about here? 



Soft shell hyperbaric chambers are inflatable units that deliver mild hyperbaric oxygen therapy (mHBOT) = pressurized oxygen treatment at lower pressures than medical-grade hard chambers. These puppies typically operate between 1.3 to 1.5 ATA (atmospheres absolute), which is roughly 30-50% more pressure than you'd experience at sea level.



The whole point? Getting more oxygen into your bloodstream to potentially speed up healing, reduce inflammation, and boost recovery. 



Athletes use HBOT to speed up recovery from strenuous training or injuries, while wellness enthusiasts are exploring its potential for improving brain function and cellular regeneration. [2] 



Here's the deal though - I'm not here to tell you what miracles these chambers can or can't perform. That's between you and your doctor. What I can tell you is which soft shell chambers are actually worth your hard-earned cash if you're thinking about jumping into the home HBOT game.



Important disclaimer: This review is for informational purposes only and doesn't constitute medical advice. Always consult with a healthcare professional before using hyperbaric oxygen therapy, especially if you have any underlying health conditions.



Why Choose a Soft Shell Hyperbaric Chamber? (Pros & Cons)



Let me break down what you're getting into with soft shell chambers versus their hard shell cousins.



Infographic comparing soft shell and hard shell hyperbaric chambers, detailing their advantages and limitations for home and medical use.



✅ Advantages of Soft Shell Chambers




Affordability: Hard shell chambers can run you $100K+. Most soft shells fall between $5K-$15K = way more accessible for home use.



Portability & Convenience: These things deflate and pack away like a giant air mattress. You can literally store one in a closet when you're not using it. Try doing that with a rigid acrylic chamber that looks like a medical submarine.



Comfort: Many users find soft shells less claustrophobic than hard chambers. The fabric walls feel less clinical, and you've got viewing windows to keep you connected to the outside world.



Ease of Use: Most soft shell systems are designed for solo operation. No need for a technician or assistant - just zip yourself in and hit the power button.




🤔 Limitations of Soft Shell Chambers




Lower pressure limitations represent the biggest trade-off. Soft chambers max out around 1.5 ATA, while hard chambers can safely reach 3.0+ ATA. For certain medical conditions requiring higher pressures, soft shells simply won't cut it. [3] 



Oxygen delivery differences matter more than most people realize. Soft chambers typically use oxygen concentrators to achieve 90-95% oxygen purity, not the 100% medical-grade oxygen found in hard chambers. This impacts the therapeutic dose you're actually receiving.



Durability concerns with fabric materials versus rigid acrylic or steel construction. While modern soft chambers use NASA-grade materials, they're still more vulnerable to punctures, wear, and potential failure over heavy long-term use.




How We Picked the Best Soft Shell Hyperbaric Chambers



I didn't just pick these chambers out of thin air. Here's exactly what I looked for:




Operating Pressure Standards
I focused exclusively on chambers offering 1.3-1.5 ATA pressure. Why this range? Below 1.3 ATA, you're getting minimal therapeutic benefits - basically expensive relaxation. Above 1.5 ATA in a soft shell design raises serious safety concerns about material integrity and proper pressure regulation.



Recent research indicates that even mild pressures in this range can provide measurable benefits. A 2024 study showed mHBOT at 1.3 ATA reduced neuroinflammation and improved cognitive function in post-concussion patients. [4]




Size and Design Priorities

Lying chambers dominate the market because they accommodate the widest range of users. I looked for internal dimensions supporting users up to 6'5" comfortably - that means 84-90 inch internal length minimum. Internal diameter matters too; 32+ inches prevents that cramped feeling during longer sessions.



Sitting chambers serve a specific niche. If you're claustrophobic, have mobility issues, or want to read/work during sessions, vertical designs make sense. However, they're less common and typically more expensive.



Multi-person claims require skepticism. True two-person soft chambers are rare. Most "2-person" models are just wider single-person units that might accommodate a parent with a small child, but don't expect comfortable dual adult use.





Material Quality Deep Dive
Medical-grade TPU construction became my non-negotiable baseline. I prioritized chambers using multi-layered (2-3 layer) thermoplastic polyurethane with heat-welded seams. Glued seams fail more frequently and create potential leak points.



Zipper quality separates amateur from professional designs. Look for pressure-sealed zippers with dual-sided access (internal and external pulls). This isn't just convenience - it's a critical safety feature for emergency exit.




Safety Feature Requirements
Multiple pressure relief valves topped my safety checklist. Every chamber should include at least one automatic valve (factory-set to prevent over-pressurization) and one manual valve (user-operable from inside and outside).



Emergency exit mechanisms can't be afterthoughts. Quick-release zippers or dedicated emergency valves allow rapid depressurization if something goes wrong.



Viewing windows serve dual purposes: reducing claustrophobia and allowing external monitoring. I preferred chambers with multiple large windows using clear, non-toxic TPU materials.




Component Quality Standards
Air compressor specifications matter more than most buyers realize. Oil-free designs prevent contamination, while noise levels below 60 dB make sessions more pleasant. Look for manufacturers that specify actual decibel ratings.



Oxygen concentrator compatibility varies significantly. Systems designed for concentrator use need 5-10 LPM flow rates and should achieve 90-96% oxygen purity levels for effective therapy.



Climate control inclusion transforms the user experience. Air coolers and dehumidifiers prevent the hot, stuffy feeling that can ruin longer sessions.





The Best Soft Shell Hyperbaric Chambers of 2025





  
    
      Chamber Model
      Best For
      Price
      Pressure
      Key Advantages
    
  
  
    
      LUX AIR 36-Inch
      Overall Best
      $14,749
      1.4 ATA
      
        • Highest pressure (33% more)
        • J-style door for solo use
        • Premium NASA materials
        • 3-year warranty
      
    
    
      OXY-AIR 40-Inch
      Spacious Design
      $10,990
      1.3 ATA
      
        • Largest diameter (40")
        • ISO certified
        • Perfect for tall users
        • Clinical quality
      
    
    
      Summit to Sea Shallow Dive
      Portability
      $6,995
      1.3 ATA
      
        • Most portable
        • Redundant compressors
        • Translucent design
        • Best under $7K
      
    
    
      OxyMa
      Best Value
      $6,729
      1.3-1.4 ATA
      
        • Lowest price
        • Pressure options
        • Perfect for beginners
        • Compact design
      
    
    
      Summit to Sea Dive Vertical
      Sitting Chamber
      $9,000-$12,000
      1.3 ATA
      
        • Vertical sitting design
        • 38" diameter base
        • Ideal for mobility issues
        • Read during sessions
      
    
  




  
    Quick Guide:
    Green badge (1.4 ATA) = Higher therapeutic pressure
    Orange badge (1.3 ATA) = Standard therapeutic pressure
    Blue badge (1.3-1.4 ATA) = Flexible pressure options
  




1. LUX AIR 36-Inch Soft Hyperbaric Oxygen Chamber - Best Overall



The LUX AIR 36-Inch Soft Hyperbaric Oxygen Chamber, is the best overall soft shelled Hyperbaric chamber for home use.



This is my top pick for good reason. This chamber earned top marks for delivering the most complete package at a reasonable price point. Hyperbaric PRO designed the LUX AIR with their signature J-style door system, which honestly makes entry and exit easier than any other chamber I've reseaerched. Plus, the LUX AIR delivers 33% more pressure than standard 1.3 ATA chambers, which could make a meaningful difference in therapeutic benefits.



Price: $14,749Manufacturer: Hyperbaric PROPressure: 1.4 ATA



Key Specifications:




36-inch diameter, 89-inch length



Medical-grade 3-layer PET Polyester/TPU with Dacron technology



J-style door design for easy solo entry/exit



2-person weight capacity




What Sets It Apart: The J-shape door is brilliant - you can get in and out without assistance, unlike chambers with traditional zippered entries. The 16-inch elevation platform is included, plus you get a 10 LPM FDA-approved DeVilbiss oxygen concentrator and dehumidifier (normally a $700 add-on).





✅ Pros:




Higher pressure than most competitors (1.4 vs 1.3 ATA)



Innovative door design for independent use



Premium NASA-trusted materials



Excellent component package with quality concentrator



Silent pressure relief valves eliminate annoying hissing



3-year warranty






🤔 Cons:




Premium pricing puts it above many budgets



Larger footprint requires more space



Overkill if you just want basic mHBOT






➡️ Best For: Serious users who want maximum pressure and convenience features, don't mind paying extra for quality engineering.



Here's a very useful video that  demonstrates the chamber.




https://www.youtube.com/watch?v=stVM83g313s




Available online through Hyperbaric PRO with 3-year warranty and ISO certifications







2. OXY-AIR 40-Inch Hyperbaric Oxygen Chamber - Best Spacious Design







Oxygen Health Systems created the largest soft chamber available with their 40-inch diameter design. If you're tall, broad, or just don't like feeling cramped, this is your chamber. The 40-inch diameter is among the largest available in soft shells.



Price: $12,990Manufacturer: Oxygen Health SystemsPressure: 1.3 ATA



Key Specifications:




40-inch diameter (one of the largest available)



Medical-grade materials with durable construction



Standard 1.3 ATA pressure



ISO certifications (14001, 13485, 9001)






✅ Pros:




Spacious interior for comfort



Solid build quality and certifications



Reasonable price for the size



Suitable for clinical and home use



ISO certified manufacturing






🤔 Cons:




Only 1.3 ATA pressure (lower than LUX AIR)



Limited details on specific components included



Larger chambers need more space and airflow






➡️ Best For: Larger individuals or anyone who prioritizes interior space over maximum pressure.



🛒Price: $12,990 through Oxygen Health Systems online store







3. Summit to Sea Shallow Dive - Best for Portability







This is the most portable option on our list. If you need something you can actually travel with or store easily, the Shallow Dive delivers. I was impressed by how quickly this system sets up and breaks down for transport or storage.



Price: $6,995Manufacturer: Summit to SeaPressure: 1.3 ATA



Key Specifications:




26-inch diameter, 84-inch length



Single-bag urethane-coated nylon shell



Lightweight and portable design



Redundant compressors for safety




Unique Features: The translucent material lets room light diffuse in, reducing the cave-like feeling. You get two compressors for redundancy, plus a comprehensive accessory package including cleaning supplies and setup instructions on a thumb drive.





✅ Pros:




Most portable and lightweight option



Redundant compressors for safety



Comprehensive accessory package included



Translucent walls reduce claustrophobia



Good value at under $7K



Patented sound suppression technology






🤔 Cons:




Smaller 26-inch diameter limits comfort for larger users



Single-bag design may be less durable long-term



Basic feature set compared to premium options






➡️ Best For: Users who prioritize portability, travel frequently, or have limited storage space.




https://www.youtube.com/watch?v=tdxKQ1bFKS0




🛒 Price: $6,995 through Health Products For You



4. OxyMa Hyperbaric Chamber - Best Value







Oxygen Health Systems hit the sweet spot with their OxyMa model. You get solid construction, reliable safety features, and effective therapy at a price that won't require a second mortgage.



Price: $8,600Manufacturer: Oxygen Health SystemsPressure: Available in 1.3 ATA and 1.4 ATA options



Key Specifications:




28-inch diameter



Available in both 1.3 and 1.4 ATA versions



High-quality medical-grade materials



Compact yet comfortable design



Applications: Sports recovery, wound healing, general wellness






✅ Pros:




Excellent price-to-feature ratio



Pressure options allow customization to needs



Solid safety features included



Good for beginners to HBOT



ISO certifications for quality assurance



Compact design fits most home spaces






🤔 Cons:




Smaller diameter than premium options



Fewer luxury features than higher-end chambers



Basic component package






➡️ Best For: First-time buyers or budget-conscious users who want reliable mHBOT therapy without premium pricing.



🛒 Price: $8,600 through Oxygen Health Systems' secure online store



5. Summit to Sea Dive Vertical - Best Sitting Chamber







Some people just can't or don't want to lie down for 60-90 minutes. This vertical chamber solves this problem. The vertical design lets you sit comfortably during sessions.



Price: $9,000-$12,000 rangeManufacturer: Summit to SeaPressure: 1.3 ATA



Key Specifications:




38-inch diameter base



Vertical design for sitting position



Vertical zipper entry for easy access



Durable medical-grade materials






✅ Pros:




Comfortable sitting position



Easy vertical entry/exit



Good for reading or light activities during sessions



Spacious feeling despite smaller footprint






🤔 Cons:




Higher price than horizontal alternatives



Limited availability (through dealers only)



May not fit very tall users comfortably






➡️ Best For: Users who prefer sitting, with claustrophobia, mobility limitations, or who want to remain productive during therapy sessions.




https://www.youtube.com/watch?v=UXiS0hcxO2A




🛒 Price: $9,000-$12,000 through authorized dealers



Key Features to Consider When Buying



ATA Pressure



Understanding pressure specifications prevents disappointment later. 1.3 ATA = 4.3 PSI above atmospheric pressure, while 1.4 ATA = 5.9 PSI, and 1.5 ATA = 7.4 PSI. These differences seem small but research suggests even modest pressure increases can enhance therapeutic benefits Frontiers in Neurology.



"But does higher pressure really matter in soft chambers?" The answer depends on your goals. For general wellness and recovery, 1.3 ATA provides measurable benefits. For enhanced cognitive function or more intensive recovery protocols, 1.4-1.5 ATA may offer advantages.



Size and Dimensions



Internal versus external dimensions trip up many buyers. A chamber with 36-inch external diameter might only provide 32-33 inches of usable internal space due to material thickness and internal frame structures.



Lying vs Sitting: Horizontal chambers work for most people and typically offer more length. Vertical chambers are better if you have trouble lying flat or want to read during sessions.



User height calculations require adding 6-8 inches to your height for comfortable positioning. If you're 6 feet tall, look for chambers with 78+ inch internal length.



Material Construction Quality




Heat-welded seams versus glued construction makes the difference between years of reliable service and premature failure. Heat welding creates molecular bonds in TPU materials that are significantly stronger than adhesive connections.



Medical-Grade TPU: This is the gold standard. Look for 2-3 layer construction for durability and leak prevention.



Seam Construction: Heat-welded seams beat glued seams every time. They're stronger and less likely to fail over time.



Zipper Quality: You want airtight, pressure-sealed zippers, preferably with dual-sided access (inside and outside pulls) for safety.




Essential Component Assessment




Air compressor noise levels impact your experience significantly. Manufacturers claiming "quiet" operation should specify actual decibel ratings. Anything over 65 dB becomes annoying during longer sessions.



Oxygen concentrator flow rates determine therapy effectiveness. 5 LPM minimum for basic benefit, 8-10 LPM for optimal therapy in most chambers. Don't assume higher numbers are always better - match flow rate to chamber volume.



Internal frame systems prevent chamber collapse before full inflation and maintain shape during use. Lightweight aluminum or fiberglass frames work best - avoid chambers without frames entirely.



Air Cooler/Dehumidifier: Essential for comfort during longer sessions. You'll get hot and humid inside without proper climate control.




Safety Feature Verification




Pressure relief valve redundancy can save your life. Look for chambers with both automatic (factory-set) and manual (user-controlled) pressure relief systems. Single-valve designs create unnecessary risk.



Emergency exit procedures should be simple enough to execute under stress. Practice emergency procedures when you first receive your chamber - don't wait for an actual emergency to figure it out.



Pressure gauge accuracy affects both safety and therapy effectiveness. Quality chambers include both internal and external gauges that are easy to read and properly calibrated.



Viewing Windows: Multiple large windows reduce claustrophobia and allow external monitoring. Clear, non-toxic TPU construction is important.



Monitoring Equipment: Internal and external pressure gauges let you track performance. Some units include power failure alarms.




Noise Level



This is often overlooked but crucial for home use. Compressors and oxygen concentrators can be loud. Look for decibel ratings - anything under 55 dB is considered quiet.



Who Can Benefit Most from Soft Shell Hyperbaric Chambers?



Athletes use HBOT to speed up recovery from strenuous training or injuries, while others explore its potential for improving brain function, especially after concussions or traumatic brain injuries. The FDA has approved HBOT for specific medical conditions, but soft shell chambers are often used for general wellness purposes.



Common users include:




Athletes seeking faster recovery represent the largest user group I encounter. Research shows mHBOT can reduce inflammation and accelerate tissue repair, making it valuable for both endurance and strength athletes PMC.



Wellness enthusiasts looking for general health optimization find soft chambers particularly appealing. The convenience of home therapy supports consistent use patterns that clinical visits often can't match.



Individuals with chronic fatigue or inflammatory conditions may benefit from the anti-inflammatory effects of mHBOT. A 2024 study demonstrated reduced oxidative stress and improved energy levels in chronic fatigue patients Universal Neuro Care.



Busy professionals appreciate the ability to multitask during sessions (particularly in sitting chambers) while still receiving therapeutic benefits.




Frequently Asked Questions




Do I need a prescription for a soft shell hyperbaric chamber? 
This varies by region and seller. In the United States, chambers operating below 1.5 ATA are typically classified as wellness devices rather than medical equipment. However, check local regulations and seller policies - some companies require physician clearance regardless of legal requirements.




How long does a typical session last? 
Most protocols recommend 60-90 minute sessions. Start with shorter 30-45 minute sessions to acclimate, then gradually increase duration based on comfort and therapeutic goals.




How often can I use a soft shell chamber? 
Daily use is generally considered safe for healthy individuals, though 3-5 times per week is more common. Some users prefer daily sessions during acute recovery periods, then reduce frequency for maintenance.




What does it feel like inside? 
The initial pressurization creates a "popping" sensation in your ears similar to airplane descent. Once pressurized, most people describe feeling relaxed and slightly energized. The environment is warm and humid, hence the importance of dehumidification systems.




Are soft shell chambers safe? 
When used as directed with proper safety features, soft chambers have excellent safety records. The Undersea & Hyperbaric Medical Society acknowledges their safety at appropriate pressure levels, though they emphasize proper training and equipment maintenance UHMS.




How much electricity do these chambers use?
Most systems consume 1200-1500 watts during operation, similar to a hair dryer or microwave. Expect 1.5-2.5 kWh per session, adding roughly $0.20-0.40 to your electricity bill per session at average rates.




What maintenance is required? 
Monthly cleaning with mild soap solutions, quarterly zipper lubrication, and annual professional inspection of pressure systems. Most manufacturers provide detailed maintenance schedules - follow them religiously to maintain warranty coverage.




Can I use a chamber if I'm claustrophobic? 
Sitting chambers and lying chambers with multiple large windows significantly reduce claustrophobic feelings. Many users who initially worried about claustrophobia find the experience less confining than expected, especially with clear viewing panels and internal lighting.




What's the difference between soft shell and hard shell chambers?
Hard shells offer higher pressures (2.0+ ATA), 100% oxygen delivery, and greater durability but cost $100K+ and require permanent installation. Soft shells offer portability, lower cost, and home-friendly operation at lower pressures.





Bottom Line



Soft shell hyperbaric chambers represent a legitimate way to access mHBOT benefits without clinical facility costs or scheduling constraints. The technology has matured significantly, with modern chambers offering genuine therapeutic benefits backed by growing research evidence.



My top recommendation remains the LUX AIR 36-Inch for users who can afford the premium price - its combination of higher pressure, superior construction, and comprehensive features justifies the investment. For budget-conscious buyers, the OxyMa chamber delivers solid therapy at an accessible price point.



The key is matching features to your specific needs. Athletes might prioritize higher pressure and faster recovery protocols. Wellness enthusiasts might prefer comfort features and ease of use. Portable users should focus on the Summit to Sea options despite their size limitations.



Most importantly: consult with a healthcare provider before beginning any hyperbaric therapy regimen. While mHBOT has an excellent safety profile, individual health conditions can create contraindications or require modified protocols.



What questions do you still have about soft shell chambers? Have you had experience with any of these models? I'd love to hear your thoughts and experiences in the comments below.







Sources and references cited throughout this article include peer-reviewed research from scientific journals, manufacturer specifications, and regulatory guidance from organizations like the FDA and UHMS. Always verify current regulations and consult healthcare providers for medical advice.

### Seoul Apartment Dwellers Raise 100 Million Won for Manager Needing HBOT Amid Leukemia Fight

Residents of Apgujeong Hyundai Apartment raised about 100 million Korean won for Kim Misuk, their 52-year-old former administrative manager diagnosed with acute leukemia.



Kim worked at the apartment office for three years and lives alone without family support.



The community first collected 5.45 million won in early August and then launched a major campaign called Beautiful Companionship.



The campaign gathered 94.665 million won from 847 of the 3,300 households in just over two weeks.



Resident leaders delivered the full amount to Kim at Soonchunhyang University Bucheon Hospital on September 17.




Residents of the Apgujeong Hyundai Apartment in Gangnam-gu, Seoul, have shown strong community support by raising approximately 100 million Korean won for their former administrative manager battling acute leukemia.



Kim Misuk, 52, received the diagnosis in July and faced severe health challenges, including breathing issues that required hyperbaric oxygen therapy. 



Hyperbaric Oxygen Therapy, often used for conditions like blood cancers to increase oxygen levels in the body, proved expensive for Kim, who lives alone without parents or siblings. 



The donations, totaling 100,115,000 Korean won, came from 847 households out of the apartment's 3,300, according to the Apgujeong Hyundai Apartment Residents' Committee. The effort highlights the residents' response to Kim's three years of dedicated service at the office.



Lee Tae-young, chairman of the residents' committee, second from left, and other residents of Apgujeong Hyundai Apartment are handing over a donation to Kim Mi-suk / Source: Chosun



Initial Support and Campaign Launch



The community first acted in early August, when residents collected 5,450,000 Korean won in cash and delivered it directly to Kim. 



Her condition had worsened, making the need for financial help clear. On August 28, the residents’ representative council approved a larger fundraising drive named Beautiful Companionship. 



To spread the word, they posted notices on the apartment’s bulletin board and displayed banners at the office. This approach quickly engaged many households, as reported by the residents' committee.



Aerial photo of the Apgujeong Old Hyundai Apartment complex in Seoul, Korea / Source: mk.co.kr



Rapid Fundraising Success



The Beautiful Companionship campaign ran for just over two weeks, ending on September 15. It raised 94,665,000 Korean won, pushing the total past 100 million when added to the earlier amount. 



Out of the 3,300 households in the Apgujeong Old Hyundai Apartment complex, 847 took part, showing broad participation. 



Lee Tae-young, head of the residents’ representative council, led the group that visited Soonchunhyang University Bucheon Hospital in Bucheon City, Gyeonggi Province, on September 17 to hand over the funds to Kim. 



The hospital visit included Lee and other residents, as documented in photos provided by the committee.



Community Sentiment and Hopes for Recovery



Lee Tae-young expressed the group's feelings during the handover. “All residents are earnestly hoping for Kim’s swift recovery, who has always been diligent and sincere,” he said, according to the Apgujeong Hyundai Apartment Residents' Committee. 



This statement reflects the appreciation for Kim's work ethic over her three years in the role. The committee served as the primary source for all details in this report, including donation figures, timelines, and the hospital delivery. 



Does Hyperbaric Oxygen Therapy Help Treating Leukemia?



Kim's treatment included hyperbaric oxygen therapy, a costly procedure that partly drove the fundraising effort. The therapy involves breathing pure oxygen in a pressurized chamber, typically at 2.5 times normal atmospheric pressure.



While doctors use the treatment for various medical conditions, its effectiveness specifically for leukemia remains largely unproven in clinical settings, according to scientific reviews.



Laboratory Studies Show Initial Promise



Research on leukemia cells in controlled laboratory environments has demonstrated encouraging results. Studies found that hyperbaric oxygen induces cell death in T-leukemia and B-myeloma cancer cells by activating specific death pathways while shutting down survival mechanisms.



Scientists observed the treatment triggers a biological process called apoptosis, essentially forcing cancer cells to self-destruct. In experiments on Molt-4 human leukemia cells, hyperbaric oxygen reduced cancer cell growth and enhanced the effectiveness of artemisinin, an anticancer drug.



Chen and colleagues, who published findings in 2007, showed the therapy killed both types of blood cancer cells in laboratory conditions. Based on these results, researchers Tonomura and Granowitz argued in an editorial that hyperbaric oxygen deserves investigation as a novel leukemia treatment.



Limited Evidence Beyond the Laboratory



The challenge lies in translating laboratory success to real patients. Two older animal experiments using leukemia models found no significant differences in cancer growth or spread after hyperbaric oxygen treatment, raising questions about real-world effectiveness.



Clinical trials specifically examining the therapy for leukemia remain scarce. One ongoing study looks at safety in chronic leukemia patients undergoing stem cell transplants, but focuses on preventing complications rather than fighting cancer directly, according to clinical trial databases.



A comprehensive 2012 review published in Targeted Oncology concluded that while hyperbaric oxygen shows no evidence of promoting cancer growth, the data on leukemia specifically proves insufficient for clinical recommendations. The review found too few studies to draw meaningful conclusions about therapeutic value.



How the Treatment Works



The therapy floods the bloodstream with dissolved oxygen, far more than hemoglobin can normally carry. This creates oxidative stress that cancer cells struggle to handle, according to research findings.



When combined with chemotherapy drugs like cytarabine, hyperbaric oxygen made leukemia cells more vulnerable to medication in laboratory experiments. The treatment appeared to push cancer cells into growth phases where they become most susceptible to drugs.



Cost and Accessibility Concerns



The treatment's expense creates barriers for patients like Kim. Sessions typically last one to two hours and may need repeating daily for weeks. Without insurance coverage for experimental cancer uses, costs accumulate quickly.



Medical facilities require specialized pressurized chambers and trained staff, limiting availability. The therapy does carry risks, including oxygen toxicity, pressure-related ear and sinus problems, and in rare cases, seizures.



Current Medical Consensus



Recent research published in Frontiers in Oncology suggests hyperbaric oxygen might enhance cancer immunotherapy by improving the tumor microenvironment. The therapy appears to help immune cells penetrate tumors more effectively and may reduce resistance to checkpoint inhibitor drugs.



However, scientists emphasize these findings come primarily from animal models and require validation in human trials before changing treatment protocols.



Medical experts say rigorous clinical trials must determine which leukemia types might respond, optimal treatment schedules, and whether benefits outweigh risks. Different forms of leukemia may respond differently, adding complexity to treatment decisions.



For now, patients and families should view hyperbaric oxygen as experimental for leukemia treatment. The laboratory findings warrant continued research but remain too limited to guide standard medical care, according to the scientific consensus.



The fundraising effort by Apgujeong Hyundai Apartment residents addresses a real financial burden Kim faces, regardless of whether the therapy ultimately proves effective against her cancer. The community's support ensures she can access all available treatment options during her fight against acute leukemia.

### Arizona Therapist Dies in Hyperbaric Chamber Fire

Dr. Walter Foxcroft, 43, died in a flash fire inside a hyperbaric chamber at his clinic on Wednesday night.



The incident occurred just before 11 p.m. at Havasu Health and Hyperbarics in Lake Havasu City, Arizona.



Firefighters found his body inside the scorched oxygen therapy device; no other injuries occurred.



Hyperbaric chambers use high oxygen levels, which increase fire risks, according to fire officials.



The clinic, founded last year, specialized in integrative therapies and now remains closed during the probe.




Dr. Walter Foxcroft, a 43-year-old board-certified physical therapist, died Wednesday night after a flash fire erupted inside a hyperbaric chamber at his clinic in Lake Havasu City, Arizona. Emergency crews responded to reports of a person trapped in the burning device around 10:50 p.m., arriving to find the building filled with smoke. Firefighters pronounced Foxcroft dead at the scene, according to the Lake Havasu City Fire Department. 



The blaze involved the clinic's oxygen therapy machine, where his scorched body was discovered. No other injuries were reported, and crews ventilated the facility before handing the case to investigators.



Understanding the Incident



A flash fire involves a rapid spread of flames when flammable gas, vapor, or dust ignites, creating a fast-moving blaze. In this case, the fire broke out inside the hyperbaric chamber, a sealed enclosure that controls barometric pressure by increasing air or oxygen levels. 



These devices carry high flammability risks due to their elevated oxygen concentrations, which can accelerate combustion. The Lake Havasu City Fire Department noted that firefighters checked for additional hazards before securing the site. The cause of the fire remains under investigation by police and fire officials, as reported by the Daily Mail.



Background on Dr. Foxcroft



Foxcroft brought 27 years of experience to healthcare, holding certifications in hyperbaric oxygen therapy (HBOT), neurofeedback, photobiomodulation, and spine mobilization. HBOT treats conditions like decompression sickness, carbon monoxide poisoning, and non-healing wounds by delivering pure oxygen under pressure. 



He earned his Doctorate in Physical Therapy from Touro University Nevada in 2012 and a Bachelor of Science in Physiological Sciences from the University of Arizona in 2005, per his LinkedIn profile.



Before entering physical therapy, Foxcroft served as the University of Arizona mascot, Wilbur T. Wildcat, where he performed energetic routines including his signature moonwalk. Arizona Cheerleaders & Mascots remembered him in an Instagram post: 




Wally was an unforgettable presence on the sidelines - an energetic, charismatic performer known for his signature moonwalk and passion for bringing joy to Arizona fans. The group added: He proudly returned for Homecoming, reconnecting with current mascots and sharing his spontaneous spirit as Wilbur with all of us. Wally’s dedication to uplifting others - through performance, healing, and innovation - will never be forgotten. Thank you, Wilbur, for the spirit, the showmanship, and the legacy you leave behind.




Foxcroft later worked as the mascot for the Arizona Cardinals, joining the team at Super Bowl XLIII in 2009. He founded Havasu Health and Hyperbarics last year as Arizona's first integrative naturopathic HBOT center, according to KARK reports cited by the Daily Mail.



Clinic and Aftermath



The clinic, located near the Arizona-California border, focused on advanced therapies but will stay closed until further notice amid the investigation. 



It is unclear why Foxcroft was inside the chamber late at night. He is survived by his wife, Tiffany, and their children. The Daily Mail provided details on the incident, Foxcroft's career, and tributes from his university community.

### Family of Nine Survives Carbon Monoxide Poisoning at Hadassah Hospital

A family of nine experienced dizziness, headaches, nausea, and vomiting during Rosh Hashanah.



Doctors at Hadassah University Medical Center diagnosed carbon monoxide poisoning after blood tests.



The poisoning came from a home generator that released the toxic gas indoors.



Patients received hyperbaric oxygen therapy, which filters carbon monoxide from the blood.



All family members recovered fully and returned home without lasting effects.




A family of nine sought care at Hadassah University Medical Center in Jerusalem after unusual symptoms struck during the Rosh Hashanah holiday. 



The group, consisting of two parents and seven children, reported dizziness, headaches, nausea, and vomiting. 



Medical staff quickly identified high levels of carbon monoxide (CO) in their blood, confirming poisoning as the cause. 



Treatment in a hyperbaric chamber proved effective, and all patients were discharged home on Thursday with no reported long-term damage. This incident highlights the dangers of the colorless, odorless gas in enclosed spaces, according to hospital experts. Fire and rescue teams traced the exposure to a generator near the home.



Initial Symptoms and Diagnosis



The family arrived at the pediatric emergency department on the Mount Scopus campus of Hadassah University Medical Center. Dr. David Rechtman, head of the department, noted the unusual presentation.



"The parents arrived with their children, reporting unusual symptoms with an unknown cause," recalled Dr. Rechtman, as reported by The Jerusalem Post.



Dr. Talia Dor-Wolman, a senior neurologist and head of the Pediatric Neurological Diseases Service, examined the group. She suspected poisoning based on the symptoms. Blood tests then revealed elevated carbon monoxide levels, leading to the official diagnosis. 



Carbon monoxide binds to hemoglobin in the blood, preventing oxygen transport and causing tissue damage if untreated.



Source of the Poisoning



An investigation by fire and rescue teams pinpointed the source. A generator attached to the home had been releasing carbon monoxide into the indoor air. This setup created a buildup of the gas in an enclosed space with low oxygen levels. Such generators, often used for power during holidays or outages, require proper ventilation to avoid this risk.



Dr. Rechtman explained the gas's dangers:




"Carbon monoxide is a very toxic gas, which can become dangerously concentrated in enclosed spaces with low oxygen levels. In extreme cases, exposure to carbon monoxide can harm the central nervous system, causing death or irreversible developmental damage. Since the gas is colorless and odorless, its presence in the home is often not detected until physical symptoms appear."




All family members remained conscious throughout the ordeal, which aided their prompt treatment.



Hyperbaric Chamber Treatment



The patients received initial care in the Mount Scopus emergency room before transfer by ambulance to the Ein Kerem campus. There, they entered the hyperbaric medicine unit, where hyperbaric oxygen therapy (HBOT) was administered. This method involves breathing pure oxygen in a pressurized chamber, which exceeds normal atmospheric pressure.



Dr. Eyal Avraham, a vascular surgeon and head of the unit, described the process:



"Hyperbaric oxygen therapy is one of the main treatments for carbon monoxide (CO) poisoning. In a hyperbaric chamber, the patient inhales pure oxygen at higher than atmospheric pressure. This process rapidly filters CO from the blood, oxygen is efficiently delivered to tissues affected by the oxygen shortage, and the risk of neurological damage, one of the dangers of carbon monoxide inhalation, is reduced."



HBOT works by displacing carbon monoxide from hemoglobin and reducing inflammation in affected tissues. The therapy typically lasts 90 to 120 minutes per session, depending on severity, and is compatible with standard medical monitoring equipment. No compatibility issues arose in this case, as the chamber supports pediatric and adult patients alike.



Full Recovery and Discharge



Following the hyperbaric sessions, the entire family showed significant improvement. Doctors monitored them for neurological effects, but none developed. All nine were released home on Thursday, September 26, 2025, with instructions to avoid similar exposures. 



The hospital emphasized installing carbon monoxide detectors in homes, especially near fuel-burning devices like generators. This event underscores the importance of early detection and specialized care in preventing permanent harm from such poisonings. 



(Source: The Jerusalem Post, reporting by Itay Gal, updated September 27, 2025)

### New Evidence Supports Hyperbaric Oxygen for Radiation Enteritis

Hyperbaric oxygen therapy (HBOT) lowers the risk of radiation enteritis (RE) by 68 percent in clinical trials.



HBOT improves gastrointestinal symptoms with a mean difference of -1.31 on symptom scales.



Treatment often uses 2.0-2.5 atmospheres absolute (ATA) pressure for 90-120 minutes per session.



Sessions typically occur once daily, five times weekly, over 30-40 treatments.



Evidence indicates HBOT cuts inflammation markers like IL-6, CRP, and TNF-α while boosting immunoglobulins.




A new systematic review and meta-analysis examines the role of hyperbaric oxygen therapy (HBOT) in treating radiation enteritis (RE), a common side effect of pelvic radiation in cancer patients. 



Researchers from Chengdu University of Traditional Chinese Medicine and Nanjing University of Traditional Chinese Medicine analyzed 22 clinical studies with 1,318 participants. 



The review, published in Frontiers in Medicine under the gastroenterology section, finds moderate-quality evidence that HBOT reduces RE incidence and eases symptoms. Six randomized controlled trials (RCTs) formed the basis of the meta-analysis. 



HBOT involves breathing pure oxygen in a pressurized chamber, which increases oxygen delivery to tissues damaged by radiation. The study highlights HBOT's potential to promote mucosal repair and lower inflammation, though it calls for standardized protocols. 



Lead author Yuhan Wang and colleagues stress the need for individualized adjustments to maximize benefits while monitoring safety.



Study Design and Methods



The research team conducted a search across nine databases to gather evidence on HBOT for RE. They focused on outcomes like gastrointestinal symptoms, immune function, and inflammation levels. 



Inclusion criteria covered clinical trials assessing HBOT's effects on RE, graded by the Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer (RTOG/EORTC) system. 



This grading scale classifies RE severity from mild (grade 1) to life-threatening (grade 4). Meta-analysis pooled data from RCTs using odds ratios (OR) for incidence and mean differences (MD) for symptoms. Sources included peer-reviewed journals and clinical registries, ensuring a broad evidence base. 



The review notes limitations in study quality, with most evidence rated moderate to low due to small sample sizes and variability in protocols.



Key Findings on Efficacy



HBOT showed clear benefits in preventing and managing RE. The meta-analysis revealed a significant reduction in overall RE incidence [OR = 0.32, 95% confidence interval (CI) (0.14, 0.72), P = 0.006]. 



For severe cases—grade 3 or higher per RTOG/EORTC criteria—the effect was even stronger [OR = 0.37, 95% CI (0.17, 0.82), P = 0.01]. Patients experienced fewer gastrointestinal issues, such as diarrhea and pain, with HBOT improving symptom scores [MD = -1.31, 95% CI (-2.48, -0.13), P = 0.03]. 



Low-quality evidence pointed to decreased inflammatory markers, including interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α). HBOT also raised levels of immunoglobulins like IgA, IgG, and IgM, supporting immune recovery in damaged intestinal tissues. 



These results align with HBOT's mechanism of enhancing oxygen supply to hypoxic areas, aiding tissue healing post-radiation.

### Single HBOT Session Alters Healthy Retina Function

Researchers examined 20 patients with healthy retinas before and after one hyperbaric oxygen therapy session.



Full-field electroretinography showed a significant drop in scotopic 0.01 ERG b-wave amplitude, with p = 0.029.



Spectral-domain optical coherence tomography detected thickening in the retinal pigment epithelium in the 3-mm nasal subfield, p = 0.023.



No other retinal or choroidal changes reached statistical significance.



Findings suggest short-term impairment in rod-bipolar cell function, calling for further research on reversibility.




A new study published in Frontiers in Ophthalmology explores how a single session of hyperbaric oxygen therapy affects the healthy retina. 



Conducted by Turkish researchers Nur Demir, Selin Gamze Sumen, and Belma Kayhan, the research used full-field electroretinography (ffERG) and spectral-domain optical coherence tomography (SD-OCT) to measure changes. 



Participants included 20 patients aged 18 to 66 years, all with normal retinas but indications for hyperbaric oxygen therapy (HBOT) due to conditions like sensorineural hearing loss or avascular necrosis. Tests occurred before and within 24 hours after the session. 



The average age was 43.2 years, with a standard deviation of 11.4 years. Results indicate minor but significant shifts in retinal function, raising questions about HBOT's short-term effects on eye health. The study, affiliated with institutions in Istanbul, Turkey, emphasizes the need for more investigation.



Study Design and Methods



The researchers selected patients from Turkey. All had healthy retinas confirmed by comprehensive eye exams. HBOT involves breathing pure oxygen in a pressurized chamber, which can create hyperoxia - a state of elevated oxygen levels that may cause retinal vasoconstriction and reactive oxygen species production. 



ffERG measures the retina's electrical response to light, assessing photoreceptor and bipolar cell activity. SD-OCT provides detailed images of retinal layers and the choroid, the vascular layer beneath the retina. 



Assessments focused on the Early Treatment Diabetic Retinopathy Study (ETDRS) grid, a standard layout for mapping retinal areas.



Key Findings from Electroretinography



ffERG results showed one notable change: the scotopic 0.01 ERG b-wave amplitude decreased significantly after HBOT, with a p-value of 0.029. Scotopic conditions simulate dim light, testing rod cells and bipolar cells. The b-wave reflects rod-bipolar cell function, suggesting acute impairment in this pathway. 



No other ffERG measures, such as a-wave amplitudes or photopic responses, differed statistically before and after treatment. According to the study authors, this points to a targeted effect on low-light vision processing without broader retinal disruption.



Optical Coherence Tomography Results



SD-OCT scans revealed thickening in the retinal pigment epithelium (RPE) in the 3-mm nasal subfield of the ETDRS grid, with p = 0.023. The RPE supports photoreceptors by absorbing light and maintaining retinal health. 



Choroidal thickness and other retinal layers showed no significant changes. SD-OCT, which uses light waves for high-resolution cross-sections, confirmed these shifts occurred within 24 hours. The authors note that hyperoxia from HBOT may trigger these adaptations, but long-term impacts remain unclear.



Implications and Future Research



The study concludes that one HBOT session causes an acute alteration in rod-bipolar cell function, as seen in electrophysiological responses. 



No evidence of reversibility appears in the data, prompting calls for additional studies. Sources include the original article in Frontiers in Ophthalmology, Retina section, with affiliations to Turkish health institutions. 



This work builds on prior knowledge of HBOT's risks, such as oxidative stress in the retina, while highlighting its use for non-eye conditions.

### Hyperbaric Oxygen Linked to Reduced Insulin Resistance.

QUICK TAKES




A scoping review in Frontiers in Medicine assessed HBOT effects on insulin resistance and related markers.



Researchers screened 230 studies and included 17 that addressed insulin, insulin sensitivity, or insulin resistance.



The review reports HBOT appears to improve fasting glycaemia and decrease insulin resistance, with effects noted after one session.



HBOT also reduced levels of proinflammatory cytokines that contribute to insulin resistance, but duration of benefit remains unknown.



Authors state translation into clinical care requires robust randomized clinical trials (RCTs) that are currently lacking.






A scoping review published in Frontiers in Medicine evaluated available evidence on Hyperbaric Oxygen Therapy (HBOT) and its effects on insulin resistance in patients with Diabetes Mellitus (DM). 



Authors Mafalda Sampaio Alves et al. screened 230 articles and selected 17 for analysis. The review reports that “the HBOT appears to improve fasting glycaemia and decrease insulin resistance in patients with DM, with effects appearing after 1 treatment session.” 



The paper highlights reductions in proinflammatory cytokines but notes the persistence of these effects and the responsible molecular mechanisms remain unclear. (Source: Frontiers in Medicine.)



Hyperbaric Oxygen Therapy (HBOT) is an established treatment modality for specific indications such as diabetic foot ulcers. 



The review authors note that formal indications for HBOT do not currently include most diabetes-related comorbidities. 



The paper cites the global burden of diabetes and associated mortality; the World Health Organization provides global diabetes data and context on diabetes-related deaths. (Sources: Frontiers in Medicine; World Health Organization.)



Methods and scope



The team used a scoping review methodology to gather all available data addressing insulin, insulin resistance, or insulin sensitivity in the context of HBOT. 



Exclusion criteria included studies that did not address insulin resistance, those using normobaric oxygen only, and records without translation into English, Spanish, or Portuguese. From 230 initial records, 17 studies met the eligibility criteria and were analyzed. (Source: Frontiers in Medicine.)



Findings




Clinical signals: The review reports consistent findings across included studies that HBOT is associated with improved fasting blood glucose and reduced measures of insulin resistance, sometimes after a single treatment session.



Inflammation: Multiple studies in the review observed reductions in proinflammatory cytokines, biological mediators that can impair insulin signaling and contribute to insulin resistance. Brief explanation: proinflammatory cytokines are signaling proteins (for example, interleukins and tumor necrosis factor) that promote inflammation and can interfere with insulin action.



Uncertainties: The review notes that the duration of improved insulin sensitivity after HBOT is not established and that the specific molecular drivers of the effect remain undefined. The authors call for higher-quality randomized clinical trials to confirm efficacy and safety. (Source: Frontiers in Medicine.)




Clinical implications and limitations



The authors conclude HBOT shows potential as an intervention to improve glycaemic control and insulin sensitivity in patients with DM, but they stop short of recommending routine clinical use for this purpose pending RCT evidence. 



The review does not provide a single standardized HBOT protocol; the studies reviewed used varied treatment regimens, so there is no consensus in the paper on exact pressure, session length, or cumulative exposure required to achieve the reported effects. 



For formal HBOT indications and practice standards, the Undersea and Hyperbaric Medical Society (UHMS) maintains guidance and position statements. 



Next steps and research priorities



The review identifies several research priorities: well-designed randomized clinical trials to test HBOT against standard care or sham controls for insulin resistance outcomes; standardized reporting of HBOT parameters (pressure in atmospheres absolute, session duration, and number of sessions); and mechanistic studies to map cytokine and molecular pathway changes. 



ClinicalTrials.gov lists ongoing and completed trials across HBOT indications and can be searched for trials targeting metabolic endpoints. (Sources: Frontiers in Medicine; ClinicalTrials.gov.)



Sources




Frontiers in Medicine: scoping review by Mafalda Sampaio Alves et al. (article in Pulmonary Medicine section). (Frontiers in Medicine review)



World Health Organization: diabetes fact sheet and global mortality data. (World Health Organization diabetes fact sheet)



Undersea and Hyperbaric Medical Society: HBOT indications and practice resources. (Undersea and Hyperbaric Medical Society)



ClinicalTrials.gov: registry for randomized clinical trials and study protocols. (ClinicalTrials.gov)




Note on reportingThis article summarizes findings and conclusions presented by the authors of the Frontiers in Medicine scoping review. No additional experimental results or unpublished statements were introduced. Direct phrases from the review are presented in italics and attributed to the original publication.

### Diver Fully Recovers from Severe DCS via Hyperbaric Therapy

Hyperbaric oxygen therapy resolved all symptoms in a diver with severe Type II DCS.



The patient had gas emboli in the pulmonary artery, right ventricle, and hepatic portal vein.



Symptoms included chest tightness, dyspnea, fatigue, and joint pain post-dive.



Treatment involved recompression, leading to discharge without complications.



The case stresses timely hyperbaric intervention for multi-organ DCS cases.




A diver who developed severe Type II decompression sickness (DCS) with gas emboli in several organs made a full recovery through hyperbaric oxygen therapy. 



The treatment shrank bubbles and restored normal function, allowing discharge without lasting effects. This outcome appears in a case report published in Frontiers in Medicine, Intensive Care Medicine and Anesthesiology section (Volume 12, 2025; doi: 10.3389/fmed.2025.1690176). 



Authors Yan Wang and colleagues from Naval Medical Center in Shanghai, China, and The Second Hospital of the Navy of the Southern Theater Command in Sanya, China, detail the incident. 



Dive Incident and Symptom Onset



The diver reached 19 meters depth for 120 minutes during a task involving heavy lifting. He followed the Chinese Air Diving Decompression Table, a protocol specifying ascent stops to expel inert gases and avoid bubble formation. Decompression took 45 minutes, deemed conservative by the authors.



Thirty minutes after surfacing, symptoms emerged: chest tightness, shortness of breath, dyspnea, fatigue, and pain in the left knee and thigh. These indicate Type II DCS, which impacts the cardiovascular or nervous systems, differing from Type I's limited effects on skin or limbs.



Detection of Gas Emboli



Computed tomography (CT) scans of the chest and abdomen confirmed gas emboli—inert gas bubbles—in the pulmonary artery, right ventricle, and hepatic portal vein. 



Such bubbles can trigger respiratory distress, shock, liver dysfunction, or pain, as described in the report. DCS results from pressure changes causing gas to form bubbles in tissues and blood, even after protocol use if exertion heightens risks.



Hyperbaric Oxygen Therapy Success



Hyperbaric oxygen therapy (HBOT) provided the key to recovery. This method places patients in a chamber pressurized to 2.5-3 atmospheres absolute (ATA), shrinking bubbles via Boyle's law and enhancing oxygen delivery to tissues. 



The patient underwent recompression promptly, which the authors credit for halting progression and achieving full symptom resolution.



The report notes complete recovery, with no ongoing issues upon discharge. HBOT aligns with Undersea and Hyperbaric Medical Society guidelines for DCS, typically involving 90-120 minute sessions at specified pressures, compatible with standard multiplace or monoplace chambers. No equipment versions are specified, but the therapy's efficacy underscores its role in severe cases.



Broader Lessons on DCS Management



This case demonstrates HBOT's reliability for Type II DCS with widespread emboli. The authors conclude: The patient recovered completely after timely recompression therapy and was discharged. 



They point to DCS's variability and the need for swift intervention, drawing from the report's findings in Frontiers in Medicine (doi: 10.3389/fmed.2025.1690176). 



The incident reinforces monitoring post-dive symptoms and accessing HBOT facilities, especially after demanding dives.







© 2025 Wang, wang, ai, chen, li and jing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).

### Bryan Johnson's 90-Day Hyperbaric Oxygen Experiment: The $100,000 Gamble That Paid Off

Bryan Johnson just spent 90 days locked in a hyperbaric oxygen chamber for 90 minutes at a time. 



The man who's famous for spending $2 million annually to reverse aging decided to test whether breathing pure oxygen under pressure could actually turn back his biological clock.



The results? 




His inflammation dropped to zero. 



His telomeres (the protective caps on chromosomes that shorten with age) grew by 300 base pairs, roughly equivalent to reversing a decade of aging. 



His skin transformed across his entire body, with UV damage improving by over 10%.




"Is this an important therapy or is this some other overblown longevity therapy that doesn't deliver results?"  -Johnson asked himself before starting. 



After seeing his biomarker improvements, he called HBOT "the most efficacious longevity therapy I've done since starting this endeavor."



The Science Behind the Chamber



Hyperbaric oxygen therapy works by saturating your body with pure oxygen under increased pressure. At 2 atmospheres (= equivalent to being 33 feet underwater), your blood plasma can carry up to 15 times more oxygen than normal [1]. 



This flood of oxygen triggers a cascade of biological responses: stem cell activation, new blood vessel formation, and cellular repair mechanisms that typically slow with age.



The therapy isn't new. 



Scuba divers use it for decompression sickness. Stroke patients rely on it for brain recovery. Elite athletes swear by it for performance gains. 



Michael Jackson famously slept in a hyperbaric chamber in the 1980s, believing it would help him live to 150. 



But using it specifically for longevity with rigorous biomarker testing? That's where Johnson's experiment breaks new ground."



His protocol was aggressive: 




60 sessions over 90 days, each lasting 90 minutes. 



The pattern involved 20 minutes breathing pure oxygen, a 5-minute break on regular air, then repeating. 




This oxygen cycling - going from high O2 to low O2 - mimics the beneficial stress response that triggers cellular adaptation.







The Installation Nightmare



"I knew if it was at some local clinic where it took a 15 minute drive to get there, I would never be able to spend the 5,400 minutes doing that," - Johnson explained. 



So he installed a medical-grade chamber in his home clinic.



But damn if it wasn't complicated. 



The first oxygen concentrator only reached 92% purity when he needed 100%. 



Johnson had to source medical-grade oxygen canisters and retrofit the entire system. The investment? While he doesn't specify exact costs, professional-grade home chambers run between $20,000 to $100,000, plus installation and oxygen supplies [3].



"A lot of my friends couldn't even get inside the chamber. They're too claustrophobic," - Johnson admitted. 



The mask creates breathing resistance. The pressurization takes two minutes to reverse in an emergency. Living in earthquake-prone California, he wondered: "What if something goes wrong?"



The Mental Battle



By day 5, Johnson was questioning everything. By day 30, he nearly quit.



"My days are incredibly busy. I'm running four different companies. I have various therapies throughout the day. And I'm producing content to share the results with the world," - he said. "Can I really see this thing through?"



The breakthrough came when he realized he could bring electronics inside. Since the chamber maintains 21% oxygen (same as regular air), it's safe for laptops and phones. Suddenly, those 90-minute sessions became his most productive work time.



"It became part of a daily ritual that I actually look forward to every day, where I could work and focus on my most important things and be doing the therapy at the same time."



The Shocking Results



After 90 days, Johnson's biomarkers told a story that even surprised him:




Inflammation: His high-sensitivity C-reactive protein (hs-CRP) showed no detectable levels of systemic inflammation. Zero. "Inflammation is oftentimes the biggest culprit of problematic disease and dysfunction inside the body," - Johnson noted. "HBOT took inflammation in my body to zero."





Blood Vessel Growth: VEGF (vascular endothelial growth factor) increased by 300%. This protein signals new blood vessel formation. With over 60,000 miles of blood vessels in the human body, Johnson wondered: "How many miles of blood vessels did I lay down track for?"





Gut Health: His Akkermansia levels (a beneficial gut bacteria linked to metabolic health) increased by 1,000%. "I had been taking an Akkermansia supplement for two months, and it was still undetectable even before HBOT,"  - he explained. The therapy dramatically improved his body's absorption.





Brain Health: PTAL127, a specific Alzheimer's disease marker, declined by 28.6%. He was already below the risk threshold, but the additional improvement was significant.





Skin Transformation: This was the most visually dramatic change. Studies show HBOT can increase collagen fiber density by 12.8%, elastic fiber length by 144%, and blood vessel count by 40.9% [2]. Johnson's UV damage improved by over 10% according to multi-spectral imaging.




"To see those variables take place in my own skin across my entire body, it just transformed the health of my skin across my body," - he said.



Bryan Johnshon's Before and After Biomarkers infographic.



The Telomere Question



You think telomeres are just another biomarker?



Not quite. These protective chromosome caps are like the plastic tips on shoelaces = they prevent genetic material from fraying. We lose 20-40 base pairs annually as we age. Johnson gained 300.



His telomeres measured 11.4 kilobases before HBOT, 11.7 after. That 2.6% increase represents roughly a decade of aging reversed. For context, his telomere length matches that of a 10-year-old.



The study Johnson referenced showed older adults (65+) experiencing up to 38% telomere elongation. His more modest gains make sense given his already optimized baseline. 



(Ed. note: Most 47-year-olds would kill for 10-year-old telomeres.)



The Dark Side Nobody Talks About



While Johnson's results paint a rosy picture, HBOT isn't without risks. Common side effects include ear pain from pressure changes, temporary vision changes, and in rare cases, oxygen toxicity or lung collapse [1]. 



Claustrophobia affects many users = Johnson mentioned several friends who couldn't even enter the chamber.



The therapy is contraindicated for people with certain lung conditions, recent ear surgery, or those taking specific medications. Some users report fatigue, headaches, or sinus pressure during initial sessions [1].



"Before you do HBOT, make sure you consult your doctor as what you may do may be unique to your certain conditions," - Johnson emphasized.







The Money Question



"So what's this going to cost me?"



Clinical sessions typically run $200-500 each. Johnson's 60-session protocol would cost $12,000-30,000 at a clinic. Home chambers range from basic soft-shell models around $5,000 to medical-grade hard chambers exceeding $100,000 [3]. 



Add oxygen supplies, maintenance, and electricity = you're looking at a serious investment.



Johnson's building something called Blueprint Quantified to certify clinics that take an evidence-based approach. 



The idea? Measure biomarkers before therapy, complete the protocol, measure again. No more guessing whether treatments work.



"This is going to improve healthcare. It's going to improve outcomes," - he said.



The Maintenance Mystery



Now that Johnson's completed his initial protocol, the question becomes: What's next?



"Currently, the thought is 20 sessions every three months might be appropriate," - he explained. "You're trying to prime the body just enough, but not too much."



The optimal maintenance dose remains unknown. Too little and benefits fade. Too much and you risk diminishing returns or potential side effects. Johnson's experimenting with different schedules and promises to share results.



Cost comparison between at home usage of HBOT chamber Vs going to a clinic



Should You Try This?



HBOT shows promise for multiple conditions beyond longevity. Studies demonstrate benefits for wound healing, radiation injury, carbon monoxide poisoning, and certain infections [2]. Athletes report improved recovery and performance. The therapy's anti-inflammatory effects could benefit various chronic conditions.



But it's not magic. Results vary based on individual health status, protocol adherence, and specific goals. Johnson's dramatic improvements came from an aggressive protocol most people can't replicate = both in terms of time commitment and financial investment.



"People oftentimes make the mistake where their sessions are spread out too far apart," - Johnson warned. "They need to be within some kind of constrained timeframe for the benefits to accumulate."



The Bigger Picture



Johnson's experiment represents something larger than personal optimization. He's systematically testing longevity interventions with rigorous measurement, sharing both successes and failures publicly. This transparency challenges the wellness industry's tendency toward unsubstantiated claims.



"Are we the first generation who won't die?" - Johnson asks.



Maybe that's hyperbolic. But if therapies like HBOT can reverse specific aging markers, extend healthspan, and improve quality of life, we're certainly the first generation with tools to meaningfully slow biological aging.



The real question isn't whether HBOT works = Johnson's biomarkers prove it can. 



The question is whether the benefits justify the cost, time, and commitment for your specific situation. As HBOT centers proliferate and technology improves, accessibility should increase.



Until then, Johnson's 5,400-minute experiment provides the most comprehensive personal case study we have. Zero inflammation. Younger telomeres. Transformed skin. For a man spending millions to reverse aging, calling HBOT his most efficacious therapy yet speaks volumes.



"I hope that as HBOT increases in popularity, more centers open, systems become cheaper, and more people have greater accessibility," Johnson concluded.



Given his results, that hope might soon become reality.




https://www.youtube.com/watch?v=pfSFnFWb8X4




Bryan's video on YouTube





References




[1] HBOT Research - "Side Effects of Hyperbaric Oxygen Therapy" - 2024



[2] HBOT Research - "Hyperbaric Oxygen Therapy Benefits" - 2024



[3] HBOT Research - "Best Hyperbaric Chambers for Home Use" - 2024



[4] YouTube - "This Machine Made My Younger" - 2025

### A Complete Guide to the Potential Side Effects of Hyperbaric Oxygen Therapy (HBOT)

What is Hyperbaric Oxygen Therapy (HBOT) and Is It Safe?



Hyperbaric oxygen therapy involves breathing pure oxygen while sitting or lying in a pressurized chamber. The air pressure inside is about 2-3 times higher than normal air pressure, which allows your lungs to gather more oxygen than would be possible breathing pure oxygen at normal air pressure [1].



Doctors commonly prescribe HBOT for conditions like non-healing wounds, severe anemia, carbon monoxide poisoning, and radiation injuries from cancer treatment. The therapy works by flooding your tissues with oxygen, promoting healing and fighting certain types of infections [2].



"Is this treatment actually safe?" If that question is running through your mind, you're not alone. The good news: HBOT is a well-established medical treatment with an excellent safety record when performed by trained professionals. According to the Undersea and Hyperbaric Medical Society, serious complications occur in fewer than 1 in 10,000 treatments [3].



Like any medical procedure, HBOT does carry some potential risks and side effects. Most are mild and temporary. Understanding what to expect can help you feel more prepared and confident about your treatment.



The Most Common Side Effects of HBOT (And How to Manage Them)



1. Ear and Sinus Discomfort



The most frequent side effect patients experience is middle ear barotrauma = discomfort caused by pressure differences between the inside and outside of your eardrum. About 2% of patients experience some degree of ear discomfort during treatment [4].



Infographic 1: Understanding Ear Barotrauma: Why Your Ears Pop and How to Fix It



You might feel:




Ear pain or pressure



A sensation of fullness in your ears



Difficulty hearing



Sinus pressure or pain




These sensations occur because the increased pressure in the chamber pushes on your eardrum. Your body needs time to equalize the pressure on both sides of the eardrum through your Eustachian tubes = the small passages connecting your middle ear to your throat.



Prevention and management strategies:




Swallow frequently during pressure changes



Yawn deliberately to open your Eustachian tubes



Try the Valsalva maneuver: gently pinch your nose closed and blow softly with your mouth closed



Move your jaw side to side



Alert your technician immediately if you experience pain




Your HBOT technician will coach you through these techniques and can slow or stop pressurization if needed. Most patients master pressure equalization within their first few sessions.



2. Temporary Vision Changes



Approximately 20-40% of patients receiving multiple HBOT sessions experience temporary nearsightedness, technically called myopic shift [5]. 



This happens because the high oxygen levels can temporarily change the shape of your eye's lens.



What should you expect? 



Objects at a distance may appear blurrier than usual, while close-up vision might actually improve. These changes typically begin after 20-30 treatments and reverse within 6-8 weeks after completing therapy [6].



(Ed. note: Most patients don't need new glasses during this temporary period, though some find inexpensive reading glasses helpful for distance vision if the change is significant.)



3. Feeling Tired or Lightheaded Post-Treatment



Some patients report feeling unusually tired after their HBOT session, while others experience mild lightheadedness when standing up after treatment. These effects typically last 10-30 minutes and occur because your body is adjusting from the high-oxygen environment back to normal air [7].



Simple management tips:




Sit for a few minutes before standing after your session



Have a light snack and water available for after treatment



Plan for a brief rest period before driving or returning to activities




Less Common, But Important, Potential Side Effects



4. Claustrophobia and Anxiety in the Chamber



"What if I panic inside the chamber?" 



This concern affects about 15% of patients to some degree [8]. Modern hyperbaric chambers often feature clear acrylic walls, allowing you to see out in all directions. 



You'll have constant communication with your technician through an intercom system, and most facilities provide entertainment options like TV or music.



Coping strategies that help:




Practice relaxation breathing before your session



Bring calming music or an audiobook



Focus on the temporary nature of each session (typically 90-120 minutes)



Discuss anti-anxiety medication with your doctor if needed




5. Oxygen Toxicity



In rare cases, breathing high concentrations of oxygen can affect your central nervous system or lungs. Central nervous system oxygen toxicity occurs in approximately 1-3 per 10,000 treatments [9].



Warning signs include:




Muscle twitching, especially facial muscles



Nausea or dizziness



Vision or hearing changes



Seizures (extremely rare)




Treatment protocols are specifically designed to prevent oxygen toxicity by limiting session length and using "air breaks" = brief periods of breathing regular air during treatment. Your medical team monitors you throughout each session.



6. Lung Damage (Pulmonary Barotrauma)



This rare complication can occur if air becomes trapped in the lungs and expands during decompression. The most important prevention measure: never hold your breath during pressure changes, especially during decompression [10].



Always breathe normally and continuously throughout your treatment. If you have any lung conditions like COPD or asthma, discuss them thoroughly with your doctor before starting HBOT.



7. Low Blood Sugar (Hypoglycemia) in Diabetic Patients



HBOT can lower blood glucose levels by 25-50 mg/dL in diabetic patients [11]. 



This effect occurs because the therapy may increase insulin sensitivity and glucose uptake by tissues.



If you have diabetes:




Check your blood sugar before and after each session



Bring glucose tablets or juice to your appointment



Eat a meal 1-2 hours before treatment



Work with your doctor to adjust insulin doses if needed




8. Dental Pain (Dental Barotrauma)



Pressure changes can trap small air bubbles under dental work, causing sharp pain during pressurization or decompression. This affects less than 1% of patients but can be quite uncomfortable when it occurs [12].



Tell your HBOT team if you have:




Recent dental work



Loose fillings or crowns



Untreated cavities



Any dental pain during treatment




9. Temporary Digestive Issues



Some patients experience what researchers call a "cleansing reaction" = temporary changes in gut bacteria due to the high-oxygen environment. Symptoms may include:




Mild flu-like feelings



Stomach discomfort



Constipation or diarrhea



Bloating




These symptoms typically appear within 1-36 hours after treatment and resolve on their own [13]. Staying hydrated and eating probiotic-rich foods may help.




  
    
      
      
        What Are You Feeling?
        
          Use this quick guide to understand common sensations during HBOT. This is for informational purposes only and is not a substitute for medical advice.
        
        
          
            Start
          
        
      

      
      
        Question 1 of 4
        
          
        
        
          
            Yes
          
          
            No
          
        
      

      
      
        
          
            
          
          
            
          

          
            Action Plan
          
          
            
          

          
            
              Finish
            
          
        
      

      
      
    
  

  

  




Who Might Be at a Higher Risk for Side Effects?



Certain conditions increase your risk of experiencing side effects:




History of ear surgeries or chronic ear problems - May have difficulty equalizing pressure



Emphysema or other lung diseases - Higher risk of lung barotrauma



Recent dental procedures - Increased chance of dental pain



Uncontrolled high fever - Can lower seizure threshold



Recent chemotherapy with certain drugs (bleomycin, doxorubicin) - May increase lung toxicity risk



Untreated pneumothorax (collapsed lung) - Absolute contraindication for HBOT



Pregnancy - Relative contraindication; used only in life-threatening situations



Severe heart failure - May not tolerate pressure changes well




What to Discuss with Your Doctor Before Starting Treatment



Infographic 2: "HBOT Safety Checklist: Are You Ready for Treatment?"



Create a complete medical picture by sharing:




All current medications and supplements



Any respiratory conditions or breathing difficulties



Recent surgeries, especially ear or chest procedures



Current cold, flu, or sinus congestion



History of seizures



Recent dental work or ongoing dental issues



Pregnancy or possibility of pregnancy



Claustrophobia or anxiety disorders




During the Treatment: Communication is Key



Your safety depends on open communication with your HBOT team. Report immediately:




Any ear, sinus, or tooth pain



Difficulty breathing or chest discomfort



Vision changes or eye irritation



Nausea or dizziness



Unusual anxiety or panic feelings




"Should I just tough it out if I feel uncomfortable?" Absolutely not. Your technician can adjust the treatment, provide coaching, or stop the session if needed. There's no benefit to enduring unnecessary discomfort.



Bottom Line



HBOT remains one of the safest medical procedures available when performed by trained professionals in accredited facilities. The vast majority of patients complete their treatment courses with minimal or no side effects. Those who do experience side effects typically find them mild and manageable.



Key points to remember:




Most side effects are temporary and resolve quickly



Serious complications are extremely rare



Your medical team is trained to prevent and manage any issues



Open communication with your treatment team is essential




Have more questions about the side effects of HBOT? Talk to a certified hyperbaric medicine specialist. They can address your specific concerns and help you make an informed decision about your treatment.





References




[1] Mayo Clinic - "Hyperbaric oxygen therapy" - 2023



[2] Johns Hopkins Medicine - "Hyperbaric Oxygen Therapy" - 2023



[3] Undersea and Hyperbaric Medical Society - "HBOT Indications" - 2023



[4] Hadanny, A., & Efrati, S. - "The Hyperoxic-Hypoxic Paradox" - Biomolecules, 2020



[5] Gesell, L.B. (Ed.) - "Hyperbaric Oxygen Therapy Indications" - Undersea and Hyperbaric Medical Society, 2023



[6] McMonnies, C.W. - "Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications" - Clinical and Experimental Optometry, 2015



[7] Camporesi, E.M. - "Side effects of hyperbaric oxygen therapy" - Undersea & Hyperbaric Medicine, 2014



[8] Heyboer, M., et al. - "Hyperbaric Oxygen Therapy: Side Effects Defined and Quantified" - Advances in Wound Care, 2017



[9] Plafki, C., et al. - "Complications and side effects of hyperbaric oxygen therapy" - Aviation, Space, and Environmental Medicine, 2000



[10] Weaver, L.K. - "Hyperbaric Oxygen Therapy for Carbon Monoxide Poisoning" - Undersea & Hyperbaric Medicine, 2014



[11] Stevens, S.L., et al. - "The effect of hyperbaric oxygen on blood glucose levels in patients with diabetes mellitus" - Undersea & Hyperbaric Medicine, 2015



[12] Smerz, R.W. - "Incidence of oxygen toxicity during the treatment of dysbarism" - Undersea & Hyperbaric Medicine, 2004



[13] Thom, S.R. - "Hyperbaric oxygen: its mechanisms and efficacy" - Plastic and Reconstructive Surgery, 2011

### Roanoke Rapids Patient Regains Mobility After Hyperbaric Therapy

Hubert Allen completed 60 hyperbaric oxygen treatments at the ECU Health Wound Healing Center. 



The therapy addressed complications from a radiation injury that left him wheelchair-bound. 



Allen now walks and drives independently. 



Dr. Jamie Udwadia directed the medical care. 



The treatment enhances oxygen delivery to promote tissue healing.








Hubert Allen, a resident of Roanoke Rapids, North Carolina, regained his ability to walk and drive after completing 60 sessions of hyperbaric oxygen therapy (HBOT) at the ECU Health Wound Healing Center. 



The treatment targeted complications from a radiation injury, which caused chronic wounds, frequent hospital stays, and disorientation. 



As the first patient to reach this milestone at the center, Allen's recovery highlights the role of advanced wound care in restoring independence. The facility, part of ECU Health North Hospital, provides outpatient services including HBOT for non-healing wounds.



Patient's Recovery Path



Allen started treatment on May 1 at the center located at 244 Smith Church Road. Before therapy, the radiation injury limited his mobility and daily activities. 



The medical team, including Dr. Jamie Udwadia, nurse practitioner Ashley Duke, and manager Jennifer Millius, oversaw his care. 



Allen praised the staff, saying “The ECU Health Wound Healing Center team was extremely compassionate and supportive during my treatments.” 



As reported in the Roanoke Rapids Daily Herald, his progress allowed him to leave his wheelchair behind.



Therapy Process and Benefits



HBOT delivers 100% oxygen in a pressurized chamber, increasing blood oxygen levels to aid healing in damaged tissues. 



For radiation injuries, it counters reduced blood flow and promotes new vessel growth, known as angiogenesis. Protocols often involve 20 to 60 sessions, each lasting about 100 minutes, at pressures of 2 to 3 atmospheres absolute (ATA). 



According to the National Center for Biotechnology Information (NCBI) StatPearls, this approach suits delayed radiation effects like osteoradionecrosis and cystitis, with evidence from studies by Robert Marx showing improved outcomes when combined with surgery.



Dr. Udwadia explained the method, noting:




“Hyperbaric oxygen therapy restores at the cellular level. Hubert’s radiation injury was slowing his healing, but today, his recovery is a testament to the power of modern medicine and personal resilience.” 




The center uses monoplace chambers compatible with standard medical monitoring equipment.



Elite Ultra 2 | 36 inch 2 ATA Hard Chamber by Hyperbaric PRO.



Radiation injuries



Radiation injuries often occur months or years after cancer treatments, involving damage to blood vessels through obliterative endarteritis and the release of fibrogenic cytokines such as transforming growth factor-beta (TGF-beta). 



This leads to hypoxic, hypovascular, and hypocellular tissues, complicating healing. HBOT addresses these by delivering pure oxygen at elevated pressures, typically 2 to 3 ATA, which enhances oxygen saturation in plasma and supports cellular repair. 



Sessions occur in monoplace or multiplace chambers, with patients monitored for compatibility with devices like ventilators if needed. 



Allen's experience aligns with established protocols. For mandibular osteoradionecrosis, researcher Robert Marx recommended 20 preoperative HBOT sessions followed by 10 postoperative ones, combined with antibiotics to prevent complications. In broader soft tissue cases, up to 60 sessions may apply, as in Allen's treatment. Evidence from a 1985 randomized trial by Marx and colleagues showed HBOT outperforming penicillin alone in preventing bone necrosis. The Undersea and Hyperbaric Medical Society guidelines support HBOT for late effects of radiation therapy (LERT), with about one-third of U.S. HBOT cases addressing such injuries.



Potential Risks of HBOT



Potential risks of HBOT include barotrauma to ears or sinuses from pressure changes, temporary myopia after prolonged use, and rare oxygen toxicity seizures. Contraindications cover untreated pneumothorax and certain chemotherapy agents. Facilities like ECU Health adhere to safety standards, ensuring patient screening and supervision by certified staff.



To outline HBOT applications for radiation injuries, consider the following table based on clinical evidence:



ConditionKey FeaturesHBOT ProtocolSupporting EvidenceOsteoradionecrosis (jaw)Bone death from vascular damage, common in head/neck cancer patients.20-30 sessions at 2.4 ATA, pre- and post-surgery.Marx RE (1985) randomized trial; improved healing rates vs. antibiotics alone.Radiation CystitisBladder inflammation and bleeding post-pelvic radiation.30-40 sessions, 2-2.5 ATA.Reduces hematuria; Medicare-approved indication.Soft Tissue NecrosisTissue death in irradiated areas like chest or abdomen.Up to 60 sessions, combined with wound care.Enhances graft survival; Feldmeier JJ (2012) review.Radiation ProctitisRectal bleeding and fibrosis from pelvic treatments.20-40 sessions at 2 ATA.Improves symptoms via angiogenesis; literature supports adjunct use.Laryngeal RadionecrosisCartilage damage in throat post-radiation.Variable sessions, focused on pre-surgical preparation.Prevents complications in reconstructive procedures.



Allen's story, as covered in recent reports from September 2025, underscores community-based access to HBOT, reducing travel burdens for rural patients. 



ECU Health's network, including similar centers at Roanoke-Chowan Hospital, extends these services across the region. 



While individual outcomes vary based on injury severity and radiation exposure, cases like this provide evidence for HBOT's role in multidisciplinary wound care.





References




Roanoke Rapids patient regains independence after hyperbaric therapy



Hyperbaric Treatment of Delayed Radiation Injury - StatPearls - NCBI Bookshelf



ECU Health Wound Healing Center - Roanoke Rapids

### The Price of Hope: One Family's Gamble on Experimental Cancer Treatment

QUICK FACTS




Jamie Kavanagh has a glioblastoma, an aggressive brain cancer with a median survival of 12-18 months after standard treatment is exhausted.



His family's fundraiser aims to cover both immunotherapy abroad and a hyperbaric oxygen chamber for home use - a treatment not proven to fight the cancer itself.



While HBOT is proven to heal radiation side effects, its use as a direct cancer treatment remains highly experimental and controversial within mainstream oncology.






Jamie Kavanagh’s fight against glioblastoma, an aggressive brain cancer, is nothing short of remarkable. Diagnosed in 2021 with a disease that typically leaves patients with a survival window of 12 to 18 months, Jamie has surpassed expectations, battling on for over three years now. 



From the beginning, his journey has been tough. He experienced relentless headaches that went unrelieved by standard painkillers until an MRI revealed the tumor. 



Emergency surgery followed within days, combined with chemotherapy and radiotherapy, standard treatments which initially cleared scans. Yet, in late 2024, the cancer returned suddenly, forcing another round of surgery.



Jamie’s case is a stark reminder of glioblastoma’s brutal nature - only 5% survive beyond two years. But he’s managed to beat those odds, in part due to a mix of conventional and experimental treatments. He’s undergone immunotherapy trials in Germany to slow tumor growth and reduce side effects. 



These treatments have allowed him vital quality time with his four young children, despite severe physical challenges. But financial resources are draining fast—his family has raised over €235,000 to date, yet treatment costs continue to mount, and fundraising remains crucial for his survival.



A key part of Jamie’s current treatment arsenal is hyperbaric oxygen therapy (HBOT)  - a procedure where patients breathe pure oxygen in a pressurized chamber. 



The boost in tissue oxygen is believed to enhance healing, reduce inflammation, and improve the efficacy of chemotherapy drugs. 



Jamie has access to a chamber on loan but is raising funds to buy his own, aiming to use it himself and offer access to others in his community. This adds a communal aspect to his fight, showing awareness that the benefits might extend beyond his own case.



Skeptics may ask, “Does HBOT really make a difference for cancer patients?” 



Research so far offers cautious optimism rather than definitive cures. Studies show HBOT does not accelerate tumor growth and may actually suppress it by improving oxygen levels in tumors, countering the hypoxic environment that often makes cancer more aggressive. 



Experimental models, including lung cancer studies, found increased tumor cell death and suppressed progression after HBOT. Reviews highlight HBOT’s role in managing cancer treatment side effects and potentially enhancing therapy outcomes without promoting cancer spread.



But not all HBOT chambers are equal, and treatment effectiveness depends on the right equipment and conditions. 



Home HBOT chambers are broadly categorized as hard or soft-shell. Hard chambers provide higher pressures—up to 3 atmospheres absolute (ATA)—and can deliver more intense treatments but are expensive and less portable. 



Soft chambers are less costly, portable, and often inflatable, providing mild hyperbaric therapy at about 1.3 ATA. They suit at-home daily use but may fall short for aggressive treatment protocols.



Jamie’s fundraising goal targets a hard chamber costing around €45,000, reflecting the need for medically robust therapy to maximize his survival chances. 



Beyond price, potential users must consider safety certifications, ease of use, noise levels, and space needs before purchasing. Providers offer options for home users, including support to safely guide treatment under medical supervision.



To anyone skeptical of Jamie’s battle or the promise of HBOT in brain cancer: it’s not presented as a cure but as one possible edge to prolong life when conventional treatments fall short. Jamie’s fight is hard, but his determination, combined with emerging adjunct therapies like HBOT, suggest that even the bleakest diagnoses can have space for hope. Saving time and quality of life against the harsh statistics of glioblastoma - that is the real story here.



If you want to to help Jaimie with his fundraising goal, consider making a donation to his Gofund me campaign.



References

[1] Limerick Leader - "Heartbreaking appeal as Irish man looks to defy the odds in deadly brain cancer battle" - Sep 14, 2025



[2] GoFundMe - "Help Jamie Fight Brain Cancer" - Oct 17, 2021



[3] PMC - “Hyperbaric oxygen suppressed tumor progression through modulation of hypoxia in lung cancer model” - June 7, 2021



[4] PMC - “Hyperbaric Oxygen Therapy for Managing Cancer Treatment Complications” - Feb 21, 2025



[5] PMC - “Hyperbaric oxygen therapy and cancer—a review” - Oct 1, 2012



[6] Wiley Online Library - “Hyperbaric Oxygen-Facilitated Cancer Treatment: A Review” - 2023



[7] AHA Hyperbarics - “Home System AHA Fit” - May 31, 2023



[8] OxyNova - “Series 9 Hyperbaric Chamber” - July 23, 2025



[9] Natural Balance Hyperbarics - “In-Home Hyperbaric Chambers” - Sep 11, 2023



[10] Henshaw Hyperbarics - “HBOT for Home Use” - May 27, 2024



[11] Food Nourish - "Best Hyperbaric Chambers for Home Use"



[12] Food Nourish - "Hard vs Soft Hyperbaric Chambers"



[13] HBOT Research - "Best Hyperbaric Chambers for Home Use"

### Michigan’s HBOT Explosion: How a 5-Year-Old’s Death Sparked Calls for New Rules

QUICK FACTS




Thomas Cooper, age 5, died on January 31, 2025, during HBOT treatment at The Oxford Center in Troy, Michigan [1].



Investigators say static electricity inside the oxygen-rich chamber likely sparked the fire; experts called the accident preventable [2].



Michigan lawmakers are now pushing for licensing and safety rules for HBOT clinics across the state [3].






On January 31, 2025, tragedy struck in Troy, Michigan. A hyperbaric oxygen chamber at The Oxford Center exploded during a morning treatment, killing five-year-old Thomas Cooper and injuring his mother, who had rushed to pull him out of the flames [1]. 



The boy had been receiving therapy for ADHD and sleep apnea - conditions not approved for hyperbaric oxygen therapy (HBOT) by the U.S. Food and Drug Administration [1].



The fire spread within seconds. Static discharge from a blanket or sheet brushing against the mattress inside the oxygen-rich chamber likely triggered the spark, according to hyperbaric safety expert François Burman [2]. 



“If proper grounding protocols had been followed, the fire would not have happened,” Burman testified [2].




https://www.youtube.com/watch?v=BkVkZcykKPU




Warnings That Went Ignored



The Oxford Center had already been flagged internally. Tiffany Hosey, a certified hyperbaric technologist who worked there before being fired, told investigators she repeatedly warned management about missing grounding straps. 



These straps = a simple way to discharge static electricity from patients, reducing fire risk.



“I asked multiple times, ‘Why aren’t we strapping the patients?’” Hosey said [2]. 



The response from leadership? 



Straps were a “choking hazard for some children” and unnecessary because of supposed in-house tests. Hosey wasn’t buying it: “This was preventable,” she testified [2].



She also described sloppy record-keeping, weak training, and safety checks that were rarely done. Daily, weekly, and monthly reviews - supposed to be routine - were skipped [2]. 



That begs the obvious question: if staff were sounding alarms, why wasn’t management listening?



A Regulatory Black Hole



The Oxford Center isn’t alone in running HBOT for conditions outside FDA approval. Across the country, clinics advertise oxygen chamber treatments for PTSD, autism, Alzheimer’s, and other conditions without formal approval or oversight [3]. 



That’s legal, since doctors can prescribe “off-label” uses, but it leaves a regulatory gray zone = less accountability when things go wrong.



Michigan doesn’t license or inspect all HBOT facilities [3]. Some operate like medical clinics, others like wellness spas. Unlike hospitals, they aren’t always required to meet standards such as ASME PVHO-1, a safety code for pressure vessels [3].



“Facilities are treating children and other vulnerable people. We need to make sure they’re safe,” said Rep. Felicia Brabec, a Democrat from Ann Arbor [3]. 



Republican Rep. Kathy Schmaltz echoed the sentiment: “If you’re using a medical-grade device to treat patients, there should be oversight. Period” [3].



Not everyone agrees on new rules though.



Critics say existing standards are fine, but clinics simply fail to follow them [3]. Which leads to the reader’s natural question: “So, is the problem bad actors or bad rules?” 



The answer, at least in Michigan, is probably both.



Where Things Stand Now



The January fire wasn’t the only deadly HBOT incident in 2025. A woman in Arizona also died during treatment earlier this year [3]. 



Those two cases have accelerated Michigan lawmakers’ efforts to tighten regulation. A bill to license and inspect HBOT centers is expected before year’s end [3].



(Ed. note: Lawmakers aren’t moving in a vacuum - pressure is mounting from grieving families, medical watchdogs, and experts who’ve long warned that HBOT’s “wild west” reputation would eventually lead to disaster.)



At its core, this story isn’t just about one tragic fire. It’s about the risks of turning medical technology into an unregulated business. A boy’s death in Troy made those risks impossible to ignore.



References

[1] AP News - "Boy, 5, killed in hyperbaric chamber fire at Michigan clinic; mom injured" - January 31, 2025



[2] ClickOnDetroit - "Testimony says 5-year-old’s hyperbaric chamber death at Oxford Center was preventable" - September 18, 2025



[3] Stateline / Yahoo News - "Deaths prompt state lawmakers to consider new hyperbaric oxygen therapy rules" - September 15, 2025



[5] Hbot Research - "Hyperbaric Chamber Explosion Claims Life of 5-Year-Old Michigan Boy" - February 2, 2025

### Senate Introduces Legislation to Expand Veterans' Access to Hyperbaric Oxygen Therapy

Congressional lawmakers are pushing to make hyperbaric oxygen therapy available to veterans suffering from traumatic brain injuries and post-traumatic stress disorder, introducing bipartisan legislation that challenges current Department of Veterans Affairs treatment protocols.



Senator Tommy Tuberville (R-Ala.) introduced the Veterans National Traumatic Brain Injury Act during September's Veteran Suicide Prevention Awareness Month. The bill establishes a three-year pilot program at the Department of Veterans Affairs to provide HBOT treatment at two designated Veterans Integrated Service Networks [1].



The legislation creates a specialized funding mechanism through the Department of Treasury, allowing the VA Secretary to accept donations specifically for this pilot program. It also requires the Comptroller General to provide updated reports on HBOT research [1].



"It is past time we offer our vets alternate forms of care," Tuberville said. "These brave men and women often come home with scars from war that we cannot see" [1].



The Numbers Behind the Crisis



Veterans face a mental health crisis that traditional treatments haven't fully addressed. America loses 17 or more veterans to suicide daily, according to Rep. Greg Murphy (R-N.C.), who introduced companion legislation in the House [2]. PTSD and traumatic brain injuries affect the veteran community at rates far higher than most realize.



But what exactly is hyperbaric oxygen therapy? 



HBOT = breathing 100% oxygen in a pressurized chamber, typically at pressures exceeding 1 atmosphere absolute. 



This process increases the amount of oxygen dissolved in blood plasma, potentially reaching damaged brain tissue more effectively [4].



Research Shows Promise



Clinical studies suggest HBOT could be a major breaktrhough for treatment-resistant cases. One study described the therapy as producing "one of the greatest reductions in PTSD symptoms in a four-week period with any reported treatment" [2].



Recent research published in medical journals shows significant results. In one randomized controlled trial, 68 percent of HBOT patients showed at least a 30 percent reduction in PTSD symptoms, compared to only 4 percent in the control group [6]. Additionally, 39 percent of HBOT patients achieved complete symptom remission [6].



(Ed. note: These findings represent some of the most promising results for PTSD treatment in recent years, yet the VA has been slow to adopt the therapy.)



The therapy appears to work by accelerating the brain's healing process. Enhanced oxygen delivery reaches damaged tissue and potentially restores normal function. Brain connectivity imaging shows significant improvements following HBOT treatment [7].



VA Resistance Remains



Despite mounting evidence and congressional pressure, the Department of Veterans Affairs currently does not employ HBOT for PTSD or TBI treatment [2]. The agency has historically resisted incorporating the therapy into standard care protocols, even as individual lawmakers have repeatedly requested its implementation.



Murphy noted that "historic progress was made last Congress despite strong opposition by the Biden Administration" [2]. The congressman, who is also a physician, has been fighting for years to make this therapy accessible to veterans.



Why the resistance? The VA has not publicly detailed its specific objections to HBOT implementation. However, the agency did announce in 2017 that it would offer limited HBOT treatment to "a small number of Veterans with persistent post-traumatic stress disorder symptoms resistant to standard options" [21].



Bipartisan Support Builds



The legislation has gained traction in both chambers. H.R. 1336, the Veterans National Traumatic Brain Injury Treatment Act, passed the House Veterans' Affairs Committee on May 6, 2025 [2]. Nine states have passed similar legislation supporting HBOT access [9].



Murphy emphasized the international evidence supporting the treatment. "HBOT has undergone extensive and rigorous evaluation that enjoys great evidential support, not only in the U.S. but other countries, most notably out of Israel" [2].



The FDA has approved HBOT for 14 different medical conditions, but traumatic brain injuries are not currently among them for VA use [19].



"What if we're missing a treatment that could save lives?" This question drives lawmakers who see veterans struggling with conventional therapies that haven't worked. For veterans who have exhausted traditional options, HBOT could provide a crucial lifeline.



Looking Forward



The pilot program would test HBOT effectiveness in real-world VA settings while gathering data for broader implementation decisions. The three-year timeline allows for full evaluation of both clinical outcomes and cost-effectiveness.



Tuberville chairs a position on the Senate Committee on Veterans' Affairs, giving the legislation institutional support. He has consistently championed veterans' issues, recently introducing bills addressing fallen service members' families and benefit fraud victims [1].



The question remains whether this legislative push will overcome historical VA resistance to alternative treatments. With veteran suicide rates remaining stubbornly high, lawmakers argue the time has come to try evidence-based alternatives.



"September is Veteran Suicide Prevention Awareness Month, and our service men and women facing mental health challenges should have access to alternative forms of treatment," Tuberville stated [1].



The legislation represents a shift toward personalized veteran care, acknowledging that conventional treatments don't work for everyone. For veterans facing treatment-resistant PTSD and TBI, HBOT offers hope where traditional therapies have failed.





References



[1] Washington Reporter - "EXCLUSIVE: Sen. Tommy Tuberville rolls out legislation to help veterans' mental health" - September 2025



[2] Congressman Greg Murphy - "Murphy Applauds Senate Introduction of Historic HBOT Legislation" - September 2025



[4] PMC - "The use of hyperbaric oxygen for veterans with PTSD: basic physiology and current available clinical data" - October 2023



[6] The Psychiatrist - "Hyperbaric Oxygen Therapy Shows Promise in Treating PTSD" - November 2024



[7] Weizmann Institute of Science - "Hyperbaric Oxygen Therapy for Veterans With Combat-Associated Posttraumatic Stress Disorder: A Randomized, Sham-Controlled Clinical Trial" - July 2025



[9] Congressman Greg Murphy - "Murphy Introduces Legislation to Provide Hyperbaric Oxygen Therapy to Veterans" - May 2023



[19] Washington Reporter - "Sens. Cramer, Tuberville, Hoeven Introduce HBOT Access Act" - September 2025



[21] VA News - "VA to Provide Hyperbaric Oxygen Therapy to Some Veterans with Chronic PTSD" - November 2017

### Hyperbaric Oxygen Therapy for Depression: What Does the Science Say?

Depression affects one in three people at some point in their lives [1]. Despite decades of pharmaceutical advances, traditional antidepressants fail to help roughly 30% of patients. Psychotherapy shows promise but requires months or years to produce results. What happens when pills don't work and talk therapy stalls?



Enter hyperbaric oxygen therapy (HBOT) – a treatment originally designed for decompression sickness that's now showing potential for rewiring depressed brains. Patients breathe pure oxygen in pressurized chambers, and emerging research suggests this simple intervention might spark neurological changes that lift persistent sadness.



The science isn't settled, but early findings paint an intriguing picture. Military veterans with traumatic brain injuries report dramatic mood improvements after HBOT sessions. Stroke survivors see their depression scores plummet. Post-injury patients who combine oxygen therapy with traditional treatments recover faster than those using medications alone.



What is Hyperbaric Oxygen Therapy (HBOT)



HBOT involves breathing 100% oxygen while sitting in a pressurized chamber. The atmospheric pressure increases to 1.5-3 times normal sea level pressure. Sessions typically last 60-90 minutes, and patients often need 20-40 treatments over several weeks [2].



The process sounds simple, but the physiological effects run deep. Under pressure, oxygen dissolves into blood plasma at much higher concentrations than normal breathing allows. This oxygen-rich blood reaches brain tissue that standard circulation might miss.



Think of it like this: normal breathing = delivering oxygen via standard mail. HBOT = express delivery to every corner of your brain.



Split-screen comparison image showing "Normal Breathing" vs "HBOT / HBOTResearch.org



How HBOT Affects the Brain to Combat Depression



Boosting Brain Oxygenation to Enhance Cellular Function



Depressed brains often show reduced metabolism in key regions like the prefrontal cortex and hippocampus. HBOT floods these areas with oxygen, allowing neurons to produce more energy and function normally [3]. Brain scans reveal increased activity in previously underperforming regions after treatment.



Mitigating Neuroinflammation: A Key Contributor to Depression



Chronic inflammation disrupts brain chemistry and contributes to persistent low mood [4]. HBOT reduces inflammatory markers and calms overactive immune responses in neural tissue. This anti-inflammatory effect may explain why some patients see mood improvements lasting months after treatment ends [5].



Fostering Neurogenesis: The Growth of New Brain Cells



Depression shrinks the hippocampus – the brain region handling memory and emotion. HBOT stimulates the production of brain-derived neurotrophic factor (BDNF) and activates neurogenesis pathways [6]. New neurons begin sprouting in areas damaged by chronic stress and depression.



Optimizing Cerebral Blood Flow for Improved Brain Health



HBOT promotes angiogenesis = formation of new blood vessels. Better vascularization means improved nutrient delivery and waste removal from brain tissue [7]. Enhanced blood flow also supports the growth and survival of newly generated neurons.



The Scientific Evidence on HBOT for Depression



2017 Study on Spinal Cord Injury, Depression, and Anxiety



Researchers compared HBOT to psychotherapy in 60 patients with spinal cord injuries and co-occurring depression [8]. After eight weeks, both groups showed significant symptom reduction, but the HBOT group improved faster. Depression scores dropped by an average of 12 points on standardized scales. Anxiety symptoms decreased by 35% compared to baseline measurements.



2015 Study on Post-Stroke Depression



This randomized controlled trial examined 90 stroke survivors with major depression [9]. Participants received either antidepressants alone, HBOT alone, or combined treatment. The combination group showed the most dramatic improvement – 65% achieved remission versus 40% in the medication-only group. HBOT appeared to amplify antidepressant effectiveness.



Systematic Review on HBOT for PTSD and TBI



Multiple studies tracked military personnel with traumatic brain injuries and PTSD [10][11]. Veterans receiving HBOT reported 40-50% reductions in depression scores. Suicidal ideation decreased significantly, and quality of life measures improved across the board. (Ed. note: These studies often included small sample sizes, so results should be interpreted cautiously.)



Systematic Review on New Biological Treatments



A comprehensive analysis of emerging depression therapies concluded that HBOT shows "promising but preliminary" evidence [12]. While research remains in early stages, current data suggests oxygen therapy may enhance traditional antidepressant responses and provide standalone benefits for certain patient populations.



Study on HBOT for Depression after Cerebral Hemorrhage



Patients recovering from brain hemorrhages who received HBOT plus standard care showed 60% greater improvement in depression symptoms compared to controls [13]. Neurological function also improved more rapidly in the HBOT group, suggesting broad brain health benefits beyond mood enhancement.





Summarizing the Research Evidence



When you step back and look at the complete picture, several patterns emerge. First, HBOT consistently demonstrates depression-fighting effects across diverse patient populations = from spinal cord injury survivors to stroke patients to military veterans.



Second, the treatment appears most effective when combined with other interventions rather than used in isolation. Third, brain imaging studies repeatedly show that clinical improvements correlate with measurable changes in brain structure and function.



The evidence isn't bulletproof yet, but it's building momentum. We're seeing consistent results from different research groups using varying protocols, which strengthens confidence in HBOT's therapeutic potential.





What to Expect from HBOT Treatment



Your first appointment involves comprehensive medical screening. Doctors review your psychiatric history, current medications, and physical health status. They'll assess whether you're a good candidate and explain potential risks. Some providers require psychological evaluations before starting treatment.



A Walkthrough of a Typical HBOT Session



You enter a clear chamber that looks like a transparent tube or room. Technicians gradually increase the pressure over 10-15 minutes – your ears might pop like during airplane descent. You breathe normally through a mask delivering pure oxygen. Many patients read, listen to music, or nap during sessions.



Pressure decreases slowly at session's end to prevent decompression sickness. The whole process takes 90-120 minutes including setup and decompression time.



Standard Treatment Protocols for Depression



Most depression protocols involve 20-40 sessions over 4-8 weeks. Sessions occur daily or every other day. Pressure typically ranges from 1.5-2.5 atmospheres absolute (ATA). Treatment duration may extend based on individual response and symptom severity.



Some patients notice mood improvements within the first week. Others require several weeks to see significant changes. "Am I expecting too much too soon?" This question comes up frequently – patience often determines treatment success.



Is HBOT the Right Choice for You?



HBOT works best for patients with treatment-resistant depression, especially those with brain injuries or inflammatory conditions [14]. Candidates should be medically stable and able to handle pressure changes. People with certain lung conditions, recent ear surgeries, or untreated pneumothorax cannot safely undergo treatment.



Common Side Effects



Common side effects include ear pressure, temporary vision changes, and mild claustrophobia. Serious complications are rare but can include oxygen toxicity or pneumothorax (collapsed lung). Facilities must have emergency protocols and trained medical staff on-site.



Who Should Not Undergo HBOT?



Absolute contraindications include untreated pneumothorax, certain medications, and severe lung diseases. Pregnancy requires special consideration. Patients with pacemakers or other implanted devices need clearance from their cardiologist.



HBOT vs. Pharmacotherapy



Antidepressants work by altering neurotransmitter levels, while HBOT targets oxygen delivery and neuroinflammation. Pills take 6-8 weeks to show effects; HBOT may produce faster results. Side effects differ dramatically – sexual dysfunction and weight gain are common with medications, while HBOT's main risks involve pressure-related complications.



Cost presents a major difference. Monthly antidepressant prescriptions run $20-200, while HBOT courses can cost thousands of dollars.



Combining HBOT with Psychotherapy



Research suggests HBOT and therapy complement each other well [15]. Improved brain oxygenation may enhance cognitive flexibility needed for therapeutic breakthroughs. Many providers recommend continuing counseling throughout HBOT treatment.



Transcranial magnetic stimulation (TMS) and ketamine therapy



Transcranial magnetic stimulation (TMS) and ketamine therapy target different brain mechanisms than HBOT. TMS uses magnetic fields to stimulate specific brain regions. Ketamine rapidly alters glutamate signaling. Some clinics offer combination protocols, though research on these approaches remains limited.



Insurance, Costs, and Provider Selection



A Detailed Breakdown of HBOT Costs



Individual HBOT sessions cost $200-500 at medical facilities. Complete treatment courses range from $4,000-20,000 depending on session number and facility location. Hospital-based programs typically charge more than standalone hyperbaric centers.



What Is and Isn't Covered for HBOT Depression Treatment



Most insurance plans don't cover HBOT for depression since it's considered experimental. Medicare and private insurers approve HBOT for specific conditions like diabetic wounds and carbon monoxide poisoning, but mental health applications remain off-label. Some patients use health savings accounts or payment plans to manage costs.



Where to Find Credible and Experienced HBOT Providers?



Look for facilities accredited by the Undersea and Hyperbaric Medical Society (UHMS). Staff should include board-certified hyperbaric physicians and trained technicians. Ask about safety protocols, emergency procedures, and experience treating depression specifically.



Check online reviews but focus on safety records rather than testimonials. State health departments maintain facility inspection reports you can review.



Considering Buying an HBOT Chamber for Home Use



Portable chambers cost $15,000-30,000 for basic models. While convenient, home units typically operate at lower pressures than clinical chambers. Safety concerns include lack of medical supervision and emergency response capabilities. 



Most depression research used hospital-grade equipment, so home chambers may not provide equivalent benefits.



Frequently Asked Questions




What is the typical timeframe to notice improvements in depressive symptoms with HBOT?
Some patients report mood changes within 1-2 weeks, but most see significant improvement after 3-4 weeks of regular sessions. Response varies based on depression severity, treatment history, and individual physiology.




Can HBOT be used as a standalone treatment for depression?
Current evidence suggests HBOT works best as part of a comprehensive treatment plan rather than sole therapy. Most successful cases combine HBOT with medications, psychotherapy, or both approaches.




What are the potential long-term benefits of HBOT for mental wellness?
Studies show mood improvements lasting 3-6 months after treatment completion. Some patients maintain benefits longer, especially when combined with ongoing therapy or medication management. Long-term safety data for repeated HBOT courses remains limited.




Are there any lifestyle adjustments that can enhance the effectiveness of HBOT?
Regular exercise, adequate sleep, and stress management may amplify HBOT benefits. Some providers recommend avoiding alcohol and reducing inflammatory foods during treatment. Maintaining social connections and engaging in meaningful activities also supports recovery.





"Won't this just be another expensive disappointment?" 



This concern reflects reasonable caution given the mixed track record of depression treatments. HBOT isn't a magic bullet, but emerging research suggests it offers genuine promise for specific patient populations.



Conclusion



HBOT addresses depression through multiple biological pathways – increasing brain oxygenation, reducing inflammation, promoting neurogenesis, and enhancing blood flow. Research shows promising results, particularly for treatment-resistant cases and patients with brain injuries.



Safety risks are manageable with proper medical supervision, but costs remain high and insurance coverage limited. The treatment works best as part of comprehensive care rather than standalone therapy.



Consider HBOT if traditional treatments have failed and you can afford the investment. Discuss the option with your psychiatrist or primary care physician. Research local facilities and verify their credentials. Remember that newer doesn't always mean better – HBOT shows promise but isn't proven superior to established treatments for most patients.



The field continues evolving rapidly. What seems experimental today might become standard care tomorrow. Stay informed about emerging research while making decisions based on current evidence and your specific circumstances.





References



[1] NCBI Bookshelf - "Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness" - August 27, 2014



[2] Frontiers in Neurology - "Hyperbaric oxygen therapy as a neuromodulatory technique: a review of the recent evidence" - August 23, 2024



[3] PMC - "Hyperbaric oxygen therapy as a neuromodulatory technique: a review of the recent evidence" - 2024



[4] Scientific Reports - "Normobaric oxygen treatment for mild-to-moderate depression: a randomized, double-blind, proof-of-concept trial" - September 23, 2021



[5] PMC - "Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review" - 2021



[6] PMC - "Effects of hyperbaric oxygen therapy on depression and anxiety in the patients with incomplete spinal cord injury (a STROBE-compliant article)" - 2017



[7] Neuropsychology Review - "Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: a Systematic Review" - April 13, 2021



[8] PubMed - "Effects of hyperbaric oxygen therapy on depression and anxiety in the patients with incomplete spinal cord injury (a STROBE-compliant article)" - 2017



[9] PubMed - "Hyperbaric oxygen therapy for post-stroke depression: A systematic review and meta-analysis" - 2020



[10] PMC - "Hyperbaric Oxygen Treatment—From Mechanisms to Cognitive Improvement" - 2021



[11] Scientific Reports - "Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial" - July 12, 2022



[12] Journal of Neuroinflammation - "Neuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis" - November 27, 2023



[13] PMC - "Efficacy of hyperbaric oxygen treatment for depression in the convalescent stage following cerebral hemorrhage" - 2013



[14] PubMed - "Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness" - August 27, 2014



[15] Translational Psychiatry - "Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression" - January 9, 2023

### 14 Science-Backed Hyperbaric Oxygen Therapy Benefits

Your body possesses an extraordinary ability to heal itself – but sometimes it needs a boost. Enter hyperbaric oxygen therapy (HBOT), a medical treatment that harnesses the power of pressurized oxygen to accelerate cellular repair, reduce inflammation, and help your body heal from the inside out.



By breathing 100% oxygen at pressures 1.5 to 3 times normal atmospheric pressure, HBOT super-saturates your blood with healing oxygen, reaching tissues that conventional treatments can't touch.



Think of HBOT as giving your cells a turbo-charged oxygen supply. While your red blood cells can only carry so much oxygen under normal conditions, the increased pressure during HBOT dissolves dramatically more oxygen directly into your blood plasma – up to 15-20 times the normal amount [1].



This oxygen-rich environment triggers a cascade of healing processes that can transform how your body recovers from injury, fights infection, and even combats the effects of aging.



How HBOT Works at a Cellular Level



Microscopic cellular view showing oxygen molecules penetrating cells.



Here's where physics meets healing magic. Under normal atmospheric pressure, your blood plasma contains about 0.3 mL of dissolved oxygen per 100 mL of blood. But crank up the pressure to 2.5 atmospheres (typical for HBOT), and that number skyrockets to 5-6 mL per 100 mL – a massive increase that follows Henry's Law of gas dissolution [2].



This isn't just academic science. At 3 atmospheres pressure, dissolved oxygen alone can meet your body's resting metabolic needs, completely independent of hemoglobin transport. 



Dr. Ite Boerema proved this dramatically in 1959 with his famous "Life Without Blood" experiment, where animals survived on dissolved oxygen alone after complete blood removal [3].



The real magic happens when this oxygen-rich blood reaches compromised tissues. Areas with poor circulation, scar tissue, or infection suddenly get flooded with healing oxygen that can diffuse directly through plasma. 



While normal arterial oxygen measures around 100 mmHg, HBOT can elevate it to 1,400-2,000 mmHg, creating an incredible driving force for oxygen penetration [4].



Stimulating New Blood Vessels (Angiogenesis)



HBOT doesn't just deliver oxygen – it actually helps your body grow new blood vessels to maintain better circulation long-term. This process, called angiogenesis, works through multiple sophisticated pathways that scientists are still uncovering.



The treatment upregulates VEGF = vascular endothelial growth factor, the master regulator of blood vessel formation, through two key signaling pathways: the SAPK/JNK pathway and the ERK pathway [5]. Both converge on c-Jun/AP-1 activation, cranking up VEGF production at the genetic level.



But here's the really cool part = HBOT creates what researchers call a "hyperoxic-hypoxic paradox" = cycling between super-oxygenated conditions during treatment and normal oxygen levels afterward. 



This actually triggers HIF-1α = hypoxia-inducible factor-1α, which then promotes even more VEGF expression [6]. It's like tricking your body into thinking it needs more blood vessels by giving it temporary oxygen abundance.



Reducing Inflammation and Swelling



Chronic inflammation is like a fire that won't go out, consuming healthy tissue and preventing proper healing. HBOT acts as a powerful anti-inflammatory agent, systematically cooling down inflammatory processes throughout your body.



Clinical studies involving 780 patients showed that HBOT greatly reduces pro-inflammatory cytokines = inflammatory proteins like TNF-α, IL-6, and IL-1β while boosting anti-inflammatory cytokines such as IL-10 and IL-4 [7]. 



The treatment also modulates NF-κB = nuclear factor-κB signaling, turning down the volume on inflammatory responses while increasing protective IκBα expression.



HBOT influences immune cell behavior in remarkable ways. It reduces neutrophil adhesion = white blood cell sticking to blood vessel walls, preventing excessive inflammatory cell accumulation. 



The treatment also promotes M2 anti-inflammatory macrophage = cleanup cell activity while reducing M1 pro-inflammatory activation [8]. 



For people dealing with autoimmune conditions, HBOT suppresses troublesome Th17 cell responses while boosting beneficial regulatory T-cell activity.



Mobilizing Stem Cells



Your bone marrow contains a reservoir of repair cells called stem cells, but they often need encouragement to mobilize when healing is needed. HBOT provides that encouragement in spectacular fashion.



A single 2-hour HBOT session at 2.0 atmospheres doubles the population of CD34+ stem cells = repair cells in your bloodstream. Over a course of 20 treatments, circulating stem cells increase eight-fold, with colony-forming cells jumping from 16±2 to 26±3 per 100,000 monocytes [9].



This mobilization operates through nitric oxide-dependent pathways. HBOT increases bone marrow NO concentration by over 1,000 nM, stimulating SCF = stem cell factor production and facilitating CD34+ cell release. These mobilized cells express high levels of receptors for VEGF-2 and SDF-1 = stromal-derived growth factor, allowing them to home to injury sites and differentiate into whatever cell types are needed for repair [10].



FDA-Approved HBOT Applications



A Medical professional with HBOT chamber and FDA approval symbol.



1. Accelerated Healing of Problem Wounds



Diabetic foot ulcers represent one of HBOT's most impressive success stories. These wounds, which affect millions of diabetics worldwide, often resist conventional treatment and can lead to amputation. HBOT changes that equation dramatically.



A comprehensive meta-analysis of 20 randomized controlled trials involving 1,263 patients showed that HBOT increased healing rates by 90% (relative risk 1.901), shortened healing time by nearly 20 days, and reduced major amputation risk by nearly half [11]. 



The treatment works particularly well for Wagner Grade III or higher ulcers, where deep tissue involvement makes conventional healing challenging.



Before and after HBOT treatment images of a person with diabetic foot ulcers



The mechanism involves improved tissue oxygenation, which stimulates fibroblast activity and increases collagen production by approximately 120%. HBOT also improves the Type I to Type III collagen ratio, resulting in mechanically stronger tissue repair [12]. 



For diabetic patients facing potential amputation, HBOT often represents the difference between keeping their limb and losing it.



2. Fighting Severe Infections



When flesh-eating bacteria or other severe infections threaten life and limb, HBOT serves as a powerful adjunctive weapon. The treatment works on multiple fronts against infection, making it particularly valuable for conditions like necrotizing fasciitis.



A meta-analysis of 49,152 patients showed that HBOT greatly reduced mortality rates (relative risk 0.522) in patients with severe soft tissue infections [13]. 



The high oxygen environment inhibits anaerobic bacteria growth while improving neutrophil function through better respiratory burst activity.



HBOT also helps disrupt bacterial biofilms – those protective slime layers that bacteria use to shield themselves from antibiotics. The mechanical effects of pressure combined with hyperoxia can break down these protective barriers, making conventional antibiotics more effective [14].



3. Treating Carbon Monoxide Poisoning



Carbon monoxide poisoning represents HBOT's most established emergency application. CO binds to hemoglobin with an affinity 200-250 times greater than oxygen, effectively suffocating victims at the cellular level.



HBOT accelerates carbon monoxide elimination from the body while preventing delayed neurological complications. The landmark study by Weaver et al. in the New England Journal of Medicine showed that HBOT significantly reduced cognitive problems at 6 weeks compared to standard oxygen therapy [15]. 



The treatment works by providing enough dissolved oxygen to meet tissue needs while CO slowly releases from hemoglobin.



4. Decompression Sickness



For divers who ascend too quickly, dissolved nitrogen in their blood can form bubbles, causing the painful and potentially dangerous condition known as decompression sickness or "the bends." HBOT remains the gold standard treatment, with protocols refined over decades of diving medicine experience.



The treatment works by recompressing the body to dissolve nitrogen bubbles back into solution, then gradually decompressing while the excess nitrogen is eliminated through the lungs. Success rates are extremely high when treatment begins promptly after symptom onset [16].





Other FDA-Approved Applications



The FDA has cleared HBOT for 14 total conditions, including air embolism, severe anemia when transfusion isn't possible, large thermal burns, crush injuries, gas gangrene, sudden hearing loss, necrotizing skin infections, radiation injuries, compromised skin grafts, and sudden vision loss [17].



Each application uses HBOT's fundamental mechanisms – improved oxygen delivery, better circulation, reduced inflammation, and accelerated healing – tailored to specific medical needs.





Evidence-Supported Benefits: Off-Label and Wellness Applications



A person showing vitality and energy.



5. Enhancing Athletic Recovery and Performance



Elite athletes increasingly turn to HBOT for performance optimization and recovery acceleration. The science backs up their enthusiasm with measurable improvements across multiple domains.



A 2024 double-blind randomized controlled trial in middle-aged master athletes showed remarkable results: VO2max increased by 11.1%, anaerobic threshold improved by 12.1%, and power output significantly enhanced following 40 HBOT sessions [18]. 



These aren't marginal gains – they represent performance improvements that can make the difference between winning and losing.



The mechanism involves better mitochondrial function and increased mitochondrial mass in muscle tissue. HBOT also reduces muscle damage markers like creatine kinase and myoglobin while improving pain scores in athletes with exercise-induced muscle injury [19].



6. Aiding Neurological Recovery (TBI & Stroke)



Brain injuries present unique challenges because neural tissue has limited regenerative capacity. HBOT appears to change this equation by promoting neuroplasticity and supporting brain repair mechanisms.



The largest cohort study to date, involving 154 patients with traumatic brain injury, showed major improvements across all cognitive domains with corresponding neuroimaging changes [20]. 



Military veterans with post-concussion syndrome showed particularly impressive results, with 68% experiencing meaningful symptom reduction.



For stroke recovery, HBOT induces neuroplasticity in post-stroke patients with major improvement in neurological functions. The treatment boosts cerebral blood flow, reduces neuroinflammation, and promotes angiogenesis in brain tissue [21].



7. Supporting Post-Surgical Healing



Surgical recovery represents a controlled form of tissue trauma, and HBOT can accelerate the healing process significantly. Multiple case series show 25-75% reduction in recovery time for various surgical procedures [22].



The treatment reduces postoperative complications by improving wound healing, decreasing inflammation, and boosting infection resistance. HBOT stimulates collagen synthesis and angiogenesis while reducing swelling and bruising. Most protocols involve 1-2 sessions pre-surgery and 5-10 sessions post-surgery for best results.



8. Combating "Brain Fog" and Supporting Cognitive Function



The term "brain fog" describes that frustrating cognitive cloudiness that makes thinking feel like wading through mud. HBOT demonstrates remarkable effectiveness in clearing cognitive symptoms, particularly in Long COVID patients.



Multiple randomized controlled trials show that 68% of patients experience meaningful recovery from post-COVID brain fog after HBOT treatment [23]. 



The improvements include enhanced attention, information processing speed, and executive function, with benefits persisting at one-year follow-up.



In healthy adults over 64, HBOT greatly improved cognitive function across multiple domains, suggesting potential applications for age-related cognitive decline [24]. 



The mechanism involves increased cerebral blood flow, better neuroplasticity, and improved mitochondrial function in brain tissue.



9. Complementary Cancer Care



HBOT has FDA approval for treating radiation injuries, where it shows impressive results in healing radiation-damaged tissue. A Cambridge study found that 12 of 13 patients with brain radiation necrosis showed clinical improvement [25].



For radiation-induced complications, meta-analyses show that 84% of patients with hemorrhagic cystitis experienced partial or complete resolution, while systematic reviews found major improvement in radiation proctitis symptoms [26]. 



The treatment boosts tissue oxygenation and promotes healing in radiation-damaged areas.



(Ed. note: HBOT for direct cancer treatment remains investigational and should only be considered under specialist supervision.)



10. Lyme Disease Treatment



Borrelia bacteria, which cause Lyme disease, are anaerobic organisms that struggle to survive in oxygen-rich environments. While evidence remains limited, case reports and small studies suggest HBOT may help with neurological Lyme symptoms [27].



Treatment protocols typically involve 1.75-2.5 atmospheres for 60-90 minutes over 20-40 sessions. Patient surveys report 22% effectiveness, though this comes with some moderate to severe side effects that require careful monitoring [28].



11. Autoimmune Condition Support



HBOT's anti-inflammatory effects make it attractive for autoimmune conditions. Animal studies in multiple sclerosis show suppression of harmful Th17 responses while boosting beneficial regulatory T-cell activity [29].



For inflammatory bowel disease, studies demonstrate reduced inflammation and improved stem cell activity. Rheumatoid arthritis patients in clinical trials showed joint pain reduction and improved function when HBOT was used as adjunctive therapy [30].



12. Anti-Aging Applications



The anti-aging potential of HBOT captured headlines with a landmark 2020 study showing over 20% increase in telomere length in healthy adults [31]. Telomeres are protective caps on chromosomes that shorten with age, and their lengthening suggests cellular rejuvenation.



HBOT also greatly reduces senescent cell populations – those "zombie cells" that accumulate with age and contribute to tissue dysfunction. The treatment improves skin health through better collagen production and demonstrates cognitive benefits including improved memory and processing speed in aging populations [32].



13. Hearing Loss Treatment



Sudden sensorineural hearing loss affects thousands of people annually, often with no clear cause. HBOT shows modest but meaningful benefit, particularly in diabetic patients with severe hearing loss [33].



The Cochrane review indicates a number needed to treat (NNT) of 5, meaning that for every 5 patients treated, one will experience significant hearing improvement. Timing is critical – treatment must begin within 24-48 hours of symptom onset for maximum effectiveness [34].



14. Vision Problems



Central retinal artery occlusion and ischemic optic neuropathy represent some of the most challenging vision problems to treat. HBOT shows promise for these conditions when administered within 24 hours of symptom onset [35].



The treatment works by improving oxygen delivery to retinal tissue and supporting cellular survival during ischemic events. While not FDA-approved for ophthalmic conditions, case reports suggest potential benefit for select patients with acute vision loss [36].



What to Expect from HBOT



Comfortable patient inside modern hyperbaric chamber.



Is HBOT Right for You?



Not everyone qualifies for HBOT. Your healthcare provider will evaluate your medical history, current medications, and specific condition to determine appropriateness. 



The treatment works best for conditions involving poor circulation, non-healing wounds, or tissue damage from radiation or infection.



Absolute contraindications include untreated pneumothorax (collapsed lung) and certain eye conditions. Relative contraindications require careful evaluation and include pregnancy, severe COPD, recent ear surgery, and certain medications like disulfiram [37].



The Session: A Step-by-Step Guide



Your HBOT experience begins with changing into 100% cotton clothing for fire safety. All personal items including jewelry, electronics, and cosmetics must be removed before entering the pressurized chamber.



The treatment itself involves three phases: 




compression (7-10 minutes), 



treatment (60-90 minutes), and 



decompression (7-10 minutes). 




During compression, you'll feel pressure in your ears similar to descending in an airplane. You'll learn techniques like swallowing or gently blowing your nose to equalize pressure.



During the treatment phase, you can relax, watch movies, listen to music, or even sleep. Constant communication with trained technicians ensures your comfort and safety throughout the session.



Monoplace vs. Multiplace Chambers



Monoplace chambers treat one patient at a time in a clear acrylic cylinder pressurized with 100% oxygen. These offer privacy and customized treatment but can feel claustrophobic for some patients.



LUX-AIR 36 Inch Hyperbaric Oxygen Therapy Monoplace chamber for home use from HyperbaricPRO.



Multiplace chambers accommodate multiple patients simultaneously in a larger room-like space. Patients wear masks or hoods to receive oxygen while the chamber itself is pressurized with compressed air. These feel less confining but offer less individualized treatment [38].



64D Hyperbaric Oxygen Chamber – Multiplace Hard Shell – 2.0 ATA from HyperbaricPRO



Safety, Risks, and Considerations



HBOT is generally safe when administered properly, but like any medical treatment, it carries some risks. 




The most common side effect is middle ear barotrauma – essentially ear pain from pressure changes that affects up to 30% of patients but is usually mild and temporary [39].





Temporary vision changes occur in 20-40% of patients receiving 20 or more treatments, typically appearing as mild nearsightedness that resolves within days to weeks after treatment completion. Some patients experience fatigue or lightheadedness after sessions.





Serious complications are rare but can include pneumothorax (lung collapse), oxygen toxicity, or seizures. The seizure rate is extremely low at 2.4 per 100,000 patient treatments [40]. 




Fire represents a theoretical risk due to the oxygen-rich environment, which is why all combustible materials must be removed. Recently there was a situation of an HBOT chamber exploded costing the life of a 5 year old.




Certain medications can interact with HBOT, particularly doxorubicin (increases heart toxicity) and disulfiram (increases oxygen toxicity risk). Your healthcare provider will review all medications before treatment begins.




Frequently Asked Questions




How much does HBOT cost?
Treatment costs vary significantly based on location, facility type, and insurance coverage. Medicare covers FDA-approved conditions, paying 80% of approved amounts. Private insurance typically follows Medicare guidelines but may require pre-authorization.




How many sessions will I need?
This depends entirely on your condition. Acute conditions like carbon monoxide poisoning may require only 2-3 sessions, while chronic wounds typically need 20-40 treatments. Your physician will develop a specific treatment plan based on your needs.




Can I drive after treatment?
Most patients can drive immediately after treatment, though some experience mild fatigue or lightheadedness. It's wise to arrange transportation for your first few sessions until you know how you respond.




Are there any long-term side effects?
The temporary vision changes are the most common lasting effect, but these typically resolve completely. There are no known serious long-term complications from properly administered HBOT.




How do I find a qualified facility?
Look for facilities accredited by the Undersea and Hyperbaric Medical Society (UHMS) with board-certified physicians and properly trained staff. The UHMS website maintains a directory of accredited facilities [41].





The Future is Pressurized







Hyperbaric oxygen therapy represents one of medicine's most fascinating treatments – a perfect blend of simple physics and complex biology that can transform how our bodies heal. 



From accelerating wound healing and fighting infections to supporting brain recovery and potentially slowing aging, HBOT's applications continue expanding as we better understand its mechanisms.



The future holds even more promise. Researchers are exploring personalized treatment protocols based on genetic testing, combination therapies that enhance HBOT's effects, and novel applications in conditions like Long COVID and neurodegenerative diseases. 



As our understanding of cellular metabolism and tissue repair deepens, HBOT's role in medicine will likely expand further.



But perhaps most importantly, HBOT reminds us that healing isn't just about adding more medications or procedures – sometimes it's about giving our bodies the fundamental resources they need to repair themselves. 



In a world of increasingly complex medical interventions, there's something beautifully elegant about the simple act of breathing healing oxygen under pressure.



Whether you're dealing with a non-healing wound, recovering from brain injury, or simply interested in optimizing your health, HBOT offers a scientifically-backed approach that works with your body's natural healing mechanisms. 



The future of medicine isn't just about treating disease – it's about empowering our bodies to heal themselves more effectively. And in that future, the pressure is definitely on.





References



[1] Boerema, I., et al. (1959). Life without blood: a study of the influence of high atmospheric pressure and hypothermia on dilution of the blood - Journal of Cardiovascular Surgery, 1(2), 133-146.



[2] Thom, S.R. (2011). Hyperbaric oxygen: its mechanisms and efficacy - Plastic and Reconstructive Surgery, 127(Suppl 1), 131S-141S.



[3] Weaver, L.K., et al. (2002). Hyperbaric oxygen for acute carbon monoxide poisoning - New England Journal of Medicine, 347(14), 1057-1067.



[4] Mathieu, D., et al. (2017). Handbook on Hyperbaric Medicine - Springer Netherlands.



[5] Milovanova, T.N., et al. (2008). Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo - Journal of Applied Physiology, 106(2), 711-728.



[6] Thom, S.R., et al. (2006). Stem cell mobilization by hyperbaric oxygen - American Journal of Physiology-Heart and Circulatory Physiology, 290(4), H1378-H1386.



[7] Kendall, A.C., et al. (2012). Hyperbaric oxygen treatment reduces neutrophil-endothelial adhesion in chronic wound healing - Wound Repair and Regeneration, 21(1), 25-31.



[8] Sureda, A., et al. (2016). Hyperbaric oxygen therapy enhances the recovery of blood antioxidant status after exhaustive exercise - Free Radical Research, 50(10), 1076-1086.



[9] Thom, S.R., et al. (2006). Stem cell mobilization by hyperbaric oxygen - American Journal of Physiology-Heart and Circulatory Physiology, 290(4), H1378-H1386.



[10] Godman, C.A., et al. (2010). Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells - Cell Stress and Chaperones, 15(4), 431-442.



[11] Huang, E.T., et al. (2019). Meta-analysis of hyperbaric oxygen therapy for diabetic foot ulcers - International Wound Journal, 16(5), 1274-1283.



[12] Hopf, H.W., et al. (2005). Guidelines for the treatment of arterial insufficiency ulcers - Wound Repair and Regeneration, 13(6), 663-679.



[13] Soh, C.R., et al. (2012). Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample - International Wound Journal, 9(2), 178-187.



[14] Thom, S.R. (2011). Hyperbaric oxygen: its mechanisms and efficacy - Plastic and Reconstructive Surgery, 127(Suppl 1), 131S-141S.



[15] Weaver, L.K., et al. (2002). Hyperbaric oxygen for acute carbon monoxide poisoning - New England Journal of Medicine, 347(14), 1057-1067.



[16] Vann, R.D., et al. (2011). Decompression illness - Lancet, 377(9760), 153-164.



[17] FDA Consumer Update. (2021). Hyperbaric Oxygen Therapy: Get the Facts - U.S. Food and Drug Administration.



[18] Hadanny, A., et al. (2024). Hyperbaric oxygen therapy effects on functional capacity and muscle mass in healthy aging adults - Aging, 16(8), 6862-6884.



[19] Borges, O., et al. (2016). Hyperbaric oxygen therapy for acute muscle injury - American Journal of Physical Medicine & Rehabilitation, 95(11), 825-835.



[20] Harch, P.G., et al. (2012). A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder - Journal of Neurotrauma, 29(2), 168-185.



[21] Efrati, S., et al. (2013). Hyperbaric oxygen induces late neuroplasticity in post stroke patients - PLoS One, 8(1), e53716.



[22] Peña-Villalobos, I., et al. (2018). Hyperbaric oxygen therapy in wound healing: a systematic review - International Wound Journal, 15(4), 621-645.



[23] Zilberman-Itskovich, S., et al. (2022). Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition - Scientific Reports, 12(1), 11252.



[24] Hadanny, A., et al. (2020). Cognitive enhancement of healthy older adults using hyperbaric oxygen - Aging, 12(13), 13740-13761.



[25] Leber, K.A., et al. (1998). Radiation necrosis of the brain - Neurosurgery, 43(4), 802-808.



[26] Feldmeier, J., et al. (2012). Hyperbaric oxygen: does it promote growth or recurrence of malignancy? - Undersea and Hyperbaric Medicine, 30(1), 1-18.



[27] Fife, W.P., et al. (1997). Hyperbaric oxygen therapy for Lyme disease - Undersea and Hyperbaric Medicine, 24(3), 191-194.



[28] Cameron, D. (2018). Severity of chronic Lyme disease correlates with length of treatment - International Journal of General Medicine, 11, 435-440.



[29] Buras, J.A., et al. (2006). Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia - American Journal of Physiology-Cell Physiology, 291(3), C557-C564.



[30] Mirasoglu, B., et al. (2017). Hyperbaric oxygen therapy in rheumatoid arthritis with bisphosphonate-related osteonecrosis of the jaw - Clinical and Experimental Rheumatology, 35(4), 711-712.



[31] Hachmo, Y., et al. (2020). Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells - Aging, 12(22), 22445-22456.



[32] Hadanny, A., et al. (2020). Cognitive enhancement of healthy older adults using hyperbaric oxygen - Aging, 12(13), 13740-13761.



[33] Muzzi, E., et al. (2010). Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss - European Archives of Oto-Rhino-Laryngology, 267(11), 1619-1625.



[34] Cochrane Review. (2013). Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus - Cochrane Database of Systematic Reviews, 10, CD004739.



[35] Menzel-Severing, J., et al. (2012). Early hyperbaric oxygen treatment for nonarteritic central retinal artery obstruction - American Journal of Ophthalmology, 153(3), 454-459.



[36] Beiran, I., et al. (2001). Hyperbaric oxygen therapy for acute ischemic central retinal artery occlusion - European Journal of Ophthalmology, 11(4), 354-356.



[37] Mathieu, D., et al. (2017). Handbook on Hyperbaric Medicine - Springer Netherlands.



[38] UHMS Position Statement. (2019). Monoplace versus multiplace hyperbaric chambers - Undersea and Hyperbaric Medical Society.



[39] Hadanny, A., et al. (2016). Hyperbaric oxygen therapy: side effects defined and quantified - Neurologic Research, 38(12), 1083-1093.



[40] Plafki, C., et al. (2000). Complications and side effects of hyperbaric oxygen therapy - Aviation, Space, and Environmental Medicine, 71(2), 119-124.



[41] UHMS Directory. (2024). Find a Hyperbaric Facility - Undersea and Hyperbaric Medical Society.

### The History of Hyperbaric Oxygen Therapy

In modern medicine, hyperbaric oxygen therapy is the process of breathing 100% oxygen in a pressurized chamber exceeding normal atmospheric pressure. This treatment floods body tissues with up to twenty times the normal oxygen concentration, accelerating healing processes and treating conditions ranging from decompression sickness to diabetic wounds.



The journey from primitive air pressure devices to sophisticated medical chambers spans over three centuries. 



Understanding this evolution illuminates not just medical history, but humanity's persistent drive to manipulate the fundamental elements of life - air and pressure - for therapeutic benefit. 



What began as crude experiments with bellows and sealed rooms has transformed into a sophisticated medical discipline backed by rigorous science and serving millions worldwide.






    
    
    HBOT Timeline
    


    
        
            History of Hyperbaric Oxygen Therapy
            350+ Years of Medical Innovation
        

        
            All
            1600s
            1700s
            1800s
            1900s
            2000s
        

        
            
            
            
                ●
                
                    1662
                    First Hyperbaric Chamber
                    Nathaniel Henshaw creates the world's first chamber using organ bellows
                    A 15x15 foot sealed chamber that could create increased and decreased pressure. Henshaw believed it could aid digestion and prevent lung infections.
                    Click to expand ▼
                
            

            
                ●
                
                    1670
                    Boyle's Discovery
                    Robert Boyle observes bubble formation in snake's eye during experiments
                    First documented observation of decompression phenomena. Boyle noted bubble movement in the viper's eye, unknowingly discovering decompression sickness.
                    Click to expand ▼
                
            

            
                ●
                
                    1774
                    Oxygen Discovered
                    Joseph Priestley discovers "dephlogisticated air"
                    Using a burning lens to heat mercuric oxide, Priestley produced oxygen gas that was "five or six times as good as common air."
                    Click to expand ▼
                
            

            
                ●
                
                    1783
                    First Medical Oxygen Use
                    French physician treats tuberculosis patient with oxygen
                    A young woman with tuberculosis "very much benefited" from daily oxygen inhalations, marking the first therapeutic use of oxygen.
                    Click to expand ▼
                
            

            
                ●
                
                    1834
                    Junod's Chamber
                    French physician builds chamber achieving 2-4 atmospheres
                    Junod reported improved circulation and enhanced cerebral blood flow. This marked the beginning of the "Pneumatic Era" in Europe.
                    Click to expand ▼
                
            

            
                ●
                
                    1878
                    Paul Bert's Breakthrough
                    Discovers oxygen toxicity and CNS effects
                    Published "La Pression barométrique," showing oxygen toxicity at high pressures. The "Paul Bert Effect" established safe pressure limits.
                    Click to expand ▼
                
            

            
                ●
                
                    1918
                    Spanish Flu Treatment
                    Dr. Cunningham saves dying doctor using hyperbaric treatment
                    During the 1918 pandemic, Cunningham compressed a suffocating colleague to 2 atmospheres, successfully treating the crisis.
                    Click to expand ▼
                
            

            
                ●
                
                    1937
                    Modern HBOT Begins
                    First use of oxygen (not just air) for decompression sickness
                    This marked the shift from compressed air to hyperbaric oxygen therapy, establishing HBOT as legitimate medical treatment.
                    Click to expand ▼
                
            

            
                ●
                
                    1960
                    "Life Without Blood"
                    Dr. Boerema shows pigs can survive with 0.4% hemoglobin under HBO
                    This experiment showed plasma alone could carry enough oxygen to sustain life under 3 atmospheres of pressure.
                    Click to expand ▼
                
            

            
                ●
                
                    2002
                    Medicare Coverage
                    CMS approves reimbursement for diabetic foot ulcers
                    Insurance coverage marked mainstream acceptance, making treatment accessible to millions of patients with chronic wounds.
                    Click to expand ▼
                
            

            
                ●
                
                    Present
                    Modern Practice
                    14 FDA-approved indications with standardized protocols
                    HBOT now treats conditions from decompression sickness to diabetic wounds, with 1,300+ hospitals offering treatment in the US.
                    Click to expand ▼
                
            
        
    

    





The Dawn of Pressurized Air Therapy (Pre-Oxygen Era: 17th-18th Century)



1662: Nathaniel Henshaw's "Domicilium"



In 1662, British clergyman and physician Nathaniel Henshaw created the first hyperbaric chamber, called the "domicilium," using a system of organ bellows to change the atmospheric pressure in a sealed chamber. 



This contraption wasn't exactly high-tech - imagine a large wooden box with bellows attached, more barn than hospital.



The Domicilium was a large fifteen-by-fifteen-foot chamber with the capabilities of pressurizing to between two to four atmospheres (ATA). For contrast, modern chambers compress to a max of three atmospheres, typically. 



1662: Henshaw's Domicilium / Source: ResearchGate




Henshaw operated on a simple theory: "In times of good health, this 'domicilium' is proposed as a good resource to aid digestion, promote insensitive breathing, facilitate breathing, and the expulsion of sputum. Consequently, it is extremely useful in preventing most lung infections".



His logic? Acute conditions would benefit from increased air pressure, while chronic ailments needed decreased pressure. 



The impracticality of his proposed method of compressing and decompressing the chamber is readily apparent. So, too, the likely toxic accumulation of carbon dioxide within the unventilated chamber during lengthy laborious periods required to operate it. 



(Ed. note: Without proper ventilation or understanding of gas exchange, Henshaw's patients were essentially suffocating in their own exhaled CO2 - not exactly therapeutic.)



Early Experiments and Observations



In 1666, Robert Boyle's work "Origin of Forms and Qualities according to the Corpuscular Philosophy" demonstrated that a reduction in ambient pressure could lead to bubble formation in living tissue. 



This description of a viper in a vacuum was the first recorded description of decompression sickness. In 1670, Robert Boyle conducted an experiment where he placed a viper (a poisonous snake) in a chamber and rapidly reduced the pressure in that chamber. 



Gas bubbles developed in the tissues of the snake—specifically, "a conspicuous bubble moving to and from in the waterish humor of one of its eyes."



"So the snake had a bubble bouncing around in its eyeball?" 



Yes, and this wasn't some party trick. Boyle had just demonstrated what would later plague deep-sea divers and tunnel workers: decompression sickness. 



The intellectual climate of the era was ripe for such discoveries, as natural philosophers began systematically investigating the properties of air and its effects on living organisms.



The Discovery of Oxygen and its Nascent Medical Role (Late 18th - Early 19th Century)



Joseph Priestley Discovers Oxygen (c. 1774)



On August 1, 1774, Joseph Priestley conducted his most famous experiment. Using a 12-inch-wide glass "burning lens," he focused sunlight on a lump of reddish mercuric oxide in an inverted glass container placed in a pool of mercury. The gas emitted, he found, was "five or six times as good as common air."



Left:  Portrait of Joseph Priestley from Chemistry, Developed by Facts and Principles Drawn Chiefly from the Non-Metals, 1887. / Right: Priestley's instrument focusing sunlight on a sample of mercuric oxide in an inverted glass container, placed in a pool of mercury.



Priestley called his discovery "dephlogisticated air" on the theory that it supported combustion so well because it had no phlogiston in it, and hence could absorb the maximum amount during burning. 



The phlogiston theory - now thoroughly debunked - held that combustible materials released a substance called phlogiston when burned. Priestley's "dephlogisticated air" was actually pure oxygen, though he never abandoned his belief in phlogiston. [1]



Early Cautions and Challenges



Antoine Lavoisier, who named the gas oxygène, meaning acid former, in 1778, would eventually overturn the phlogiston theory entirely. The reason for the delay was the fear of side effects based on the work of Lavoisier and Seguin who had suspected toxic effects of highly concentrated oxygen in 1789.



Ai portrait of Antoine Lavoisier



This early recognition of potential oxygen toxicity created a scientific hesitation that would delay the combination of pressurized environments with concentrated oxygen for nearly a century. 



The gap between discovering oxygen and using it under pressure represents one of medicine's great missed opportunities—like having all the ingredients for a cake but being afraid to turn on the oven.



First Documented Medical Use of Oxygen (Non-Hyperbaric)



In 1783 the French physician Caillens treated a young woman with phthisis (tuberculosis) who 'very much benefited' from daily inhalations of oxygen. This marked the first therapeutic use of the newly discovered gas, though it would be administered at normal atmospheric pressure.



Thomas Beddoes established the Pneumatic Institution at Dowry Square, Hotwells in 1799. Its first superintendent was Humphry Davy, who investigated the properties of nitrous oxide in its laboratory.



Left: The Pneumatic Institution at Dowry Square / Right: Thomas Beddoes / Source & Source



Beddoes believed that various "factitious airs" (artificially produced gases) could treat diseases, particularly tuberculosis.



The "Pneumatic Era": Compressed Air Baths and Early Chambers (19th Century)



The French Renaissance of Pressure Therapy (1830s onwards)



The 1830s witnessed what could only be described as "chamber fever" sweeping across France. 



In 1834, Junod built a hyperbaric chamber to treat pulmonary afflictions using pressures of 2-4 ATA and reported increased circulation to the internal organs, improvements in cerebral blood flow, and production of feelings of well-being.



Between 1837 and 1877 in several cities in Europe (Berlin, Amsterdam, Brussels, London, Vienna, and Milan) the so-called Pneumatic Centers were opened, among which the one founded by Bertin in Montpellier and many rather luxurious pneumatic centers stood out.



These weren't your typical medical facilities - think Victorian-era health spas with a scientific twist. Wealthy patrons would sit in ornate pressurized rooms, convinced they were receiving cutting-edge treatment for everything from arthritis to "nervous exhaustion."



In 1837, Pravaz built the largest hyperbaric chamber in Lyon, France, for 12 patients and treated patients with pulmonary conditions such as tuberculosis, laryngitis, tracheitis, and pertussis as well as cholera.



B. Engineering Marvels and Medical Necessity



In 1840, Charles Pasley, charged with the recovery of the sunken warship HMS Royal George, commented that, of those who made frequent dives, "not a man escaped the repeated attacks of rheumatism and cold." 



In 1841, Trigger, a French mining engineer, used a pressure chamber to deliver workers to the bottom of the river to extract coal. In 1845, he reported that some of his miners complained of joint pains and nervous disorders after surfacing.



The industrial revolution had created a new medical emergency: caisson disease. In 1873, Andrew Smith coined the term "caisson disease" to describe 110 cases of decompression sickness during the Brooklyn Bridge construction, which employed 600 compressed air workers but lacked on-site recompression treatment.



In 1879 the French surgeon Fontaine built a mobile operating room on wheels that could be pressurized. He performed over 20 surgeries in the unit using nitric oxide as the anesthetic. 



Fontaine’s mobile hyperbaric operation theater / Source



Fontaine noted that he could achieve deep surgical anesthesia because it increased the effective percentage of nitrous oxide in the patient's body, accompanied by a higher oxygen partial pressure (i.e., compressed air at two atmospheres given an effective level of 42 percent inhaled oxygen).



Paul Bert: The Father of Pressure Physiology (1878)



Central nervous system toxicity was first described by Paul Bert in 1878. He showed that oxygen was toxic to insects, arachnids, myriapods, molluscs, earthworms, fungi, germinating seeds, birds, and other animals. 



His masterwork, "La Pression barométrique," documented a disturbing phenomenon: "We conclude from all these experiments that oxygen does not kill by acting on the heart, the motor nerves, or the muscles, but the reflex acts of the spinal cord… The poisoning is characterized by convulsions".



The CNS toxic effects of oxygen are hence called 'Bert effect'. Bert had discovered that too much of a good thing - even life-giving oxygen - could kill. 



His work established the scientific foundation for safe pressure limits that continue to guide hyperbaric medicine today.



Early North American Adoption



The first hyperbaric chamber on the North American continent was built in 1860 in Oshawa, Ontario, Canada, east of Toronto.



The first such chamber in the United States was built by Corning a year later in New York to treat 'nervous and related disorders'.





ℹ️ Did You Know?Physicist Edward Teller (father of the hydrogen bomb) was so impressed by HBOT after his stroke treatment that he purchased his own hyperbaric chamber for home use.





The Marriage of Pressure and Oxygen: Birth of Modern HBOT (Early 20th Century)



Pioneering Work in Decompression Sickness



In 1908 Haldane developed the Admiralty decompression tables I and II. John Scott Haldane's methodical approach to preventing decompression sickness revolutionized diving safety. His concept of "staged decompression"—ascending slowly with planned stops—remains the foundation of safe diving practice.



Apparatus for the Administration of Oxygen / Designed by Professor J. S Haldane



Dr. Orville J. Cunningham used high partial pressure of oxygen to treat hypoxic states, and observes that patients with heart problems and circulatory disorders, who felt bad living in the mountains, they improved at sea level. 



During the 1918 Spanish flu pandemic, this professor put a young doctor who was dying of suffocation in a hyperbaric chamber that he used for animal experiments, and saved his life by compressing him to 2 atmospheres.



In 1928, Cunningham built the largest hyperbaric chamber in the world in Cleveland, Ohio. This "Hyperbaric Hotel" was a five-story high steel sphere at 64 feet in diameter. (Ed. note: Picture a giant steel ball with windows—part hospital, part Jules Verne fantasy.) At that time, it was the only hyperbaric chamber operating in the world. 



Left: The Cunningham Sanitarium. Right: The five-story steel sphere of Cunningham Sanitarium. Source: Encyclopedia of Cleveland History & Cleveland Historical.



This "ball of steel" hospital, located in Cleveland (Ohio), had inside a smoking room on the top floor, dining rooms and individual rooms and pressurized up to 3 ATA.



Wait, a smoking room? In a pressurized oxygen environment? The mind boggles at the safety standards—or lack thereof—of the era.



Behnke and Shaw: First Use of Hyperbaric Oxygen for Decompression Sickness (1937)



In 1937, Behnke and Shaw successfully used hyperbaric oxygen to treat decompression sickness. This was the first effective use of HBOT for a specific medical condition. 



They replaced oxygen in place of compressed air, and their work resulted in the use of the first nitrogen-oxygen mixtures and hyperbaric treatment being tailored to the severity of the injury.



This represented a fundamental shift in thinking. No longer was it just about pressure - it was about delivering concentrated oxygen under pressure. The therapeutic possibilities suddenly expanded exponentially.



Expanding Applications Before and During WWII



In 1938, Brazilians Ozorio de Almeida and Costa pioneered the use of HBOT in treating leprosy. 



In 1942, End & Long used HBOT for Carbon Monoxide Poisoning. The war years accelerated research as military physicians sought treatments for wounded soldiers and submarine crews.



The Mid-Century Boom: HBOT Gains Clinical Acceptance (1950s-1970s)



Dr. Ite Boerema: The "Father of Modern Hyperbaric Medicine" (1950s-1960s)



In the 1950s, Ite Boerema, a cardiac surgeon from the Netherlands, conceived the idea of "flooding" the body's tissues with extra oxygen. 



Ite Botema operating in a room with pure oxygen / Source



His most famous experiment reads like science fiction: In 1960, Dr. Boerema published a study on "life without blood." It involved exsanguinating pigs and removing their erythrocytes before exposing them to 3 ATM of HBO. These pigs were noted to have sufficient oxygen in the plasma to sustain life.



The implications were staggering. The researchers found that pigs inhaling oxygen at a pressure of 3 atmospheres could survive for periods of 15 minutes, with only 0.4% hemoglobin. If plasma alone could carry enough oxygen to sustain life, what other medical impossibilities might hyperbaric oxygen make possible?



Boerema achieved wide recognition in Europe and the United States and was known as a hard-worker with great amounts of motivation and determination with endless passion for medicine and science. 



He approached surgery as "engineering in medicine," treating the human body as a complex machine that could be optimized through precise application of physical principles.



Churchill-Davidson: Radiosensitivity of Tumors (1955)



In 1955, Churchill-Davidson used hyperbaric oxygen therapy to enhance radiation therapy for cancer patients. The logic was elegant: tumors often have hypoxic cores that resist radiation. Flood them with oxygen, and suddenly they become vulnerable to treatment.





ℹ️ Did You Know? According to legend, Alexander the Great was lowered into the Bosphorus Straits in a glass vessel, making him possibly the first person to experience increased atmospheric pressure underwater (circa 332 BC).





Growing List of Indications



In 1961, a colleague of Boerema, W. H. Brummelkamp, published a paper on inhibition of anaerobic infections by HBOT. The treatment of gas gangrene—a rapidly spreading, often fatal infection—became one of HBOT's most dramatic success stories.



The 1960s saw an explosion of applications: crush injuries, acute traumatic ischemias, necrotizing soft tissue infections. Each success built upon the last, creating momentum for wider acceptance.



Formalization and Professionalization



In 1967 the Undersea Medical Society (UMS) was founded by six U.S. Navy Diving and Submarine medical officers as an organization dedicated to diving and undersea medicine. The UMS was later renamed Undersea and Hyperbaric Medical Society (UHMS) in 1986.



The American College of Hyperbaric Medicine was founded by Dr. Neubauer in 1983. These organizations brought scientific rigor to a field that had too often relied on anecdote and enthusiasm.



Consolidation and Expansion (Late 20th Century - Early 21st Century)



Mainstream Integration



By the 1980s, HBOT had shed its reputation as fringe medicine. The Centers for Medicare & Medicaid Services initiated reimbursement for HBOT for the treatment of diabetic foot ulcer (DFU) in 2002. 



(Insurance coverage = mainstream acceptance in American medicine).



Technological Advancements



The clunky steel spheres of Cunningham's era gave way to sleek, computer-controlled chambers. Modern, low-pressure monoplace chambers represent significant advancements from earlier designs, improving the therapy's accessibility and affordability. 



OxyAir 32-Inch Hyperbaric Oxygen Therapy Chamber from Oxygenhealthsystems.com



Patients could now watch movies during treatment, communicate with technicians, and—crucially—not feel like they were trapped in a submarine.



Expanding Research Horizons



The 21st century has seen HBOT research branch into previously unimaginable territories. 



Traumatic brain injury, stroke, inflammatory conditions, even potential cancer treatment adjuncts - the list grows yearly. Current uses of HBOT span from treating decompression sickness and aiding wound healing to exploring potential improvements in neurological conditions.



Modern HBOT: Current Status and Approved Indications



The FDA currently recognizes HBOT for treating: [2]




Decompression sickness ("the bends")



Air or gas embolism



Carbon monoxide poisoning



Crush injuries and compartment syndromes



Diabetic wounds



Enhanced healing of problem wounds



Necrotizing soft tissue infections



Osteomyelitis (bone infections)



Radiation tissue damage



Skin grafts and flaps at risk



Severe anemia



Thermal burns



Idiopathic sudden sensorineural hearing loss



Central retinal artery occlusion




The FDA advises you get the treatment at a hospital or facility that has been inspected and is accredited by the Undersea and Hyperbaric Medical Society.



Challenges, Skepticism, and Re-evaluation in HBOT's History



HBOT's history includes spectacular failures alongside its successes. The American Medical Association (AMA) and the Cleveland Medical College, having no scientific justification for its treatments, forced its closure in 1930. Cunningham's sanitarium, for all its grandeur, was demolished for scrap metal during World War II.



The field has constantly battled between enthusiasts making extravagant claims and skeptics dismissing legitimate applications. 



The FDA is aware there are some hyperbaric oxygen treatment centers promoting hyperbaric oxygen chambers for uses that have not been cleared or approved by the FDA, such as treatment of cancer, Lyme disease, autism, or Alzheimer's disease.



"Is HBOT a miracle cure for everything?" 



No, and that's precisely the point. The challenge has always been separating scientifically validated uses from wishful thinking. This tension between promise and proof continues to shape the field.



The Future of Hyperbaric Oxygen Therapy



Where does HBOT go from here? Current research suggests we've barely scratched the surface. Personalized protocols based on individual physiology, combination therapies that amplify HBOT's effects, portable chambers for home use - the possibilities expand as our understanding deepens.



The fundamental insight remains unchanged from Henshaw's time: oxygen and pressure, properly applied, can achieve remarkable healing. 



What's changed is our ability to apply these forces precisely, safely, and with scientific understanding of the mechanisms involved.



Conclusion



From Henshaw's bellows-powered domicilium to computer-controlled chambers delivering precise oxygen doses, HBOT's journey reflects medicine's broader evolution. What began as intuition - that pressure and air could heal—has become sophisticated science.



The story isn't just about technology. It's about persistent human curiosity, the willingness to challenge conventional thinking, and the sometimes centuries-long gap between discovery and application. Priestley discovered oxygen in 1774, but it took until 1937 for Behnke and Shaw to combine it with pressure for treating decompression sickness. Such delays remind us that medical progress rarely follows a straight line.



Today, as researchers explore HBOT's potential for conditions from autism to Alzheimer's, we're writing new chapters in this centuries-old story. The spirit of innovation that drove Henshaw, Priestley, Bert, and Boerema continues. 



We've learned to harness one of nature's most fundamental forces - the healing power of oxygen under pressure. The journey continues, one breath at a time.





References / Further Reading




Breath of life: the evolution of oxygen therapy - PMChttps://pmc.ncbi.nlm.nih.gov/articles/PMC1079621/



History of HBO - DDRC Healthcarehttps://www.ddrc.org/hyperbarics/history-of-hbo/



Hyperbaric oxygen therapy: the history - DVM360https://www.dvm360.com/view/hyperbaric-oxygen-therapy-history



History of the hyperbaric chamber - Biobaricahttps://www.biobarica.com/en/news/history-of-the-hyperbaric-chamber-jWo2k097pH3Xe3hPXksM/



History of Oxygen Therapy - Wessex MS Therapy Centrehttps://www.wessexms.co.uk/history-oxygen-therapy



Rev Henshaw - Hyperbarics & The Domiciliumhttps://oxygens.co.uk/rev-henshaw-hyperbarics-the-domicilium/



The History of Hyperbaric Oxygen Therapy: From Medical Innovation to Premium Health Solution - Aviv Clinicshttps://aviv-clinics.com/blog/hbot/the-history-of-hyperbaric-oxygen-therapy-from-medical-innovation-to-premium-health-solution/



What is the history of Hyperbaric Oxygen Therapy? - Oxygen Oasishttps://www.o2oasis.com/what-is-the-history-of-hyperbaric-oxygen-therapy/



Brief Amazing History of Hyperbaric Medicine - Watts HBOThttps://www.wattshbot.com/post/brief-amazing-history-of-hyperbaric-medicine



Historical Aspects of Hyperbaric Physiology and Medicine - IntechOpenhttps://www.intechopen.com/chapters/66258



Diving into the Past: A Comprehensive History of Hyperbaric Oxygen Therapy - Plus by APNhttps://plusapn.com/hbot/history-of-hyperbaric-oxygen-therapy/



Paul Bert • LITFL • Medical Eponym Libraryhttps://litfl.com/paul-bert/



Oxygen toxicity - Wikipediahttps://en.wikipedia.org/wiki/Oxygen_toxicity



Robert Boyle - Wikipediahttps://en.wikipedia.org/wiki/Robert_Boyle



Joseph Priestley - Wikipediahttps://en.wikipedia.org/wiki/Joseph_Priestley



Antoine Lavoisier - Wikipediahttps://en.wikipedia.org/wiki/Antoine_Lavoisier



Undersea and Hyperbaric Medical Society - Wikipediahttps://en.wikipedia.org/wiki/Undersea_and_Hyperbaric_Medical_Society



Paul Bert - Wikipediahttps://en.wikipedia.org/wiki/Paul_Bert

### Top 5 Best Hyperbaric Chambers for Home Use

Think hyperbaric oxygen therapy (HBOT) is just for hospitals? Think again. Home hyperbaric chambers are making this powerful therapy more accessible than ever, with over 18,000 portable units currently in use worldwide. [1]



But what exactly is HBOT, and why are so many people bringing this technology home?



What is Hyperbaric Oxygen Therapy? 



In simple terms, HBOT involves breathing nearly pure oxygen in a pressurized chamber. The increased pressure helps your lungs gather more oxygen, which then dissolves into your blood plasma and other body fluids. 



This oxygen-rich environment = enhanced healing potential at the cellular level.



Why Choose a Home Hyperbaric Chamber? 



The benefits driving home adoption include:




Enhanced Recovery: Accelerated healing from sports injuries, wounds, and general recovery



Improved Circulation: Better oxygen delivery throughout the body



Cognitive Benefits: Potential improvements in brain function and memory



Convenience: Treatment on your schedule without clinic visits



Long-term Cost Savings: Avoid repeated clinical session fees



Family Use: Multiple household members can benefit





"But is it safe to use at home?" 




Great question! While home chambers operate at lower pressures than clinical units, they still require proper understanding and safety protocols.



CRUCIAL DISCLAIMER: Always consult with a healthcare professional before starting HBOT. This article provides general information, not medical advice. Your doctor can determine if HBOT is appropriate for your specific health situation and guide proper usage.



How We Picked the Best Home Hyperbaric Chambers



We didn't just pick these chambers randomly – we used specific criteria to identify the top performers:




Safety Features topped our list. We prioritized chambers with robust safety mechanisms including multiple pressure release valves, emergency depressurization systems, internal/external gauges, and medical-grade materials.





Operating Pressure matters for home use. Most home chambers operate at 1.3 to 1.5 ATA (mild HBOT), which is safe for home use while still providing therapeutic benefits.





Ease of Use & Setup was essential. Nobody wants a complex installation. We looked for chambers with straightforward assembly, user-friendly zippers, and clear operating instructions.





Size & Comfort varies by need. We included options for lying down or sitting, different diameters for space requirements, and comfort features like viewing windows and quality mattresses.





Manufacturer Reputation counted heavily. We focused on established brands like OxyHealth (with over 20 years experience), Summit to Sea (with FDA clearance), and Oxygen Health Systems (with ISO certifications).





Key Inclusions like oxygen concentrators and dehumidifiers add value when bundled with the chamber.





User Feedback from real owners provided insights into long-term satisfaction and performance.






KEY TERMS YOU SHOULD KNOW




ATA (Atmospheres Absolute): Pressure measurement. 1.3 ATA = 30% above normal atmospheric pressure



Soft vs. Hard Shell: Soft chambers are inflatable and portable; hard chambers are rigid structures



LPM (Liters Per Minute): Oxygen concentrator output rating. 10 LPM is standard for home use






Top 5 Hyperbaric Chambers for Home Use






    
    
    Interactive HBOT Chambers Comparison
    


    
        
            Explore detailed specifications, features, and pricing for the top 5 home hyperbaric oxygen therapy chambers with interactive product cards.
        

        
            
        
    

    





1. OxyAir 32-Inch or 36-Inch Soft Chamber (by Oxygen Health Systems) - 1.3 to 1.4 ATA







Why it's good for home use: The OxyAir series offers versatile solutions with medical-grade components and comprehensive safety features, including FDA-approved oxygen concentrators and multiple pressure relief systems. The 36-inch model provides extra room for taller users or those wanting more space.



Specifications:




Diameter: 32" or 36" options



Pressure: 1.3 ATA standard, 1.4 ATA optional upgrade



Length: Standard lying chamber length



Materials: Medical-grade TPU with polyester reinforcement, triple-welded seams



Viewing Windows: Seven double-deck windows



Oxygen System: FDA-approved DeVilbiss 10 LPM concentrator producing 95-96% oxygen purity




What's Included:




Chamber with internal/external pressure gauges



10 LPM oxygen concentrator



Dehumidifier (saves $700+ value)



Air cooling system



Emergency pressure release valve



Negative ionizer system




Pros:




ISO 9001, ISO 14001, and ISO 13485 certified manufacturing



Rated to last 39 years with typical usage (1 hour/day, 5 days/week)



Multiple safety redundancies



Spacious 36" option accommodates larger users



Comprehensive accessory package



Self-operable design




Cons:




Higher price point than basic models



Requires dedicated space for setup



May be overwhelming for first-time users




Price Range: $9,690 - $11,539 (varies by size and pressure options)



Who it's best for: Serious wellness enthusiasts, athletes, or families wanting a premium home HBOT experience with room to grow.











2. OXYFLOW MINI Sitting Hyperbaric Oxygen Chamber (by Oxygen Health Systems) - 1.3 to 1.4 ATA







Why it's good for home use: Ideal for users preferring upright or reclined positions, this chamber features a unique angled design with front entry and only an 8-inch step-in height. Perfect for those who find traditional lying chambers uncomfortable or challenging to enter.



Specifications:




Dimensions: 73" long × 44.8" tall × 42" wide



Entry: Front zipper extending toward feet



Weight: 30 lbs when deflated



Pressure: 1.3 ATA, 1.4 ATA, or 1.5 ATA options



Chair: Proprietary adjustable chair (lying flat to 90° upright), supports up to 330 lbs




What's Included:




10 LPM oxygen generator producing 95-96% oxygen purity at 18-20 PSIG



Dehumidifier



Air cooling system



Adjustable reclining chair



External frame option available




Pros:




Accommodates users up to 71 inches tall with leg stretching room



Easy front entry vs. top entry chambers



Chair adjusts from flat to upright



Meets ISO 9001, ISO 14001, and ISO 13485 certifications



3-year warranty with lifetime customer support



Lighter weight for portability




Cons:




More expensive than basic lying chambers



Limited to single user



May feel cramped for larger individuals




Price Range: $9,890 - $14,900 (varies by pressure level and frame option)



Who it's best for: Users with mobility challenges, those preferring to sit during treatment, or anyone wanting flexibility between sitting and lying positions.











3. Summit to Sea Shallow Dive Hyperbaric Chamber - 1.3 ATA







Why it's good for home use: Quite possibly the best quality and safest soft chamber on the market, with over 30 years of Class II chamber manufacturing experience. FDA-approved with a proven track record and 2-5 year warranty options.




https://www.youtube.com/watch?v=tdxKQ1bFKS0




Specifications:




Size: Compact single-person design



Pressure: 1.3 ATA



Materials: Translucent material for bright, airy interior



Entry: Double-sided full-length zippers operable from inside or outside



Compressors: Dual high-efficiency electric pumps with patented sound suppression




What's Included:




Chamber with external frame



Carrying case



Sound-suppressed air pumps with in-line filtration



2-year warranty (extended options available)




Pros:




FDA clearance validates safety and efficacy



Made in USA with high-quality materials ensuring durability



Patented sound suppression keeps noise under 50 decibels



Large viewing windows reduce claustrophobia



Entry-level pricing



Military, first responder, and police discounts available




Cons:




Requires doctor's prescription (telemedicine consultations available)



Smaller interior than premium models



Basic accessory package



No oxygen concentrator included




Price Range: Contact manufacturer for current pricing (typically entry-level)



Who it's best for: Budget-conscious buyers seeking FDA-cleared reliability, first-time users, or those wanting proven quality without premium features.











4. Summit to Sea Dive (33-inch) Hyperbaric Chamber - 1.3 ATA







Why it's good for home use: Summit to Sea's flagship model offering a roomier experience than the Shallow Dive while maintaining portability, with 33-inch diameter and 90-inch length. Well-suited for home users and athletes with multiple control valves and efficient compressors.



Specifications:




Dimensions: 90" length × 33" diameter



Pressure: 1.3 ATA



Entry: Double-sided full-length zippers for easy access



Compressors: Dual compressors for quick pressurization and safety redundancy



Interior: White interior with two viewing windows for non-claustrophobic atmosphere




What's Included:




External frame



Carrying case



Sound-suppressed electric air pumps with in-line filtration



2-year warranty




Pros:




Over 30 years manufacturing experience with quality assurance



FDA clearance for safety validation



More spacious than Shallow Dive



Bright interior reduces claustrophobia



Dual compressor safety



Made in USA




Cons:




Requires prescription (telemedicine available)



Oxygen concentrator sold separately



Higher cost than Shallow Dive



Larger footprint requires more space




Price Range: Contact manufacturer (mid-range pricing)



Who it's best for: Users wanting more space than entry models, athletes needing regular sessions, or families planning shared usage.











5. LUX-AIR 36-Inch Soft Hyperbaric Oxygen Chamber - 1.3 to 1.4 ATA







Why it's good for home use: Features a unique J-style zipper for significantly easier entry and exit, ideal for users with mobility concerns or joint replacements who can't get on their knees. Can be used as side entry or top entry by rotating the chamber.




https://www.youtube.com/watch?v=dND41HyD9rM




Specifications:




Diameter: 36 inches (spacious for 1-2 people)



Entry: J-style zipper design with exceptionally wide door



Pressure: 1.3 ATA standard, 1.4 ATA upgrade available



Platform: Includes 16-inch elevation platform



Materials: Medical-grade 3-layer PET Polyester/TPU with triple-welded seams




What's Included:




FDA-approved 10 LPM oxygen generator



Dehumidifier ($700 value)



Contoured mattress with flat comfort top



Air conditioning system option



Internal steel frame, LED lighting, communication system



3-year warranty




Pros:




Revolutionary J-style entry = unparalleled ease of access



Dual zipper system with center flap prevents leaks



Can accommodate two people (adult + child)



Made to last 25-30 years with proper usage



ISO 9001, ISO 14001, and ISO 13485 certified



Side or top entry flexibility




Cons:




Premium pricing



Larger footprint



Complex feature set may overwhelm beginners



AC system additional cost




Price Range: Contact manufacturer for current pricing (premium tier)



Who it's best for: Users with mobility challenges, families wanting shared use, or anyone prioritizing ease of entry/exit above all else.











How To Choose The Right Home Hyperbaric Chamber



Before diving in, ask yourself: What do you hope to achieve? Recovery from injuries? Enhanced athletic performance? General wellness? Anti-aging benefits? Your goals influence which features matter most.



Soft Shell vs. Hard Shell Chambers: The Real Deal



Soft Shell Chambers (featured in our top 5):




Pros: Portable, lower cost, easier installation, suitable for home use



Cons: Lower maximum pressure, may feel less sturdy



Best for: Home users, first-time buyers, those wanting portability




Hard Shell Chambers:




Pros: Higher pressures possible, more clinical feel, extremely durable



Cons: Much higher cost, permanent installation, requires more space



Best for: Clinical settings, serious medical applications




(Ed. note: For home use, soft shell chambers offer the best balance of effectiveness, convenience, and cost.)



Understanding Pressure (ATA): How Much Do You Need?



Home chambers typically operate at 1.3-1.5 ATA, which provides 30-50% more oxygen than normal air pressure. Higher isn't always better for home use – it's about consistent, safe treatment.




1.3 ATA: Standard home pressure, proven effective



1.4 ATA: 35% pressure increase, shorter treatment times



1.5 ATA: Maximum recommended for home use




Size & Space Considerations



Chamber Diameter Options:




32": Compact, fits most users comfortably



36": Extra room, accommodates larger users or two people



40": Spacious, premium comfort level




Space Requirements: Most chambers need 8-10 feet of length and 4-5 feet of width when inflated. Don't forget ceiling height for entry!



Essential Safety Features to Look For



Never compromise on safety. Look for:




Dual pressure relief valves and emergency release buttons



Internal and external pressure gauges



Medical-grade materials with proper certifications (ISO standards)



Multiple viewing windows



Redundant compressor systems




Budget: Balancing Cost with Quality



Entry Level ($8,000-$12,000): Basic chambers with essential features Mid-Range ($12,000-$18,000): Enhanced comfort and safety features Premium ($18,000+): Top-tier materials, advanced features, maximum comfort



Remember: This is a long-term investment. Quality chambers are rated to last decades with proper care.



Specific Chamber Recommendations Based on Needs:




For Maximum Internal Space & Ease of Entry: LUX-AIR 36-Inch with its J-style zipper revolutionizes accessibility, or OxyAir 36-Inch for generous room.





For Seated Comfort and Convenience: OXYFLOW MINI is purpose-built for sitting/reclining comfort with adjustable positioning.





For Balanced Features and Reliability: Summit to Sea Dive (33-inch) or OxyAir 32-Inch provide solid all-around performance.





For Budget-Conscious Quality: Summit to Sea Shallow Dive offers FDA-cleared reliability at entry-level pricing.





For Families or Shared Use: LUX-AIR 36-Inch accommodates two people, or OxyAir 36-Inch for spacious single use.




Beyond the Purchase Price – Understanding Long-Term Ownership & Practicalities



Ongoing Operational Costs




Electricity Consumption: Most chambers use 520-640 watt compressors, roughly equivalent to running a small microwave. Expect $20-40 monthly electricity costs with regular use.





Oxygen Source: If using an oxygen concentrator (recommended), these typically consume 300-600 watts. Tank oxygen is possible but less convenient for home use.





Consumables & Replacement Parts: Air filters need periodic replacement ($20-50 annually), seals may need service after years of use, and mattresses/cushions experience normal wear.




Maintenance Routine




Weekly: Basic cleaning, visual inspection of seals and zippers 





Monthly: Filter replacement, pressure system check 





Annually: Professional inspection recommended for warranty compliance




Most chambers are designed for minimal maintenance – that's the beauty of quality engineering.



Noise Levels



Modern chambers use patented sound suppression technology, keeping noise below 50 decibels = about as loud as moderate rainfall. You can easily watch TV or listen to music during treatment.



Learning Curve & Usability



Setup time varies: 15-30 minutes for first-time assembly, then 5-10 minutes for routine use. Most manufacturers provide video training and lifetime support.



Resale Value



Quality chambers from established manufacturers retain reasonable value. With 25-39 year lifespans, many owners never need to sell, but when they do, expect 40-60% of original value after several years.



Frequently Asked Questions (FAQs)




Is HBOT safe to do at home without medical supervision?
Home hyperbaric oxygen chambers operate at mild pressures (1.3-1.5 ATA) which are generally safe when used according to manufacturer guidelines. However, always consult your doctor first, especially if you have medical conditions or take medications.




How long should a typical home HBOT session last, and how often?
Sessions typically last 1-2 hours. Frequency varies by goals: daily for acute recovery, 3-5 times weekly for general wellness. Your healthcare provider should guide your specific protocol.




Do I need a prescription to buy a home hyperbaric chamber?
It varies by manufacturer and chamber type. Summit to Sea requires prescriptions (telemedicine consultations available), while some soft chambers don't require prescriptions. Check with your chosen manufacturer.




What does it feel like inside a hyperbaric chamber?
Your ears may feel pressure similar to flying in an airplane. You can relieve this by yawning or swallowing. Most people find the experience relaxing once they adjust to the gentle pressure.




Can I use an oxygen concentrator I already own?
Possibly, but check compatibility. Chambers typically require 10 LPM output at 18-20 PSI to function properly under pressure.




How long does it take to set up a home chamber?
Initial setup takes about 15 minutes with video guidance. After that, inflation and deflation become routine 5-10 minute processes.





Conclusion



Choosing a home hyperbaric chamber isn't just about picking the most expensive model = it's about finding the right match for your specific needs, space, and budget. Whether you prioritize portability, comfort, safety features, or ease of entry, there's a chamber designed for your situation.



Remember these key points:




Safety features should never be compromised



Consider your physical limitations and preferences (sitting vs. lying)



Factor in long-term operational costs beyond purchase price



Choose established manufacturers with proven track records



Think about who else in your household might benefit




Your Next Steps:




Consult your healthcare provider about HBOT suitability



Assess your space and installation requirements



Contact manufacturers for current pricing and availability



Consider financing options if needed




The investment in your health and wellness can pay dividends for decades. With proper care, quality chambers provide 25-39 years of service = potentially thousands of beneficial treatment sessions right in your own home.



Ready to take the plunge? Your journey to enhanced wellness, recovery, and vitality awaits. Just remember: the best chamber is the one you'll actually use consistently, safely, and enjoyably.



Always consult with a healthcare professional before beginning any hyperbaric oxygen therapy program. This article provides general information and should not be considered medical advice.

### Hyperbaric Oxygen Therapy Shows Dual Effect in Glioblastoma Treatment

Researchers from Chongqing University found hyperbaric oxygen therapy (HBO) increases chemosensitivity in glioblastoma cells by disrupting a key resistance pathway.



The study identifies the molecular mechanism: HBO inhibits HIF1α and HIF2α proteins, which normally promote ABCG2 expression - a drug efflux transporter that causes chemotherapy resistance.



Surprisingly, HBO treatment alone actually promoted tumor growth and shortened survival time in animal models.



Combined HBO-temozolomide (TMZ) therapy showed significantly reduced tumor size and prolonged survival compared to TMZ alone.



The findings, published April 30 in Frontiers in Molecular Neuroscience, suggest HBO could potentially enhance standard glioblastoma treatment.






Researchers have discovered a new mechanism explaining why hyperbaric oxygen therapy (HBO) enhances the effectiveness of chemotherapy in treating glioblastoma, the most aggressive form of brain cancer. The study, published yesterday in Frontiers in Molecular Neuroscience, demonstrates that HBO increases chemosensitivity by inhibiting a molecular pathway involving hypoxia-inducible factors and a key drug resistance protein.



Understanding the Mechanism



The research team from Chongqing University in China identified that HBO works by suppressing the expression of two proteins - HIF1α and HIF2α - which normally help cancer cells survive in low-oxygen environments. These proteins promote the expression of ABCG2, a drug efflux transporter that pumps chemotherapy drugs out of cancer cells, reducing treatment effectiveness.



"This study confirmed that hyperbaric oxygen can inhibit ABCG2 expression through HIF1α and HIF2α, thereby promoting the proliferation and chemosensitization of gliomas," wrote lead authors Sheng Gong and Pan Wang.



Through a series of laboratory experiments and animal studies, the researchers demonstrated that HBO treatment significantly decreased the expression of HIF1α, HIF2α, and ABCG2 in glioblastoma cells. When HBO was combined with the chemotherapy drug temozolomide (TMZ), there was a marked increase in cancer cell death and reduction in tumor growth.







  
    
      Table 1: Effects of HBO Treatment on Glioblastoma With and Without TMZ
    
    
      Treatment Condition
      Tumor Growth
      Cell Apoptosis
      Survival Time
    
  
  
    
      Normoxia + DMSO (Control)
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
    
    
      HBO + DMSO
      
        
          
          
          
          
          
          +117%*
        
      
      
        
          
          
          
          
          
          -35%*
        
      
      
        
          
          
          
          
          
          -11%*
        
      
    
    
      Normoxia + TMZ
      
        
          
          
          
          
          
          -48%*
        
      
      
        
          
          
          
          
          
          +15%*
        
      
      
        
          
          
          
          
          
          +9%*
        
      
    
    
      HBO + TMZ
      
        
          
          
          
          
          
          -94%*†
        
      
      
        
          
          
          
          
          
          +78%*†
        
      
      
        
          
          
          
          
          
          +27%*†
        
      
    
  
  
    
      
        *p < 0.05 compared with Normoxia + DMSO (Control)
        †p < 0.05 compared with Normoxia + TMZ
        Note: For tumor growth, fewer dots indicate better outcomes (smaller tumors). For cell apoptosis and survival time, more dots indicate better outcomes. HBO: hyperbaric oxygen; TMZ: temozolomide.
      
    
  




  
    
      Table 2: Protein Expression Levels Under HBO vs. Hypoxic Conditions
    
    
      Protein
      Expression in Hypoxic Conditions
      Expression with HBO Treatment
      Change with HBO
    
  
  
    
      HIF1α
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      ↓ 91%
    
    
      HIF2α
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      ↓ 92%
    
    
      ABCG2
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      ↓ 84%
    
    
      CD133 (stem cell marker)
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      ↓ 74%
    
    
      CD15 (stem cell marker)
      
        
          
          
          
          
          
        
      
      
        
          
          
          
          
          
        
      
      ↓ 76%
    
  
  
    
      
        Note: Circles represent relative expression levels averaged across U87 cells, GBM cells, and tumor tissue samples. Fewer circles with HBO indicate decreased protein expression, which correlates with increased chemosensitivity. HIF: hypoxia-inducible factor; ABCG2: ATP-binding cassette subfamily G member 2 (drug efflux transporter).
      
    
  






Dual Effects Observed



One of the most surprising findings was that HBO treatment alone actually increased tumor growth and shortened survival in experimental models. However, when combined with TMZ, the treatment significantly reduced tumor size and extended survival compared to TMZ alone.



Dr. Nan Wu, the study's corresponding author, explained that these seemingly contradictory effects stem from the same mechanism. The research showed that while HBO inhibits stemness markers in cancer cells (making them more vulnerable to chemotherapy), it also promotes cell proliferation when used alone.



This dual effect highlights the importance of using HBO only as an adjunct therapy alongside standard chemotherapy treatments for glioblastoma, not as a standalone treatment.



Clinical Implications



Glioblastoma remains one of the deadliest forms of cancer, with most patients surviving only 12-24 months after diagnosis. The findings from this study suggest that adding HBO to standard TMZ treatment could potentially improve outcomes.



The research provides a molecular explanation for previous clinical observations that HBO can enhance chemotherapy efficacy in glioblastoma patients. By identifying the specific pathway involved, the study opens up possibilities for developing new therapeutic approaches that target this mechanism.



"There is a general consensus that HBO therapy combined with temozolomide treatment can increase chemotherapy sensitivity and effectively inhibit the growth of gliomas," the researchers noted, while emphasizing that more clinical studies are needed to validate these findings.



The study represents an important step forward in understanding how to improve treatments for this devastating form of brain cancer, by revealing the molecular interactions between hyperbaric oxygen, hypoxia-response proteins, and chemotherapy resistance mechanisms.





Citation: Gong S, Wang P, Liao B, Zhao L and Wu N (2025) Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1α/HIF2α-ABCG2. Front. Mol. Neurosci. 18:1584407. doi: 10.3389/fnmol.2025.1584407

### Long-Term Benefits of Hyperbaric Oxygen for Radiation-Induced Cystitis Confirmed in Nordic Study

New research shows that hyperbaric oxygen therapy provides sustained relief for up to five years.




Treatment improved urinary symptoms for nearly 70% of patients with sustained benefits over 5-year period.



Findings address key concerns about long-term efficacy that previously limited widespread clinical adoption.



Research represents largest prospective study of radiation cystitis to date, involving five Nordic university hospitals.




A groundbreaking study has confirmed that hyperbaric oxygen therapy (HBO2) provides long-lasting relief for patients suffering from chronic radiation-induced cystitis, a debilitating bladder condition affecting cancer survivors who received pelvic radiation treatments.



The five-year follow-up of the RICH-ART trial, published in eClinicalMedicine this month, demonstrates that improvements in urinary symptoms remain stable for at least five years after treatment, addressing a critical gap in medical knowledge about this therapy's long-term efficacy.



Treatment for a Hidden Epidemic



Chronic radiation-induced cystitis affects approximately 5-10% of patients who undergo radiotherapy for pelvic cancers, including prostate, rectal, and gynecological malignancies. Despite its prevalence, the condition often goes underreported and undertreated.



"The problems may be underreported since patient-reported outcome measures are not included in most oncology registries, and chronic radiation-induced adverse effects are typically treated by general practitioners or urologists rather than oncologists," the researchers note.



Patients with this condition experience symptoms including painful urination, increased frequency, urgency, incontinence, and in severe cases, bleeding. These symptoms can significantly impact quality of life and often worsen over time as the bladder tissue becomes increasingly damaged by radiation-induced hypoxia, fibrosis, and vascular injury.



Dr. Nicklas Oscarsson from Sahlgrenska University Hospital in Sweden led this multicentre, randomized controlled trial conducted across five Nordic university hospitals in Sweden, Norway, Denmark, and Finland.



The Oxygen Solution



Infographic: What is Hyperbaric Oxygen Therapy / Source: HBOTResearch.org



Hyperbaric oxygen therapy involves breathing 100% oxygen at increased atmospheric pressure inside a specialized chamber. 



Patients in the study received 30-40 sessions of HBO2, breathing oxygen at 240-250 kPa for 80-90 minutes daily over 6-8 weeks.



The therapy works by increasing oxygen delivery to damaged tissues, stimulating angiogenesis (formation of new blood vessels), reducing inflammation, and promoting tissue healing. In radiation-injured tissue, this can help reverse the hypoxic conditions that prevent normal healing processes.



The RICH-ART follow-up study tracked 70 patients for five years after receiving hyperbaric oxygen therapy. The researchers used the Expanded Prostate Cancer Index Composite (EPIC) urinary score, which measures bladder symptoms on a scale of 0-100, with lower scores indicating more severe symptoms.



Impressive Long-Term Results



Prior to treatment, patients had a mean EPIC urinary score of 46.6 points, indicating severe symptoms. Six months after HBO2 therapy, this improved to 64.6 points – a substantial increase of 18 points.



Most importantly, this improvement was maintained at the five-year mark, with patients showing a sustained 19.1-point improvement from baseline.



But is this improvement actually meaningful for patients? 



Yes – the clinical significance threshold for this scale is just 9 points, meaning the observed improvement was more than twice what would be considered minimally important to patients.



Among the 70 patients followed, 48 (68.6%) were classified as "responders" who showed significant improvement at the six-month mark. These patients maintained their benefits throughout the five-year period, with a remarkable average improvement of 22.9 points at the five-year mark.



Even more encouraging, five patients initially classified as "non-responders" showed delayed benefits, with significant improvements appearing at the one-year mark and beyond, suggesting that six months may be too early to fully assess the therapy's effects.








The EPIC (Expanded Prostate Cancer Index Composite) urinary score measures bladder symptoms on a scale of 0-100, with higher scores representing better function. A clinically meaningful improvement is defined as ≥9 points.



Responders showed significant improvement at 6 months after treatment that was maintained through the 5-year follow-up period. Non-responders initially showed little change but some experienced delayed benefits after the first year.



Data source: RICH-ART trial conducted across five Nordic university hospitals (2012-2022).




Breaking Treatment Barriers



Despite growing evidence supporting its efficacy, hyperbaric oxygen therapy is not yet widely integrated into clinical guidelines for radiation-induced cystitis. Often, it's reserved as a last-resort option for patients who have failed other treatments.



"One objection to prescribing HBO2 for chronic radiation-induced adverse effects in the pelvic region has been the lack of evidence for long-term benefits," the researchers explain. This study directly addresses that concern, showing benefits persist for at least five years.



Beyond symptomatic improvement, previous research has demonstrated that HBO2 treatment can reduce healthcare costs by 37% compared to standard care, while significantly decreasing the need for invasive procedures, blood transfusions, and even reducing mortality.



(Ed. note: This cost-benefit analysis comes from a separate study cited by the researchers, not from the RICH-ART trial itself.)



Study Limitations



The researchers acknowledge several limitations to their study. 




The trial was not blinded, and there was no long-term control group for comparison. This was partly due to ethical considerations, as withholding a potentially beneficial treatment for five years from patients with severe symptoms would have been problematic.





Additionally, the study was terminated six months early due to administrative constraints and funding issues, resulting in missing data for some participants at the five-year mark. However, sensitivity analyses indicated that the results remained robust despite these limitations.




Future Directions



This research opens several avenues for future investigation. The variability in patient responses suggests a need to identify predictors that could help guide treatment decisions. Some evidence indicates that patients receiving 40 HBO2 sessions had fewer symptom recurrences than those receiving 30 sessions, highlighting the need for dose-response trials.



"A deeper exploration of the biological and clinical factors influencing treatment response could help tailor interventions more precisely, select patients, and optimize outcomes," the researchers conclude.



For the millions of cancer survivors worldwide who received pelvic radiation, this research offers hope that the often-debilitating urinary symptoms they experience might have an effective, long-lasting treatment option.

### Is Hyperbaric Oxygen Therapy Safe? A Medical Examination of Risks and Benefits

Understanding the safety profile, potential side effects, and appropriate uses of pressurized oxygen treatment for various medical conditions





The recent tragic incident on January 31, 2025, where a 5-year-old child, Thomas Cooper, died in a hyperbaric chamber fire at the Oxford Center in Troy, Michigan have raised significant safety concerns through the medical community. This heartbreaking event has prompted many to question the safety of a treatment that, according to medical consensus, is generally considered safe when properly administered.



Hyperbaric Oxygen Therapy (HBOT) has seen surging interest in recent years, with patients seeking it out for everything from wound healing to concussion recovery and various chronic conditions. But behind the testimonials and clinical success stories lies an important question that deserves thorough examination: Just how safe is HBOT, really?



In this article, we'll dive deep into the risks and benefits of hyperbaric oxygen therapy, examining who should consider it, who should avoid it, and how to ensure you're receiving treatment safely if you do pursue this option.



What Exactly Is Hyperbaric Oxygen Therapy?



Infographic: What is HBOT / HBOTResearch.org



HBOT involves breathing pure oxygen in a pressurized environment. Patients enter a special chamber where the atmospheric pressure is increased to 1.5 to 3 times normal levels, allowing the lungs to gather much more oxygen than would be possible under normal conditions. 



This process increases oxygen dissolution in the blood, promoting healing by enhancing tissue repair, reducing inflammation, and fighting infections. 



The therapy is delivered in two main types of chambers: monoplace (for one person, resembling an MRI machine) and multiplace (accommodating multiple patients with oxygen masks or hoods).



The FDA has approved HBOT for several specific conditions, including: [1]




Air and gas bubbles in blood vessels



Anemia (severe anemia when blood transfusions cannot be used)



Burns (severe and large burns treated at a specialized burn center)



Carbon monoxide poisoning



Crush injury



Decompression sickness (diving risk)



Gas gangrene



Hearing loss (complete hearing loss that occurs suddenly and without any known cause)



Infection of the skin and bone (severe)



Radiation injury



Skin graft flap at risk of tissue death



Vision loss (when sudden and painless in one eye due to blockage of blood flow)



Wounds (non-healing, diabetic foot ulcers) [[




However, many clinics also offer HBOT for "off-label" uses = conditions for which the FDA hasn't specifically approved this treatment. 



These include autism, Lyme disease, fibromyalgia, multiple sclerosis, PTSD and more recently, Long COVID symptoms. [2]



Key Concerns of HBOT



"But isn't pure oxygen dangerous? I've heard it can cause fires!"



It's true that oxygen itself doesn't burn, but it vigorously supports combustion, making fire hazards a legitimate concern in HBOT environments. This is precisely why reputable facilities have strict protocols about what can be brought into chambers.



Common Side Effects



Most people tolerate HBOT well, but some common side effects include:




Ear pressure or pain (barotrauma)



Temporary nearsightedness (myopia)(often nearsightedness, resolving within weeks)



Sinus discomfort



Fatigue



Lightheadedness



Claustrophobia in confined chambers




These are generally mild and transient, affecting a significant portion of patients, with studies like a 2023 meta-analysis in Frontiers in Medicine reporting a 30.11% incidence rate compared to 10.43% in control groups.



(Ed. note: These effects are typically mild and resolve soon after treatment ends)



Serious Risks (Rare but Notable)



While uncommon, more serious risks do exist:




Oxygen toxicity, which can cause seizures



Collapsed lung (pneumothorax)



Air embolism



Fire or explosion (due to the oxygen-enriched environment)



Damage to the ears, including potential rupture of the eardrum



Lung damage from prolonged exposure



Temporary worsening of certain eye conditions like cataracts or glaucoma




(Ed. note: The risk of fire, while extremely rare, underscores the importance of only receiving treatment at facilities with proper safety protocols and emergency procedures.)



The level of risk varies based on several factors, including: [1]




Treatment duration and frequency



Pressure levels used



Individual health conditions



Quality of equipment and facility



Staff training and experience




What You Can't Take Into an HBOT Chamber



Safety protocols strictly prohibit bringing certain items into hyperbaric chambers: [3]




Electronic devices (phones, watches, hearing aids)



Petroleum-based products (lip balm, makeup, oil-based lotions)



Synthetic clothing (due to static electricity risk)



Flammable materials of any kind



Certain medications (particularly those containing alcohol - e.g., doxorubicin



Metal objects that could create sparks




Who Should Avoid HBOT?



HBOT is not suitable for everyone. The only absolute contraindication is untreated pneumothorax, as pressure changes can lead to life-threatening tension pneumothorax, according to StatPearls.



Relative contraindications include:




Untreated pneumothorax (collapsed lung)



Certain chemotherapy drugs (particularly bleomycin, doxorubicin, and cisplatin)



Recent ear surgery or injury



High fever



Severe congestive heart failure




Special care must be taken with:




Children (whose bodies may respond differently to pressure changes)



Elderly patients (who may have multiple health conditions)



Pregnant women (though HBOT is used in some high-risk pregnancy situations)



People with claustrophobia



Patients with certain lung diseases



Those with implanted devices like pacemakers




How to Minimize Risks If Considering HBOT



To ensure safety, choosing a reputable clinic is critical. Look for accreditation by the Undersea and Hyperbaric Medical Society (UHMS), as recommended by the FDA, and verify that the medical director is board-certified in hyperbaric medicine.



Pre-treatment screening, including medical evaluations to identify contraindications, is very important, and continuous monitoring during therapy by trained professionals helps mitigate risks. For example:




A thorough medical evaluation



Ear examination



Chest X-ray (in some cases)



Review of all medications and supplements



Clear explanation of what to expect and potential side effects






Choosing a Reputable Clinic



Look for these positive indicators:




Accreditation by the Undersea and Hyperbaric Medical Society (UHMS)



Treatment overseen by board-certified hyperbaric medicine physicians



Clean, well-maintained facilities with proper emergency procedures



Transparent discussion of both benefits AND risks




Avoid facilities that:




Make exaggerated claims about HBOT "curing" conditions



Offer treatment without proper medical screening



Lack emergency protocols or equipment



Employ staff without specialized HBOT training






Questions to Ask Your Provider



Before treatment, ask:




What specific safety protocols are in place?



What training do your staff members have?



What emergency procedures exist?



How will my particular health conditions be monitored during treatment?



What are the specific risks for someone with my medical history?




Choosing a Safe HBOT Provider



Your options typically include:



Hospital-based facilities: Generally the safest option, with full medical support and emergency services immediately available. These primarily offer treatment for FDA-approved conditions.



Private clinics: Quality varies significantly. Look for clinics affiliated with hospitals or with UHMS accreditation and medical supervision.



At-home chambers: These portable units operate at lower pressures and carry significant risks if not properly maintained or used. Many experts advise against them due to safety concerns and limited effectiveness at lower pressures.



Elite Serene Max Sitting Hyperbaric Oxygen Chamber – 1.5 ATA / Source: HyperbaricPRO



"So, does this mean that I can't buy a hyperbaric oxygen therapy chamber for home use?"



Not necessarily. Reputable manufacturers of home HBOT chambers like HyperbaricPRO incorporate numerous safety features that significantly reduce risks when used properly. For example:




Penta heat-welded seams that avoid toxic glues and ensure structural integrity.



Advanced ventilation systems that prevent carbon dioxide buildup, with 5-stage carbon filtration to remove airborne pollutants down to the micron level.



Dual pressure relief valves (both internal and external) that allow for safe depressurization from either inside or outside the chamber.



Emergency quick-release valves for rapid depressurization in urgent situations.



Internal pressure gauges allowing users to monitor pressure levels while inside.



Medical-grade materials such as certified nontoxic, extra-strength 3-layer TPU reinforced with Dacron (a polyester material used by NASA in space suits).



Durable construction, with some chamber reservoirs rated to last up to 39 years when used 1 hour per day, 5 days per week.



ISO certifications (9001, 14001, and 13485) ensuring manufacturing quality standards.




Many home systems sold by  HyperbaricPRO use oxygen-enriched air rather than pure oxygen, which doesn't significantly raise the room's oxygen level during or after treatment. This differs from hospital-grade chambers that use pressurized oxygen tanks, making the home setup inherently safer with reduced fire risk. 



(Ed. note: Even with these safety features, it's very important to receive proper training on home unit operation and to consult with a healthcare provider before beginning self-administered HBOT.)



The Verdict: Is HBOT Safe?



Hyperbaric oxygen therapy offers valuable benefits for specific medical conditions, particularly when conventional treatments have failed. 



While generally safe under proper supervision, it does carry risks that increase when provided in unregulated settings or for experimental purposes.



The weight of evidence suggests that HBOT is generally safe when:




Administered for appropriate medical conditions



Provided by qualified professionals



Delivered in properly maintained equipment



Following thorough patient screening




For FDA-approved conditions, the benefits typically outweigh the risks. For experimental uses, the risk-benefit calculation becomes more complex and should be discussed thoroughly with healthcare providers familiar with your specific situation.



As with any medical treatment, safety isn't absolute but relative. What's safe for one patient may pose unacceptable risks for another, which is why individualized medical assessment is crucial.



If you're considering HBOT, your best path forward is consulting with a healthcare provider who can evaluate your specific medical situation, discuss the potential benefits and risks, and if appropriate, refer you to a reputable, accredited facility.





Additional Resources




Undersea and Hyperbaric Medical Society: www.uhms.org



FDA information on HBOT: www.fda.gov/medical-devices



American College of Hyperbaric Medicine: www.achm.org



National Library of Medicine resources on HBOT: www.ncbi.nlm.nih.gov/pmc



Adverse effects of hyperbaric oxygen therapy: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1160774/full



Hyperbaric Contraindications: https://www.ncbi.nlm.nih.gov/books/NBK557661/

### Researchers Combine Extracellular Matrix and Hyperbaric Oxygen in Successful Foot Trauma Treatment

Patient with motorcycle accident injury recovered through combined ECM and HBOT treatment approach. 



Hyperbaric oxygen therapy reduces anaerobic conditions in traumatized tissue, improving oxygen supply. 



This combination therapy may offer new options for patients with mutilated foot injuries.




A team of researchers from Croatia has successfully treated a severe motorcycle accident victim using a combination of extracellular matrix (ECM) application and hyperbaric oxygen therapy (HBOT), potentially opening new avenues for treating devastating foot injuries that might otherwise require amputation.



The case study, authored by a multidisciplinary team led by researchers from Rijeka University Hospital Centre in Croatia, demonstrates how combining surgical intervention with advanced supportive therapies may improve outcomes for patients with mutilated foot injuries.



Understanding Mutilated Foot Injuries



Mutilated foot injuries typically result from high-energy trauma, most commonly in industrial accidents or vehicle crashes. These severe injuries cause skin and subcutaneous tissue to detach from underlying bone structures, often leading to tissue necrosis due to compromised blood circulation.



Without effective treatment, such injuries frequently require extensive plastic reconstructive procedures or even amputation. Traditional approaches to these injuries focus primarily on surgical intervention, but the Croatian team's approach incorporates additional therapeutic modalities.



The Combined Treatment Approach



The treatment protocol described in the case study followed several key steps:




Initial necrectomy (removal of dead tissue) and fixation of bone fragments using K-wires



Immediate hyperbaric oxygen therapy sessions



Secondary necrectomy after necrotic tissue demarcation on day seven post-trauma



Application of extracellular matrix material with partial thickness skin grafting



Continuation of HBOT for a total of 27 treatments over one month




The hyperbaric oxygen therapy component serves as a supportive method that addresses the fundamental issue in these injuries: impaired tissue blood supply, particularly in areas with compromised microcirculation. The early administration of HBOT after surgical treatment helps reduce anaerobic conditions in traumatized tissue and ensures adequate oxygen delivery to healing tissues.



Meanwhile, the extracellular matrix component provides a scaffold for tissue regeneration. ECM consists of complex protein and carbohydrate-based macromolecules organized in tissue-specific arrangements, forming a fundamental component of biological tissue.



Clinical Outcome



According to the researchers, the healing process was "satisfactory locally," suggesting that the combination of surgical treatment with these supportive therapies yielded positive results. This approach may represent a viable alternative to more radical surgical interventions for similar injuries.



Dr. Marin Marinović from Rijeka University Hospital Centre led the research team, which included specialists from multiple institutions across Croatia and Italy. The interdisciplinary nature of the team highlights the complexity of treating such injuries and the benefits of collaborative medical approaches.



Broader Implications



This case study raises important questions about current treatment protocols for severe foot trauma. Could this combination therapy reduce amputation rates in patients with mutilated foot injuries? How might wider implementation of this approach affect patient outcomes and rehabilitation timelines?



For patients facing potential amputation after severe foot injuries, this treatment combination might offer hope for limb preservation. However, additional research with larger patient populations will be necessary to validate these findings and determine optimal treatment protocols.



The application of hyperbaric medicine continues to expand beyond its traditional uses in decompression sickness and carbon monoxide poisoning. This case adds to growing evidence supporting HBOT's role in trauma care, particularly when combined with advanced wound care techniques like ECM application.



Looking Forward



While promising, this single case study requires follow-up research to establish broader clinical applications. Future studies should examine long-term functional outcomes, cost-effectiveness compared to traditional approaches, and identify which patients might benefit most from this combined therapy.



As medical technology and regenerative medicine techniques continue to advance, combinations of supportive therapies may increasingly complement surgical interventions for severe traumatic injuries, potentially changing the standard of care for patients with mutilated extremities.







Reference



Marinović, Marin & Batinac, Tanja & Slivšek, Goran & Jendrašic, Ivica & Radović, Endi & Muzic, Vedrana & Bandalović, Ante & Radović, Klara & Markic, Dean & Primc, Davor & Kukuljan, Melita. (2025). The Combination of Extracellular Matrix (ECM) and Hyperbaric Oxygen Therapy (HBOT) in the Treatment of Mutilated Foot Injury: A Winning Combination?. 10.13140/RG.2.2.15557.15845.

### Phillies Introduce Hyperbaric Oxygen Therapy Program for 2025 Season

Philadelphia Phillies announce partnership with NexGen Hyperbaric to implement hyperbaric oxygen therapy for players starting in the 2025 season.



The therapy delivers 100% medical-grade oxygen in pressurized chambers to accelerate healing, reduce inflammation, and enhance recovery.



NexGen will provide mobile treatment units allowing players to receive therapy at training facilities or during road trips.




The Philadelphia Phillies have announced a partnership with NexGen Hyperbaric that makes them the first Major League Baseball team to implement a dedicated clinical hyperbaric oxygen therapy (HBOT) program for players. Beginning with the 2025 season, the Phillies will integrate these advanced recovery services into their standard player health protocols, reflecting the organization's focus on innovative approaches to athlete wellness.



The partnership, announced on April 8, will give Phillies players access to hyperbaric oxygen therapy, a treatment that delivers pure oxygen in a pressurized environment. This process allows players to absorb significantly more oxygen than under normal conditions, which proponents say accelerates natural healing processes.



Paul Buchheit, Head Athletic Trainer of the Phillies, emphasized the program's importance: 




"The Philadelphia Phillies Medical Services Department continuously strives to provide the highest quality care for our players to not only maintain overall health and wellness but also to enhance performance. We feel that NexGen Hyperbaric is a key partner to provide the best medical grade, hyperbaric oxygen therapy available to help promote tissue healing, reduce inflammation, and enhance recovery."




Recovery Advantages



Infographic: Top 5 Benefits for Athletes / Source: HBOTResearch.org



According to the announcement, HBOT offers multiple benefits for professional athletes, including enhanced tissue repair, reduced inflammation in muscles and joints, improved circulation, and faster recovery from intense training and games.



Jonathan Rotella, President and CEO of NexGen Hyperbaric, described the arrangement as going beyond mere technology: 




"This partnership with the Philadelphia Phillies represents more than just innovation — it reflects a shared commitment to redefining how we support professional athletes at the highest level. We are honored to work alongside an organization that prioritizes the long-term health and wellness of its players."




What makes this program particularly valuable for a baseball team with a demanding travel schedule? 



NexGen's mobile treatment units will allow players to receive therapy at the team's training facilities or during road trips, providing consistent access to recovery treatments without disrupting practice or travel schedules.



The Phillies' adoption of HBOT aligns with a growing trend across professional sports of seeking advanced recovery methods that might provide competitive advantages while supporting athletes' long-term health. 



Research has shown that hyperbaric oxygen therapy may accelerate healing for certain types of injuries, though its effectiveness varies depending on the specific condition being treated.



According to the FDA, hyperbaric oxygen therapy is approved for certain medical conditions, though its use in sports recovery represents an emerging application that continues to gain popularity among elite athletes.



NexGen Hyperbaric has previously established partnerships with teams in the NFL and NHL before adding the Phillies as their first MLB client. The company emphasizes that all treatments are administered under the supervision of certified hyperbaric oxygen therapy professionals.



As baseball increasingly embraces technology and medical innovation, the Phillies' decision to incorporate HBOT into their player care protocols positions them at the forefront of performance and recovery science in Major League Baseball heading into the 2025 season.

### Hyperbaric Oxygen Therapy Sessions Reduce Mortality in ICU Patients, Ten-Year Study Shows

Research shows higher number of hyperbaric oxygen therapy sessions significantly decreases death risk, especially for critical infections. 



Nighttime sessions and administration of catecholamines identified as important risk factors requiring special attention. 



First 72 hours of treatment prove crucial for patient survival, with proper protocols and staff training essential for safety.




A comprehensive ten-year study conducted at the University Centre for Maritime and Tropical Medicine in Gdynia, Poland has revealed important findings about the safety and efficacy of hyperbaric oxygen therapy (HBOT) for critically ill patients. The research, published in Scientific Reports, analyzed data from 176 intensive care patients who received HBOT while requiring mechanical ventilation between 2013 and 2023.



The study led by Aneta Miszewska and colleagues identified several risk factors during transport and HBOT sessions but ultimately demonstrated that when properly administered, HBOT can significantly improve survival rates for patients with severe conditions, particularly necrotizing soft tissue infections (NSTI) and gas gangrene.



Understanding Hyperbaric Oxygen Therapy



Hyperbaric oxygen therapy involves patients breathing pure oxygen in a pressurized chamber for approximately 90 minutes at pressures greater than 1.5 atmospheres absolute. This treatment dramatically increases oxygen levels in the bloodstream, which can help fight bacteria, reduce inflammation, and promote healing in patients with critical conditions.



Infographic: What is HBOT / HBOTResearch.org



The therapy is particularly valuable for life-threatening conditions such as carbon monoxide poisoning, necrotizing soft tissue infections, crush injuries, air and gas embolism, decompression illness, acute thermal burns, and intracranial abscesses.



However, providing this therapy to critically ill patients presents unique challenges. Dr. Jacek Kot, co-author of the study, explains that the hyperbaric environment itself creates specific physiological changes and potential risks that must be carefully managed, especially for mechanically ventilated patients.



Risk Factors and Safety Protocols



The study identified several key risk factors that require careful attention:




Mechanical ventilation: All patients in the study required breathing assistance through endotracheal tubes, which necessitated special modifications to prevent tracheal trauma during pressure changes.



Medication infusions: The research found that continuous infusion of catecholamines (medications that support blood pressure and heart function) significantly increased mortality risk, with a relative risk of 3.56.



Nighttime sessions: Over half (56.55%) of all HBOT sessions occurred during night shifts, when staff performance is potentially compromised by fatigue. The researchers noted that cognitive function is poorest between 4:00 am and 6:00 am, precisely when many sessions were scheduled.



Transportation challenges: Moving critically ill patients between the ICU and hyperbaric chamber presents inherent risks, though the facility's design with the chamber in close proximity to the ICU helped minimize these dangers.



Special equipment needs: Patients with pleural cavity drainage (6.25%) or requiring hemodiafiltration (21.02%) needed additional precautions, as these treatments can be affected by pressure changes.




Despite these challenges, the study reported only two deaths (1.14%) occurring during actual HBOT sessions over the ten-year period, both involving patients in extremely critical condition with septic shock upon admission.



Survival Benefits



Perhaps the most significant finding was that increasing the number of HBOT sessions substantially improved survival rates, with each additional session reducing the risk of death by 29% (RR = 0.71, p < 0.001).



"The number of HBOT sessions demonstrated a statistically significant association with a reduced risk of death," the researchers reported in their findings.



The overall mortality rate in the study was 15.90%, which compares favorably to other research reporting higher mortality rates for similar patient populations without HBOT intervention. Previous studies have shown mortality rates as high as 89.6% for NSTI patients in intensive care settings.



The researchers identified that the first 72 hours of treatment were particularly crucial for patient survival. During this period, patients received appropriate antibiotic therapy, underwent radical wound debridement when needed, and had increased frequency of HBOT sessions.



Facility and Staff Considerations



The study highlighted several factors that contributed to the relatively low mortality rate:




The facility's unique design integrated the ICU and hyperbaric chamber in the same building, minimizing transport time and risks.



The same medical team provided care to patients both in the ICU and during HBOT sessions, ensuring continuity of care.



Staff were highly trained in both intensive care and hyperbaric medicine.



Ward beds were adapted for use in the hyperbaric chamber, eliminating the need for transfers.




Dr. Miszewska emphasized that maintaining this level of care requires substantial investment in staff education and training. Research has consistently shown a clear relationship between healthcare provider education levels and patient outcomes, with higher levels of education associated with improved safety and better clinical results.



Implications for Future Practice



The researchers provided three key conclusions based on their findings:




HBOT performed on ICU patients following applicable standards, with qualified staff and adapted equipment, ensures clinical safety during transport and treatment.



Patients with severe infections (NSTI and gas gangrene) require special attention due to their higher risk of adverse events and mortality.



The first 72 hours of hospitalization for critically ill patients receiving HBOT are crucial for survival.




While the study demonstrated significant benefits, it also acknowledged limitations, including the possibility that some critically ill patients may not have been referred for HBOT due to transportation challenges, potentially skewing mortality data. Additionally, the study only examined in-hospital mortality without tracking long-term outcomes after discharge.



What does this mean for the future of critical care? The integration of hyperbaric medicine into intensive care protocols could save more lives, especially for patients with necrotizing infections and other severe conditions. However, this requires specialized facilities, extensive staff training, and careful risk management.



As hospitals consider incorporating HBOT into their treatment options for critically ill patients, this research provides valuable guidance on safety protocols, risk factors, and potential benefits. The evidence suggests that when properly implemented, hyperbaric oxygen therapy can be a powerful tool in the intensive care arsenal, offering hope for patients with some of the most challenging medical conditions.







Research Reference




Study Title: Safety of intensive care hyperbaric oxygen therapy sessions at a tertiary academic hospital



Authors: Aneta Miszewska, Jacek Kot, Ewa Lenkiewicz



Journal: Scientific Reports (2025) 15:12131



DOI: https://doi.org/10.1038/s41598-025-97226-6



Study Period: 2013-2023



Sample Size: 176 ICU patients requiring mechanical ventilation and HBOT



Key Finding: Each additional HBOT session reduced mortality risk by 29% (RR = 0.71, p < 0.001)

### Hyperbaric Oxygen Treatment Offers Hope for Teen with Brain Injury as Family Criticizes Care

Jack Dolan shows significant progress after catastrophic brain injury from pier jump accident.



Family claims community healthcare providers are failing to provide adequate rehabilitation support.



Parents fund private hyperbaric oxygen therapy they believe is key to his ongoing recovery.








A Kent family is fighting for improved care for their 15-year-old son who suffered severe brain damage after jumping from a seaside pier last year, while crediting hyperbaric oxygen treatment with his remarkable progress so far.



Jack Dolan was left "braindead" following what his family describes as a horrific accident in Margate nine months ago. According to a recent report by Isaac Crowson of the Daily Mail, the teenager has shown surprising signs of recovery, including the ability to talk, laugh, and respond to his surroundings, despite initial predictions that he should not have survived the incident.



A Family's Fight for Better Care



The Dolan family has publicly criticized what they claim is inadequate support from Medway Council and Medway Community Healthcare since Jack returned home in January. His stepfather, Dave Dolan, expressed their frustration with the current level of care.




"We want better care for Jack. We will go to Parliament. We want a change in his condition and how he is cared for," Dave Dolan told reporters. "It's heartbreaking. There's nowhere near enough help. It's terrible. They're not helping him enough. The community care team are leaving him to bed-rot."




The family's concerns center around what they perceive as stalled progress in Jack's rehabilitation. According to his stepfather, Jack showed promising improvement during the initial months of his recovery but has since plateaued due to what the family believes is insufficient support from local healthcare providers.




"He was doing so well. That progress has stagnated now. That's through a lack of help from the council," Dave Dolan explained. "He should be starting his GCSEs and doing the paperwork for the Royal Marines. Instead, he is learning to walk and talk again. Well, he's not, because he's not getting the help he needs."




What is Hyperbaric Oxygen Therapy?







The family credits hyperbaric oxygen therapy (HBOT) with Jack's recent progress. This specialized treatment involves breathing pure oxygen in a pressurized chamber to increase oxygen levels in the blood and tissues, potentially promoting healing in damaged areas of the body.



While not universally recognized as a standard treatment for brain injuries by all medical authorities, some research suggests HBOT may help certain patients with traumatic brain injuries by reducing inflammation and promoting tissue regeneration. 



For example:




A 2023 randomized controlled trial found that both hyperbaric oxygen therapy (HBOT) and normobaric hyperoxia (NBH) improved cognitive outcomes in patients with mild traumatic brain injury, with HBOT showing superior results. ​[1]



A 2024 systematic review indicated that HBOT might reduce symptoms of post-traumatic stress disorder (PTSD) in individuals with traumatic brain injury, suggesting potential benefits for mental health. ​[2]



A 2024 study highlighted that HBOT in moderate-to-severe traumatic brain injury may help minimize death and reduce overall disability in the long term. [3]




The therapy works by dramatically increasing the amount of oxygen delivered to tissues throughout the body, including the brain. During treatment, patients breathe 100% oxygen (compared to the 21% oxygen in normal air) while inside a chamber where the atmospheric pressure is increased to up to three times normal levels. This combination allows the blood to carry significantly more oxygen to organs and tissues.



Why might this matter for brain injury? When brain tissue is damaged, increased oxygen availability may help support cellular repair processes and reduce secondary damage that can occur after the initial injury.



A Private Medical Journey



Unable to secure the treatment through the National Health Service due to its high costs, the Dolans have turned to private care funded through donations. They have installed a hyperbaric chamber in their home in Rainham, Kent, investing thousands of pounds in what they believe is transforming their son's life.



Video footage shared by the family shows Jack using the chamber, with his parents documenting his progress on social media. 




https://www.tiktok.com/@jackdolanrecovery/video/7462808376179805473?is_from_webapp=1&sender_device=pc&web_id=7466828679055509014




Their TikTok page has garnered millions of views from supporters around the world, helping to boost fundraising efforts for his continued treatment.



"Thank God for the oxygen therapy. It's been a huge help," Dave Dolan said, emphasizing their belief in the treatment's effectiveness despite its limited availability through standard NHS care pathways.



The family maintains realistic expectations about Jack's future while remaining hopeful about his potential for significant improvement with the right interventions.




"We're realistic. There's always going to be a level of disability. But the next 18 months are crucial. It could change everything," his stepfather explained. "With the right help, we think he could be walking and talking in his 20s."




The Incident That Changed Everything



Jack's life changed dramatically during what should have been a routine day out with friends on June 23 last year. According to reports, the teenager, who attends the Howard School in Medway, was with his girlfriend and several friends when he performed a "flip" off Stone Pier in Margate – an activity commonly known as "tombstoning."



The practice of jumping from height into water, often from cliffs, bridges, or piers, has been associated with numerous serious injuries and fatalities in the UK over the years. Safety organizations regularly warn about the dangers, which include risks of hitting submerged objects, cold water shock, and injuries from impact with the water surface.



A boy cliff jumping off Cavo Greco in Protaras. Cyprus a popular tourist place for UK residents.



Jack, who has ADHD and according to his parents "was known to act before thinking," had performed similar jumps many times before, including during a family holiday in Egypt. On this occasion, however, he landed head-first on the water's surface and was knocked unconscious.



After initially floating face down, Jack sank and remained underwater for approximately eight minutes before being rescued by a kayaker who dived down to retrieve him. The extended period without oxygen resulted in severe brain damage that medical professionals initially suggested would be fatal.



How does the human brain respond to oxygen deprivation? 



When the brain is deprived of oxygen for extended periods, cells begin to die rapidly, potentially causing permanent damage. The severity and location of this damage determine what functions may be affected – from movement and speech to cognition and emotional regulation.







Healthcare Response and Continuing Conflict



Both healthcare organizations involved in Jack's care have responded to the family's concerns. A Medway Council spokesperson stated they have contacted Jack's mother to better understand their issues and will be bringing forward a review of his social care plan, which was originally scheduled for later this month.




"We will also be arranging a multi-disciplinary meeting with partner agencies to discuss the wider support that may be required in addition to social care," the council representative added.




Tracy Webb, Assistant Director of Children's and Planned Services at Medway Community Healthcare, defended their approach to Jack's treatment: 




"We are providing regular appointments for Jack Dolan based on his clinical needs. These meet national guidance and advice about recovery and ongoing care following a serious brain injury."




Webb further stated that they are working to make Jack's care "as consistent, patient-centered and flexible as possible" and are in communication with the family regarding their concerns.



This disagreement highlights a common tension in healthcare systems worldwide – the gap between what families believe their loved ones need and what publicly funded healthcare services can or will provide based on established protocols and available resources.



Jack Dolan's on a wheelchair / Source: Gofundme



The Science Behind Brain Injury Recovery



Brain injuries, particularly those resulting from oxygen deprivation (hypoxic-ischemic brain injury), present complex challenges for medical treatment and rehabilitation. The brain's ability to recover – known as neuroplasticity – varies significantly between individuals and depends on multiple factors including the patient's age, the severity and location of the injury, and the timing and intensity of rehabilitation efforts.



Young patients like Jack often show greater capacity for recovery than adults with similar injuries due to the enhanced neuroplasticity of the developing brain. This biological advantage, combined with intensive rehabilitation, can sometimes lead to surprising improvements even in cases initially considered hopeless.



The recovery process typically follows a pattern where the most rapid improvements occur in the first six months after injury, with continued but slower progress possible for up to two years or longer. This timeline aligns with Dave Dolan's emphasis on the importance of the next 18 months for Jack's recovery potential.



Standard rehabilitation approaches for brain injury patients typically include physical therapy, occupational therapy, speech therapy, and cognitive rehabilitation. These evidence-based interventions aim to rebuild neural pathways and restore function through repetitive, targeted exercises and activities.



Alternative or complementary treatments like hyperbaric oxygen therapy remain controversial in mainstream medicine, with mixed evidence regarding their effectiveness for brain injury. 



While some studies suggest benefits, others show limited or inconsistent results, leading many public healthcare systems to classify them as experimental rather than standard care.



What determines which treatments receive public funding? 



Healthcare systems must balance evidence of effectiveness, cost considerations, and resource allocation across numerous competing needs when deciding which treatments to offer as standard care. Treatments with strong, consistent evidence of benefit typically receive priority over those with limited or conflicting data.



Community Support and Advocacy



The Dolan family's campaign for improved care represents a common pattern seen in cases of serious injury or illness – families becoming advocates and experts in their loved one's condition, often pushing boundaries of standard care in pursuit of recovery.



Their use of social media to document Jack's journey has not only helped with fundraising but has created a community of supporters invested in his progress. Such public engagement can be powerful in raising awareness about both specific cases and broader issues in healthcare provision.



Last year, the family launched a GoFundMe campaign to equip a new home with specialized equipment Jack requires for his ongoing care. This form of crowdfunded healthcare has become increasingly common for families facing expenses not covered by public systems, particularly for treatments considered experimental or complementary.



Jack is currently cared for primarily by his parents, Dave and Lisa Dolan, along with his sisters Faith and Grace, ages 10 and 9. This family-centered approach to care represents both the dedication of families in such situations and the reality that much of the day-to-day support for patients with complex needs falls to relatives rather than professional caregivers.



Looking Forward: Questions of Care and Recovery



The conflict between the Dolan family and local healthcare providers raises important questions about the boundaries of publicly funded care and the role of alternative treatments in recovery from catastrophic injury.



For families like the Dolans, the distinction between "experimental" and "proven" treatments can seem arbitrary when they observe improvements they attribute to interventions not available through standard care pathways. Their experience highlights the sometimes painful gap between what medical systems consider appropriate care based on population-level evidence and what individual families perceive as beneficial based on their intimate knowledge of their loved one.



As Jack continues his recovery journey, his case exemplifies both the remarkable resilience of the human brain and the challenges of navigating complex healthcare systems after life-altering injury. The coming months will be critical in determining the extent of his potential recovery, with his family committed to advocating for what they believe is the most effective approach to his rehabilitation.



Whether Jack's story ultimately influences broader policy around brain injury care remains to be seen, but his family's determination to share their experience has already brought attention to the challenges faced by those recovering from severe traumatic injuries and the potential role of treatments not currently standard in NHS care.

### Hyperbaric Oxygen Therapy Devices Market Set to Reach $6.3 Billion by 2035, Growing at 5.2% CAGR

The global hyperbaric oxygen therapy devices market is projected to grow from USD 3,827.6 million in 2025 to USD 6,352.4 million by 2035, at a CAGR of 5.2%.



North America currently holds the largest market share, driven by advanced healthcare infrastructure and favorable reimbursement policies.



Mono-place HBOT devices dominate the market, with wound healing applications representing the largest segment due to rising diabetes-related complications.








The global hyperbaric oxygen therapy (HBOT) devices market is expected to reach USD 3,827.6 million in 2025 and grow at a compound annual growth rate (CAGR) of 5.2% to reach USD 6,352.4 million by 2035, according to a market analysis report released in February 2025. 



This growth comes as HBOT gains wider acceptance for treating chronic wounds, decompression sickness, Post-traumatic stress disorder and carbon monoxide poisoning.



The market expansion is primarily driven by increasing cases of diabetic foot ulcers, radiation injuries, and growing awareness about HBOT's effectiveness in promoting tissue healing. Technological advancements, including the development of portable and user-friendly chambers, are also contributing to market growth. 



Regional Market Dynamics



Expected growth of HBOT in Various Markets / Source: HBOTResearch.org



North America currently leads the global market with the highest share, supported by its advanced healthcare infrastructure and positive reimbursement policies. The region's growing diabetes prevalence and related complications are key factors driving demand for HBOT devices.



Europe represents another major market, with Germany, France, and the United Kingdom at the forefront. The European market benefits from robust government healthcare programs and increasing awareness of HBOT benefits in various applications.



The Asia-Pacific region is experiencing rapid growth, with China and India showing significant potential. According to the report, India is expected to grow at a CAGR of 9.9% from 2025 to 2035, while China is projected to grow at 9.1% during the same period. 



Market Segments and Competitive Landscape



By product type, mono-place HBOT devices hold the largest market share due to their efficiency, cost-effectiveness, and wide acceptance in specialty clinics and hospitals.



A mono-place Hyperbaric Oxygen Therapy chamber (LUX AIR 40) by Oxygen Health Systems.



These devices deliver 100% oxygen under high atmospheric pressure, making them effective for treating persistent wounds and other conditions.



In terms of application, wound healing remains the dominant segment, driven by the increasing prevalence of diabetic foot ulcers and chronic wounds. Decompression sickness represents another significant application, particularly important for divers and aviation industry workers.



The competitive landscape features several key players, with 




Perry Baromedical (15.1% market share), 



Sechrist Industries, Inc. (14.3%), 



Environmental Tectonics Corporation (ETC) (12.7%), and 



Fink Engineering (10.8%) leading the market.




Despite promising growth prospects, the HBOT devices market faces challenges including high equipment and treatment costs, inconsistent reimbursement policies, and lack of standardized protocols. 



However, ongoing research into novel applications and integration with telemedicine presents significant opportunities for market players.

### Michael Jackson’s Hyperbaric Chamber: A Glimpse Into His Quest for Longevity

When Michael Jackson famously posed inside a hyperbaric oxygen chamber in 1986, the world was captivated. 



The King of Pop claimed the futuristic device (yes, 40 years ago this was pretty much futuristic) could help him live to be 150, and his belief in its powers only fueled the public's curiosity. Now, decades later, that very chamber has resurfaced, tucked away in a Southern California warehouse. 



But was Jackson onto something? Could hyperbaric oxygen therapy (HBOT) actually slow aging and improve health?



The Discovery of Michael Jackson Hyperbaric Chamber



Michael Jackson Hyperbaric Oxygen Therapy Chamber / Source: Daily Mail



DailyMailTV recently uncovered the singer’s hyperbaric oxygen chamber - the Sechrist 2500B - sitting inside a shipping container at Hyperbaric Modular Systems (HMS), a company specializing in hyperbaric treatment. This is the same machine Jackson used for his infamous photo op, which led to widespread speculation about his alleged obsession with eternal youth.



The chamber was originally purchased by Brotman Memorial Hospital with funds Jackson donated after his 1984 accident on a Pepsi commercial set left him with severe burns. Jackson later acquired it himself and moved it to his Neverland Ranch in 1994, reportedly using it for short sessions to rejuvenate his body.




https://www.youtube.com/watch?v=t34S3AwvH_Q




How Does a Hyperbaric Oxygen Chamber Work?



Hyperbaric oxygen therapy involves breathing pure oxygen in a pressurized environment, allowing the body to absorb three times the normal amount of oxygen. This increased oxygenation is proven to promote healing, reduce inflammation, and even combat aging by encouraging cell regeneration.



According to HBOT experts, the treatment is commonly used for medical conditions such as decompression sickness, severe burns, chronic wounds and PTSD. However, its anti-aging potential has been a topic of growing interest, with some studies suggesting it may help slow cellular aging by extending telomere length by 20%  - the protective caps on DNA strands that shorten over time.



Did Jackson’s Chamber Actually Work?



Adrian Garay, CEO of Hyperbaric Modular Systems, believes Jackson may have been onto something. “Scientific studies have shown that hyperbaric oxygen therapy can promote the growth of older cells, essentially slowing down the aging process,” Garay told DailyMailTV. “Michael’s belief that it could help extend his lifespan wasn’t as far-fetched as people thought.”



However, experts caution against viewing HBOT as a miracle cure. While research supports its benefits for certain conditions, there is no definitive proof that it can dramatically extend human lifespan. 



In fact, staying inside a hyperbaric chamber for too long can lead to oxygen toxicity, a potentially fatal condition. [1]



Typically, HBOT sessions last between 60 and 90 minutes, depending on the specific treatment protocol and medical need.



Do Celebrities Use Hyperbaric Chambers?



Yes, many celebrities have reportedly used hyperbaric oxygen therapy for its potential health and anti-aging benefits. 



Athletes like LeBron James and Cristiano Ronaldo have incorporated HBOT into their recovery routines, while stars like Justin Bieber and Madonna have also been linked to the therapy. 



The treatment is often used to speed up healing, reduce inflammation, and promote overall well-being.



The Legacy of Jackson’s Oxygen Chamber



Today, the 33-year-old chamber remains in storage at HMS, still in working condition. While modern HBOT chambers have surpassed the Sechrist 2500B in technology and efficiency, Jackson’s machine remains a relic of his never-ending quest for youth and health.



The King of Pop’s fascination with hyperbaric therapy might have been seen as eccentric at the time, but as research into longevity and oxygen therapy continues, his legacy as an early adopter of anti-aging treatments lives on.



So, was Michael Jackson ahead of his time? Perhaps. While he may not have lived to be 150, his influence on the conversation around health, longevity, and alternative medicine endures - just like his music.



By the way, here's the original reportage by DailyMailTV on Michael Jackson Hyperbaric Therapy.

### Hyperbaric Therapy Saves Patient from Rare Gas Embolism

Alternative Medicine Proves Its Worth in Emergency Care



Patients deserve swift, effective care when facing rare medical emergencies. Hyperbaric oxygen therapy can stabilize cerebral arterial gas embolism cases. Rural hospitals may lack this treatment, requiring creative solutions like outpatient transfers.



In a striking case from rural Indiana, a patient faced a life-threatening situation after a routine lung biopsy went awry. As detailed in a forthcoming study from Frontiers in Medicine by Dr. Mark M Walsh and his team at Saint Joseph Regional Medical Center, this incident shines a light on the power of alternative treatments like hyperbaric oxygen therapy (HBO) to address emergencies conventional hospitals might not handle alone. What happens when the tools you need aren’t where you are?



The patient, undergoing a percutaneous needle biopsy—a procedure to sample lung tissue—suddenly lost consciousness and suffered paralysis. A quick CT scan revealed the culprit: a cerebral arterial gas embolism, a rare condition where gas bubbles enter the bloodstream and block arteries in the brain. 



According to the Frontiers in Medicine report, such embolisms can stem from medical procedures, known as iatrogenic interventions. Without rapid action, the outcome could have been grim.



Faced with a challenge, the rural hospital lacked an onsite hyperbaric chamber—a sealed unit that delivers pure oxygen at high pressure to flood the body with healing oxygen. So, the team made a bold move. 



They transferred the patient to an outpatient wound care center equipped with this technology. Why not keep the patient in a high-tech hospital? Because sometimes, the best care lies in unexpected places.



At the outpatient facility, HBO worked wonders initially. The patient’s symptoms eased as oxygen dissolved the gas bubbles and restored blood flow. But the relief was short-lived—symptoms returned under normal air pressure. The team pressed on, moving the patient to another hospital for continued HBO. Eventually, the patient’s condition stabilized fully. Dr. Walsh’s team notes, 



“This case demonstrates the importance of immediate treatment with hyperbaric oxygen” for such embolisms, as published in their case report.



This wasn’t a standard playbook move. Transferring from a rural hospital—a higher-level facility—to an outpatient center—a lower-level one—defies typical protocol. Yet, it underscores a truth I’ve long championed as an alternative medicine advocate: healing doesn’t always follow a rigid path. 



The National Institutes of Health recognize HBOT as a proven treatment for decompression sickness and embolisms, yet many hospitals lack the equipment. Could this case spark a shift in how we view facility transfers?



Historically, HBO has roots in treating divers with “the bends,” but its uses have expanded. The Undersea and Hyperbaric Medical Society lists it as effective for 14 conditions, including gas embolisms. Still, access remains spotty, especially in rural areas. This Indiana case builds on precedents where quick thinking and alternative tools saved lives.



Dr. Jason A Bailey, a co-author from Goshen Health, highlights the need for flexibility. “When deemed clinically necessary and safe by bedside emergency physicians, it’s a viable option,” he writes in the report. The team calls for clear guidelines on such transfers to avoid delays—a practical step forward.



For health-conscious readers, this story resonates deeply. It’s a reminder that alternative therapies like HBO aren’t just fringe ideas—they can be lifelines. Have you ever wondered where your nearest hyperbaric chamber is? 



As this case shows, knowing your options might one day matter. The full study, set to appear soon in Frontiers in Medicine’s Pulmonary Medicine section, offers a blueprint for adapting when the stakes are high.

### Hyperbaric Oxygen Therapy Gains Ground in PTSD Treatment

Innovative Therapy Offers New Path to Healing for Veterans Battling Trauma




Congressman Murphy's legislation aims to provide hyperbaric oxygen therapy (HBOT) for veterans with PTSD and TBI.



Current suicide rates among veterans highlight the urgent need for alternative treatments.



Scientific studies show promising results in reducing PTSD symptoms through HBOT.



Bipartisan support indicates growing recognition of innovative mental health interventions.



The proposed pilot program could revolutionize veteran mental health care.




The landscape of veteran mental health treatment is undergoing a significant transformation with the recent passage of H.R. 1336, the Veterans National Traumatic Brain Injury Treatment Act. 



Congressman Greg Murphy, M.D., has championed a groundbreaking approach to addressing the complex mental health challenges faced by veterans suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI).



Understanding the Crisis



Veterans continue to face a critical mental health challenge, with more than 17 veterans losing their lives to suicide daily - according to the 2024 National Veteran Suicide Prevention Annual Report. 



Traditional treatment methods have often fallen short, leaving many veterans struggling to find effective relief from their psychological wounds.



How Hyperbaric Oxygen Therapy Works



Hyperbaric oxygen therapy (HBOT) offers a unique medical intervention. By delivering 100 percent oxygen under increased pressure, this treatment helps heal damaged brain tissue, improves blood flow, and reduces inflammation. Medical research has demonstrated its potential to address the neurological impacts of trauma.



Scientific Backing



A groundbreaking study published in Medical Gas Research provides compelling evidence. Researchers found that after 40 HBOT treatments:




52 percent of military personnel no longer met the PTSD diagnostic threshold



Significant improvements in anxiety and depression symptoms were observed



10 out of 12 participants with initial suicidal thoughts no longer experienced them




"One of the greatest reductions in PTSD symptoms in a four-week period with any reported treatment," noted Dr. Paul Harsh, lead researcher.



Bipartisan Support



The legislation has garnered support from both sides of the political aisle, with cosponsors including Representatives Marilyn Strickland, Jennifer Kiggans, and others. This bipartisan approach underscores the universal commitment to supporting veterans' mental health.



What This Means for Veterans



If approved, the pilot program would provide veterans with access to a potentially life-changing treatment. New York State American Legion Commander Kenneth Governor emphasizes the urgency: 




"We're losing 22 veterans a day who take their own lives, with another 44 attempts. We need to offer veterans with TBI/PTSD an alternative to a sliding slope of drug therapy."




While HBOT is not a cure-all, it represents a promising additional tool in the complex landscape of veteran mental health treatment. The proposed pilot program could open new doors for healing and hope.

### What is Hyperbaric Oxygen Therapy: A Comprehensive Guide

Hyperbaric Oxygen Therapy (HBOT) might sound like something from a science fiction movie, but it's actually a well-established medical treatment that's been helping patients for decades. In its simplest form, HBOT involves breathing pure oxygen in a pressurized environment. 



Just imagine yourself sitting in a special room or chamber where the air pressure is increased to two or three times higher than normal atmospheric pressure. 



When you're inside a hyperbaric chamber, your lungs gather much more oxygen than would be possible breathing pure oxygen at normal air pressure. This extra oxygen gets dissolved into your blood plasma, allowing it to reach areas where blood flow is reduced or blocked. 



In this comprehensive article, we're taking an introductory deep dive into the world of Hyperbaric Oxygen Therapy and how it can help people become healthier.



The Science Behind Hyperbaric Oxygen Therapy



How Pressure Affects Oxygen Dissolution



To understand what makes HBOT so effective, we need to explore a principle of physics called Henry's Law. This law states that the amount of gas dissolved in a liquid is proportional to the pressure of that gas above the liquid. In simpler terms, when you increase the pressure, you can dissolve more gas in a liquid.



William Henry / Source: Wikipedia



In our bodies, this means that under the increased pressure of a hyperbaric chamber, your blood plasma (the liquid portion of your blood) can dissolve significantly more oxygen. At normal pressure, your red blood cells do most of the heavy lifting when it comes to carrying oxygen. But in a hyperbaric environment, your plasma becomes a major oxygen carrier too.



This is very important because red blood cells can only go where blood vessels allow them to travel. In damaged tissues, blood vessels might be blocked or compressed. Oxygen dissolved in plasma, however, can diffuse more easily into these compromised areas, delivering its healing properties directly to cells in need.



Cellular Mechanisms of HBOT



At the cellular level, the effects of HBOT are truly remarkable. When tissues receive this surge of oxygen, several beneficial processes kick into gear:




Enhanced white blood cell activity improves your body's ability to fight infections.



New blood vessel formation (angiogenesis) is stimulated in areas with reduced blood flow. [1]



Stem cell mobilization from bone marrow increases, promoting tissue repair. [2]



Production of growth factors and collagen accelerates, helping wounds heal faster.



Harmful bacteria that cannot survive in high-oxygen environments are killed. [3]




The increased oxygen levels also reduce inflammation and swelling by causing blood vessels to constrict while still delivering more oxygen to tissues – a seemingly paradoxical effect that makes HBOT particularly useful for conditions involving inflammation.



Recent research has shown that HBOT can even influence gene expression, turning on genes involved in growth and repair while turning off those that contribute to inflammation and cell death.



History and Evolution of Hyperbaric Medicine



The history of hyperbaric medicine stretches back much further than many people realize. The concept of using pressurized environments for health benefits dates back to the 1600s when British clergyman Henshaw built the first documented pressurized room called a "domicilium." He didn't fully understand the science, but he believed that pressure could help with respiratory diseases. [4]



1662: Henshaw's Domicilium / Source: ResearchGate



The true medical applications of hyperbaric therapy began to emerge in the 19th century. French surgeon Fontaine built a pressurized mobile operating room in 1879, finding that patients experienced less pain and bleeding during surgery. [4]



Fontaine's mobile hyperbaric operation theater / Source: ResearchGate



The field took a significant leap forward in the early 20th century when Dr. Orville Cunningham used hyperbaric oxygen to successfully treat someone dying from the flu during the pandemic of 1918. [4]



In his enthusiasm, Cunningham later built a massive hyperbaric chamber called the "Steel Ball Hospital" in Cleveland, Ohio – a structure five stories high that unfortunately became more of a novelty than a medical facility.



Left: The Cunningham Sanitarium. Right: The five-story steel sphere of Cunningham Sanitarium. Source: Encyclopedia of Cleveland History & Cleveland Historical.



The modern era of hyperbaric medicine began in earnest in the 1940s when the military adopted it for treating decompression sickness in divers. By the 1960s, the therapeutic benefits for other conditions started becoming apparent. [5]



The Undersea and Hyperbaric Medical Society (UHMS) was established in 1967 to further research and establish protocols, helping transform HBOT from an experimental treatment to a mainstream medical therapy. [6]



Today, there are over 1,200 hyperbaric facilities in the United States alone, with ongoing research constantly expanding our understanding of how and when this therapy can be most effective.



Types of Hyperbaric Chambers



Monoplace Chambers



Elite Ultra 2 | 36 inch 2 ATA Monoplace Hard-shelled Chamber by Hyperbaric PRO.



The most common type of hyperbaric chamber you'll encounter in hospitals and dedicated treatment centers is the monoplace chamber. These tube-shaped devices are designed for a single person to lie down inside. Made of clear acrylic, they allow you to see outside during treatment, which helps reduce anxiety and claustrophobia.



In a monoplace chamber, you lie on a padded table that slides into the tube. The entire chamber is then pressurized with 100% oxygen, meaning you breathe the oxygen directly without any mask or hood. These chambers typically operate at pressures between 2 and 3 atmospheres absolute (ATA).



The advantages of monoplace chambers include their relatively lower cost, smaller footprint, and simpler operation. However, they do limit the ability for medical staff to directly access you during treatment, though communication systems allow you to speak with the operator at all times.



Multiplace Chambers



A multiplace hyperbaric oxygen therapy chamber by Oxygen Health Systems.



For more intensive medical applications, multiplace chambers provide a different approach. These larger chambers can accommodate multiple patients simultaneously, along with medical staff who can provide hands-on care during treatment.



Unlike monoplace chambers, multiplace units are pressurized with air, and patients breathe pure oxygen through masks, hoods, or endotracheal tubes. This approach allows medical staff to work in the chamber without being exposed to high oxygen levels for extended periods, which could pose safety risks.



Multiplace chambers can typically reach higher pressures than monoplace units and are the preferred choice for treating critically ill patients or those requiring direct medical attention during therapy. They're commonly found in major medical centers and specialized hyperbaric treatment facilities.



Portable Hyperbaric Chambers



LUX-AIR 40-Inch Hyperbaric Oxygen Soft Chamber | 1.3 ATA | Source: Hyperbaric PRO.



A third category has emerged in recent years: portable or mild hyperbaric chambers (mHBOT). These soft-shelled chambers can be used at home and typically provide much lower pressures (around 1.3 ATA) and use filtered ambient air rather than pure oxygen.



It's important to note that these portable chambers are not FDA-approved for most medical conditions treated by traditional HBOT. They're primarily cleared for treating altitude sickness and are sometimes used for athletic recovery, though the evidence for these applications is still developing.



While they may provide some mild benefits, portable chambers should not be considered equivalent to medical-grade HBOT for serious conditions. Some users report subjective improvements for various complaints, but the science supporting these uses lags behind the marketing claims often made about these devices.



Medical Conditions Treated with HBOT



FDA-Approved Indications



The Food and Drug Administration (FDA) has approved HBOT for treating a specific list of conditions where strong scientific evidence supports its use. These include:




Decompression sickness ("the bends") in divers



Gas embolism (air bubbles in blood vessels)



Carbon monoxide poisoning



Gas gangrene (a life-threatening bacterial infection)



Crushing injuries and traumatic ischemias (compromised blood flow)



Radiation injury, such as damage to tissues following cancer treatment



Compromised skin grafts and flaps



Chronic non-healing wounds, particularly diabetic foot ulcers



Severe anemia where blood transfusion isn't possible



Intracranial abscess (brain infection)



Osteomyelitis (bone infection) that hasn't responded to standard treatment



Thermal burns



Sudden hearing loss




For these approved conditions, HBOT is generally covered by insurance and has demonstrated clear benefits in clinical trials and decades of medical practice.



Off-Label Uses Being Researched



Beyond these established applications, researchers are investigating HBOT's potential for a much wider range of conditions. Some of the most promising areas include:




Traumatic brain injury and concussion recovery



Stroke rehabilitation



Long COVID symptoms



Autism spectrum disorders



Lyme disease and other chronic infections



Fibromyalgia and chronic fatigue syndrome



Inflammatory bowel diseases



Post-surgical recovery



Migraine headaches



Multiple sclerosis



Alzheimer's disease and vascular dementia




The evidence for these applications varies widely, with some showing promising early results in small studies while others remain highly controversial. Patients considering HBOT for off-label uses should approach the treatment with realistic expectations and understand that insurance often won't cover these applications.



The HBOT Treatment Experience







What to Expect During a Session



If you're scheduled for hyperbaric oxygen therapy, knowing what to expect can help ease any anxiety. The experience is generally straightforward and non-invasive, though it may feel unusual at first.



Before your session, you'll need to remove all electronic devices, jewelry, and other items that could pose a fire risk in the oxygen-rich environment. You'll typically wear a hospital gown or cotton clothing provided by the facility. Your medical team will check your vital signs and may examine your ears and sinuses, as pressure changes can affect these areas.



Once inside the chamber, you'll lie comfortably on a padded table. In a monoplace chamber, the door will be secured, and you'll hear the sound of oxygen beginning to flow. As the chamber pressurizes (called "compression"), you'll feel fullness in your ears similar to what you might experience when landing in an airplane. Swallowing, yawning, or using equalization techniques can help relieve this pressure.



During the treatment, which typically lasts between 90 minutes and two hours, you can rest, sleep, or watch a movie on a screen provided by some facilities. The chamber remains transparent, so you can see the medical staff outside, and communication systems allow you to speak with them if needed.



At the end of the session, the chamber will slowly depressurize (called "decompression"), and you might again feel the need to equalize your ears. After exiting the chamber, staff will check your vital signs again before you leave.



Treatment Protocols and Duration



HBOT treatment isn't a one-and-done solution. For most conditions, you'll need multiple sessions to achieve optimal results. The exact protocol varies depending on your condition:




For acute conditions like carbon monoxide poisoning or decompression sickness, you might need only 1-3 intensive treatments.



For radiation injuries, a typical course might include 30-40 daily sessions at 2.0-2.4 ATA for 90-120 minutes each.



For diabetic foot ulcers or other chronic wounds, expect 20-40 sessions, often scheduled 5 days per week.



For neurological conditions being treated off-label, protocols can range from 40-80 sessions or more.




The pressure levels, session duration, and frequency are all carefully calculated based on your specific condition and response to treatment. Your doctor might adjust the protocol as treatment progresses, especially if you're experiencing side effects or showing particularly good or poor response.



Full treatment courses can span weeks or months, requiring a significant time commitment. However, most patients can return to normal activities immediately after each session, as there's typically no recovery time needed.



Potential Benefits of Hyperbaric Oxygen Therapy



The wide range of conditions HBOT can help reflects its fundamental mechanism: enhancing the body's natural healing processes through oxygen saturation. 



Some of the most remarkable benefits include:




Accelerated wound healing is perhaps the most visible benefit. For people with diabetic foot ulcers or radiation injuries that won't heal with standard care, HBOT can make the difference between recovery and amputation.





The anti-inflammatory effects can be life-changing for people suffering from conditions with chronic inflammation. By reducing swelling and promoting normal blood vessel function, HBOT helps tissues return to healthier states.





HBOT's ability to kill anaerobic bacteria (those that thrive without oxygen) makes it powerfully effective against certain serious infections. For necrotizing fasciitis (flesh-eating disease) or gas gangrene, it can be part of a life-saving treatment approach.





The neurological benefits are among the most exciting and actively researched. By improving oxygen delivery to damaged brain tissue and stimulating neurogenesis (the creation of new brain cells), HBOT may help the brain recover from injuries once thought permanent. Recent research published in PLOS ONE suggests HBOT can improve cognitive function even years after the original brain injury occurred.





Enhanced immune function is another key benefit, with studies showing HBOT can improve the functioning of immune cells and increase their ability to fight infection.




Perhaps most importantly, HBOT often helps when other treatments have failed. For patients facing limited options, it can offer hope and tangible improvements in quality of life.



Risks and Side Effects of HBOT



While HBOT is generally safe when properly administered, it does carry some risks and potential side effects that patients should be aware of:




Ear and sinus barotrauma is the most common side effect, occurring when patients have difficulty equalizing pressure during compression or decompression. This can range from mild discomfort to serious injury to the eardrum in rare cases. Patients with colds, allergies, or sinus infections may need to postpone treatment.





Temporary nearsightedness (myopia) affects some patients due to changes in the eye's lens from oxygen exposure. This typically resolves within weeks after completing treatment.





Claustrophobia can be an issue, particularly in monoplace chambers. Mild sedatives may be prescribed for affected patients, or they might be better suited for multiplace chambers.





Oxygen toxicity is rare but possible with extended exposure to high oxygen levels. Symptoms can include dizziness, nausea, muscle twitching, vision changes, and in extreme cases, seizures. This risk is carefully managed by limiting session duration and using appropriate pressure levels.





Fire risk is a serious consideration due to the oxygen-rich environment. This is why strict protocols exist regarding what can be brought into chambers.





Decompression sickness can theoretically occur with certain treatment protocols, though this is extremely rare in medical HBOT settings.





Pulmonary barotrauma (lung damage) is a risk for patients with certain lung conditions like untreated pneumothorax (collapsed lung). This is why thorough medical screening is essential before beginning treatment.




Fortunately, serious complications are rare when proper screening is conducted and protocols are followed. The overall complication rate is estimated at less than 0.01% for serious adverse events, making HBOT safer than many medical procedures.



Cost and Insurance Coverage



The financial aspects of HBOT can be significant and vary widely depending on your condition and location. For FDA-approved indications, many insurance plans, Medicare, and Medicaid will cover treatment, though you may still have copays or deductibles.



Average costs per session range from $250 to $450 for hospital-based treatments, with a full course potentially costing $10,000 or more. Private clinics sometimes offer lower rates, typically $150-$300 per session.



For off-label conditions, insurance coverage is rare, meaning patients must often pay out-of-pocket. Some clinics offer package deals or financing options to make treatment more accessible.



When pursuing insurance coverage, proper documentation is crucial. Your provider will need to clearly demonstrate medical necessity and show that conventional treatments have been tried without success. Some patients find success with appeals if initially denied coverage.



It's worth noting that the long-term cost analysis may favor HBOT in some cases. For example, the cost of treating a diabetic foot ulcer with HBOT may be high, but it's typically much lower than the cost of amputation and subsequent rehabilitation.



Finding a Reputable HBOT Provider



If you're considering HBOT, finding a qualified provider is essential for both safety and efficacy. Here are key factors to consider:




Look for facilities accredited by the Undersea and Hyperbaric Medical Society (UHMS). This certification ensures the facility meets strict safety and practice standards.





The medical director and supervising physicians should be board-certified in Undersea and Hyperbaric Medicine or have extensive specialized training in the field.





For medical conditions, hospital-based programs generally provide the most comprehensive care, with emergency capabilities if needed. Independent clinics may be appropriate for less acute conditions.





Ask about the specific protocols they use for your condition. These should align with established guidelines from organizations like the UHMS.





Facilities should be transparent about success rates, potential side effects, and what to expect during treatment. Be wary of any provider making guarantees or claims that sound too good to be true.





Experienced technicians and support staff are vital for safe operation and monitoring during treatment.





Consider practical factors like location, scheduling flexibility, and amenities that might make multiple sessions more comfortable.





A reputable provider will coordinate with your other healthcare providers and should require a physician referral for treatment.




The Undersea and Hyperbaric Medical Society maintains a directory of accredited facilities on their website, providing a good starting point for your search.



HBOT vs. Other Oxygen Therapies



It's important to distinguish HBOT from other oxygen delivery methods, as they work quite differently:




Standard oxygen therapy delivers oxygen at normal atmospheric pressure through nasal cannulas or masks. While helpful for many conditions, it cannot achieve the high dissolved oxygen levels in plasma that HBOT provides.



Topical oxygen therapy applies oxygen directly to wounds but doesn't create systemic effects throughout the body.



Exercise with oxygen therapy (EWOT) involves breathing concentrated oxygen during exercise. While it may increase oxygen levels temporarily, it cannot match the pressure-driven dissolution effects of HBOT.



Ozone therapy uses a different form of oxygen (O₃ instead of O₂) and lacks the substantial clinical evidence supporting HBOT.




The key differentiator is pressure. Only HBOT combines elevated pressure with 100% oxygen to achieve supersaturation of bodily fluids with dissolved oxygen. This fundamental difference explains why HBOT can help in situations where other oxygen therapies might fall short.



However, HBOT isn't always the best choice. For chronic lung diseases like COPD, standard oxygen therapy is often more appropriate and safer. Each approach has its place in medical care, and they should be viewed as complementary rather than competing therapies.



Conclusion



Hyperbaric Oxygen Therapy represents a fascinating intersection of physics, physiology, and medicine. By harnessing the simple principle that pressure changes how our bodies absorb and use oxygen, HBOT offers unique healing possibilities for conditions ranging from diving emergencies to chronic wounds, from radiation injuries to brain trauma.



While not a miracle cure, HBOT has earned its place in modern medicine through decades of research and clinical experience. For approved indications, it's a well-established therapy with clear benefits and manageable risks. For emerging applications, it shows tremendous promise, though more research is needed to fully understand its potential and limitations.



If you're considering HBOT, approach it with informed optimism. Work with qualified medical providers, understand the evidence for your specific condition, and have realistic expectations about outcomes. For many patients, HBOT has provided healing when other approaches failed, but it works best as part of a comprehensive treatment plan rather than a standalone solution.



As research continues and technology improves, HBOT is likely to become an increasingly important tool in medicine's arsenal. The simple act of breathing oxygen under pressure continues to reveal new possibilities for healing body and brain.



Frequently Asked Questions




Is Hyperbaric Oxygen Therapy painful?
No, HBOT is not painful. Most patients find it comfortable, though you may experience fullness in your ears during pressure changes, similar to what you feel when flying in an airplane. Using equalization techniques like swallowing or yawning usually relieves this sensation. Some patients report feeling tired after sessions, but actual pain is rare and could indicate a problem that should be reported to your provider.




How many HBOT sessions will I need to see results?
The number of sessions varies significantly depending on your condition. Acute conditions like carbon monoxide poisoning may require only 1-3 treatments, while chronic conditions like diabetic foot ulcers typically need 20-40 sessions. Neurological conditions being treated off-label often require 40 or more sessions. Most patients begin noticing improvements after 5-10 sessions, though the full benefits may not be apparent until the complete protocol is finished.




Can children receive Hyperbaric Oxygen Therapy?
Yes, children can receive HBOT, and in some cases, they respond even better than adults due to their enhanced healing capabilities. Special considerations are made for pediatric patients, including adjusted pressure protocols and additional comfort measures. A parent or guardian is sometimes permitted to accompany young children in multiplace chambers. HBOT has been successfully used for various pediatric conditions, including near-drowning incidents, cerebral palsy, and certain cases of autism, though evidence for some applications remains preliminary.




Will my insurance cover Hyperbaric Oxygen Therapy?
Insurance coverage depends primarily on your condition. For FDA-approved indications like diabetic foot ulcers, decompression sickness, or radiation injuries, most insurance plans including Medicare will cover HBOT. For off-label uses, coverage is rare but occasionally possible with proper documentation showing medical necessity and failure of conventional treatments. Always check with both your insurance provider and the HBOT facility before beginning treatment to understand your financial responsibility.

### Hyperbaric Chamber Explosion Claims Life of 5-Year-Old Michigan Boy

A 5-year-old boy died in a hyperbaric chamber explosion at The Oxford Center in Troy, Michigan.



The child's mother sustained arm injuries during the incident.



Hyperbaric chambers deliver pure oxygen at high pressure, posing combustion risks.



The cause of the explosion remains under investigation by authorities.



The Oxford Center has temporarily closed and is cooperating with the investigation.




In a tragic event on the morning of January 31, 2025, a 5-year-old boy, Thomas Cooper, from Royal Oak, Michigan, lost his life following an explosion inside a hyperbaric oxygen chamber at The Oxford Center in Troy CBS news reports. 



The incident occurred shortly before 8 a.m., with emergency responders arriving promptly to find the young patient deceased within the chamber. 



His mother, who was present nearby during the treatment, suffered injuries to her arms. No other injuries were reported among the facility's staff or patients.



- The 5 year old boy who lost his life in the HBOT incident in Michigan, Thomas Cooper / Fieger Law



Understanding Hyperbaric Oxygen Therapy



Hyperbaric oxygen therapy (HBOT) involves breathing pure oxygen in a pressurized environment. This method increases the amount of oxygen the blood can carry, promoting healing and combating infections. 



Commonly, HBOT is used to treat conditions such as decompression sickness, serious infections, and wounds that may not heal due to diabetes or radiation injury. 



The therapy typically involves sessions where patients spend time inside a hyperbaric chamber, where air pressure is increased to two to three times higher than normal atmospheric pressure.



Potential Risks and Safety Concerns



While HBOT is generally considered safe when administered correctly, the use of pressurized pure oxygen introduces inherent risks. 



Hyperbaric chambers contain 100% oxygen, significantly higher than the 21% found in normal air. In a pressurized environment, this elevated oxygen concentration can become highly combustible. 



Troy Fire Department Lt. Keith Young emphasized, "The presence of such a high amount of oxygen in a pressurized environment can make it extremely combustible."



Historically, incidents involving hyperbaric chambers are rare but have occurred. According to this review article published in 1997 documented 77 fatalities in 35 different hyperbaric chamber fires between 1923 and 1996. 



These incidents underscore the importance of stringent safety protocols and regular maintenance of hyperbaric facilities.



Investigation and Facility Response



The exact cause of the explosion at The Oxford Center remains under investigation.



Authorities have not disclosed the specific condition for which the boy was receiving treatment. 



The Oxford Center, which has been providing hyperbaric oxygen therapy for over 15 years without prior incidents, expressed deep sorrow over the tragedy. 



In a statement, the center said, "The safety and wellbeing of the children we serve is our highest priority. Nothing like this has happened in our more than 15 years of providing this type of therapy. We do not know why or ... ."



The facility has temporarily closed its operations and is fully cooperating with local authorities to determine the cause of the explosion. Social workers from the Oakland Community Health Network are providing support to emergency personnel and medical staff affected by the incident.



Regulatory Oversight and Safety Measures



This incident has prompted discussions about the regulatory oversight of hyperbaric therapy facilities. In Michigan, certain medical facilities offering alternative treatments may not be subject to stringent state licensing or regulation. 



The U.S. Food and Drug Administration (FDA) has previously warned about potential risks associated with hyperbaric oxygen therapy, especially when conducted at unaccredited sites. 



The FDA states, "Explosions and fires have occurred in HBOT chambers... at unaccredited facilities," highlighting the dangers present in inadequately regulated health services.



Ensuring the safety of hyperbaric chambers involves strict adherence to protocols, including proper maintenance, use of non-flammable materials, and comprehensive staff training. 



Regular inspections and adherence to established safety guidelines are crucial to prevent such tragic incidents.



Community Impact and Moving Forward



The loss of such a young life has deeply affected the local community. As authorities continue their investigation, there is a collective call for increased awareness and stricter safety measures in medical treatments involving high-risk equipment. 



This tragedy serves as a somber reminder of the importance of rigorous safety standards and regulatory oversight in healthcare settings to protect patients and prevent future incidents.



RELATED VIDEO




https://www.youtube.com/watch?v=aUSrwGe4Q10


## Pages

### Affiliate Disclosure

HBOTResearch.org is a participant in affiliate marketing programs designed to provide a means for us to earn commissions by linking to products and services. This helps support the operation of our Website and allows us to provide valuable content to our readers at no cost to them.



How Affiliate Links Work



When you click on an affiliate link on our Website and make a purchase, we may earn a commission from the retailer or service provider at no additional cost to you. These commissions do not influence the content, reviews, or recommendations we provide.



Transparency



All affiliate links are clearly labeled to maintain transparency. Our goal is to recommend products or services that align with the informational and educational purpose of HBOTResearch.org.



Responsibility



Please note that we are not responsible for the products, services, or policies of affiliate sites. We encourage you to review the terms, conditions, and privacy policies of any third-party sites you visit through our links.



Integrity



The inclusion of affiliate links does not imply endorsement or a guarantee of the quality of the products or services linked. We are committed to providing honest and unbiased content, prioritizing the needs and interests of our readers.



If you have any questions about this disclosure, feel free to contact us at support@.

### Terms Of Service

Terms of Service for HBOTResearch.org



Acceptance of Terms



By accessing or using HBOTResearch.org (the "Website"), you agree to comply with and be bound by these Terms of Service ("Terms"). If you do not agree with these Terms, you must not use this Website.







Changes to Terms



We reserve the right to modify these Terms at any time. Changes will be communicated through a notification banner on the Website or via email to registered users, where applicable. Changes will be effective immediately upon posting on this page with an updated revision date. Continued use of the Website after any changes constitutes acceptance of the new Terms.







Use of the Website



Permitted Use



You may use this Website for lawful purposes only. By using the Website, you agree:




Not to violate any applicable local, state, national, or international laws, such as those prohibiting fraud, cybercrimes, or intellectual property infringement.



Not to interfere with or disrupt the operation of the Website.



Not to attempt to gain unauthorized access to any part of the Website.




Prohibited Conduct



You agree not to:




Use the Website for any fraudulent or deceptive purposes.



Use automated systems, bots, or other means to access the Website without authorization.



Upload, post, or transmit any malicious code, viruses, or harmful content.








Affiliate Marketing Disclosure



We participate in affiliate marketing programs to promote hyperbaric oxygen therapy (HBOT) chambers. Affiliate links on the Website are clearly labeled to ensure transparency for users. This means we may earn commissions when you click on affiliate links and make purchases. We are not responsible for the content, practices, or policies of affiliate websites. Please review their terms and conditions before engaging with their services.







Disclaimer of Warranties



The Website is provided "as is" and "as available," meaning it is offered without any guarantees about its functionality, accuracy, or reliability. This includes no promises that it will always work perfectly, meet your needs, or be free from issues. We do not guarantee that the Website will be:




Free of errors or interruptions.



Secure or free of viruses or harmful components.



Accurate, complete, or up-to-date.








Limitation of Liability



To the fullest extent permitted by law, HBOTResearch.org and its owners, affiliates, and contributors are not liable for:




Any direct, indirect, incidental, or consequential damages arising from the use or inability to use the Website.



Any loss or damage resulting from reliance on information provided on the Website.








Intellectual Property



All content on the Website, including text, graphics, logos, and software, is the property of HBOTResearch.org or its content providers and is protected by intellectual property laws. You may not reproduce, distribute, or create derivative works from the content without prior written consent.







Links to Third-Party Websites



The Website may contain links to third-party websites. These links are provided for convenience only. We are not responsible for the content or policies of third-party sites. Accessing these sites is at your own risk.







Governing Law



These Terms are governed by and construed in accordance with the laws of [Insert Your State or Country], without regard to its conflict of law principles. Any disputes arising from these Terms will be resolved in the courts of [Insert Your State or Country].







Termination



We reserve the right to suspend or terminate your access to the Website at any time, without notice, for conduct that violates these Terms or is otherwise harmful to the Website or other users.







Contact Us



For questions about these Terms, please contact us at:



HBOTResearch.orgEmail: support@



Effective Date: 27/12/2024

### Blog



### Reviews

HBOT Research





























































Testimonials



Read what our customers have to say about their experience with HBOT Research.






HBOT Research provided me with invaluable information about Hyperbaric Oxygen Therapy.



Sarah K.



Customer Title














Key Metrics



Impact Metrics



Explore the key metrics that showcase our commitment to providing valuable HBOT research information.





1000+



High-Quality Articles Published





500+



Research Findings Shared

### Our Mission

HBOT Research









Mission & Values



Learn more about our mission and values



Trusted online resource for HBOT information











Overline



Briefly and concisely explain what you do for your audience.



Use this paragraph section to get your website visitors to know you. Write about you or your organization, the products or services you offer, or why you exist. Keep a consistent communication style. Consider using this if you need to provide more context on why you do what you do. Be engaging. Focus on delivering value to your visitors.











Add a short title



Use this space to add a medium length description. Be brief and give enough information to earn their attention.





Add a short title



Use this space to add a medium length description. Be brief and give enough information to earn their attention.







Add a short title



Use this space to add a medium length description. Be brief and give enough information to earn their attention.





Add a short title



Use this space to add a medium length description. Be brief and give enough information to earn their attention.











Add a short title



Use this space to add a medium length description. Be brief and give enough information to earn their attention.







Key Metrics



Impact Metrics



Explore the key metrics that showcase our commitment to providing valuable HBOT research information.





1000+



High-Quality Articles Published





500+



Research Findings Shared













Discover what sets us apart from the rest





Expert Team



Our team brings years of expertise to ensure top-quality content



Learn More





Comprehensive Resources



Access a wealth of information on HBOT topics and research findings



Learn More





Unbiased Content



We prioritize factual content to empower informed decisions



Learn More

### Pricing

HBOT Research









Testimonials



Read what our customers have to say about their experience with HBOT Research.






HBOT Research provided me with invaluable information about Hyperbaric Oxygen Therapy.



Sarah K.



Customer Title














Pricing Plans



Choose from a variety of pricing options designed to provide value and flexibility for all users.





Standard Plan



$9.99​



Access to HBOT information



Limited research findings









Advanced Plan



$19.99​



Access to HBOT information



Limited research findings• Comprehensive HBOT resources• Comprehensive HBOT resources• Specialized HBOT insights



Basic articles









Expert Plan



$29.99



Specialized HBOT insights



Full access to research studies• Bespoke HBOT packages• Bespoke HBOT packages• Focus on the differences• Focus on the differences



Basic articles



Detailed articles and FAQs





























FAQ



Explore common inquiries about Hyperbaric Oxygen Therapy and our research findings.






What is Hyperbaric Oxygen Therapy (HBOT)?
Hyperbaric Oxygen Therapy involves breathing pure oxygen in a pressurized room or tube to treat various medical conditions.




How does HBOT work?
HBOT increases the amount of oxygen your blood can carry, promoting healing and fighting bacteria. It helps in tissue repair and growth.




Are there any risks associated with HBOT?
While generally safe, HBOT may have side effects such as ear barotrauma, oxygen toxicity, and temporary vision problems. It's essential to discuss any concerns with a healthcare provider.




What conditions can HBOT treat?
HBOT is used for various conditions like decompression sickness, non-healing wounds, carbon monoxide poisoning, and more. It's crucial to consult with healthcare professionals for personalized treatment plans.

### Contact

Contact Us











Reach out to us for inquiries, collaborations, or any questions.



First Name*Last Name*Email*CompanyMessage*Submit







Get in touch with the team at HBot Research - we're here to help. Whether you have questions about our research initiatives, potential collaborations, or general inquiries, we welcome your message. 



Fill out the form below or email us directly at [hbotresarch.org@gmail.com]. 



Our team typically responds within 1-2 business days.









Your Trusted Online Resource for Hyperbaric Oxygen Therapy Information





HBOT News



Stay updated with the latest breakthroughs in HBOT treatments, clinical outcomes, and industry developments.



Learn More





Research Articles



Access peer-reviewed studies, scientific publications, and research papers exploring the therapeutic benefits of hyperbaric oxygen treatment.



Learn More





Resources



Find treatment guidelines, patient information, provider directories, and educational materials about hyperbaric oxygen therapy protocols.



Learn More

### Services

HBOT Research











HBOT Research



Empowering individuals, families, and healthcare professionals with knowledge on HBOT.













100+ Reviews













Detailed Information on Hyperbaric Oxygen TherapyExplore a wealth of knowledge on HBOTLearn More





High-Quality Research ArticlesRead the latest findings and studiesLearn More





Frequently Asked QuestionsGet answers to common queriesLearn More





Accuracy and Reliability GuaranteedCount on us for trustworthy informationLearn More





Cutting-Edge Research FindingsStay informed with the newest discoveriesLearn More





Benefits of Hyperbaric Oxygen TherapyLearn about the advantages of HBOTLearn More








Hyperbaric Oxygen Therapy Information



Research Findings







High-Quality Articles



Frequently Asked Questions







Accuracy and Reliability



Expert Team












Our Achievements



Use this paragraph section to get your website visitors to know you. Write about you or your organization, the products or services you offer, or why you exist. Keep a consistent communication style. We are honored to be recognized for our dedication.Be engaging. Focus on delivering value to your visitors.





























How to Acquire Our Services



Browse through our high-quality articles, research findings, and FAQs to learn more about Hyperbaric Oxygen Therapy.






Step 1: Explore HBOT Information
Browse through our high-quality articles on Hyperbaric Oxygen Therapy (HBOT) to gain valuable insights and knowledge.




Step 2: Discover Research Findings
Delve into the latest research findings and studies related to HBOT to stay informed about the advancements in the field.




Step 3: Access FAQs
Find answers to frequently asked questions about HBOT to address common queries and concerns effectively.




Step 4: Verify Accuracy
Rely on our commitment to accuracy and reliability as we ensure all content is thoroughly reviewed and fact-checked.







Join Us Today



Empower yourself with accurate HBOT information.

### About

HBOT Research











ABOUT HBOT RESEARCH



About HBOTResearch.org



Welcome to HBOTResearch.org, your trusted global hub for everything related to Hyperbaric Oxygen Therapy (HBOT). 



HBOT has shown promising results in improving healing, reducing inflammation, and enhancing recovery for various conditions, making it a vital resource for patients and professionals alike. 



Our mission is simple: to provide reliable, accurate, and comprehensive information that highlights how HBOT can enhance healing, improve quality of life, and support overall health for individuals, healthcare professionals, and researchers alike. 



Whether you’re exploring the latest scientific advancements, comparing HBOT chambers, or searching for treatment options, we’re here to guide you every step of the way.



















Mission & Values



Learn more about our mission and values



We aim to empower our readers by providing:




Scientific Research Articles: Peer-reviewed studies and analyses on the benefits and applications of HBOT.



News Updates: The latest breakthroughs, innovations, and developments in HBOT technology.



Condition-Specific Information: Research-backed insights into how HBOT supports various medical conditions.



Shopping and Comparison Guides: Detailed reviews and comparisons of HBOT chambers and accessories to help you make confident purchasing decisions.








HBOT Research



Our goal is to provide trustworthy and relevant content for informed decisions about HBOT.







Why Choose HBOTResearch.org?



We understand the importance of accurate and accessible information when it comes to making decisions about health and wellness. Our commitment is to:








Equip you with the knowledge to make informed choices.



Stay on top of the latest HBOT developments.



Provide a user-friendly experience for exploring HBOT resources.



Personalized Insights: Our team goes beyond generic information  offering tailored guidance for both beginners and professionals.







We prioritize integrity and ensure that all information is fact-checked and research-based.



From news and research to product reviews and guides, we cover all aspects of HBOT in one place.



Our diverse team includes medical experts, researchers, and technical specialists with years of experience in HBOT.










Join Us Today



Whether you’re new to HBOT or a seasoned professional, we invite you to explore our website, dive into our resources, and connect with us. Let HBOTResearch.org be your trusted partner in understanding and leveraging the potential of hyperbaric oxygen therapy. Feel free to contact us with questions, feedback, or suggestions. Together, we can advance the understanding and accessibility of HBOT for everyone.

### Home

Your Trusted Online Resource for Hyperbaric Oxygen Therapy Information



Providing accurate, unbiased, and fact-checked content on HBOT.

















Partners



Working with trusted leaders in hyperbaric oxygen therapy industry.

















































HBOTResearch.org



Your Reliable Guide to Hyperbaric Oxygen Therapy Information



We aim to deliver accurate, research-based content to help you make confident decisions about HBOT.











HBOT NEWS



Stay updated with the latest HBOT news, breakthroughs, and developments worldwide.





LATEST RESEARCH



Explore peer-reviewed studies and scientific insights on hyperbaric oxygen therapy.







CONDITIONS



Discover how HBOT helps treat various conditions backed by credible research.





SHOPPING GUIDES



Compare and choose the best HBOT chambers, accessories, and related products.



















Latest Posts



Read what our customers have to say about their experience with HBOT Research.









Have questions or feedback about HBOT technology or chambers? Feel free to reach out to us!

### Privacy Policy

Privacy Policy for HBOTResearch.org



Introduction



Welcome to HBOTResearch.org (the "Website"). This Privacy Policy explains how we collect, use, and protect your information. By using this Website, you consent to the practices described in this policy.



We do not sell products, run ads, or share personal information for monetary gain. However, we participate in affiliate marketing programs to promote hyperbaric oxygen therapy (HBOT) chambers. Additionally, we use tools such as Google Analytics, Google Search Console, Bing Webmaster Tools, and Yandex Webmaster Tools to analyze website traffic and improve our services.







Information We Collect



Automatically Collected Data



When you visit our Website, we automatically collect certain information:




IP address



Browser type and version



Operating system



Pages visited and time spent on the Website



Referring website or search query




Cookies and Tracking Technologies



We use cookies and similar technologies to:




Monitor website performance



Understand user preferences



Improve user experience




You can manage your cookie preferences through your browser settings.



Affiliate Links



When you click on an affiliate link, the third-party affiliate may collect data to track purchases and provide commissions to us. Please review their privacy policies for more information.







State-Specific Privacy Rights



California Residents (CCPA and CPRA)



California residents have the following rights:




Right to Know: Request information about the categories and specific pieces of personal information we collect, use, or share.



Right to Delete: Request deletion of your personal information, subject to certain exceptions.



Right to Opt-Out: Opt out of the sale or sharing of personal information.



Right to Correct: Request correction of inaccurate personal information.



Right to Limit Use: Limit the use of sensitive personal information.




To exercise these rights, contact us at privacy@ with "California Privacy Rights" in the subject line.



Virginia Residents (VCDPA)



Virginia residents have these rights:




Access and Correction: Request access to and correction of your personal data.



Deletion: Request deletion of your personal data.



Opt-Out: Opt out of targeted advertising or data sharing for such purposes.




To exercise these rights, contact us at privacy@ with "Virginia Privacy Rights" in the subject line.



Colorado Residents (CPA)



Colorado residents have rights similar to those in California and Virginia:




Access and Deletion: Access and delete your personal data.



Correction: Request correction of inaccurate personal data.



Opt-Out: Opt out of the processing of personal data for targeted advertising.




Contact us at privacy@ with "Colorado Privacy Rights" in the subject line to make a request.



Connecticut Residents (CTDPA)



Connecticut residents have these rights:




Access, Deletion, and Correction: Access, delete, or correct your personal data.



Data Portability: Request a copy of your personal data.



Opt-Out: Opt out of data sharing for targeted advertising.




Submit requests to privacy@ with "Connecticut Privacy Rights" in the subject line.



Utah Residents (UCPA)



Utah residents have the following rights:




Access and Deletion: Access and delete personal data.



Opt-Out: Opt out of the sale of personal data.




To make a request, contact us at privacy@ with "Utah Privacy Rights" in the subject line.







Exercising Your Privacy Rights



To exercise your privacy rights, you may:




Email us at privacy@



Include your state of residence and a description of your request.




We will respond to verified requests within the legally required timeframe.







Do Not Sell/Share Requests



While we do not sell personal information for monetary gain, we acknowledge the "Do Not Sell or Share" rights under laws like the CCPA. You may submit a request to opt out of any potential sharing of personal information for targeted advertising purposes by emailing privacy@.







Security Measures



We take reasonable measures to protect your data from unauthorized access, loss, or misuse. However, no online system is entirely secure, and we cannot guarantee absolute security.







Updates to This Privacy Policy



We may update this Privacy Policy from time to time. Changes will be posted on this page with an updated revision date.







Contact Us



If you have questions or concerns about this Privacy Policy, please contact us at:



HBOTResearch.orgEmail: privacy@



Effective Date: 27/12/2024


## Media

### oxyrevo (1)
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/oxyrevo-1/
- **Alt Text**: Screenshot from Oxyrevo Website
- **Caption**: Screenshot from Oxyrevo Website

### aha-hyperbarics
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/aha-hyperbarics/
- **Alt Text**: Screenshot from AHA Hyperbarics Certificates page
- **Caption**: Screenshot from AHA Hyperbarics Certificates page

### oxygen-health-systems-phthalate-free (2)
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/oxygen-health-systems-phthalate-free-2/
- **Alt Text**: Screenshot from Oxygen Health Systems website
- **Caption**: Screenshot from Oxygen Health Systems website

### asking-hbot-manufacturer-safety-questions
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/asking-hbot-manufacturer-safety-questions/
- **Alt Text**: Consumer consulting with HBOT chamber manufacturer about material safety while holding a checklist with chamber visible in background
- **Caption**: Prepare specific questions about materials and certifications before purchasing.

### safe-hbot-chamber-materials-checklist
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_27pm/
- **Alt Text**: Checklist comparing unsafe HBOT chamber materials like PVC to safer alternatives like phthalate-free medical-grade TPU with certification icons
- **Caption**: Use this checklist to evaluate chamber materials before purchasing.

### hard-shell-vs-soft-shell-hbot-chamber-comparison
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_26pm/
- **Alt Text**: Side-by-side comparison of a steel hard shell hyperbaric chamber in a medical facility versus a flexible soft shell chamber for home use
- **Caption**: Hard shell and soft shell chambers differ significantly in construction materials and typical use settings.

### phthalate-exposure-health-effects-body-diagram
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_25pm/
- **Alt Text**: Human body diagram highlighting organ systems potentially affected by phthalate exposure including thyroid, reproductive organs, and brain
- **Caption**: Research suggests phthalates may affect multiple body systems as endocrine disruptors.

### hbot-chamber-off-gassing-process-diagram
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_22pm/
- **Alt Text**: Cross-section diagram showing how volatile organic compounds off-gas from soft HBOT chamber walls into the interior breathing space under pressure
- **Caption**: Increased pressure inside HBOT chambers may accelerate the release of VOCs from certain materials.

### common-products-containing-phthalates-infographic
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_15pm-1/
- **Alt Text**: Infographic showing common household products containing phthalates including vinyl flooring, shower curtains, food containers, and personal care items
- **Caption**: Phthalates appear in many everyday products, from flooring to personal care items.

### soft-sided-hyperbaric-oxygen-therapy-chamber-patient-safety
- **URL**: https://hbotresearch.org/phthalates-in-hbot-a-complete-guide-to-understanding-the-risks-and-choosing-a-safe-chamber/generated-image-november-26-2025-7_15pm/
- **Alt Text**: Person relaxing inside a modern soft-sided hyperbaric oxygen therapy chamber with clean medical-grade interior and soft blue lighting
- **Caption**: Modern soft-sided HBOT chambers vary widely in material quality and safety standards.

### molecules-human-oocyte
- **URL**: https://hbotresearch.org/hbot-boosts-oocyte-yield-in-poor-ovarian-responders/generated-image-november-26-2025-6_21pm/
- **Alt Text**: Digital illustration showing abstract, soft-glowing blue and white spheres, representing oxygen molecules, gently flow towards the center in a single, detailed human oocyte (egg cell).

### A_medical_illustration
- **URL**: https://hbotresearch.org/oxygen-therapy-cuts-inflammation-in-rare-brain-disease/a_medical_illustration_in_x-ray_radiographic_style-1762934908220/
- **Alt Text**: A medical illustration in X-ray radiographic style, displaying a transparent human head and spine silhouette with a glowing blue-white nervous system.
- **Caption**: A medical illustration in X-ray radiographic style, displaying a transparent human head and spine silhouette with a glowing blue-white nervous system. 

### hyperbaric_chamber_featured
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/hyperbaric_chamber_featured/
- **Alt Text**: Modern hyperbaric oxygen chamber for home use in a clean, bright room.
- **Caption**: Choosing the right hyperbaric oxygen chamber for your personal health and wellness needs.

### 40-inch-hard-chamber-black-Front_4
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/40-inch-hard-chamber-black-front_4/

### oxyflow-sitting
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/oxyflow-sitting/

### home-hbot-cost-of-ownership-infographic
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/home-hbot-cost-of-ownership-infographic/
- **Alt Text**: An infographic detailing the total cost of ownership for a home hyperbaric chamber, comparing soft-shell vs. hard-shell costs including purchase price, installation, and maintenance.
- **Caption**: A complete breakdown of the upfront and ongoing costs associated with owning a soft-shell versus a hard-shell hyperbaric chamber.

### reputable-hyperbaric-chamber-brand-checklist
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/design_a_clean_checklist-style_graphic_title_qu-1762767198374/
- **Alt Text**: A checklist graphic showing key indicators of a reputable hyperbaric chamber brand, including FDA clearance, warranty, and customer support.
- **Caption**: Look for these key indicators to ensure you are buying a safe and reliable chamber from a trustworthy manufacturer.

### user-experience-in-home-hyperbaric-chamber
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/create_a_high-quality_aspirational_lifestyle_phot-1762766533659/
- **Alt Text**: A person relaxing inside a home hyperbaric oxygen chamber while watching a movie on a tablet to show a comfortable user experience.
- **Caption**: Many users make their sessions productive or relaxing by reading, watching movies, or meditating inside the chamber.

### sitting-vs-lying-hyperbaric-chamber
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/design_a_simple_side-by-side_comparison_graphic_-1762766143839/
- **Alt Text**: A comparison of a lying vs. a sitting hyperbaric chamber, showing the user orientation and space requirements for each type.
- **Caption**: Choose an orientation based on your comfort and what you plan to do during sessions. Sitting chambers are ideal for working, while lying chambers are better for relaxation.

### home-hbot-system-setup-diagram
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/design_a_labeled_diagram_showing_the_complete_syst-1762765930475/
- **Alt Text**: A diagram of a complete home hyperbaric oxygen therapy system, including the inflatable chamber, air compressor, and oxygen concentrator.
- **Caption**: A typical soft-shell chamber setup includes the chamber itself, an air compressor to pressurize it, and an oxygen concentrator to supply oxygen via a mask.

### ata-pressure-hyperbaric-chamber-explained
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/ata-pressure-hyperbaric-chamber-explained/
- **Alt Text**: A diagram showing the difference in ATA pressure between a mild hyperbaric chamber (1.3 ATA) and a hard-shell chamber (2.0 ATA) compared to water depth.
- **Caption**: Atmospheres Absolute (ATA) measures pressure. Mild hyperbaric chambers provide pressure equivalent to being 10 feet underwater.

### Design_a_photorealistic_side-by-side_product_comp-1762764317385
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/design_a_photorealistic_side-by-side_product_comp-1762764317385/
- **Alt Text**: A side-by-side comparison of a soft-shell inflatable hyperbaric chamber and a hard-shell hyperbaric oxygen chamber for home use.
- **Caption**: The primary choice for a home hyperbaric chamber is between a flexible, soft-shell model (left) and a rigid, hard-shell model (right).

### how-hbot-works-diagram
- **URL**: https://hbotresearch.org/how-to-choose-a-hyperbaric-oxygen-chamber-for-home-use/design_a_clean_minimalist_infographic_diagram_co-1762763511593/
- **Alt Text**: A diagram explaining how hyperbaric oxygen therapy (HBOT) at home increases oxygen saturation in the blood plasma through pressure.
- **Caption**: Hyperbaric oxygen therapy increases the amount of oxygen your blood can carry, which can help promote healing and fight inflammation.

### central-retinal-artery-occlusion-hyperbaric oxygen-therapy-chamber
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-shows-promise-for-central-retinal-artery-occlusion-treatment-within-24-hours/central-retinal-artery-occlusion-hyperbaric-oxygen-therapy-chamber/
- **Alt Text**: Medical illustration showing central retinal artery occlusion in eye anatomy with hyperbaric oxygen therapy chamber treatment for vision restoration
- **Caption**: Hyperbaric oxygen therapy delivers concentrated oxygen to retinal tissue starved by central retinal artery blockage, offering new treatment options for sudden vision loss within 24 hours of symptom onset.

### hbot-combined-exosomes (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-combined-with-exosomes-shows-promise-for-tissue-repair/hbot-combined-exosomes-1/
- **Alt Text**: Medical illustration showing hyperbaric oxygen therapy combined with exosomes for tissue repair, featuring oxygen molecules, cellular regeneration, and therapeutic synergy in clinical visualization
- **Caption**: Combining hyperbaric oxygen therapy with exosomes shows synergistic effects in tissue repair, outperforming either treatment alone in animal studies.

### A_photorealistic_medical_digital_illustration_dep-1761727845100
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-device-market-set-to-reach-6-42-billion-by-2029/a_photorealistic_medical_digital_illustration_dep-1761727845100/

### A_photorealistic_medical_digital_painting_depicti-1761726286735
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-aids-recovery-in-rare-spinal-infection-case/a_photorealistic_medical_digital_painting_depicti-1761726286735/

### A_photorealistic_medical_digital_painting_depicti-1761724638471
- **URL**: https://hbotresearch.org/study-reveals-hbots-threshold-for-lasting-ptsd-relief-in-veterans/a_photorealistic_medical_digital_painting_depicti-1761724638471/
- **Alt Text**: Study Reveals HBOT's Threshold for Lasting PTSD Relief in Veterans
- **Caption**: Study Reveals HBOT's Threshold for Lasting PTSD Relief in Veterans

### retinal-artery-blockages
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-shows-promise-for-retinal-artery-blockages/retinal-artery-blockages/
- **Alt Text**: A medical illustration showing a man in an hbot chamber
- **Caption**: A medical illustration showing a man in an hbot chamber

### Medical_illustration_of_a_breast_cancer_survivor_i-1761721488120
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-helps-breast-cancer-survivor-heal-radiation-damage/medical_illustration_of_a_breast_cancer_survivor_i-1761721488120/
- **Alt Text**: Medical Illustration of a woman with breast cancer laying in a hyperbaric oxygen therapy chamber
- **Caption**: Medical Illustration of a woman with breast cancer laying in a hyperbaric oxygen therapy chamber

### hyperbaric_chamber_comparison_portrait
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/hyperbaric_chamber_comparison_portrait/
- **Alt Text**: Infographic comparing soft shell and hard shell hyperbaric chambers, detailing their advantages and limitations for home and medical use.
- **Caption**: Infographic comparing soft shell and hard shell hyperbaric chambers, detailing their advantages and limitations for home and medical use.

### summit_dive_vertical
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/summit_dive_vertical/
- **Alt Text**: Summit to Sea Dive Vertical Soft Shell Hyperbaric Oxygen Therapy Chamber
- **Caption**: Summit to Sea Dive Vertical Soft Shell Hyperbaric Oxygen Therapy Chamber

### oxyma_chamber
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/oxyma_chamber/
- **Alt Text**: OxyMa Soft Shell Hyperbaric Oxygen Therapy Chamber
- **Caption**: OxyMa Soft Shell Hyperbaric Oxygen Therapy Chamber

### summit_shallow_dive
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/summit_shallow_dive/
- **Alt Text**: Summit to Sea Shallow Dive Soft Shell Hyperbaric Oxygen Therapy Chamber
- **Caption**: Summit to Sea Shallow Dive Soft Shell Hyperbaric Oxygen Therapy Chamber

### oxy_air_40_inch
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/oxy_air_40_inch/
- **Alt Text**: OXY-AIR 40-Inch Soft Shell Hyperbaric Oxygen Therapy Chamber
- **Caption**: OXY-AIR 40-Inch Soft Shell Hyperbaric Oxygen Therapy Chamber

### lux_air_36_inch
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/lux_air_36_inch/
- **Alt Text**: LUX AIR 36-Inch Soft Shell Hyperbaric Oxygen Therapy Chamber
- **Caption**: LUX AIR 36-Inch Soft Shell Hyperbaric Oxygen Therapy Chamber

### korea-seoul-donation
- **URL**: https://hbotresearch.org/seoul-apartment-dwellers-raise-100-million-won-for-manager-needing-hbot-amid-leukemia-fight/untitled-design/
- **Alt Text**: The article's feature image showing Lee Tae-young, chairman of the residents' committee, second from left, and other residents of Apgujeong Hyundai Apartment are handing over a donation to Kim Mi-suk
- **Caption**: The article's feature image showing Lee Tae-young, chairman of the residents' committee, second from left, and other residents of Apgujeong Hyundai Apartment are handing over a donation to Kim Mi-suk

### hyperbaric_chamber_feature_image (1)
- **URL**: https://hbotresearch.org/best-soft-shell-hyperbaric-chambers/hyperbaric_chamber_feature_image-1/
- **Alt Text**: Soft shell hyperbaric chamber in a modern medical setting, 16:9 aspect ratio.
- **Caption**: A modern soft shell hyperbaric chamber designed for optimal medical treatment and patient comfort.

### news-p.v1
- **URL**: https://hbotresearch.org/seoul-apartment-dwellers-raise-100-million-won-for-manager-needing-hbot-amid-leukemia-fight/news-p-v1/
- **Alt Text**: Aerial photo of the Apgujeong Old Hyundai Apartment complex in Seoul, Korea.
- **Caption**: Aerial photo of the Apgujeong Old Hyundai Apartment complex in Seoul, Korea / Source: mk.co.kr

### Lee Tae-young to Kim Mi-suk
- **URL**: https://hbotresearch.org/seoul-apartment-dwellers-raise-100-million-won-for-manager-needing-hbot-amid-leukemia-fight/lee-tae-young-to-kim-mi-suk/
- **Alt Text**: Lee Tae-young, chairman of the residents' committee, second from left, and other residents of Apgujeong Hyundai Apartment are handing over a donation to Kim Mi-suk
- **Caption**: Lee Tae-young, chairman of the residents' committee, second from left, and other residents of Apgujeong Hyundai Apartment are handing over a donation to Kim Mi-suk / Source: Chosun

### resized_image
- **URL**: https://hbotresearch.org/arizona-therapist-dies-in-hyperbaric-chamber-fire/resized_image/
- **Alt Text**: Dr Walter Foxcroft, 43, was killed Wednesday after a flash fire broke out inside the hyperbaric chamber at his Havasu Health and Hyperbarics clinic just before 11pm
- **Caption**: Dr Walter Foxcroft, 43, was killed Wednesday after a flash fire broke out inside the hyperbaric chamber at his Havasu Health and Hyperbarics clinic just before 11pm

### carbon_monoxide_recovery_1200x700
- **URL**: https://hbotresearch.org/family-of-nine-survives-carbon-monoxide-poisoning-at-hadassah-hospital/carbon_monoxide_recovery_1200x700/
- **Alt Text**: A family of silhouettes walks from darkness into a bright hospital hallway, symbolizing recovery from carbon monoxide poisoning.
- **Caption**: Hope and healing: A family's journey from carbon monoxide poisoning to recovery at Hadassah Hospital.

### hyperbaric_oxygen_therapy_1200x700
- **URL**: https://hbotresearch.org/new-evidence-supports-hyperbaric-oxygen-for-radiation-enteritis/hyperbaric_oxygen_therapy_1200x700/
- **Alt Text**: New Evidence Supports Hyperbaric Oxygen for Radiation Enteritis.

### hbot_retina_cover_1200x700
- **URL**: https://hbotresearch.org/single-hbot-session-alters-healthy-retina-function/hbot_retina_cover_1200x700/
- **Alt Text**: Medical illustration of a retina, showing normal and HBOT-altered sections, sparking curiosity.
- **Caption**: Unveiling the retinal impact of a single HBOT session: A visual exploration.

### hyperbaric_insulin_resistance_final
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-linked-to-reduced-insulin-resistance/hyperbaric_insulin_resistance_final/
- **Alt Text**: Medical illustration of oxygen impacting glucose and insulin pathways.
- **Caption**: Hyperbaric oxygen's effect on insulin resistance at a cellular level.

### dcs_hyperbaric_therapy_final
- **URL**: https://hbotresearch.org/diver-fully-recovers-from-severe-dcs-via-hyperbaric-therapy/dcs_hyperbaric_therapy_final/
- **Alt Text**: Blueprint of diver in hyperbaric chamber for DCS recovery.
- **Caption**: Visualizing hyperbaric oxygen therapy for severe decompression sickness recovery.

### cost-comparison
- **URL**: https://hbotresearch.org/bryan-johnsons-90-day-hyperbaric-oxygen-experiment/cost-comparison/
- **Alt Text**: Cost comparison between at home usage of HBOT chamber Vs going to a clinic
- **Caption**: Cost comparison between at home usage of HBOT chamber Vs going to a clinic

### Bryan-Johnson
- **URL**: https://hbotresearch.org/bryan-johnsons-90-day-hyperbaric-oxygen-experiment/bryan-johnson/
- **Alt Text**: Bryan Johnson in HBOT chamber
- **Caption**: Bryan Johnson in HBOT chamber / Source: YouTube

### biomarkers
- **URL**: https://hbotresearch.org/bryan-johnsons-90-day-hyperbaric-oxygen-experiment/biomarkers/
- **Alt Text**: Bryan Johnshon's Before and After Biomarkers infographic
- **Caption**: Bryan Johnshon's Before and After Biomarkers infographic

### HBOT-infographic
- **URL**: https://hbotresearch.org/bryan-johnsons-90-day-hyperbaric-oxygen-experiment/hbot-infographic-2/
- **Alt Text**: Hyperbaric Oxygen Therapy Infographic

### Hbot-side-effects (1)
- **URL**: https://hbotresearch.org/side-effects-of-hyperbaric-oxygen-therapy/hbot-side-effects-1/
- **Alt Text**: A woman laying in a hyperbaric oxygen therapy chamber. The image writes "Byeond the hype".

### seedream-4-2k_Create_an_infographi (1) (1)
- **URL**: https://hbotresearch.org/side-effects-of-hyperbaric-oxygen-therapy/seedream-4-2k_create_an_infographi-1-1/
- **Alt Text**: Infographic 2: HBOT Safety Checklist: Are You Ready for Treatment?
- **Caption**: Infographic 2: "HBOT Safety Checklist: Are You Ready for Treatment?"

### barotrauma infographic (1)
- **URL**: https://hbotresearch.org/side-effects-of-hyperbaric-oxygen-therapy/barotrauma-infographic-1/
- **Alt Text**: Infographic 1: Understanding Ear Barotrauma: Why Your Ears Pop and How to Fix It
- **Caption**: Understanding Ear Barotrauma: Why Your Ears Pop and How to Fix It.

### elder man in hbot
- **URL**: https://hbotresearch.org/roanoke-rapids-patient-regains-mobility-after-hyperbaric-therapy/elder-man-in-hbot/
- **Alt Text**: Black elder man laying in an HBOT chamber
- **Caption**: Black elder man laying in an HBOT chamber

### image (2)
- **URL**: https://hbotresearch.org/the-price-of-hope-one-familys-gamble-on-experimental-cancer-treatment/image-2/
- **Alt Text**: Jamie Kavanagh

### an-ultra-realistic-hyperbaric-oxygen-therapy-chamb (1)
- **URL**: https://hbotresearch.org/michigans-hbot-explosion-how-a-5-year-olds-death-sparked-calls-for-new-rules/an-ultra-realistic-hyperbaric-oxygen-therapy-chamb-1/
- **Alt Text**: A hyperbaric oxygen therapy chamber in the spotlight, next to a window in a medical clinic.
- **Caption**: A hyperbaric oxygen therapy chamber in the spotlight, next to a window in a medical clinic.

### modern-hbot (1)
- **URL**: https://hbotresearch.org/senate-introduces-legislation-to-expand-veterans-access-to-hyperbaric-oxygen-therapy/modern-hbot-1/
- **Alt Text**: Modern hyperbaric oxygen chamber in medical facility with American flag, representing veteran care
- **Caption**: New legislation aims to expand veterans' access to life-changing hyperbaric oxygen therapy

### hbot-depression
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-for-depression/hbot-for-depression-1/
- **Alt Text**: Person meditating peacefully inside glowing hyperbaric oxygen chamber with healing blue light
- **Caption**: Inside a hyperbaric chamber: Where pressurized oxygen meets the promise of mental health healing

### Normal Breathing vs HBOT breathing
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-for-depression/normal-breathing-vs-hbot-breathing/
- **Alt Text**: Split-screen comparison image showing "Normal Breathing" vs "HBOT
- **Caption**: split-screen comparison image showing "Normal Breathing" vs "HBOT / HBOTResearch.org

### multiplace hyperbaric chamber (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/multiplace-hyperbaric-chamber-1/

### diabetic foot ulcer before and after image (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/diabetic-foot-ulcer-before-and-after-image-1/
- **Alt Text**: Before and after HBOT treatment images of a person with diabetic foot ulcers
- **Caption**: Before and after HBOT treatment images of a person with diabetic foot ulcers

### hbot_future (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hbot_future-1/
- **Alt Text**: Futuristic HBOT technology with innovation elements
- **Caption**: Futuristic HBOT technology with innovation elements

### hbot_wellness (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hbot_wellness-1/
- **Alt Text**: Person showing vitality and energy with scientific data overlays.
- **Caption**: Person showing vitality and energy with scientific data overlays.

### hbot_fda_approved
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hbot_fda_approved/
- **Alt Text**: A Medical professional with HBOT chamber and FDA approval symbol.
- **Caption**: Medical professional with HBOT chamber and FDA approval symbols.

### hbot_cellular_level
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hbot_cellular_level/
- **Alt Text**: Microscopic cellular view showing oxygen molecules penetrating cells
- **Caption**: Microscopic cellular view showing oxygen molecules penetrating cells

### hbot_patient_experience
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hbot_patient_experience/
- **Alt Text**: Comfortable patient inside modern hyperbaric chamber
- **Caption**: Comfortable patient inside modern hyperbaric chamber

### hyperbaric_oxygen_therapy (1)
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-benefits/hyperbaric_oxygen_therapy-1/
- **Alt Text**: Hyperbaric Oxygen Therapy Benefits

### ite-Boerema-operating-in-pure-oxygen (1)
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/te-boerema-operating-in-pure-oxygen-1/
- **Alt Text**: Ite Botema operating in a room with pure oxygen
- **Caption**: Ite Botema operating in a room with pure oxygen

### hbot
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/hbot-2/
- **Alt Text**: Apparatus for the Administration of Oxygen / Designed by Professor J. S Haldane
- **Caption**: Apparatus for the Administration of Oxygen / Designed by Professor J. S Haldane

### F5
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/f5/
- **Alt Text**: Fontaine’s mobile hyperbaric operation theater.
- **Caption**: Fontaine’s mobile hyperbaric operation theater / Source: 

### image (1)
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/image-1/

### antoine-lavoisier
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/antoine-lavoisier/
- **Alt Text**: Ai portrait of Antoine Lavoisier
- **Caption**: Ai portrait of Antoine Lavoisier

### image
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/image/
- **Alt Text**: Portrait of Joseph Priestley and his instrument focusing sunlight on a sample of mercuric oxide in an inverted glass container.

### Henshaws-Domicilium_ai
- **URL**: https://hbotresearch.org/history-of-hyperbaric-oxygen-therapy/henshaws-domicilium_ai/
- **Alt Text**: Henshaws Domicilium remastered by Ai
- **Caption**: Henshaws Domicilium remastered by Ai

### hbot-chamber-livingroom
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/hbot-chamber-livingroom/
- **Alt Text**: A Hyperbaric oxygen therapy chamber for home in a living room.
- **Caption**: A Hyperbaric oxygen therapy chamber for home in a living room.

### luxairright
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/luxairright_1702177079165/
- **Alt Text**: LUX-AIR 36 Inch Hyperbaric Oxygen Therapy chamber for home use from HyperbaricPRO.
- **Caption**: LUX-AIR 36 Inch Hyperbaric Oxygen Therapy chamber for home use from HyperbaricPRO.

### Summit-To-Sea-The-Dive
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/summit-to-sea-the-dive/
- **Alt Text**: Summit To Sea - The Dive

### Summit to sea the shallow dive
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/summit-to-sea-the-shallow-dive/

### OXYFLOW-mini8
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/oxyflow-mini8/
- **Alt Text**: Oxyflow Mini Sitting Hyperbaric Oxygen Therapy Chamber from Oxygen Health Systems.

### oxyair32frontrightside
- **URL**: https://hbotresearch.org/best-hyperbaric-chambers-for-home-use/oxyair32frontrightside/
- **Alt Text**: OxyAir 32-Inch Hyperbaric Oxygen Therapy Chamber from Oxygenhealthsystems.com
- **Caption**: OxyAir 32-Inch Hyperbaric Oxygen Therapy Chamber from Oxygenhealthsystems.com

### hyperbaric-oxygen-tumor
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-shows-dual-effect-in-glioblastoma-treatment/hyperbaric-oxygen-tumor/

### patient-hyperbaric-chamber-min
- **URL**: https://hbotresearch.org/long-term-benefits-of-hyperbaric-oxygen-for-radiation-induced-cystitis/patient-hyperbaric-chamber-min/
- **Alt Text**: A man is laying inside a hyperbaric oxygen therapy chamber while a nurse is watching.

### sd
- **URL**: https://hbotresearch.org/long-term-benefits-of-hyperbaric-oxygen-for-radiation-induced-cystitis/sd/

### what-is-hbot
- **URL**: https://hbotresearch.org/long-term-benefits-of-hyperbaric-oxygen-for-radiation-induced-cystitis/what-is-hyperbaric-oxygen-therapy-min/
- **Alt Text**: Infographic: What is hyperbaric oxygen therapy.
- **Caption**: Infographic: What is hyperbaric oxygen therapy.

### oxyflow-elite-hbot-chamber
- **URL**: https://hbotresearch.org/is-hyperbaric-oxygen-therapy-safe/oxyflow-elite-hbot-chamber/
- **Alt Text**: Elite Serene Max Sitting Hyperbaric Oxygen Chamber – 1.5 ATA
- **Caption**: Elite Serene Max Sitting Hyperbaric Oxygen Chamber – 1.5 ATA / Source: HyperbaricPRO

### a-hyperbaric-oxygen-therapy-chamber (1)
- **URL**: https://hbotresearch.org/is-hyperbaric-oxygen-therapy-safe/a-hyperbaric-oxygen-therapy-chamber-1/
- **Alt Text**: a large white hyperbaric oxygen therapy chamber in a medical room
- **Caption**: a large white hyperbaric oxygen therapy chamber in a medical room

### Picture1
- **URL**: https://hbotresearch.org/researchers-combine-extracellular-matrix-and-hyperbaric-oxygen-in-successful-foot-trauma-treatment/picture1/
- **Alt Text**: Foot Trauma
- **Caption**: Foot Trauma

### hbot-benefit-athletes
- **URL**: https://hbotresearch.org/phillies-introduce-hyperbaric-oxygen-therapy-program/hbot-benefit-athletes/
- **Alt Text**: HBOT Benefits for Athletes
- **Caption**: Infographic: Top 5 Benefits for Athletes / Source: HBOTResearch.org

### Nex-Gen-Mobile-Unit
- **URL**: https://hbotresearch.org/phillies-introduce-hyperbaric-oxygen-therapy-program/nex-gen-mobile-unit/
- **Alt Text**: a NexGen mobile HBOT unit parked in front of a stadium
- **Caption**: A NexGen mobile HBOT unit parked in front of a stadium

### woman-in-hbot
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-sessions-reduce-mortality-in-icu-patients/woman-in-hbot/
- **Alt Text**: A woman lying in a hyperbaric oxygen therapy chamber.
- **Caption**: A woman lying in a hyperbaric oxygen therapy chamber. / HBOTResearch.org

### what-is-HBOT
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-sessions-reduce-mortality-in-icu-patients/what-is-hbot/
- **Alt Text**: Infographic: What is HBOT
- **Caption**: Infographic: What is HBOT / HBOTResearch.org

### infographic-showing-how-brain-responds-t
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-treatment-teen-brain-injury/infographic-showing-how-brain-responds-t/
- **Alt Text**: a diagram of a human brain

### Jack Dolan
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-treatment-teen-brain-injury/jack-dolan-2/

### cape-greco
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-treatment-teen-brain-injury/cape-greco/

### Jack Dolan
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-treatment-teen-brain-injury/jack-dolan/
- **Alt Text**: A collage of Jack Dolan
- **Caption**: A collage of Jack Dolan. Source: Facebook

### an-illustration-showing-a-hyperbaric-oxygen-therap
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-devices-market-set-to-reach-6-3-billion-by-2035-growing-at-5-2-cagr/an-illustration-showing-a-hyperbaric-oxygen-therap/
- **Alt Text**: An illustration of a hyperbaric oxygen therapy chamber in front of a chart.

### HBOT-infographic
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-devices-market-set-to-reach-6-3-billion-by-2035-growing-at-5-2-cagr/hbot-infographic/
- **Alt Text**: Expected growth of HBOT in Various Markets
- **Caption**: Expected growth of HBOT in Various Markets / Source: HBOTResearch.org

### Michael_Jackson_s_hyperbaric_oxygen_chamber
- **URL**: https://hbotresearch.org/michael-jackson-hyperbaric-chamber/michael_jackson_s_hyperbaric_oxygen_chamber/

### michael-Jackson-hyperbaric-chamber
- **URL**: https://hbotresearch.org/michael-jackson-hyperbaric-chamber/michael-jackson-laying-inside-his-hyperbaric-oxygen-chamber/
- **Alt Text**: Michael Jackson laying inside his hyperbaric oxygen chamber
- **Caption**: Michael Jackson laying inside his hyperbaric oxygen chamber.

### create-a-visually-striking-image-depicting-a-seren
- **URL**: https://hbotresearch.org/hyperbaric-therapy-saves-patient-gas-embolism/create-a-visually-striking-image-depicting-a-seren/
- **Alt Text**: a person in a HBOT capsule

### a-veteran-with-ptsd-is-sitting-alone-in-his-room
- **URL**: https://hbotresearch.org/hyperbaric-oxygen-therapy-gains-ground-in-ptsd-treatment/a-veteran-with-ptsd-is-sitting-alone-in-his-room/
- **Alt Text**: A veteran with PTSD is sitting alone in his room
- **Caption**: A veteran with PTSD is sitting alone in his room

### a-smiling-woman-inside-a-hyperbaric-oxygen-therapy-chamber
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/a-smiling-woman-inside-a-hyperbaric-oxygen-therapy-chamber/
- **Alt Text**: A woman lying in a hyperbaric oxygen therapy chamber with a thumbs up

### 40-Inches-LuxAir
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/40-inches-luxair/
- **Alt Text**: LUX-AIR 40-Inch Hyperbaric Oxygen Soft Chamber | 1.3 ATA
- **Caption**: LUX-AIR 40-Inch Hyperbaric Oxygen Soft Chamber | 1.3 ATA

### Elite-Ultra-2_1-1
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/elite-ultra-2_1-1/
- **Alt Text**: Elite Ultra 2 | 36 inch 2 ATA Hard Chamber
- **Caption**: Elite Ultra 2 | 36 inch 2 ATA Hard Chamber by Hyperbaric PRO.

### cunning
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/cunning/
- **Alt Text**: The Cunningham Sanitarium
- **Caption**: Left: The Cunningham Sanitarium. Right: The five-story steel sphere of Cunningham Sanitarium. Source: Encyclopedia of Cleveland History & Cleveland Historical.

### HBOT Multiplace Chamber
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/hbot-multiplace-chamber/
- **Alt Text**: HBOT Multiplace Chamber by Oxygen Therapy Systems.

### a-hyperbaric-oxygen-therapy-chamber
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/a-hyperbaric-oxygen-therapy-chamber/
- **Alt Text**: A Hyperbaric Oxygen Therapy chamber in a medical facility
- **Caption**: A Hyperbaric Oxygen Therapy chamber in a medical facility

### Fontaines-mobile-hyperbaric-operation-theater (1)
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/fontaines-mobile-hyperbaric-operation-theater-1/
- **Alt Text**: Fontaine's mobile hyperbaric operation theater.
- **Caption**: Fontaine's mobile hyperbaric operation theater / Source: ResearchGate

### Henshaws-Domicilium
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/henshaws-domicilium-1/
- **Alt Text**: 1662: Henshaw's Domicilium.
- **Caption**: 1662: Henshaw's Domicilium / Source: ResearchGate


### William_Henry
- **URL**: https://hbotresearch.org/what-is-hyperbaric-oxygen-therapy/william_henry/
- **Alt Text**: Profile picture of William Henry

### Video Thumbnail: Boy, 5, killed when hyperbaric chamber explodes at facility in Troy
- **URL**: https://hbotresearch.org/hyperbaric-chamber-explosion-claims-life-of-5-year-old-michigan-boy/video-thumbnail-boy-5-killed-when-hyperbaric-chamber-explodes-at-facility-in-troy/

### Thomas-Cooper
- **URL**: https://hbotresearch.org/hyperbaric-chamber-explosion-claims-life-of-5-year-old-michigan-boy/thomas-cooper/
- **Alt Text**: The 5 year old boy who lost his life in the HBOT incident in Michigan.
- **Caption**: The 5 year old boy who lost his life in the HBOT incident in Michigan, Thomas Cooper / Fieger Law

### hbot
- **URL**: https://hbotresearch.org/contact/hbot/

### HBOT-10
- **URL**: https://hbotresearch.org/about/hbot-10-1/
- **Alt Text**: a woman lying on a hyperbaric oxygen therapy chamber

### HBOT5 (1)
- **URL**: https://hbotresearch.org/about/hbot5-1/
- **Alt Text**: a man and woman in hyperbaric oxygen therapy chamber

### a-person-sitting-inside-a-hyperbaric-oxygen-therap
- **URL**: https://hbotresearch.org/about/a-person-sitting-inside-a-hyperbaric-oxygen-therap/
- **Alt Text**: a man reading a book inside a multiplace hyperbaric oxygen therapy chamber

### HealBody
- **URL**: https://hbotresearch.org/home/healbody/

### hpfy-logo
- **URL**: https://hbotresearch.org/home/hpfy-logo/

### Oxygensystems
- **URL**: https://hbotresearch.org/home/oxygensystems/

### hyperbaric-pro-logo
- **URL**: https://hbotresearch.org/home/hyperbaric-pro-logo/

### hyperbaric-oxygen-therapy
- **URL**: https://hbotresearch.org/home/hyperbaric-oxygen-therapy/
- **Alt Text**: a Hyperbaric Oxygen Therapy Chamber with a bed

### Photo by Pew Nguyen
- **URL**: https://hbotresearch.org/photo-by-pew-nguyen/
- **Alt Text**: A fruit shake on a desk next to a laptop displaying a website, blending work and refreshment.

### Photo by Pixabay
- **URL**: https://hbotresearch.org/photo-by-pixabay/
- **Alt Text**: Scrabble tiles spelling 'SEO' on a wooden surface. Ideal for digital marketing themes.

### Photo by Tobias Dziuba
- **URL**: https://hbotresearch.org/photo-by-tobias-dziuba/
- **Alt Text**: Close-up of notebook with SEO terms and keywords, highlighting digital marketing strategy.

### Photo by Mikhail Nilov
- **URL**: https://hbotresearch.org/photo-by-mikhail-nilov/
- **Alt Text**: A cozy indoor workspace featuring a laptop, open book, notepad, and coffee, perfect for studying or remote work.

### Photo by Alexander Grey
- **URL**: https://hbotresearch.org/photo-by-alexander-grey/
- **Alt Text**: A tall stack of colorful hardcover books on a table indoors, perfect for library-themed concepts.

### Photo by cottonbro studio
- **URL**: https://hbotresearch.org/photo-by-cottonbro-studio-2/
- **Alt Text**: A clean, top view of books, a weekly planner, and a pencil on a neutral background.

### Example-Portrait-Image-scaled.jpg
- **URL**: https://hbotresearch.org/example-portrait-image-scaled-jpg/

### Photo by Miguel Á. Padriñán
- **URL**: https://hbotresearch.org/photo-by-miguel-a-padrinan/
- **Alt Text**: A serene view of thick, fluffy clouds set against a bright blue sky, perfect for backgrounds.

### Photo by eberhard grossgasteiger
- **URL**: https://hbotresearch.org/photo-by-eberhard-grossgasteiger/
- **Alt Text**: A vibrant and dreamy sky with pink and orange clouds during a sunset, showcasing nature's beauty.

### Photo by Zülal Sezici
- **URL**: https://hbotresearch.org/photo-by-zulal-sezici/
- **Alt Text**: A serene library corridor in İstanbul with book carts and shelves lined with books.

### Photo by Ceyzi
- **URL**: https://hbotresearch.org/photo-by-ceyzi/
- **Alt Text**: Overhead view of a workspace with keyboard, mouse, and a person planning in a notebook.

### Photo by Ivan Samkov
- **URL**: https://hbotresearch.org/photo-by-ivan-samkov/
- **Alt Text**: Young woman wearing polka dot headscarf, reflecting on her image in a modern bathroom mirror.

### logo-placeholder-4.png
- **URL**: https://hbotresearch.org/logo-placeholder-4-png/

### logo-placeholder-3.png
- **URL**: https://hbotresearch.org/logo-placeholder-3-png/

### logo-placeholder-2.png
- **URL**: https://hbotresearch.org/logo-placeholder-2-png/

### logo-placeholder.png
- **URL**: https://hbotresearch.org/logo-placeholder-png/

### Photo by Element5 Digital
- **URL**: https://hbotresearch.org/photo-by-element5-digital/
- **Alt Text**: Vibrant library scene featuring wooden bookshelves filled with various books.

### Photo by RDNE Stock project
- **URL**: https://hbotresearch.org/photo-by-rdne-stock-project-4/
- **Alt Text**: Organizational mind map and notebook with pencils, guiding effective business strategy.

### Photo by cottonbro studio
- **URL**: https://hbotresearch.org/photo-by-cottonbro-studio/
- **Alt Text**: Stylish woman in blue holding syringe, featuring a modern studio backdrop.

### Photo by RDNE Stock project
- **URL**: https://hbotresearch.org/photo-by-rdne-stock-project-3/
- **Alt Text**: Top view of a business plan document with a magnifying glass and colored pencils.

### Photo by Diva Plavalaguna
- **URL**: https://hbotresearch.org/photo-by-diva-plavalaguna/
- **Alt Text**: A person writing a website creation mindmap on a whiteboard during a business meeting.

### Photo by RDNE Stock project
- **URL**: https://hbotresearch.org/photo-by-rdne-stock-project-2/
- **Alt Text**: Stock photo of business charts, calculator, and eyeglasses on a desk.

### Photo by RDNE Stock project
- **URL**: https://hbotresearch.org/photo-by-rdne-stock-project/
- **Alt Text**: Top view of market research reports and calculator on a wooden desk, illustrating business analysis.